id	sid	tid	token	lemma	pos
cord-281487-x0a9qgjs	1	1	key	key	JJ
cord-281487-x0a9qgjs	1	2	:	:	:
cord-281487-x0a9qgjs	1	3	cord-281487-x0a9qgjs	cord-281487-x0a9qgjs	CD
cord-281487-x0a9qgjs	1	4	authors	author	NNS
cord-281487-x0a9qgjs	1	5	:	:	:
cord-281487-x0a9qgjs	1	6	Kim	Kim	NNP
cord-281487-x0a9qgjs	1	7	,	,	,
cord-281487-x0a9qgjs	1	8	Min	Min	NNP
cord-281487-x0a9qgjs	1	9	Young	Young	NNP
cord-281487-x0a9qgjs	1	10	;	;	:
cord-281487-x0a9qgjs	1	11	Brennan	Brennan	NNP
cord-281487-x0a9qgjs	1	12	,	,	,
cord-281487-x0a9qgjs	1	13	Daniel	Daniel	NNP
cord-281487-x0a9qgjs	1	14	C.	C.	NNP
cord-281487-x0a9qgjs	1	15	;	;	:
cord-281487-x0a9qgjs	1	16	Shah	Shah	NNP
cord-281487-x0a9qgjs	1	17	,	,	,
cord-281487-x0a9qgjs	1	18	Pali	Pali	NNP
cord-281487-x0a9qgjs	1	19	title	title	NN
cord-281487-x0a9qgjs	1	20	:	:	:
cord-281487-x0a9qgjs	1	21	General	General	NNP
cord-281487-x0a9qgjs	1	22	Approach	Approach	NNP
cord-281487-x0a9qgjs	1	23	to	to	IN
cord-281487-x0a9qgjs	1	24	the	the	DT
cord-281487-x0a9qgjs	1	25	Clinical	Clinical	NNP
cord-281487-x0a9qgjs	1	26	Care	Care	NNP
cord-281487-x0a9qgjs	1	27	of	of	IN
cord-281487-x0a9qgjs	1	28	Solid	Solid	NNP
cord-281487-x0a9qgjs	1	29	Organ	Organ	NNP
cord-281487-x0a9qgjs	1	30	Transplant	Transplant	NNP
cord-281487-x0a9qgjs	1	31	Recipients	recipient	NNS
cord-281487-x0a9qgjs	1	32	with	with	IN
cord-281487-x0a9qgjs	2	1	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	2	2	Infection	Infection	NNP
cord-281487-x0a9qgjs	2	3	:	:	:
cord-281487-x0a9qgjs	2	4	Management	management	NN
cord-281487-x0a9qgjs	2	5	for	for	IN
cord-281487-x0a9qgjs	2	6	Transplant	Transplant	NNP
cord-281487-x0a9qgjs	2	7	Recipients	Recipients	NNP
cord-281487-x0a9qgjs	2	8	date	date	NN
cord-281487-x0a9qgjs	2	9	:	:	:
cord-281487-x0a9qgjs	2	10	2020	2020	CD
cord-281487-x0a9qgjs	2	11	-	-	SYM
cord-281487-x0a9qgjs	2	12	10	10	CD
cord-281487-x0a9qgjs	2	13	-	-	SYM
cord-281487-x0a9qgjs	2	14	29	29	CD
cord-281487-x0a9qgjs	2	15	journal	journal	NN
cord-281487-x0a9qgjs	2	16	:	:	:
cord-281487-x0a9qgjs	2	17	Curr	Curr	NNP
cord-281487-x0a9qgjs	2	18	Transplant	Transplant	NNP
cord-281487-x0a9qgjs	2	19	Rep	Rep	NNP
cord-281487-x0a9qgjs	2	20	DOI	DOI	NNP
cord-281487-x0a9qgjs	2	21	:	:	:
cord-281487-x0a9qgjs	2	22	10.1007	10.1007	CD
cord-281487-x0a9qgjs	3	1	/s40472	/s40472	NNP
cord-281487-x0a9qgjs	3	2	-	-	:
cord-281487-x0a9qgjs	3	3	020	020	CD
cord-281487-x0a9qgjs	4	1	-00305-y	-00305-y	RB
cord-281487-x0a9qgjs	5	1	sha	sha	NNP
cord-281487-x0a9qgjs	5	2	:	:	:
cord-281487-x0a9qgjs	6	1	378db8927c28cc6b2e15a709c85d771eddee2fbe	378db8927c28cc6b2e15a709c85d771eddee2fbe	NNP
cord-281487-x0a9qgjs	6	2	doc_id	doc_id	CD
cord-281487-x0a9qgjs	6	3	:	:	:
cord-281487-x0a9qgjs	6	4	281487	281487	CD
cord-281487-x0a9qgjs	6	5	cord_uid	cord_uid	NNS
cord-281487-x0a9qgjs	6	6	:	:	:
cord-281487-x0a9qgjs	6	7	x0a9qgjs	x0a9qgjs	LS
cord-281487-x0a9qgjs	6	8	PURPOSE	purpose	NN
cord-281487-x0a9qgjs	6	9	OF	of	IN
cord-281487-x0a9qgjs	6	10	REVIEW	review	NN
cord-281487-x0a9qgjs	6	11	:	:	:
cord-281487-x0a9qgjs	7	1	Insufficient	insufficient	JJ
cord-281487-x0a9qgjs	7	2	knowledge	knowledge	NN
cord-281487-x0a9qgjs	7	3	about	about	IN
cord-281487-x0a9qgjs	7	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	7	5	and	and	CC
cord-281487-x0a9qgjs	7	6	the	the	DT
cord-281487-x0a9qgjs	7	7	potential	potential	JJ
cord-281487-x0a9qgjs	7	8	risks	risk	NNS
cord-281487-x0a9qgjs	7	9	of	of	IN
cord-281487-x0a9qgjs	7	10	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	7	11	are	be	VBP
cord-281487-x0a9qgjs	7	12	limiting	limit	VBG
cord-281487-x0a9qgjs	7	13	organ	organ	NN
cord-281487-x0a9qgjs	7	14	transplantation	transplantation	NN
cord-281487-x0a9qgjs	7	15	in	in	IN
cord-281487-x0a9qgjs	7	16	wait	wait	NN
cord-281487-x0a9qgjs	7	17	-	-	HYPH
cord-281487-x0a9qgjs	7	18	listed	list	VBN
cord-281487-x0a9qgjs	7	19	candidates	candidate	NNS
cord-281487-x0a9qgjs	7	20	and	and	CC
cord-281487-x0a9qgjs	7	21	deferring	defer	VBG
cord-281487-x0a9qgjs	7	22	essential	essential	JJ
cord-281487-x0a9qgjs	7	23	health	health	NN
cord-281487-x0a9qgjs	7	24	care	care	NN
cord-281487-x0a9qgjs	7	25	in	in	IN
cord-281487-x0a9qgjs	7	26	solid	solid	JJ
cord-281487-x0a9qgjs	7	27	organ	organ	NN
cord-281487-x0a9qgjs	7	28	transplant	transplant	NN
cord-281487-x0a9qgjs	7	29	recipients	recipient	NNS
cord-281487-x0a9qgjs	7	30	.	.	.
cord-281487-x0a9qgjs	8	1	In	in	IN
cord-281487-x0a9qgjs	8	2	this	this	DT
cord-281487-x0a9qgjs	8	3	review	review	NN
cord-281487-x0a9qgjs	8	4	,	,	,
cord-281487-x0a9qgjs	8	5	we	-PRON-	PRP
cord-281487-x0a9qgjs	8	6	expand	expand	VBP
cord-281487-x0a9qgjs	8	7	the	the	DT
cord-281487-x0a9qgjs	8	8	understanding	understanding	NN
cord-281487-x0a9qgjs	8	9	and	and	CC
cord-281487-x0a9qgjs	8	10	present	present	VB
cord-281487-x0a9qgjs	8	11	an	an	DT
cord-281487-x0a9qgjs	8	12	overview	overview	NN
cord-281487-x0a9qgjs	8	13	of	of	IN
cord-281487-x0a9qgjs	8	14	the	the	DT
cord-281487-x0a9qgjs	8	15	optimized	optimize	VBN
cord-281487-x0a9qgjs	8	16	management	management	NN
cord-281487-x0a9qgjs	8	17	of	of	IN
cord-281487-x0a9qgjs	8	18	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	8	19	in	in	IN
cord-281487-x0a9qgjs	8	20	solid	solid	JJ
cord-281487-x0a9qgjs	8	21	organ	organ	NN
cord-281487-x0a9qgjs	8	22	transplant	transplant	NN
cord-281487-x0a9qgjs	8	23	recipients	recipient	NNS
cord-281487-x0a9qgjs	8	24	.	.	.
cord-281487-x0a9qgjs	9	1	RECENT	recent	JJ
cord-281487-x0a9qgjs	9	2	FINDINGS	finding	NNS
cord-281487-x0a9qgjs	9	3	:	:	:
cord-281487-x0a9qgjs	10	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	10	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	10	3	are	be	VBP
cord-281487-x0a9qgjs	10	4	at	at	IN
cord-281487-x0a9qgjs	10	5	an	an	DT
cord-281487-x0a9qgjs	10	6	increased	increase	VBN
cord-281487-x0a9qgjs	10	7	risk	risk	NN
cord-281487-x0a9qgjs	10	8	of	of	IN
cord-281487-x0a9qgjs	10	9	severe	severe	JJ
cord-281487-x0a9qgjs	10	10	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	10	11	.	.	.
cord-281487-x0a9qgjs	11	1	The	the	DT
cord-281487-x0a9qgjs	11	2	unique	unique	JJ
cord-281487-x0a9qgjs	11	3	characteristics	characteristic	NNS
cord-281487-x0a9qgjs	11	4	of	of	IN
cord-281487-x0a9qgjs	11	5	transplant	transplant	NN
cord-281487-x0a9qgjs	11	6	recipients	recipient	NNS
cord-281487-x0a9qgjs	11	7	can	can	MD
cord-281487-x0a9qgjs	11	8	make	make	VB
cord-281487-x0a9qgjs	11	9	it	-PRON-	PRP
cord-281487-x0a9qgjs	11	10	more	more	RBR
cord-281487-x0a9qgjs	11	11	difficult	difficult	JJ
cord-281487-x0a9qgjs	11	12	to	to	TO
cord-281487-x0a9qgjs	11	13	identify	identify	VB
cord-281487-x0a9qgjs	11	14	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	11	15	.	.	.
cord-281487-x0a9qgjs	12	1	Based	base	VBN
cord-281487-x0a9qgjs	12	2	on	on	IN
cord-281487-x0a9qgjs	12	3	the	the	DT
cord-281487-x0a9qgjs	12	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	12	5	data	datum	NNS
cord-281487-x0a9qgjs	12	6	to	to	IN
cord-281487-x0a9qgjs	12	7	date	date	NN
cord-281487-x0a9qgjs	12	8	and	and	CC
cord-281487-x0a9qgjs	12	9	our	-PRON-	PRP$
cord-281487-x0a9qgjs	12	10	experience	experience	NN
cord-281487-x0a9qgjs	12	11	,	,	,
cord-281487-x0a9qgjs	12	12	we	-PRON-	PRP
cord-281487-x0a9qgjs	12	13	present	present	VBP
cord-281487-x0a9qgjs	12	14	testing	testing	NN
cord-281487-x0a9qgjs	12	15	,	,	,
cord-281487-x0a9qgjs	12	16	management	management	NN
cord-281487-x0a9qgjs	12	17	,	,	,
cord-281487-x0a9qgjs	12	18	and	and	CC
cord-281487-x0a9qgjs	12	19	prevention	prevention	NN
cord-281487-x0a9qgjs	12	20	methods	method	NNS
cord-281487-x0a9qgjs	12	21	for	for	IN
cord-281487-x0a9qgjs	12	22	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	12	23	.	.	.
cord-281487-x0a9qgjs	13	1	Comprehensive	comprehensive	JJ
cord-281487-x0a9qgjs	13	2	diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	13	3	tests	test	NNS
cord-281487-x0a9qgjs	13	4	should	should	MD
cord-281487-x0a9qgjs	13	5	be	be	VB
cord-281487-x0a9qgjs	13	6	performed	perform	VBN
cord-281487-x0a9qgjs	13	7	to	to	TO
cord-281487-x0a9qgjs	13	8	determine	determine	VB
cord-281487-x0a9qgjs	13	9	disease	disease	NN
cord-281487-x0a9qgjs	13	10	severity	severity	NN
cord-281487-x0a9qgjs	13	11	,	,	,
cord-281487-x0a9qgjs	13	12	phase	phase	NN
cord-281487-x0a9qgjs	13	13	of	of	IN
cord-281487-x0a9qgjs	13	14	illness	illness	NN
cord-281487-x0a9qgjs	13	15	,	,	,
cord-281487-x0a9qgjs	13	16	and	and	CC
cord-281487-x0a9qgjs	13	17	identify	identify	VB
cord-281487-x0a9qgjs	13	18	other	other	JJ
cord-281487-x0a9qgjs	13	19	comorbidities	comorbiditie	NNS
cord-281487-x0a9qgjs	13	20	in	in	IN
cord-281487-x0a9qgjs	13	21	transplant	transplant	NN
cord-281487-x0a9qgjs	13	22	recipients	recipient	NNS
cord-281487-x0a9qgjs	13	23	diagnosed	diagnose	VBN
cord-281487-x0a9qgjs	13	24	with	with	IN
cord-281487-x0a9qgjs	13	25	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	13	26	.	.	.
cord-281487-x0a9qgjs	14	1	Outpatients	outpatient	NNS
cord-281487-x0a9qgjs	14	2	should	should	MD
cord-281487-x0a9qgjs	14	3	receive	receive	VB
cord-281487-x0a9qgjs	14	4	education	education	NN
cord-281487-x0a9qgjs	14	5	for	for	IN
cord-281487-x0a9qgjs	14	6	preventative	preventative	JJ
cord-281487-x0a9qgjs	14	7	measures	measure	NNS
cord-281487-x0a9qgjs	14	8	and	and	CC
cord-281487-x0a9qgjs	14	9	optimal	optimal	JJ
cord-281487-x0a9qgjs	14	10	health	health	NN
cord-281487-x0a9qgjs	14	11	care	care	NN
cord-281487-x0a9qgjs	14	12	delivery	delivery	NN
cord-281487-x0a9qgjs	14	13	minimizing	minimize	VBG
cord-281487-x0a9qgjs	14	14	potential	potential	JJ
cord-281487-x0a9qgjs	14	15	infectious	infectious	JJ
cord-281487-x0a9qgjs	14	16	exposures	exposure	NNS
cord-281487-x0a9qgjs	14	17	.	.	.
cord-281487-x0a9qgjs	15	1	Multidisciplinary	multidisciplinary	JJ
cord-281487-x0a9qgjs	15	2	interventions	intervention	NNS
cord-281487-x0a9qgjs	15	3	should	should	MD
cord-281487-x0a9qgjs	15	4	be	be	VB
cord-281487-x0a9qgjs	15	5	provided	provide	VBN
cord-281487-x0a9qgjs	15	6	to	to	IN
cord-281487-x0a9qgjs	15	7	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	15	8	transplant	transplant	NN
cord-281487-x0a9qgjs	15	9	recipients	recipient	NNS
cord-281487-x0a9qgjs	15	10	for	for	IN
cord-281487-x0a9qgjs	15	11	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	15	12	because	because	IN
cord-281487-x0a9qgjs	15	13	of	of	IN
cord-281487-x0a9qgjs	15	14	the	the	DT
cord-281487-x0a9qgjs	15	15	complexity	complexity	NN
cord-281487-x0a9qgjs	15	16	of	of	IN
cord-281487-x0a9qgjs	15	17	caring	care	VBG
cord-281487-x0a9qgjs	15	18	for	for	IN
cord-281487-x0a9qgjs	15	19	transplant	transplant	NN
cord-281487-x0a9qgjs	15	20	recipients	recipient	NNS
cord-281487-x0a9qgjs	15	21	.	.	.
cord-281487-x0a9qgjs	16	1	SUMMARY	summary	NN
cord-281487-x0a9qgjs	16	2	:	:	:
cord-281487-x0a9qgjs	17	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	17	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	17	3	should	should	MD
cord-281487-x0a9qgjs	17	4	strictly	strictly	RB
cord-281487-x0a9qgjs	17	5	adhere	adhere	VB
cord-281487-x0a9qgjs	17	6	to	to	IN
cord-281487-x0a9qgjs	17	7	infection	infection	NN
cord-281487-x0a9qgjs	17	8	prevention	prevention	NN
cord-281487-x0a9qgjs	17	9	measures	measure	NNS
cord-281487-x0a9qgjs	17	10	.	.	.
cord-281487-x0a9qgjs	18	1	Understanding	understanding	NN
cord-281487-x0a9qgjs	18	2	of	of	IN
cord-281487-x0a9qgjs	18	3	the	the	DT
cord-281487-x0a9qgjs	18	4	transplant	transplant	NN
cord-281487-x0a9qgjs	18	5	specific	specific	JJ
cord-281487-x0a9qgjs	18	6	pathophysiology	pathophysiology	NN
cord-281487-x0a9qgjs	18	7	and	and	CC
cord-281487-x0a9qgjs	18	8	development	development	NN
cord-281487-x0a9qgjs	18	9	of	of	IN
cord-281487-x0a9qgjs	18	10	effective	effective	JJ
cord-281487-x0a9qgjs	18	11	treatment	treatment	NN
cord-281487-x0a9qgjs	18	12	strategies	strategy	NNS
cord-281487-x0a9qgjs	18	13	for	for	IN
cord-281487-x0a9qgjs	18	14	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	18	15	should	should	MD
cord-281487-x0a9qgjs	18	16	be	be	VB
cord-281487-x0a9qgjs	18	17	prioritized	prioritize	VBN
cord-281487-x0a9qgjs	18	18	.	.	.
cord-281487-x0a9qgjs	19	1	The	the	DT
cord-281487-x0a9qgjs	19	2	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	19	3	disease	disease	NN
cord-281487-x0a9qgjs	19	4	2019	2019	CD
cord-281487-x0a9qgjs	20	1	(	(	-LRB-
cord-281487-x0a9qgjs	20	2	COVID-	covid-	NN
cord-281487-x0a9qgjs	20	3	19	19	CD
cord-281487-x0a9qgjs	20	4	)	)	-RRB-
cord-281487-x0a9qgjs	20	5	pandemic	pandemic	NN
cord-281487-x0a9qgjs	20	6	has	have	VBZ
cord-281487-x0a9qgjs	20	7	led	lead	VBN
cord-281487-x0a9qgjs	20	8	to	to	IN
cord-281487-x0a9qgjs	20	9	unique	unique	JJ
cord-281487-x0a9qgjs	20	10	challenges	challenge	NNS
cord-281487-x0a9qgjs	20	11	in	in	IN
cord-281487-x0a9qgjs	20	12	solid	solid	JJ
cord-281487-x0a9qgjs	20	13	organ	organ	NN
cord-281487-x0a9qgjs	20	14	transplantation	transplantation	NN
cord-281487-x0a9qgjs	20	15	as	as	IN
cord-281487-x0a9qgjs	20	16	centers	center	NNS
cord-281487-x0a9qgjs	20	17	balance	balance	VBP
cord-281487-x0a9qgjs	20	18	the	the	DT
cord-281487-x0a9qgjs	20	19	risk	risk	NN
cord-281487-x0a9qgjs	20	20	of	of	IN
cord-281487-x0a9qgjs	20	21	caring	care	VBG
cord-281487-x0a9qgjs	20	22	for	for	IN
cord-281487-x0a9qgjs	20	23	immunosuppressed	immunosuppressed	JJ
cord-281487-x0a9qgjs	20	24	patients	patient	NNS
cord-281487-x0a9qgjs	20	25	with	with	IN
cord-281487-x0a9qgjs	20	26	the	the	DT
cord-281487-x0a9qgjs	20	27	best	good	JJS
cord-281487-x0a9qgjs	20	28	timing	timing	NN
cord-281487-x0a9qgjs	20	29	and	and	CC
cord-281487-x0a9qgjs	20	30	urgency	urgency	NN
cord-281487-x0a9qgjs	20	31	of	of	IN
cord-281487-x0a9qgjs	20	32	transplantation	transplantation	NN
cord-281487-x0a9qgjs	20	33	.	.	.
cord-281487-x0a9qgjs	21	1	Insufficient	insufficient	JJ
cord-281487-x0a9qgjs	21	2	knowledge	knowledge	NN
cord-281487-x0a9qgjs	21	3	about	about	IN
cord-281487-x0a9qgjs	21	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	21	5	and	and	CC
cord-281487-x0a9qgjs	21	6	the	the	DT
cord-281487-x0a9qgjs	21	7	potential	potential	JJ
cord-281487-x0a9qgjs	21	8	risks	risk	NNS
cord-281487-x0a9qgjs	21	9	of	of	IN
cord-281487-x0a9qgjs	21	10	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	21	11	for	for	IN
cord-281487-x0a9qgjs	21	12	transplant	transplant	NN
cord-281487-x0a9qgjs	21	13	donors	donor	NNS
cord-281487-x0a9qgjs	21	14	and	and	CC
cord-281487-x0a9qgjs	21	15	recipients	recipient	NNS
cord-281487-x0a9qgjs	21	16	are	be	VBP
cord-281487-x0a9qgjs	21	17	limiting	limit	VBG
cord-281487-x0a9qgjs	21	18	organ	organ	NN
cord-281487-x0a9qgjs	21	19	transplantation	transplantation	NN
cord-281487-x0a9qgjs	21	20	as	as	RB
cord-281487-x0a9qgjs	21	21	well	well	RB
cord-281487-x0a9qgjs	21	22	as	as	IN
cord-281487-x0a9qgjs	21	23	research	research	NN
cord-281487-x0a9qgjs	21	24	in	in	IN
cord-281487-x0a9qgjs	21	25	transplantation	transplantation	NN
cord-281487-x0a9qgjs	21	26	[	[	-LRB-
cord-281487-x0a9qgjs	21	27	1	1	CD
cord-281487-x0a9qgjs	21	28	]	]	-RRB-
cord-281487-x0a9qgjs	21	29	[	[	-LRB-
cord-281487-x0a9qgjs	21	30	2	2	CD
cord-281487-x0a9qgjs	21	31	]	]	-RRB-
cord-281487-x0a9qgjs	21	32	[	[	-LRB-
cord-281487-x0a9qgjs	21	33	3	3	CD
cord-281487-x0a9qgjs	21	34	]	]	-RRB-
cord-281487-x0a9qgjs	21	35	.	.	.
cord-281487-x0a9qgjs	22	1	However	however	RB
cord-281487-x0a9qgjs	22	2	,	,	,
cord-281487-x0a9qgjs	22	3	transplantation	transplantation	NN
cord-281487-x0a9qgjs	22	4	is	be	VBZ
cord-281487-x0a9qgjs	22	5	essential	essential	JJ
cord-281487-x0a9qgjs	22	6	for	for	IN
cord-281487-x0a9qgjs	22	7	lifesaving	lifesave	VBG
cord-281487-x0a9qgjs	22	8	transplants	transplant	NNS
cord-281487-x0a9qgjs	22	9	of	of	IN
cord-281487-x0a9qgjs	22	10	heart	heart	NN
cord-281487-x0a9qgjs	22	11	,	,	,
cord-281487-x0a9qgjs	22	12	lung	lung	NN
cord-281487-x0a9qgjs	22	13	,	,	,
cord-281487-x0a9qgjs	22	14	or	or	CC
cord-281487-x0a9qgjs	22	15	liver	liver	NN
cord-281487-x0a9qgjs	22	16	and	and	CC
cord-281487-x0a9qgjs	22	17	for	for	IN
cord-281487-x0a9qgjs	22	18	deceased	deceased	JJ
cord-281487-x0a9qgjs	22	19	donor	donor	NN
cord-281487-x0a9qgjs	22	20	kidney	kidney	NN
cord-281487-x0a9qgjs	22	21	transplantations	transplantation	NNS
cord-281487-x0a9qgjs	22	22	(	(	-LRB-
cord-281487-x0a9qgjs	22	23	KT	KT	NNP
cord-281487-x0a9qgjs	22	24	)	)	-RRB-
cord-281487-x0a9qgjs	22	25	in	in	IN
cord-281487-x0a9qgjs	22	26	candidates	candidate	NNS
cord-281487-x0a9qgjs	22	27	with	with	IN
cord-281487-x0a9qgjs	22	28	a	a	DT
cord-281487-x0a9qgjs	22	29	lack	lack	NN
cord-281487-x0a9qgjs	22	30	of	of	IN
cord-281487-x0a9qgjs	22	31	dialysis	dialysis	NN
cord-281487-x0a9qgjs	22	32	access	access	NN
cord-281487-x0a9qgjs	22	33	or	or	CC
cord-281487-x0a9qgjs	22	34	who	who	WP
cord-281487-x0a9qgjs	22	35	are	be	VBP
cord-281487-x0a9qgjs	22	36	highly	highly	RB
cord-281487-x0a9qgjs	22	37	sensitized	sensitize	VBN
cord-281487-x0a9qgjs	22	38	[	[	-LRB-
cord-281487-x0a9qgjs	22	39	4	4	CD
cord-281487-x0a9qgjs	22	40	]	]	-RRB-
cord-281487-x0a9qgjs	22	41	.	.	.
cord-281487-x0a9qgjs	23	1	To	to	TO
cord-281487-x0a9qgjs	23	2	assist	assist	VB
cord-281487-x0a9qgjs	23	3	in	in	IN
cord-281487-x0a9qgjs	23	4	the	the	DT
cord-281487-x0a9qgjs	23	5	timing	timing	NN
cord-281487-x0a9qgjs	23	6	of	of	IN
cord-281487-x0a9qgjs	23	7	transplantation	transplantation	NN
cord-281487-x0a9qgjs	23	8	during	during	IN
cord-281487-x0a9qgjs	23	9	the	the	DT
cord-281487-x0a9qgjs	23	10	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	23	11	pandemic	pandemic	NN
cord-281487-x0a9qgjs	23	12	,	,	,
cord-281487-x0a9qgjs	23	13	Massie	Massie	NNP
cord-281487-x0a9qgjs	23	14	et	et	NNP
cord-281487-x0a9qgjs	23	15	al	al	NNP
cord-281487-x0a9qgjs	23	16	.	.	NNP
cord-281487-x0a9qgjs	23	17	developed	develop	VBD
cord-281487-x0a9qgjs	23	18	a	a	DT
cord-281487-x0a9qgjs	23	19	model	model	NN
cord-281487-x0a9qgjs	23	20	for	for	IN
cord-281487-x0a9qgjs	23	21	mortality	mortality	NN
cord-281487-x0a9qgjs	23	22	of	of	IN
cord-281487-x0a9qgjs	23	23	wait	wait	NN
cord-281487-x0a9qgjs	23	24	-	-	HYPH
cord-281487-x0a9qgjs	23	25	listed	list	VBN
cord-281487-x0a9qgjs	23	26	patients	patient	NNS
cord-281487-x0a9qgjs	23	27	and	and	CC
cord-281487-x0a9qgjs	23	28	transplant	transplant	NN
cord-281487-x0a9qgjs	23	29	recipients	recipient	NNS
cord-281487-x0a9qgjs	23	30	in	in	IN
cord-281487-x0a9qgjs	23	31	relation	relation	NN
cord-281487-x0a9qgjs	23	32	to	to	IN
cord-281487-x0a9qgjs	23	33	COVID-19	covid-19	VB
cord-281487-x0a9qgjs	23	34	[	[	-LRB-
cord-281487-x0a9qgjs	23	35	5	5	CD
cord-281487-x0a9qgjs	23	36	]	]	-RRB-
cord-281487-x0a9qgjs	23	37	.	.	.
cord-281487-x0a9qgjs	24	1	Kidney	kidney	NN
cord-281487-x0a9qgjs	24	2	transplantation	transplantation	NN
cord-281487-x0a9qgjs	24	3	(	(	-LRB-
cord-281487-x0a9qgjs	24	4	KT	KT	NNP
cord-281487-x0a9qgjs	24	5	)	)	-RRB-
cord-281487-x0a9qgjs	24	6	reliably	reliably	RB
cord-281487-x0a9qgjs	24	7	provides	provide	VBZ
cord-281487-x0a9qgjs	24	8	survival	survival	NN
cord-281487-x0a9qgjs	24	9	benefit	benefit	NN
cord-281487-x0a9qgjs	24	10	unless	unless	IN
cord-281487-x0a9qgjs	24	11	mortality	mortality	NN
cord-281487-x0a9qgjs	24	12	risk	risk	NN
cord-281487-x0a9qgjs	24	13	for	for	IN
cord-281487-x0a9qgjs	24	14	KT	KT	NNP
cord-281487-x0a9qgjs	24	15	recipients	recipient	NNS
cord-281487-x0a9qgjs	24	16	exposed	expose	VBN
cord-281487-x0a9qgjs	24	17	to	to	IN
cord-281487-x0a9qgjs	24	18	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	24	19	is	be	VBZ
cord-281487-x0a9qgjs	24	20	50	50	CD
cord-281487-x0a9qgjs	24	21	%	%	NN
cord-281487-x0a9qgjs	24	22	or	or	CC
cord-281487-x0a9qgjs	24	23	higher	high	JJR
cord-281487-x0a9qgjs	24	24	and	and	CC
cord-281487-x0a9qgjs	24	25	community	community	NN
cord-281487-x0a9qgjs	24	26	risk	risk	NN
cord-281487-x0a9qgjs	24	27	of	of	IN
cord-281487-x0a9qgjs	24	28	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	24	29	acquisition	acquisition	NN
cord-281487-x0a9qgjs	24	30	is	be	VBZ
cord-281487-x0a9qgjs	24	31	50	50	CD
cord-281487-x0a9qgjs	24	32	%	%	NN
cord-281487-x0a9qgjs	24	33	or	or	CC
cord-281487-x0a9qgjs	24	34	more	more	JJR
cord-281487-x0a9qgjs	24	35	per	per	IN
cord-281487-x0a9qgjs	24	36	month	month	NN
cord-281487-x0a9qgjs	24	37	over	over	IN
cord-281487-x0a9qgjs	24	38	the	the	DT
cord-281487-x0a9qgjs	24	39	first	first	JJ
cord-281487-x0a9qgjs	24	40	6	6	CD
cord-281487-x0a9qgjs	24	41	months	month	NNS
cord-281487-x0a9qgjs	24	42	[	[	-LRB-
cord-281487-x0a9qgjs	24	43	5	5	CD
cord-281487-x0a9qgjs	24	44	]	]	-RRB-
cord-281487-x0a9qgjs	24	45	.	.	.
cord-281487-x0a9qgjs	25	1	To	to	IN
cord-281487-x0a9qgjs	25	2	date	date	NN
cord-281487-x0a9qgjs	25	3	,	,	,
cord-281487-x0a9qgjs	25	4	the	the	DT
cord-281487-x0a9qgjs	25	5	mortality	mortality	NN
cord-281487-x0a9qgjs	25	6	of	of	IN
cord-281487-x0a9qgjs	25	7	KT	KT	NNP
cord-281487-x0a9qgjs	25	8	recipients	recipient	NNS
cord-281487-x0a9qgjs	25	9	with	with	IN
cord-281487-x0a9qgjs	25	10	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	25	11	is	be	VBZ
cord-281487-x0a9qgjs	25	12	much	much	RB
cord-281487-x0a9qgjs	25	13	less	less	JJR
cord-281487-x0a9qgjs	25	14	than	than	IN
cord-281487-x0a9qgjs	25	15	50	50	CD
cord-281487-x0a9qgjs	25	16	%	%	NN
cord-281487-x0a9qgjs	25	17	(	(	-LRB-
cord-281487-x0a9qgjs	25	18	Table	table	NN
cord-281487-x0a9qgjs	25	19	2	2	CD
cord-281487-x0a9qgjs	25	20	)	)	-RRB-
cord-281487-x0a9qgjs	25	21	.	.	.
cord-281487-x0a9qgjs	26	1	However	however	RB
cord-281487-x0a9qgjs	26	2	,	,	,
cord-281487-x0a9qgjs	26	3	this	this	DT
cord-281487-x0a9qgjs	26	4	model	model	NN
cord-281487-x0a9qgjs	26	5	does	do	VBZ
cord-281487-x0a9qgjs	26	6	not	not	RB
cord-281487-x0a9qgjs	26	7	account	account	VB
cord-281487-x0a9qgjs	26	8	for	for	IN
cord-281487-x0a9qgjs	26	9	the	the	DT
cord-281487-x0a9qgjs	26	10	risk	risk	NN
cord-281487-x0a9qgjs	26	11	of	of	IN
cord-281487-x0a9qgjs	26	12	living	live	VBG
cord-281487-x0a9qgjs	26	13	kidney	kidney	NN
cord-281487-x0a9qgjs	26	14	donors	donor	NNS
cord-281487-x0a9qgjs	26	15	,	,	,
cord-281487-x0a9qgjs	26	16	and	and	CC
cord-281487-x0a9qgjs	26	17	this	this	DT
cord-281487-x0a9qgjs	26	18	should	should	MD
cord-281487-x0a9qgjs	26	19	be	be	VB
cord-281487-x0a9qgjs	26	20	considered	consider	VBN
cord-281487-x0a9qgjs	26	21	in	in	IN
cord-281487-x0a9qgjs	26	22	transplant	transplant	NN
cord-281487-x0a9qgjs	26	23	decision	decision	NN
cord-281487-x0a9qgjs	26	24	-	-	HYPH
cord-281487-x0a9qgjs	26	25	making	making	NN
cord-281487-x0a9qgjs	26	26	.	.	.
cord-281487-x0a9qgjs	27	1	Candidates	candidate	NNS
cord-281487-x0a9qgjs	27	2	and	and	CC
cord-281487-x0a9qgjs	27	3	families	family	NNS
cord-281487-x0a9qgjs	27	4	should	should	MD
cord-281487-x0a9qgjs	27	5	be	be	VB
cord-281487-x0a9qgjs	27	6	educated	educate	VBN
cord-281487-x0a9qgjs	27	7	about	about	IN
cord-281487-x0a9qgjs	27	8	increased	increase	VBN
cord-281487-x0a9qgjs	27	9	risks	risk	NNS
cord-281487-x0a9qgjs	27	10	,	,	,
cord-281487-x0a9qgjs	27	11	and	and	CC
cord-281487-x0a9qgjs	27	12	transplant	transplant	NN
cord-281487-x0a9qgjs	27	13	teams	team	NNS
cord-281487-x0a9qgjs	27	14	should	should	MD
cord-281487-x0a9qgjs	27	15	ensure	ensure	VB
cord-281487-x0a9qgjs	27	16	that	that	IN
cord-281487-x0a9qgjs	27	17	households	household	NNS
cord-281487-x0a9qgjs	27	18	are	be	VBP
cord-281487-x0a9qgjs	27	19	willing	willing	JJ
cord-281487-x0a9qgjs	27	20	to	to	TO
cord-281487-x0a9qgjs	27	21	adhere	adhere	VB
cord-281487-x0a9qgjs	27	22	to	to	IN
cord-281487-x0a9qgjs	27	23	the	the	DT
cord-281487-x0a9qgjs	27	24	mitigation	mitigation	NN
cord-281487-x0a9qgjs	27	25	precautions	precaution	NNS
cord-281487-x0a9qgjs	27	26	that	that	WDT
cord-281487-x0a9qgjs	27	27	may	may	MD
cord-281487-x0a9qgjs	27	28	be	be	VB
cord-281487-x0a9qgjs	27	29	more	more	RBR
cord-281487-x0a9qgjs	27	30	stringent	stringent	JJ
cord-281487-x0a9qgjs	27	31	than	than	IN
cord-281487-x0a9qgjs	27	32	local	local	JJ
cord-281487-x0a9qgjs	27	33	official	official	JJ
cord-281487-x0a9qgjs	27	34	guidance	guidance	NN
cord-281487-x0a9qgjs	27	35	.	.	.
cord-281487-x0a9qgjs	28	1	Transplantation	transplantation	NN
cord-281487-x0a9qgjs	28	2	centers	center	NNS
cord-281487-x0a9qgjs	28	3	have	have	VBP
cord-281487-x0a9qgjs	28	4	rapidly	rapidly	RB
cord-281487-x0a9qgjs	28	5	adopted	adopt	VBN
cord-281487-x0a9qgjs	28	6	management	management	NN
cord-281487-x0a9qgjs	28	7	practices	practice	NNS
cord-281487-x0a9qgjs	28	8	that	that	WDT
cord-281487-x0a9qgjs	28	9	will	will	MD
cord-281487-x0a9qgjs	28	10	continue	continue	VB
cord-281487-x0a9qgjs	28	11	to	to	TO
cord-281487-x0a9qgjs	28	12	evolve	evolve	VB
cord-281487-x0a9qgjs	28	13	as	as	IN
cord-281487-x0a9qgjs	28	14	knowledge	knowledge	NN
cord-281487-x0a9qgjs	28	15	for	for	IN
cord-281487-x0a9qgjs	28	16	severe	severe	JJ
cord-281487-x0a9qgjs	28	17	acute	acute	JJ
cord-281487-x0a9qgjs	28	18	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	28	19	syndrome	syndrome	NN
cord-281487-x0a9qgjs	28	20	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	28	21	2	2	CD
cord-281487-x0a9qgjs	29	1	(	(	-LRB-
cord-281487-x0a9qgjs	29	2	SARS	SARS	NNP
cord-281487-x0a9qgjs	29	3	-	-	HYPH
cord-281487-x0a9qgjs	29	4	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	29	5	)	)	-RRB-
cord-281487-x0a9qgjs	29	6	expands	expand	VBZ
cord-281487-x0a9qgjs	29	7	[	[	-LRB-
cord-281487-x0a9qgjs	29	8	1	1	CD
cord-281487-x0a9qgjs	29	9	,	,	,
cord-281487-x0a9qgjs	29	10	2	2	CD
cord-281487-x0a9qgjs	29	11	]	]	-RRB-
cord-281487-x0a9qgjs	29	12	.	.	.
cord-281487-x0a9qgjs	30	1	This	this	DT
cord-281487-x0a9qgjs	30	2	review	review	NN
cord-281487-x0a9qgjs	30	3	article	article	NN
cord-281487-x0a9qgjs	30	4	will	will	MD
cord-281487-x0a9qgjs	30	5	provide	provide	VB
cord-281487-x0a9qgjs	30	6	an	an	DT
cord-281487-x0a9qgjs	30	7	overview	overview	NN
cord-281487-x0a9qgjs	30	8	of	of	IN
cord-281487-x0a9qgjs	30	9	our	-PRON-	PRP$
cord-281487-x0a9qgjs	30	10	current	current	JJ
cord-281487-x0a9qgjs	30	11	understanding	understanding	NN
cord-281487-x0a9qgjs	30	12	of	of	IN
cord-281487-x0a9qgjs	30	13	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	30	14	as	as	IN
cord-281487-x0a9qgjs	30	15	a	a	DT
cord-281487-x0a9qgjs	30	16	basis	basis	NN
cord-281487-x0a9qgjs	30	17	for	for	IN
cord-281487-x0a9qgjs	30	18	optimizing	optimize	VBG
cord-281487-x0a9qgjs	30	19	the	the	DT
cord-281487-x0a9qgjs	30	20	care	care	NN
cord-281487-x0a9qgjs	30	21	of	of	IN
cord-281487-x0a9qgjs	30	22	this	this	DT
cord-281487-x0a9qgjs	30	23	vulnerable	vulnerable	JJ
cord-281487-x0a9qgjs	30	24	population	population	NN
cord-281487-x0a9qgjs	30	25	.	.	.
cord-281487-x0a9qgjs	31	1	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	31	2	is	be	VBZ
cord-281487-x0a9qgjs	31	3	an	an	DT
cord-281487-x0a9qgjs	31	4	infectious	infectious	JJ
cord-281487-x0a9qgjs	31	5	viral	viral	JJ
cord-281487-x0a9qgjs	31	6	disease	disease	NN
cord-281487-x0a9qgjs	31	7	caused	cause	VBN
cord-281487-x0a9qgjs	31	8	by	by	IN
cord-281487-x0a9qgjs	31	9	SARS	SARS	NNP
cord-281487-x0a9qgjs	31	10	-	-	HYPH
cord-281487-x0a9qgjs	31	11	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	31	12	[	[	-LRB-
cord-281487-x0a9qgjs	31	13	6	6	CD
cord-281487-x0a9qgjs	31	14	]	]	-RRB-
cord-281487-x0a9qgjs	31	15	.	.	.
cord-281487-x0a9qgjs	32	1	SARS	SARS	NNP
cord-281487-x0a9qgjs	32	2	-	-	HYPH
cord-281487-x0a9qgjs	32	3	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	32	4	spike	spike	NN
cord-281487-x0a9qgjs	32	5	proteins	protein	NNS
cord-281487-x0a9qgjs	32	6	bind	bind	VBP
cord-281487-x0a9qgjs	32	7	to	to	IN
cord-281487-x0a9qgjs	32	8	the	the	DT
cord-281487-x0a9qgjs	32	9	angiotensinconverting	angiotensinconverting	NN
cord-281487-x0a9qgjs	32	10	enzyme	enzyme	NN
cord-281487-x0a9qgjs	32	11	2	2	CD
cord-281487-x0a9qgjs	32	12	(	(	-LRB-
cord-281487-x0a9qgjs	32	13	ACE2	ACE2	NNP
cord-281487-x0a9qgjs	32	14	)	)	-RRB-
cord-281487-x0a9qgjs	32	15	,	,	,
cord-281487-x0a9qgjs	32	16	which	which	WDT
cord-281487-x0a9qgjs	32	17	is	be	VBZ
cord-281487-x0a9qgjs	32	18	located	locate	VBN
cord-281487-x0a9qgjs	32	19	on	on	IN
cord-281487-x0a9qgjs	32	20	the	the	DT
cord-281487-x0a9qgjs	32	21	surface	surface	NN
cord-281487-x0a9qgjs	32	22	of	of	IN
cord-281487-x0a9qgjs	32	23	many	many	JJ
cord-281487-x0a9qgjs	32	24	cell	cell	NN
cord-281487-x0a9qgjs	32	25	types	type	NNS
cord-281487-x0a9qgjs	32	26	including	include	VBG
cord-281487-x0a9qgjs	32	27	heart	heart	NN
cord-281487-x0a9qgjs	32	28	,	,	,
cord-281487-x0a9qgjs	32	29	lung	lung	NN
cord-281487-x0a9qgjs	32	30	,	,	,
cord-281487-x0a9qgjs	32	31	kidney	kidney	NN
cord-281487-x0a9qgjs	32	32	,	,	,
cord-281487-x0a9qgjs	32	33	liver	liver	NN
cord-281487-x0a9qgjs	32	34	,	,	,
cord-281487-x0a9qgjs	32	35	gastrointestinal	gastrointestinal	JJ
cord-281487-x0a9qgjs	32	36	tract	tract	NN
cord-281487-x0a9qgjs	32	37	and	and	CC
cord-281487-x0a9qgjs	32	38	triggers	trigger	VBZ
cord-281487-x0a9qgjs	32	39	internalization	internalization	NN
cord-281487-x0a9qgjs	32	40	of	of	IN
cord-281487-x0a9qgjs	32	41	the	the	DT
cord-281487-x0a9qgjs	32	42	virus	virus	NN
cord-281487-x0a9qgjs	32	43	[	[	-LRB-
cord-281487-x0a9qgjs	32	44	6	6	CD
cord-281487-x0a9qgjs	32	45	]	]	-RRB-
cord-281487-x0a9qgjs	32	46	.	.	.
cord-281487-x0a9qgjs	33	1	The	the	DT
cord-281487-x0a9qgjs	33	2	targeting	targeting	NN
cord-281487-x0a9qgjs	33	3	of	of	IN
cord-281487-x0a9qgjs	33	4	ACE2	ACE2	NNP
cord-281487-x0a9qgjs	33	5	by	by	IN
cord-281487-x0a9qgjs	33	6	SARS	SARS	NNP
cord-281487-x0a9qgjs	33	7	-	-	HYPH
cord-281487-x0a9qgjs	33	8	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	33	9	leads	lead	VBZ
cord-281487-x0a9qgjs	33	10	to	to	IN
cord-281487-x0a9qgjs	33	11	reduced	reduce	VBN
cord-281487-x0a9qgjs	33	12	ACE2	ACE2	NNP
cord-281487-x0a9qgjs	33	13	level	level	NN
cord-281487-x0a9qgjs	33	14	and	and	CC
cord-281487-x0a9qgjs	33	15	increased	increase	VBN
cord-281487-x0a9qgjs	33	16	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	33	17	II	ii	CD
cord-281487-x0a9qgjs	33	18	levels	level	NNS
cord-281487-x0a9qgjs	33	19	[	[	-LRB-
cord-281487-x0a9qgjs	33	20	7	7	CD
cord-281487-x0a9qgjs	33	21	]	]	-RRB-
cord-281487-x0a9qgjs	33	22	.	.	.
cord-281487-x0a9qgjs	34	1	Subsequently	subsequently	RB
cord-281487-x0a9qgjs	34	2	,	,	,
cord-281487-x0a9qgjs	34	3	this	this	DT
cord-281487-x0a9qgjs	34	4	process	process	NN
cord-281487-x0a9qgjs	34	5	can	can	MD
cord-281487-x0a9qgjs	34	6	activate	activate	VB
cord-281487-x0a9qgjs	34	7	the	the	DT
cord-281487-x0a9qgjs	34	8	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	34	9	II	II	NNP
cord-281487-x0a9qgjs	34	10	pathway	pathway	NN
cord-281487-x0a9qgjs	34	11	,	,	,
cord-281487-x0a9qgjs	34	12	cause	cause	VB
cord-281487-x0a9qgjs	34	13	dysregulation	dysregulation	NN
cord-281487-x0a9qgjs	34	14	of	of	IN
cord-281487-x0a9qgjs	34	15	complement	complement	NN
cord-281487-x0a9qgjs	34	16	,	,	,
cord-281487-x0a9qgjs	34	17	hypercoagulation	hypercoagulation	NN
cord-281487-x0a9qgjs	34	18	,	,	,
cord-281487-x0a9qgjs	34	19	hypoxia	hypoxia	NN
cord-281487-x0a9qgjs	34	20	,	,	,
cord-281487-x0a9qgjs	34	21	hypotension	hypotension	NN
cord-281487-x0a9qgjs	34	22	,	,	,
cord-281487-x0a9qgjs	34	23	and	and	CC
cord-281487-x0a9qgjs	34	24	cytokine	cytokine	NN
cord-281487-x0a9qgjs	34	25	storm	storm	NN
cord-281487-x0a9qgjs	34	26	[	[	-LRB-
cord-281487-x0a9qgjs	34	27	8	8	CD
cord-281487-x0a9qgjs	34	28	]	]	-RRB-
cord-281487-x0a9qgjs	34	29	.	.	.
cord-281487-x0a9qgjs	35	1	In	in	IN
cord-281487-x0a9qgjs	35	2	addition	addition	NN
cord-281487-x0a9qgjs	35	3	to	to	IN
cord-281487-x0a9qgjs	35	4	direct	direct	JJ
cord-281487-x0a9qgjs	35	5	invasion	invasion	NN
cord-281487-x0a9qgjs	35	6	by	by	IN
cord-281487-x0a9qgjs	35	7	SARS	SARS	NNP
cord-281487-x0a9qgjs	35	8	-	-	HYPH
cord-281487-x0a9qgjs	35	9	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	35	10	,	,	,
cord-281487-x0a9qgjs	35	11	these	these	DT
cord-281487-x0a9qgjs	35	12	complex	complex	JJ
cord-281487-x0a9qgjs	35	13	processes	process	NNS
cord-281487-x0a9qgjs	35	14	can	can	MD
cord-281487-x0a9qgjs	35	15	cause	cause	VB
cord-281487-x0a9qgjs	35	16	to	to	IN
cord-281487-x0a9qgjs	35	17	damage	damage	NN
cord-281487-x0a9qgjs	35	18	to	to	IN
cord-281487-x0a9qgjs	35	19	multiple	multiple	JJ
cord-281487-x0a9qgjs	35	20	organs	organ	NNS
cord-281487-x0a9qgjs	35	21	[	[	-LRB-
cord-281487-x0a9qgjs	35	22	8	8	CD
cord-281487-x0a9qgjs	35	23	]	]	-RRB-
cord-281487-x0a9qgjs	35	24	.	.	.
cord-281487-x0a9qgjs	36	1	In	in	IN
cord-281487-x0a9qgjs	36	2	a	a	DT
cord-281487-x0a9qgjs	36	3	prospective	prospective	JJ
cord-281487-x0a9qgjs	36	4	study	study	NN
cord-281487-x0a9qgjs	36	5	of	of	IN
cord-281487-x0a9qgjs	36	6	20,133	20,133	CD
cord-281487-x0a9qgjs	36	7	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	36	8	patients	patient	NNS
cord-281487-x0a9qgjs	36	9	with	with	IN
cord-281487-x0a9qgjs	36	10	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	36	11	,	,	,
cord-281487-x0a9qgjs	36	12	old	old	JJ
cord-281487-x0a9qgjs	36	13	age	age	NN
cord-281487-x0a9qgjs	36	14	,	,	,
cord-281487-x0a9qgjs	36	15	male	male	NN
cord-281487-x0a9qgjs	36	16	,	,	,
cord-281487-x0a9qgjs	36	17	obesity	obesity	NN
cord-281487-x0a9qgjs	36	18	,	,	,
cord-281487-x0a9qgjs	36	19	and	and	CC
cord-281487-x0a9qgjs	36	20	comorbidities	comorbiditie	NNS
cord-281487-x0a9qgjs	36	21	,	,	,
cord-281487-x0a9qgjs	36	22	including	include	VBG
cord-281487-x0a9qgjs	36	23	chronic	chronic	JJ
cord-281487-x0a9qgjs	36	24	cardiac	cardiac	NN
cord-281487-x0a9qgjs	36	25	,	,	,
cord-281487-x0a9qgjs	36	26	pulmonary	pulmonary	JJ
cord-281487-x0a9qgjs	36	27	,	,	,
cord-281487-x0a9qgjs	36	28	kidney	kidney	NN
cord-281487-x0a9qgjs	36	29	,	,	,
cord-281487-x0a9qgjs	36	30	liver	liver	NN
cord-281487-x0a9qgjs	36	31	disease	disease	NN
cord-281487-x0a9qgjs	36	32	,	,	,
cord-281487-x0a9qgjs	36	33	were	be	VBD
cord-281487-x0a9qgjs	36	34	risk	risk	NN
cord-281487-x0a9qgjs	36	35	factors	factor	NNS
cord-281487-x0a9qgjs	36	36	of	of	IN
cord-281487-x0a9qgjs	36	37	death	death	NN
cord-281487-x0a9qgjs	36	38	[	[	-LRB-
cord-281487-x0a9qgjs	36	39	9	9	CD
cord-281487-x0a9qgjs	36	40	]	]	-RRB-
cord-281487-x0a9qgjs	36	41	.	.	.
cord-281487-x0a9qgjs	37	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	37	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	37	3	have	have	VBP
cord-281487-x0a9qgjs	37	4	several	several	JJ
cord-281487-x0a9qgjs	37	5	factors	factor	NNS
cord-281487-x0a9qgjs	37	6	contributing	contribute	VBG
cord-281487-x0a9qgjs	37	7	to	to	IN
cord-281487-x0a9qgjs	37	8	the	the	DT
cord-281487-x0a9qgjs	37	9	risk	risk	NN
cord-281487-x0a9qgjs	37	10	of	of	IN
cord-281487-x0a9qgjs	37	11	worse	bad	JJR
cord-281487-x0a9qgjs	37	12	outcomes	outcome	NNS
cord-281487-x0a9qgjs	37	13	,	,	,
cord-281487-x0a9qgjs	37	14	including	include	VBG
cord-281487-x0a9qgjs	37	15	advanced	advanced	JJ
cord-281487-x0a9qgjs	37	16	age	age	NN
cord-281487-x0a9qgjs	37	17	,	,	,
cord-281487-x0a9qgjs	37	18	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	37	19	,	,	,
cord-281487-x0a9qgjs	37	20	defective	defective	JJ
cord-281487-x0a9qgjs	37	21	mucocutaneous	mucocutaneous	JJ
cord-281487-x0a9qgjs	37	22	barrier	barrier	NN
cord-281487-x0a9qgjs	37	23	,	,	,
cord-281487-x0a9qgjs	37	24	co	co	NN
cord-281487-x0a9qgjs	37	25	-	-	NN
cord-281487-x0a9qgjs	37	26	infection	infection	NN
cord-281487-x0a9qgjs	37	27	,	,	,
cord-281487-x0a9qgjs	37	28	drug	drug	NN
cord-281487-x0a9qgjs	37	29	-	-	HYPH
cord-281487-x0a9qgjs	37	30	induced	induce	VBN
cord-281487-x0a9qgjs	37	31	leukopenia	leukopenia	NN
cord-281487-x0a9qgjs	37	32	,	,	,
cord-281487-x0a9qgjs	37	33	and	and	CC
cord-281487-x0a9qgjs	37	34	underlying	underlie	VBG
cord-281487-x0a9qgjs	37	35	cardiovascular	cardiovascular	JJ
cord-281487-x0a9qgjs	37	36	comorbidities	comorbiditie	NNS
cord-281487-x0a9qgjs	37	37	[	[	-LRB-
cord-281487-x0a9qgjs	37	38	10	10	CD
cord-281487-x0a9qgjs	37	39	]	]	-RRB-
cord-281487-x0a9qgjs	37	40	.	.	.
cord-281487-x0a9qgjs	38	1	The	the	DT
cord-281487-x0a9qgjs	38	2	mortality	mortality	NN
cord-281487-x0a9qgjs	38	3	rates	rate	NNS
cord-281487-x0a9qgjs	38	4	of	of	IN
cord-281487-x0a9qgjs	38	5	transplant	transplant	NN
cord-281487-x0a9qgjs	38	6	recipients	recipient	NNS
cord-281487-x0a9qgjs	38	7	with	with	IN
cord-281487-x0a9qgjs	38	8	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	38	9	may	may	MD
cord-281487-x0a9qgjs	38	10	be	be	VB
cord-281487-x0a9qgjs	38	11	higher	high	JJR
cord-281487-x0a9qgjs	38	12	than	than	IN
cord-281487-x0a9qgjs	38	13	in	in	IN
cord-281487-x0a9qgjs	38	14	the	the	DT
cord-281487-x0a9qgjs	38	15	general	general	JJ
cord-281487-x0a9qgjs	38	16	population	population	NN
cord-281487-x0a9qgjs	38	17	.	.	.
cord-281487-x0a9qgjs	39	1	Chaudhry	Chaudhry	NNP
cord-281487-x0a9qgjs	39	2	et	et	NNP
cord-281487-x0a9qgjs	39	3	al	al	NNP
cord-281487-x0a9qgjs	39	4	.	.	.
cord-281487-x0a9qgjs	40	1	compared	compare	VBN
cord-281487-x0a9qgjs	40	2	the	the	DT
cord-281487-x0a9qgjs	40	3	mortality	mortality	NN
cord-281487-x0a9qgjs	40	4	between	between	IN
cord-281487-x0a9qgjs	40	5	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	40	6	transplant	transplant	NN
cord-281487-x0a9qgjs	40	7	recipients	recipient	NNS
cord-281487-x0a9qgjs	40	8	and	and	CC
cord-281487-x0a9qgjs	40	9	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	40	10	non	non	JJ
cord-281487-x0a9qgjs	40	11	-	-	JJ
cord-281487-x0a9qgjs	40	12	transplant	transplant	JJ
cord-281487-x0a9qgjs	40	13	patients	patient	NNS
cord-281487-x0a9qgjs	40	14	[	[	-LRB-
cord-281487-x0a9qgjs	40	15	11	11	CD
cord-281487-x0a9qgjs	40	16	]	]	-RRB-
cord-281487-x0a9qgjs	40	17	.	.	.
cord-281487-x0a9qgjs	41	1	They	-PRON-	PRP
cord-281487-x0a9qgjs	41	2	showed	show	VBD
cord-281487-x0a9qgjs	41	3	that	that	IN
cord-281487-x0a9qgjs	41	4	transplant	transplant	NN
cord-281487-x0a9qgjs	41	5	status	status	NN
cord-281487-x0a9qgjs	41	6	itself	-PRON-	PRP
cord-281487-x0a9qgjs	41	7	does	do	VBZ
cord-281487-x0a9qgjs	41	8	not	not	RB
cord-281487-x0a9qgjs	41	9	affect	affect	VB
cord-281487-x0a9qgjs	41	10	the	the	DT
cord-281487-x0a9qgjs	41	11	mortality	mortality	NN
cord-281487-x0a9qgjs	41	12	in	in	IN
cord-281487-x0a9qgjs	41	13	patients	patient	NNS
cord-281487-x0a9qgjs	41	14	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	41	15	with	with	IN
cord-281487-x0a9qgjs	41	16	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	41	17	(	(	-LRB-
cord-281487-x0a9qgjs	41	18	22.8	22.8	CD
cord-281487-x0a9qgjs	41	19	%	%	NN
cord-281487-x0a9qgjs	41	20	in	in	IN
cord-281487-x0a9qgjs	41	21	transplant	transplant	NN
cord-281487-x0a9qgjs	41	22	recipients	recipient	NNS
cord-281487-x0a9qgjs	41	23	vs.	vs.	IN
cord-281487-x0a9qgjs	41	24	25	25	CD
cord-281487-x0a9qgjs	41	25	%	%	NN
cord-281487-x0a9qgjs	41	26	in	in	IN
cord-281487-x0a9qgjs	41	27	non	non	JJ
cord-281487-x0a9qgjs	41	28	-	-	JJ
cord-281487-x0a9qgjs	41	29	transplant	transplant	JJ
cord-281487-x0a9qgjs	41	30	patients	patient	NNS
cord-281487-x0a9qgjs	41	31	)	)	-RRB-
cord-281487-x0a9qgjs	42	1	[	[	-LRB-
cord-281487-x0a9qgjs	42	2	11	11	CD
cord-281487-x0a9qgjs	42	3	]	]	-RRB-
cord-281487-x0a9qgjs	42	4	.	.	.
cord-281487-x0a9qgjs	43	1	However	however	RB
cord-281487-x0a9qgjs	43	2	,	,	,
cord-281487-x0a9qgjs	43	3	the	the	DT
cord-281487-x0a9qgjs	43	4	proportion	proportion	NN
cord-281487-x0a9qgjs	43	5	of	of	IN
cord-281487-x0a9qgjs	43	6	severe	severe	JJ
cord-281487-x0a9qgjs	43	7	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	43	8	severity	severity	NN
cord-281487-x0a9qgjs	43	9	scores	score	NNS
cord-281487-x0a9qgjs	43	10	associated	associate	VBN
cord-281487-x0a9qgjs	43	11	with	with	IN
cord-281487-x0a9qgjs	43	12	mortality	mortality	NN
cord-281487-x0a9qgjs	43	13	was	be	VBD
cord-281487-x0a9qgjs	43	14	8.6	8.6	CD
cord-281487-x0a9qgjs	43	15	%	%	NN
cord-281487-x0a9qgjs	43	16	and	and	CC
cord-281487-x0a9qgjs	43	17	19	19	CD
cord-281487-x0a9qgjs	43	18	%	%	NN
cord-281487-x0a9qgjs	43	19	in	in	IN
cord-281487-x0a9qgjs	43	20	transplant	transplant	NN
cord-281487-x0a9qgjs	43	21	recipients	recipient	NNS
cord-281487-x0a9qgjs	43	22	and	and	CC
cord-281487-x0a9qgjs	43	23	non	non	JJ
cord-281487-x0a9qgjs	43	24	-	-	JJ
cord-281487-x0a9qgjs	43	25	transplant	transplant	JJ
cord-281487-x0a9qgjs	43	26	patients	patient	NNS
cord-281487-x0a9qgjs	43	27	[	[	-LRB-
cord-281487-x0a9qgjs	43	28	11	11	CD
cord-281487-x0a9qgjs	43	29	]	]	-RRB-
cord-281487-x0a9qgjs	43	30	.	.	.
cord-281487-x0a9qgjs	44	1	Roberts	Roberts	NNP
cord-281487-x0a9qgjs	44	2	et	et	NNP
cord-281487-x0a9qgjs	44	3	al	al	NNP
cord-281487-x0a9qgjs	44	4	.	.	NNP
cord-281487-x0a9qgjs	44	5	reported	report	VBD
cord-281487-x0a9qgjs	44	6	that	that	IN
cord-281487-x0a9qgjs	44	7	the	the	DT
cord-281487-x0a9qgjs	44	8	mortality	mortality	NN
cord-281487-x0a9qgjs	44	9	rate	rate	NN
cord-281487-x0a9qgjs	44	10	was	be	VBD
cord-281487-x0a9qgjs	44	11	higher	high	JJR
cord-281487-x0a9qgjs	44	12	in	in	IN
cord-281487-x0a9qgjs	44	13	transplant	transplant	NN
cord-281487-x0a9qgjs	44	14	recipients	recipient	NNS
cord-281487-x0a9qgjs	44	15	when	when	WRB
cord-281487-x0a9qgjs	44	16	compared	compare	VBN
cord-281487-x0a9qgjs	44	17	using	use	VBG
cord-281487-x0a9qgjs	44	18	unpublished	unpublished	JJ
cord-281487-x0a9qgjs	44	19	data	datum	NNS
cord-281487-x0a9qgjs	44	20	from	from	IN
cord-281487-x0a9qgjs	44	21	non	non	JJ
cord-281487-x0a9qgjs	44	22	-	-	JJ
cord-281487-x0a9qgjs	44	23	transplant	transplant	JJ
cord-281487-x0a9qgjs	44	24	patients	patient	NNS
cord-281487-x0a9qgjs	44	25	(	(	-LRB-
cord-281487-x0a9qgjs	44	26	16	16	CD
cord-281487-x0a9qgjs	44	27	%	%	NN
cord-281487-x0a9qgjs	44	28	in	in	IN
cord-281487-x0a9qgjs	44	29	transplant	transplant	NN
cord-281487-x0a9qgjs	44	30	recipients	recipient	NNS
cord-281487-x0a9qgjs	44	31	vs.	vs.	IN
cord-281487-x0a9qgjs	44	32	4.3	4.3	CD
cord-281487-x0a9qgjs	44	33	%	%	NN
cord-281487-x0a9qgjs	44	34	in	in	IN
cord-281487-x0a9qgjs	44	35	non	non	JJ
cord-281487-x0a9qgjs	44	36	-	-	JJ
cord-281487-x0a9qgjs	44	37	transplant	transplant	JJ
cord-281487-x0a9qgjs	44	38	patients	patient	NNS
cord-281487-x0a9qgjs	44	39	)	)	-RRB-
cord-281487-x0a9qgjs	44	40	[	[	-LRB-
cord-281487-x0a9qgjs	44	41	12	12	CD
cord-281487-x0a9qgjs	44	42	]	]	-RRB-
cord-281487-x0a9qgjs	44	43	.	.	.
cord-281487-x0a9qgjs	45	1	In	in	IN
cord-281487-x0a9qgjs	45	2	another	another	DT
cord-281487-x0a9qgjs	45	3	study	study	NN
cord-281487-x0a9qgjs	45	4	,	,	,
cord-281487-x0a9qgjs	45	5	the	the	DT
cord-281487-x0a9qgjs	45	6	mortality	mortality	NN
cord-281487-x0a9qgjs	45	7	rate	rate	NN
cord-281487-x0a9qgjs	45	8	was	be	VBD
cord-281487-x0a9qgjs	45	9	20.5	20.5	CD
cord-281487-x0a9qgjs	45	10	%	%	NN
cord-281487-x0a9qgjs	45	11	among	among	IN
cord-281487-x0a9qgjs	45	12	376	376	CD
cord-281487-x0a9qgjs	45	13	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	45	14	transplant	transplant	NN
cord-281487-x0a9qgjs	45	15	recipients	recipient	NNS
cord-281487-x0a9qgjs	45	16	[	[	-LRB-
cord-281487-x0a9qgjs	45	17	13	13	CD
cord-281487-x0a9qgjs	45	18	]	]	-RRB-
cord-281487-x0a9qgjs	45	19	.	.	.
cord-281487-x0a9qgjs	46	1	Meanwhile	meanwhile	RB
cord-281487-x0a9qgjs	46	2	,	,	,
cord-281487-x0a9qgjs	46	3	in	in	IN
cord-281487-x0a9qgjs	46	4	a	a	DT
cord-281487-x0a9qgjs	46	5	study	study	NN
cord-281487-x0a9qgjs	46	6	by	by	IN
cord-281487-x0a9qgjs	46	7	Guan	Guan	NNP
cord-281487-x0a9qgjs	46	8	et	et	FW
cord-281487-x0a9qgjs	46	9	al	al	NNP
cord-281487-x0a9qgjs	46	10	.	.	.
cord-281487-x0a9qgjs	47	1	,	,	,
cord-281487-x0a9qgjs	47	2	the	the	DT
cord-281487-x0a9qgjs	47	3	mortality	mortality	NN
cord-281487-x0a9qgjs	47	4	rate	rate	NN
cord-281487-x0a9qgjs	47	5	was	be	VBD
cord-281487-x0a9qgjs	47	6	1.4	1.4	CD
cord-281487-x0a9qgjs	47	7	%	%	NN
cord-281487-x0a9qgjs	47	8	in	in	IN
cord-281487-x0a9qgjs	47	9	1099	1099	CD
cord-281487-x0a9qgjs	47	10	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	47	11	nontransplant	nontransplant	JJ
cord-281487-x0a9qgjs	47	12	patients	patient	NNS
cord-281487-x0a9qgjs	48	1	[	[	-LRB-
cord-281487-x0a9qgjs	48	2	14	14	CD
cord-281487-x0a9qgjs	48	3	]	]	-RRB-
cord-281487-x0a9qgjs	48	4	.	.	.
cord-281487-x0a9qgjs	49	1	However	however	RB
cord-281487-x0a9qgjs	49	2	,	,	,
cord-281487-x0a9qgjs	49	3	it	-PRON-	PRP
cord-281487-x0a9qgjs	49	4	is	be	VBZ
cord-281487-x0a9qgjs	49	5	not	not	RB
cord-281487-x0a9qgjs	49	6	yet	yet	RB
cord-281487-x0a9qgjs	49	7	clear	clear	JJ
cord-281487-x0a9qgjs	49	8	whether	whether	IN
cord-281487-x0a9qgjs	49	9	transplantation	transplantation	NN
cord-281487-x0a9qgjs	49	10	affects	affect	VBZ
cord-281487-x0a9qgjs	49	11	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	49	12	associated	associate	VBN
cord-281487-x0a9qgjs	49	13	mortality	mortality	NN
cord-281487-x0a9qgjs	49	14	.	.	.
cord-281487-x0a9qgjs	50	1	In	in	IN
cord-281487-x0a9qgjs	50	2	the	the	DT
cord-281487-x0a9qgjs	50	3	future	future	NN
cord-281487-x0a9qgjs	50	4	,	,	,
cord-281487-x0a9qgjs	50	5	more	more	JJR
cord-281487-x0a9qgjs	50	6	results	result	NNS
cord-281487-x0a9qgjs	50	7	need	need	VBP
cord-281487-x0a9qgjs	50	8	to	to	TO
cord-281487-x0a9qgjs	50	9	be	be	VB
cord-281487-x0a9qgjs	50	10	accumulated	accumulate	VBN
cord-281487-x0a9qgjs	50	11	.	.	.
cord-281487-x0a9qgjs	51	1	The	the	DT
cord-281487-x0a9qgjs	51	2	common	common	JJ
cord-281487-x0a9qgjs	51	3	symptoms	symptom	NNS
cord-281487-x0a9qgjs	51	4	in	in	IN
cord-281487-x0a9qgjs	51	5	transplant	transplant	NN
cord-281487-x0a9qgjs	51	6	recipients	recipient	NNS
cord-281487-x0a9qgjs	51	7	are	be	VBP
cord-281487-x0a9qgjs	51	8	outlined	outline	VBN
cord-281487-x0a9qgjs	51	9	in	in	IN
cord-281487-x0a9qgjs	51	10	Table	Table	NNP
cord-281487-x0a9qgjs	51	11	1	1	CD
cord-281487-x0a9qgjs	51	12	.	.	.
cord-281487-x0a9qgjs	52	1	Atypical	atypical	JJ
cord-281487-x0a9qgjs	52	2	symptoms	symptom	NNS
cord-281487-x0a9qgjs	52	3	such	such	JJ
cord-281487-x0a9qgjs	52	4	as	as	IN
cord-281487-x0a9qgjs	52	5	diarrhea	diarrhea	NN
cord-281487-x0a9qgjs	52	6	are	be	VBP
cord-281487-x0a9qgjs	52	7	much	much	RB
cord-281487-x0a9qgjs	52	8	more	more	RBR
cord-281487-x0a9qgjs	52	9	common	common	JJ
cord-281487-x0a9qgjs	52	10	(	(	-LRB-
cord-281487-x0a9qgjs	52	11	22−67	22−67	CD
cord-281487-x0a9qgjs	52	12	%	%	NN
cord-281487-x0a9qgjs	52	13	)	)	-RRB-
cord-281487-x0a9qgjs	52	14	compared	compare	VBN
cord-281487-x0a9qgjs	52	15	to	to	IN
cord-281487-x0a9qgjs	52	16	the	the	DT
cord-281487-x0a9qgjs	52	17	general	general	JJ
cord-281487-x0a9qgjs	52	18	population	population	NN
cord-281487-x0a9qgjs	52	19	(	(	-LRB-
cord-281487-x0a9qgjs	52	20	2−14	2−14	CD
cord-281487-x0a9qgjs	52	21	%	%	NN
cord-281487-x0a9qgjs	52	22	)	)	-RRB-
cord-281487-x0a9qgjs	52	23	.	.	.
cord-281487-x0a9qgjs	53	1	Fever	Fever	NNP
cord-281487-x0a9qgjs	53	2	may	may	MD
cord-281487-x0a9qgjs	53	3	be	be	VB
cord-281487-x0a9qgjs	53	4	absent	absent	JJ
cord-281487-x0a9qgjs	53	5	in	in	IN
cord-281487-x0a9qgjs	53	6	up	up	IN
cord-281487-x0a9qgjs	53	7	to	to	TO
cord-281487-x0a9qgjs	53	8	50	50	CD
cord-281487-x0a9qgjs	53	9	%	%	NN
cord-281487-x0a9qgjs	53	10	of	of	IN
cord-281487-x0a9qgjs	53	11	transplant	transplant	NN
cord-281487-x0a9qgjs	53	12	recipients	recipient	NNS
cord-281487-x0a9qgjs	53	13	[	[	-LRB-
cord-281487-x0a9qgjs	53	14	10	10	CD
cord-281487-x0a9qgjs	53	15	,	,	,
cord-281487-x0a9qgjs	53	16	15	15	CD
cord-281487-x0a9qgjs	53	17	,	,	,
cord-281487-x0a9qgjs	53	18	16	16	CD
cord-281487-x0a9qgjs	53	19	]	]	-RRB-
cord-281487-x0a9qgjs	53	20	.	.	.
cord-281487-x0a9qgjs	54	1	These	these	DT
cord-281487-x0a9qgjs	54	2	atypical	atypical	JJ
cord-281487-x0a9qgjs	54	3	symptoms	symptom	NNS
cord-281487-x0a9qgjs	54	4	alongside	alongside	IN
cord-281487-x0a9qgjs	54	5	baseline	baseline	JJ
cord-281487-x0a9qgjs	54	6	cough	cough	NN
cord-281487-x0a9qgjs	54	7	,	,	,
cord-281487-x0a9qgjs	54	8	dyspnea	dyspnea	NN
cord-281487-x0a9qgjs	54	9	,	,	,
cord-281487-x0a9qgjs	54	10	or	or	CC
cord-281487-x0a9qgjs	54	11	medication	medication	NN
cord-281487-x0a9qgjs	54	12	side	side	NN
cord-281487-x0a9qgjs	54	13	effects	effect	NNS
cord-281487-x0a9qgjs	54	14	may	may	MD
cord-281487-x0a9qgjs	54	15	make	make	VB
cord-281487-x0a9qgjs	54	16	it	-PRON-	PRP
cord-281487-x0a9qgjs	54	17	more	more	RBR
cord-281487-x0a9qgjs	54	18	difficult	difficult	JJ
cord-281487-x0a9qgjs	54	19	to	to	TO
cord-281487-x0a9qgjs	54	20	identify	identify	VB
cord-281487-x0a9qgjs	54	21	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	54	22	specific	specific	JJ
cord-281487-x0a9qgjs	54	23	symptoms	symptom	NNS
cord-281487-x0a9qgjs	54	24	in	in	IN
cord-281487-x0a9qgjs	54	25	transplant	transplant	NN
cord-281487-x0a9qgjs	54	26	recipients	recipient	NNS
cord-281487-x0a9qgjs	54	27	.	.	.
cord-281487-x0a9qgjs	55	1	Due	due	IN
cord-281487-x0a9qgjs	55	2	to	to	IN
cord-281487-x0a9qgjs	55	3	high	high	JJ
cord-281487-x0a9qgjs	55	4	infectivity	infectivity	NN
cord-281487-x0a9qgjs	55	5	,	,	,
cord-281487-x0a9qgjs	55	6	transplant	transplant	NN
cord-281487-x0a9qgjs	55	7	recipients	recipient	NNS
cord-281487-x0a9qgjs	55	8	may	may	MD
cord-281487-x0a9qgjs	55	9	present	present	VB
cord-281487-x0a9qgjs	55	10	with	with	IN
cord-281487-x0a9qgjs	55	11	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	55	12	at	at	IN
cord-281487-x0a9qgjs	55	13	any	any	DT
cord-281487-x0a9qgjs	55	14	time	time	NN
cord-281487-x0a9qgjs	55	15	after	after	IN
cord-281487-x0a9qgjs	55	16	transplant	transplant	NN
cord-281487-x0a9qgjs	55	17	(	(	-LRB-
cord-281487-x0a9qgjs	55	18	Table	Table	NNP
cord-281487-x0a9qgjs	55	19	1	1	CD
cord-281487-x0a9qgjs	55	20	)	)	-RRB-
cord-281487-x0a9qgjs	55	21	.	.	.
cord-281487-x0a9qgjs	56	1	Thus	thus	RB
cord-281487-x0a9qgjs	56	2	,	,	,
cord-281487-x0a9qgjs	56	3	a	a	DT
cord-281487-x0a9qgjs	56	4	very	very	RB
cord-281487-x0a9qgjs	56	5	low	low	JJ
cord-281487-x0a9qgjs	56	6	threshold	threshold	NN
cord-281487-x0a9qgjs	56	7	for	for	IN
cord-281487-x0a9qgjs	56	8	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	56	9	testing	testing	NN
cord-281487-x0a9qgjs	56	10	should	should	MD
cord-281487-x0a9qgjs	56	11	be	be	VB
cord-281487-x0a9qgjs	56	12	considered	consider	VBN
cord-281487-x0a9qgjs	56	13	in	in	IN
cord-281487-x0a9qgjs	56	14	recipients	recipient	NNS
cord-281487-x0a9qgjs	56	15	with	with	IN
cord-281487-x0a9qgjs	56	16	even	even	RB
cord-281487-x0a9qgjs	56	17	minor	minor	JJ
cord-281487-x0a9qgjs	56	18	symptoms	symptom	NNS
cord-281487-x0a9qgjs	56	19	or	or	CC
cord-281487-x0a9qgjs	56	20	high	high	JJ
cord-281487-x0a9qgjs	56	21	-	-	HYPH
cord-281487-x0a9qgjs	56	22	risk	risk	NN
cord-281487-x0a9qgjs	56	23	exposures	exposure	NNS
cord-281487-x0a9qgjs	56	24	.	.	.
cord-281487-x0a9qgjs	57	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	57	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	57	3	diagnosed	diagnose	VBN
cord-281487-x0a9qgjs	57	4	with	with	IN
cord-281487-x0a9qgjs	57	5	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	57	6	should	should	MD
cord-281487-x0a9qgjs	57	7	be	be	VB
cord-281487-x0a9qgjs	57	8	considered	consider	VBN
cord-281487-x0a9qgjs	57	9	for	for	IN
cord-281487-x0a9qgjs	57	10	diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	57	11	tests	test	NNS
cord-281487-x0a9qgjs	57	12	to	to	TO
cord-281487-x0a9qgjs	57	13	determine	determine	VB
cord-281487-x0a9qgjs	57	14	disease	disease	NN
cord-281487-x0a9qgjs	57	15	severity	severity	NN
cord-281487-x0a9qgjs	57	16	,	,	,
cord-281487-x0a9qgjs	57	17	phase	phase	NN
cord-281487-x0a9qgjs	57	18	of	of	IN
cord-281487-x0a9qgjs	57	19	illness	illness	NN
cord-281487-x0a9qgjs	57	20	,	,	,
cord-281487-x0a9qgjs	57	21	and	and	CC
cord-281487-x0a9qgjs	57	22	identify	identify	VB
cord-281487-x0a9qgjs	57	23	other	other	JJ
cord-281487-x0a9qgjs	57	24	comorbidities	comorbiditie	NNS
cord-281487-x0a9qgjs	57	25	.	.	.
cord-281487-x0a9qgjs	58	1	Table	table	NN
cord-281487-x0a9qgjs	58	2	3	3	CD
cord-281487-x0a9qgjs	58	3	shows	show	VBZ
cord-281487-x0a9qgjs	58	4	the	the	DT
cord-281487-x0a9qgjs	58	5	current	current	JJ
cord-281487-x0a9qgjs	58	6	tests	test	NNS
cord-281487-x0a9qgjs	58	7	recommended	recommend	VBD
cord-281487-x0a9qgjs	58	8	for	for	IN
cord-281487-x0a9qgjs	58	9	transplant	transplant	NN
cord-281487-x0a9qgjs	58	10	recipients	recipient	NNS
cord-281487-x0a9qgjs	58	11	with	with	IN
cord-281487-x0a9qgjs	58	12	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	58	13	at	at	IN
cord-281487-x0a9qgjs	58	14	the	the	DT
cord-281487-x0a9qgjs	58	15	Johns	Johns	NNP
cord-281487-x0a9qgjs	58	16	Hopkins	Hopkins	NNP
cord-281487-x0a9qgjs	58	17	Comprehensive	Comprehensive	NNP
cord-281487-x0a9qgjs	58	18	Transplant	Transplant	NNP
cord-281487-x0a9qgjs	58	19	Center	Center	NNP
cord-281487-x0a9qgjs	58	20	(	(	-LRB-
cord-281487-x0a9qgjs	58	21	JH	JH	NNP
cord-281487-x0a9qgjs	58	22	-	-	HYPH
cord-281487-x0a9qgjs	58	23	CTC	CTC	NNP
cord-281487-x0a9qgjs	58	24	)	)	-RRB-
cord-281487-x0a9qgjs	58	25	.	.	.
cord-281487-x0a9qgjs	59	1	Lymphopenia	Lymphopenia	NNP
cord-281487-x0a9qgjs	59	2	is	be	VBZ
cord-281487-x0a9qgjs	59	3	a	a	DT
cord-281487-x0a9qgjs	59	4	common	common	JJ
cord-281487-x0a9qgjs	59	5	finding	finding	NN
cord-281487-x0a9qgjs	59	6	that	that	WDT
cord-281487-x0a9qgjs	59	7	correlates	correlate	VBZ
cord-281487-x0a9qgjs	59	8	with	with	IN
cord-281487-x0a9qgjs	59	9	disease	disease	NN
cord-281487-x0a9qgjs	59	10	severity	severity	NN
cord-281487-x0a9qgjs	59	11	(	(	-LRB-
cord-281487-x0a9qgjs	59	12	Tables	table	NNS
cord-281487-x0a9qgjs	59	13	2	2	CD
cord-281487-x0a9qgjs	59	14	and	and	CC
cord-281487-x0a9qgjs	59	15	3	3	CD
cord-281487-x0a9qgjs	59	16	)	)	-RRB-
cord-281487-x0a9qgjs	59	17	.	.	.
cord-281487-x0a9qgjs	60	1	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	60	2	associated	associated	JJ
cord-281487-x0a9qgjs	60	3	lymphopenia	lymphopenia	NNP
cord-281487-x0a9qgjs	60	4	may	may	MD
cord-281487-x0a9qgjs	60	5	be	be	VB
cord-281487-x0a9qgjs	60	6	caused	cause	VBN
cord-281487-x0a9qgjs	60	7	by	by	IN
cord-281487-x0a9qgjs	60	8	direct	direct	JJ
cord-281487-x0a9qgjs	60	9	virus	virus	NN
cord-281487-x0a9qgjs	60	10	-	-	HYPH
cord-281487-x0a9qgjs	60	11	induced	induce	VBN
cord-281487-x0a9qgjs	60	12	cell	cell	NN
cord-281487-x0a9qgjs	60	13	death	death	NN
cord-281487-x0a9qgjs	60	14	or	or	CC
cord-281487-x0a9qgjs	60	15	cytokine	cytokine	NN
cord-281487-x0a9qgjs	60	16	storm	storm	NN
cord-281487-x0a9qgjs	60	17	[	[	-LRB-
cord-281487-x0a9qgjs	60	18	8	8	CD
cord-281487-x0a9qgjs	60	19	,	,	,
cord-281487-x0a9qgjs	60	20	26	26	CD
cord-281487-x0a9qgjs	60	21	]	]	-RRB-
cord-281487-x0a9qgjs	60	22	,	,	,
cord-281487-x0a9qgjs	60	23	and	and	CC
cord-281487-x0a9qgjs	60	24	further	further	RB
cord-281487-x0a9qgjs	60	25	augmented	augment	VBN
cord-281487-x0a9qgjs	60	26	by	by	IN
cord-281487-x0a9qgjs	60	27	drug	drug	NN
cord-281487-x0a9qgjs	60	28	-	-	HYPH
cord-281487-x0a9qgjs	60	29	associated	associate	VBN
cord-281487-x0a9qgjs	60	30	myelotoxicity	myelotoxicity	NN
cord-281487-x0a9qgjs	60	31	in	in	IN
cord-281487-x0a9qgjs	60	32	transplant	transplant	NN
cord-281487-x0a9qgjs	60	33	recipients	recipient	NNS
cord-281487-x0a9qgjs	60	34	receiving	receive	VBG
cord-281487-x0a9qgjs	60	35	lymphocyte	lymphocyte	NN
cord-281487-x0a9qgjs	60	36	-	-	HYPH
cord-281487-x0a9qgjs	60	37	depleting	deplete	VBG
cord-281487-x0a9qgjs	60	38	agents	agent	NNS
cord-281487-x0a9qgjs	60	39	and/or	and/or	CC
cord-281487-x0a9qgjs	60	40	antimetabolites	antimetabolite	NNS
cord-281487-x0a9qgjs	60	41	.	.	.
cord-281487-x0a9qgjs	61	1	Levels	level	NNS
cord-281487-x0a9qgjs	61	2	of	of	IN
cord-281487-x0a9qgjs	61	3	C	c	NN
cord-281487-x0a9qgjs	61	4	-	-	HYPH
cord-281487-x0a9qgjs	61	5	reactive	reactive	JJ
cord-281487-x0a9qgjs	61	6	protein	protein	NN
cord-281487-x0a9qgjs	61	7	(	(	-LRB-
cord-281487-x0a9qgjs	61	8	CRP	CRP	NNP
cord-281487-x0a9qgjs	61	9	)	)	-RRB-
cord-281487-x0a9qgjs	61	10	and	and	CC
cord-281487-x0a9qgjs	61	11	IL-6	IL-6	NNP
cord-281487-x0a9qgjs	61	12	may	may	MD
cord-281487-x0a9qgjs	61	13	be	be	VB
cord-281487-x0a9qgjs	61	14	higher	high	JJR
cord-281487-x0a9qgjs	61	15	in	in	IN
cord-281487-x0a9qgjs	61	16	transplant	transplant	NN
cord-281487-x0a9qgjs	61	17	recipients	recipient	NNS
cord-281487-x0a9qgjs	61	18	with	with	IN
cord-281487-x0a9qgjs	61	19	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	61	20	than	than	IN
cord-281487-x0a9qgjs	61	21	the	the	DT
cord-281487-x0a9qgjs	61	22	general	general	JJ
cord-281487-x0a9qgjs	61	23	population	population	NN
cord-281487-x0a9qgjs	61	24	(	(	-LRB-
cord-281487-x0a9qgjs	61	25	Table	Table	NNP
cord-281487-x0a9qgjs	61	26	2	2	CD
cord-281487-x0a9qgjs	61	27	)	)	-RRB-
cord-281487-x0a9qgjs	62	1	[	[	-LRB-
cord-281487-x0a9qgjs	62	2	17	17	CD
cord-281487-x0a9qgjs	62	3	-	-	SYM
cord-281487-x0a9qgjs	62	4	19	19	CD
cord-281487-x0a9qgjs	62	5	,	,	,
cord-281487-x0a9qgjs	62	6	21	21	CD
cord-281487-x0a9qgjs	62	7	,	,	,
cord-281487-x0a9qgjs	62	8	24	24	CD
cord-281487-x0a9qgjs	62	9	,	,	,
cord-281487-x0a9qgjs	62	10	25	25	CD
cord-281487-x0a9qgjs	62	11	]	]	-RRB-
cord-281487-x0a9qgjs	62	12	.	.	.
cord-281487-x0a9qgjs	63	1	Considering	consider	VBG
cord-281487-x0a9qgjs	63	2	that	that	DT
cord-281487-x0a9qgjs	63	3	lymphopenia	lymphopenia	NNP
cord-281487-x0a9qgjs	63	4	,	,	,
cord-281487-x0a9qgjs	63	5	CRP	CRP	NNP
cord-281487-x0a9qgjs	63	6	,	,	,
cord-281487-x0a9qgjs	63	7	and	and	CC
cord-281487-x0a9qgjs	63	8	IL-6	IL-6	NNP
cord-281487-x0a9qgjs	63	9	are	be	VBP
cord-281487-x0a9qgjs	63	10	independent	independent	JJ
cord-281487-x0a9qgjs	63	11	factors	factor	NNS
cord-281487-x0a9qgjs	63	12	related	relate	VBN
cord-281487-x0a9qgjs	63	13	to	to	IN
cord-281487-x0a9qgjs	63	14	the	the	DT
cord-281487-x0a9qgjs	63	15	severity	severity	NN
cord-281487-x0a9qgjs	63	16	of	of	IN
cord-281487-x0a9qgjs	63	17	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	63	18	[	[	-LRB-
cord-281487-x0a9qgjs	63	19	27	27	CD
cord-281487-x0a9qgjs	63	20	,	,	,
cord-281487-x0a9qgjs	63	21	28	28	CD
cord-281487-x0a9qgjs	63	22	]	]	-RRB-
cord-281487-x0a9qgjs	63	23	,	,	,
cord-281487-x0a9qgjs	63	24	these	these	DT
cord-281487-x0a9qgjs	63	25	should	should	MD
cord-281487-x0a9qgjs	63	26	be	be	VB
cord-281487-x0a9qgjs	63	27	monitored	monitor	VBN
cord-281487-x0a9qgjs	63	28	closely	closely	RB
cord-281487-x0a9qgjs	63	29	in	in	IN
cord-281487-x0a9qgjs	63	30	transplant	transplant	NN
cord-281487-x0a9qgjs	63	31	recipients	recipient	NNS
cord-281487-x0a9qgjs	63	32	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	63	33	with	with	IN
cord-281487-x0a9qgjs	63	34	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	63	35	.	.	.
cord-281487-x0a9qgjs	64	1	The	the	DT
cord-281487-x0a9qgjs	64	2	incidence	incidence	NN
cord-281487-x0a9qgjs	64	3	of	of	IN
cord-281487-x0a9qgjs	64	4	liver	liver	NN
cord-281487-x0a9qgjs	64	5	dysfunction	dysfunction	NN
cord-281487-x0a9qgjs	64	6	ranges	range	VBZ
cord-281487-x0a9qgjs	64	7	from	from	IN
cord-281487-x0a9qgjs	64	8	14	14	CD
cord-281487-x0a9qgjs	64	9	to	to	TO
cord-281487-x0a9qgjs	64	10	53	53	CD
cord-281487-x0a9qgjs	64	11	%	%	NN
cord-281487-x0a9qgjs	64	12	in	in	IN
cord-281487-x0a9qgjs	64	13	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	64	14	patients	patient	NNS
cord-281487-x0a9qgjs	64	15	with	with	IN
cord-281487-x0a9qgjs	64	16	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	64	17	[	[	-LRB-
cord-281487-x0a9qgjs	64	18	34	34	CD
cord-281487-x0a9qgjs	64	19	]	]	-RRB-
cord-281487-x0a9qgjs	64	20	.	.	.
cord-281487-x0a9qgjs	65	1	Although	although	IN
cord-281487-x0a9qgjs	65	2	liver	liver	NN
cord-281487-x0a9qgjs	65	3	dysfunction	dysfunction	NN
cord-281487-x0a9qgjs	65	4	seems	seem	VBZ
cord-281487-x0a9qgjs	65	5	to	to	TO
cord-281487-x0a9qgjs	65	6	be	be	VB
cord-281487-x0a9qgjs	65	7	mild	mild	JJ
cord-281487-x0a9qgjs	65	8	in	in	IN
cord-281487-x0a9qgjs	65	9	most	most	JJS
cord-281487-x0a9qgjs	65	10	patients	patient	NNS
cord-281487-x0a9qgjs	65	11	,	,	,
cord-281487-x0a9qgjs	65	12	liver	liver	NN
cord-281487-x0a9qgjs	65	13	injury	injury	NN
cord-281487-x0a9qgjs	65	14	,	,	,
cord-281487-x0a9qgjs	65	15	especially	especially	RB
cord-281487-x0a9qgjs	65	16	hepatocellular	hepatocellular	JJ
cord-281487-x0a9qgjs	65	17	type	type	NN
cord-281487-x0a9qgjs	65	18	or	or	CC
cord-281487-x0a9qgjs	65	19	mixed	mixed	JJ
cord-281487-x0a9qgjs	65	20	type	type	NN
cord-281487-x0a9qgjs	65	21	,	,	,
cord-281487-x0a9qgjs	65	22	was	be	VBD
cord-281487-x0a9qgjs	65	23	detrimental	detrimental	JJ
cord-281487-x0a9qgjs	65	24	in	in	IN
cord-281487-x0a9qgjs	65	25	patients	patient	NNS
cord-281487-x0a9qgjs	65	26	with	with	IN
cord-281487-x0a9qgjs	65	27	severe	severe	JJ
cord-281487-x0a9qgjs	65	28	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	65	29	[	[	-LRB-
cord-281487-x0a9qgjs	65	30	35	35	CD
cord-281487-x0a9qgjs	65	31	]	]	-RRB-
cord-281487-x0a9qgjs	65	32	.	.	.
cord-281487-x0a9qgjs	66	1	Liver	liver	NN
cord-281487-x0a9qgjs	66	2	dysfunction	dysfunction	NN
cord-281487-x0a9qgjs	66	3	may	may	MD
cord-281487-x0a9qgjs	66	4	be	be	VB
cord-281487-x0a9qgjs	66	5	caused	cause	VBN
cord-281487-x0a9qgjs	66	6	by	by	IN
cord-281487-x0a9qgjs	66	7	a	a	DT
cord-281487-x0a9qgjs	66	8	direct	direct	JJ
cord-281487-x0a9qgjs	66	9	virus	virus	NN
cord-281487-x0a9qgjs	66	10	-	-	HYPH
cord-281487-x0a9qgjs	66	11	induced	induce	VBN
cord-281487-x0a9qgjs	66	12	injury	injury	NN
cord-281487-x0a9qgjs	66	13	and/or	and/or	CC
cord-281487-x0a9qgjs	66	14	provoked	provoke	VBD
cord-281487-x0a9qgjs	66	15	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	66	16	response	response	NN
cord-281487-x0a9qgjs	66	17	[	[	-LRB-
cord-281487-x0a9qgjs	66	18	34	34	CD
cord-281487-x0a9qgjs	66	19	]	]	-RRB-
cord-281487-x0a9qgjs	66	20	.	.	.
cord-281487-x0a9qgjs	67	1	Cai	Cai	NNP
cord-281487-x0a9qgjs	67	2	et	et	FW
cord-281487-x0a9qgjs	67	3	al	al	NNP
cord-281487-x0a9qgjs	67	4	.	.	NNP
cord-281487-x0a9qgjs	67	5	showed	show	VBD
cord-281487-x0a9qgjs	67	6	that	that	IN
cord-281487-x0a9qgjs	67	7	elevated	elevated	JJ
cord-281487-x0a9qgjs	67	8	liver	liver	NN
cord-281487-x0a9qgjs	67	9	enzymes	enzyme	NNS
cord-281487-x0a9qgjs	67	10	and	and	CC
cord-281487-x0a9qgjs	67	11	histopathology	histopathology	NN
cord-281487-x0a9qgjs	67	12	were	be	VBD
cord-281487-x0a9qgjs	67	13	also	also	RB
cord-281487-x0a9qgjs	67	14	associated	associate	VBN
cord-281487-x0a9qgjs	67	15	with	with	IN
cord-281487-x0a9qgjs	67	16	hepatotoxic	hepatotoxic	JJ
cord-281487-x0a9qgjs	67	17	medications	medication	NNS
cord-281487-x0a9qgjs	67	18	in	in	IN
cord-281487-x0a9qgjs	67	19	patients	patient	NNS
cord-281487-x0a9qgjs	67	20	with	with	IN
cord-281487-x0a9qgjs	67	21	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	67	22	[	[	-LRB-
cord-281487-x0a9qgjs	67	23	35	35	CD
cord-281487-x0a9qgjs	67	24	]	]	-RRB-
cord-281487-x0a9qgjs	67	25	.	.	.
cord-281487-x0a9qgjs	68	1	Thus	thus	RB
cord-281487-x0a9qgjs	68	2	,	,	,
cord-281487-x0a9qgjs	68	3	liver	liver	NN
cord-281487-x0a9qgjs	68	4	enzymes	enzyme	NNS
cord-281487-x0a9qgjs	68	5	should	should	MD
cord-281487-x0a9qgjs	68	6	be	be	VB
cord-281487-x0a9qgjs	68	7	frequently	frequently	RB
cord-281487-x0a9qgjs	68	8	monitored	monitor	VBN
cord-281487-x0a9qgjs	68	9	and	and	CC
cord-281487-x0a9qgjs	68	10	efforts	effort	NNS
cord-281487-x0a9qgjs	68	11	considered	consider	VBN
cord-281487-x0a9qgjs	68	12	to	to	TO
cord-281487-x0a9qgjs	68	13	reduce	reduce	VB
cord-281487-x0a9qgjs	68	14	non	non	JJ
cord-281487-x0a9qgjs	68	15	-	-	JJ
cord-281487-x0a9qgjs	68	16	essential	essential	JJ
cord-281487-x0a9qgjs	68	17	medications	medication	NNS
cord-281487-x0a9qgjs	68	18	with	with	IN
cord-281487-x0a9qgjs	68	19	hepatotoxic	hepatotoxic	JJ
cord-281487-x0a9qgjs	68	20	potential	potential	NN
cord-281487-x0a9qgjs	68	21	.	.	.
cord-281487-x0a9qgjs	69	1	Kidney	kidney	NN
cord-281487-x0a9qgjs	69	2	injury	injury	NN
cord-281487-x0a9qgjs	69	3	is	be	VBZ
cord-281487-x0a9qgjs	69	4	common	common	JJ
cord-281487-x0a9qgjs	69	5	in	in	IN
cord-281487-x0a9qgjs	69	6	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	69	7	patients	patient	NNS
cord-281487-x0a9qgjs	69	8	.	.	.
cord-281487-x0a9qgjs	70	1	In	in	IN
cord-281487-x0a9qgjs	70	2	a	a	DT
cord-281487-x0a9qgjs	70	3	study	study	NN
cord-281487-x0a9qgjs	70	4	of	of	IN
cord-281487-x0a9qgjs	70	5	701	701	CD
cord-281487-x0a9qgjs	70	6	patients	patient	NNS
cord-281487-x0a9qgjs	70	7	with	with	IN
cord-281487-x0a9qgjs	70	8	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	70	9	,	,	,
cord-281487-x0a9qgjs	70	10	14.4	14.4	CD
cord-281487-x0a9qgjs	70	11	%	%	NN
cord-281487-x0a9qgjs	70	12	exhibited	exhibit	VBD
cord-281487-x0a9qgjs	70	13	an	an	DT
cord-281487-x0a9qgjs	70	14	elevated	elevated	JJ
cord-281487-x0a9qgjs	70	15	serum	serum	NN
cord-281487-x0a9qgjs	70	16	creatinine	creatinine	NN
cord-281487-x0a9qgjs	70	17	at	at	IN
cord-281487-x0a9qgjs	70	18	admission	admission	NN
cord-281487-x0a9qgjs	70	19	and	and	CC
cord-281487-x0a9qgjs	70	20	5.1	5.1	CD
cord-281487-x0a9qgjs	70	21	%	%	NN
cord-281487-x0a9qgjs	70	22	developed	develop	VBD
cord-281487-x0a9qgjs	70	23	acute	acute	JJ
cord-281487-x0a9qgjs	70	24	kidney	kidney	NN
cord-281487-x0a9qgjs	70	25	injury	injury	NN
cord-281487-x0a9qgjs	70	26	(	(	-LRB-
cord-281487-x0a9qgjs	70	27	AKI	AKI	NNP
cord-281487-x0a9qgjs	70	28	)	)	-RRB-
cord-281487-x0a9qgjs	70	29	during	during	IN
cord-281487-x0a9qgjs	70	30	hospitalization	hospitalization	NN
cord-281487-x0a9qgjs	70	31	[	[	-LRB-
cord-281487-x0a9qgjs	70	32	36	36	CD
cord-281487-x0a9qgjs	70	33	]	]	-RRB-
cord-281487-x0a9qgjs	70	34	.	.	.
cord-281487-x0a9qgjs	71	1	Further	further	RB
cord-281487-x0a9qgjs	71	2	,	,	,
cord-281487-x0a9qgjs	71	3	43.9	43.9	CD
cord-281487-x0a9qgjs	71	4	%	%	NN
cord-281487-x0a9qgjs	71	5	had	have	VBD
cord-281487-x0a9qgjs	71	6	proteinuria	proteinuria	NN
cord-281487-x0a9qgjs	71	7	and	and	CC
cord-281487-x0a9qgjs	71	8	26.7	26.7	CD
cord-281487-x0a9qgjs	71	9	%	%	NN
cord-281487-x0a9qgjs	71	10	had	have	VBD
cord-281487-x0a9qgjs	71	11	hematuria	hematuria	NN
cord-281487-x0a9qgjs	71	12	at	at	IN
cord-281487-x0a9qgjs	71	13	hospital	hospital	NN
cord-281487-x0a9qgjs	71	14	admission	admission	NN
cord-281487-x0a9qgjs	71	15	[	[	-LRB-
cord-281487-x0a9qgjs	71	16	36	36	CD
cord-281487-x0a9qgjs	71	17	]	]	-RRB-
cord-281487-x0a9qgjs	71	18	.	.	.
cord-281487-x0a9qgjs	72	1	AKI	AKI	NNP
cord-281487-x0a9qgjs	72	2	may	may	MD
cord-281487-x0a9qgjs	72	3	develop	develop	VB
cord-281487-x0a9qgjs	72	4	in	in	IN
cord-281487-x0a9qgjs	72	5	response	response	NN
cord-281487-x0a9qgjs	72	6	to	to	IN
cord-281487-x0a9qgjs	72	7	the	the	DT
cord-281487-x0a9qgjs	72	8	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	72	9	phase	phase	NN
cord-281487-x0a9qgjs	72	10	and	and	CC
cord-281487-x0a9qgjs	72	11	cytokine	cytokine	NN
cord-281487-x0a9qgjs	72	12	storm	storm	NN
cord-281487-x0a9qgjs	72	13	,	,	,
cord-281487-x0a9qgjs	72	14	and	and	CC
cord-281487-x0a9qgjs	72	15	be	be	VB
cord-281487-x0a9qgjs	72	16	exacerbated	exacerbate	VBN
cord-281487-x0a9qgjs	72	17	by	by	IN
cord-281487-x0a9qgjs	72	18	hypercoagulation	hypercoagulation	NN
cord-281487-x0a9qgjs	72	19	,	,	,
cord-281487-x0a9qgjs	72	20	microangiopathy	microangiopathy	NNP
cord-281487-x0a9qgjs	72	21	,	,	,
cord-281487-x0a9qgjs	72	22	rhabdomyolysis	rhabdomyolysis	NN
cord-281487-x0a9qgjs	72	23	,	,	,
cord-281487-x0a9qgjs	72	24	acute	acute	JJ
cord-281487-x0a9qgjs	72	25	tubular	tubular	JJ
cord-281487-x0a9qgjs	72	26	necrosis	necrosis	NN
cord-281487-x0a9qgjs	72	27	,	,	,
cord-281487-x0a9qgjs	72	28	hypoxia	hypoxia	NN
cord-281487-x0a9qgjs	72	29	,	,	,
cord-281487-x0a9qgjs	72	30	and	and	CC
cord-281487-x0a9qgjs	72	31	hypotension	hypotension	NN
cord-281487-x0a9qgjs	72	32	[	[	-LRB-
cord-281487-x0a9qgjs	72	33	8	8	CD
cord-281487-x0a9qgjs	72	34	,	,	,
cord-281487-x0a9qgjs	72	35	37	37	CD
cord-281487-x0a9qgjs	72	36	]	]	-RRB-
cord-281487-x0a9qgjs	72	37	.	.	.
cord-281487-x0a9qgjs	73	1	Proteinuria	Proteinuria	NNP
cord-281487-x0a9qgjs	73	2	may	may	MD
cord-281487-x0a9qgjs	73	3	be	be	VB
cord-281487-x0a9qgjs	73	4	caused	cause	VBN
cord-281487-x0a9qgjs	73	5	by	by	IN
cord-281487-x0a9qgjs	73	6	direct	direct	JJ
cord-281487-x0a9qgjs	73	7	infection	infection	NN
cord-281487-x0a9qgjs	73	8	of	of	IN
cord-281487-x0a9qgjs	73	9	SARS	SARS	NNP
cord-281487-x0a9qgjs	73	10	-	-	HYPH
cord-281487-x0a9qgjs	73	11	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	73	12	in	in	IN
cord-281487-x0a9qgjs	73	13	podocytes	podocyte	NNS
cord-281487-x0a9qgjs	73	14	and	and	CC
cord-281487-x0a9qgjs	73	15	proximal	proximal	JJ
cord-281487-x0a9qgjs	73	16	tubular	tubular	JJ
cord-281487-x0a9qgjs	73	17	cells	cell	NNS
cord-281487-x0a9qgjs	73	18	[	[	-LRB-
cord-281487-x0a9qgjs	73	19	38	38	CD
cord-281487-x0a9qgjs	73	20	]	]	-RRB-
cord-281487-x0a9qgjs	73	21	.	.	.
cord-281487-x0a9qgjs	74	1	Patients	patient	NNS
cord-281487-x0a9qgjs	74	2	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	74	3	with	with	IN
cord-281487-x0a9qgjs	74	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	74	5	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	75	1	were	be	VBD
cord-281487-x0a9qgjs	75	2	included	include	VBN
cord-281487-x0a9qgjs	75	3	Abbreviations	abbreviation	NNS
cord-281487-x0a9qgjs	75	4	:	:	:
cord-281487-x0a9qgjs	75	5	CHF	CHF	NNP
cord-281487-x0a9qgjs	75	6	,	,	,
cord-281487-x0a9qgjs	75	7	congestive	congestive	JJ
cord-281487-x0a9qgjs	75	8	heart	heart	NN
cord-281487-x0a9qgjs	75	9	failure	failure	NN
cord-281487-x0a9qgjs	75	10	;	;	:
cord-281487-x0a9qgjs	75	11	Because	because	IN
cord-281487-x0a9qgjs	75	12	renal	renal	JJ
cord-281487-x0a9qgjs	75	13	abnormalities	abnormality	NNS
cord-281487-x0a9qgjs	75	14	are	be	VBP
cord-281487-x0a9qgjs	75	15	associated	associate	VBN
cord-281487-x0a9qgjs	75	16	with	with	IN
cord-281487-x0a9qgjs	75	17	a	a	DT
cord-281487-x0a9qgjs	75	18	high	high	JJ
cord-281487-x0a9qgjs	75	19	risk	risk	NN
cord-281487-x0a9qgjs	75	20	of	of	IN
cord-281487-x0a9qgjs	75	21	in	in	IN
cord-281487-x0a9qgjs	75	22	-	-	HYPH
cord-281487-x0a9qgjs	75	23	hospital	hospital	NN
cord-281487-x0a9qgjs	75	24	death	death	NN
cord-281487-x0a9qgjs	75	25	and	and	CC
cord-281487-x0a9qgjs	75	26	appear	appear	VBP
cord-281487-x0a9qgjs	75	27	to	to	TO
cord-281487-x0a9qgjs	75	28	be	be	VB
cord-281487-x0a9qgjs	75	29	more	more	RBR
cord-281487-x0a9qgjs	75	30	prevalent	prevalent	JJ
cord-281487-x0a9qgjs	75	31	in	in	IN
cord-281487-x0a9qgjs	75	32	transplant	transplant	NN
cord-281487-x0a9qgjs	75	33	recipients	recipient	NNS
cord-281487-x0a9qgjs	75	34	[	[	-LRB-
cord-281487-x0a9qgjs	75	35	36	36	CD
cord-281487-x0a9qgjs	75	36	]	]	-RRB-
cord-281487-x0a9qgjs	75	37	,	,	,
cord-281487-x0a9qgjs	75	38	serum	serum	NN
cord-281487-x0a9qgjs	75	39	creatinine	creatinine	NN
cord-281487-x0a9qgjs	75	40	and	and	CC
cord-281487-x0a9qgjs	75	41	urinalysis	urinalysis	NN
cord-281487-x0a9qgjs	75	42	should	should	MD
cord-281487-x0a9qgjs	75	43	be	be	VB
cord-281487-x0a9qgjs	75	44	monitored	monitor	VBN
cord-281487-x0a9qgjs	75	45	closely	closely	RB
cord-281487-x0a9qgjs	75	46	.	.	.
cord-281487-x0a9qgjs	76	1	Thrombotic	thrombotic	JJ
cord-281487-x0a9qgjs	76	2	complications	complication	NNS
cord-281487-x0a9qgjs	76	3	have	have	VBP
cord-281487-x0a9qgjs	76	4	been	be	VBN
cord-281487-x0a9qgjs	76	5	reported	report	VBN
cord-281487-x0a9qgjs	76	6	to	to	TO
cord-281487-x0a9qgjs	76	7	occur	occur	VB
cord-281487-x0a9qgjs	76	8	in	in	IN
cord-281487-x0a9qgjs	76	9	31	31	CD
cord-281487-x0a9qgjs	76	10	%	%	NN
cord-281487-x0a9qgjs	76	11	of	of	IN
cord-281487-x0a9qgjs	76	12	intensive	intensive	JJ
cord-281487-x0a9qgjs	76	13	care	care	NN
cord-281487-x0a9qgjs	76	14	unit	unit	NN
cord-281487-x0a9qgjs	76	15	(	(	-LRB-
cord-281487-x0a9qgjs	76	16	ICU	ICU	NNP
cord-281487-x0a9qgjs	76	17	)	)	-RRB-
cord-281487-x0a9qgjs	76	18	patients	patient	NNS
cord-281487-x0a9qgjs	76	19	with	with	IN
cord-281487-x0a9qgjs	76	20	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	76	21	and	and	CC
cord-281487-x0a9qgjs	76	22	pulmonary	pulmonary	JJ
cord-281487-x0a9qgjs	76	23	thromboembolism	thromboembolism	NN
cord-281487-x0a9qgjs	76	24	was	be	VBD
cord-281487-x0a9qgjs	76	25	the	the	DT
cord-281487-x0a9qgjs	76	26	most	most	RBS
cord-281487-x0a9qgjs	76	27	frequent	frequent	JJ
cord-281487-x0a9qgjs	76	28	among	among	IN
cord-281487-x0a9qgjs	76	29	them	-PRON-	PRP
cord-281487-x0a9qgjs	76	30	[	[	-LRB-
cord-281487-x0a9qgjs	76	31	39	39	CD
cord-281487-x0a9qgjs	76	32	]	]	-RRB-
cord-281487-x0a9qgjs	76	33	.	.	.
cord-281487-x0a9qgjs	77	1	Typical	typical	JJ
cord-281487-x0a9qgjs	77	2	findings	finding	NNS
cord-281487-x0a9qgjs	77	3	include	include	VBP
cord-281487-x0a9qgjs	77	4	an	an	DT
cord-281487-x0a9qgjs	77	5	increased	increase	VBN
cord-281487-x0a9qgjs	77	6	D	d	NN
cord-281487-x0a9qgjs	77	7	-	-	HYPH
cord-281487-x0a9qgjs	77	8	dimer	dimer	JJ
cord-281487-x0a9qgjs	77	9	level	level	NN
cord-281487-x0a9qgjs	77	10	,	,	,
cord-281487-x0a9qgjs	77	11	a	a	DT
cord-281487-x0a9qgjs	77	12	relatively	relatively	RB
cord-281487-x0a9qgjs	77	13	modest	modest	JJ
cord-281487-x0a9qgjs	77	14	decrease	decrease	NN
cord-281487-x0a9qgjs	77	15	in	in	IN
cord-281487-x0a9qgjs	77	16	platelet	platelet	NN
cord-281487-x0a9qgjs	77	17	count	count	NN
cord-281487-x0a9qgjs	77	18	,	,	,
cord-281487-x0a9qgjs	77	19	and	and	CC
cord-281487-x0a9qgjs	77	20	a	a	DT
cord-281487-x0a9qgjs	77	21	prolongation	prolongation	NN
cord-281487-x0a9qgjs	77	22	of	of	IN
cord-281487-x0a9qgjs	77	23	the	the	DT
cord-281487-x0a9qgjs	77	24	prothrombin	prothrombin	JJ
cord-281487-x0a9qgjs	77	25	time	time	NN
cord-281487-x0a9qgjs	77	26	in	in	IN
cord-281487-x0a9qgjs	77	27	patients	patient	NNS
cord-281487-x0a9qgjs	77	28	with	with	IN
cord-281487-x0a9qgjs	77	29	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	77	30	[	[	-LRB-
cord-281487-x0a9qgjs	77	31	40	40	CD
cord-281487-x0a9qgjs	77	32	]	]	-RRB-
cord-281487-x0a9qgjs	77	33	.	.	.
cord-281487-x0a9qgjs	78	1	At	at	IN
cord-281487-x0a9qgjs	78	2	autopsy	autopsy	NN
cord-281487-x0a9qgjs	78	3	of	of	IN
cord-281487-x0a9qgjs	78	4	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	78	5	patients	patient	NNS
cord-281487-x0a9qgjs	78	6	,	,	,
cord-281487-x0a9qgjs	78	7	segmental	segmental	JJ
cord-281487-x0a9qgjs	78	8	fibrin	fibrin	NN
cord-281487-x0a9qgjs	78	9	thrombosis	thrombosis	NN
cord-281487-x0a9qgjs	78	10	in	in	IN
cord-281487-x0a9qgjs	78	11	glomeruli	glomerulus	NNS
cord-281487-x0a9qgjs	78	12	was	be	VBD
cord-281487-x0a9qgjs	78	13	observed	observe	VBN
cord-281487-x0a9qgjs	78	14	in	in	IN
cord-281487-x0a9qgjs	78	15	renal	renal	JJ
cord-281487-x0a9qgjs	78	16	findings	finding	NNS
cord-281487-x0a9qgjs	78	17	[	[	-LRB-
cord-281487-x0a9qgjs	78	18	41	41	CD
cord-281487-x0a9qgjs	78	19	]	]	-RRB-
cord-281487-x0a9qgjs	78	20	.	.	.
cord-281487-x0a9qgjs	79	1	Considering	consider	VBG
cord-281487-x0a9qgjs	79	2	that	that	DT
cord-281487-x0a9qgjs	79	3	immobilization	immobilization	NN
cord-281487-x0a9qgjs	79	4	and	and	CC
cord-281487-x0a9qgjs	79	5	vascular	vascular	JJ
cord-281487-x0a9qgjs	79	6	damage	damage	NN
cord-281487-x0a9qgjs	79	7	increase	increase	VBP
cord-281487-x0a9qgjs	79	8	the	the	DT
cord-281487-x0a9qgjs	79	9	risk	risk	NN
cord-281487-x0a9qgjs	79	10	of	of	IN
cord-281487-x0a9qgjs	79	11	thrombosis	thrombosis	NN
cord-281487-x0a9qgjs	79	12	[	[	-LRB-
cord-281487-x0a9qgjs	79	13	40	40	CD
cord-281487-x0a9qgjs	79	14	]	]	-RRB-
cord-281487-x0a9qgjs	79	15	,	,	,
cord-281487-x0a9qgjs	79	16	thrombotic	thrombotic	JJ
cord-281487-x0a9qgjs	79	17	complications	complication	NNS
cord-281487-x0a9qgjs	79	18	of	of	IN
cord-281487-x0a9qgjs	79	19	allografts	allograft	NNS
cord-281487-x0a9qgjs	79	20	may	may	MD
cord-281487-x0a9qgjs	79	21	be	be	VB
cord-281487-x0a9qgjs	79	22	more	more	RBR
cord-281487-x0a9qgjs	79	23	common	common	JJ
cord-281487-x0a9qgjs	79	24	in	in	IN
cord-281487-x0a9qgjs	79	25	transplant	transplant	NN
cord-281487-x0a9qgjs	79	26	recipients	recipient	NNS
cord-281487-x0a9qgjs	79	27	with	with	IN
cord-281487-x0a9qgjs	79	28	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	79	29	.	.	.
cord-281487-x0a9qgjs	80	1	The	the	DT
cord-281487-x0a9qgjs	80	2	International	International	NNP
cord-281487-x0a9qgjs	80	3	Society	Society	NNP
cord-281487-x0a9qgjs	80	4	of	of	IN
cord-281487-x0a9qgjs	80	5	Thrombosis	Thrombosis	NNP
cord-281487-x0a9qgjs	80	6	and	and	CC
cord-281487-x0a9qgjs	80	7	Haemostasis	Haemostasis	NNP
cord-281487-x0a9qgjs	80	8	(	(	-LRB-
cord-281487-x0a9qgjs	80	9	ISTH	ISTH	NNP
cord-281487-x0a9qgjs	80	10	)	)	-RRB-
cord-281487-x0a9qgjs	80	11	published	publish	VBD
cord-281487-x0a9qgjs	80	12	an	an	DT
cord-281487-x0a9qgjs	80	13	interim	interim	JJ
cord-281487-x0a9qgjs	80	14	guidance	guidance	NN
cord-281487-x0a9qgjs	80	15	statement	statement	NN
cord-281487-x0a9qgjs	80	16	recommending	recommend	VBG
cord-281487-x0a9qgjs	80	17	that	that	IN
cord-281487-x0a9qgjs	80	18	prothrombin	prothrombin	NN
cord-281487-x0a9qgjs	80	19	time	time	NN
cord-281487-x0a9qgjs	80	20	,	,	,
cord-281487-x0a9qgjs	80	21	platelet	platelet	NN
cord-281487-x0a9qgjs	80	22	count	count	NN
cord-281487-x0a9qgjs	80	23	,	,	,
cord-281487-x0a9qgjs	80	24	and	and	CC
cord-281487-x0a9qgjs	80	25	D	d	NN
cord-281487-x0a9qgjs	80	26	-	-	HYPH
cord-281487-x0a9qgjs	80	27	dimer	dimer	NN
cord-281487-x0a9qgjs	80	28	concentrations	concentration	NNS
cord-281487-x0a9qgjs	80	29	should	should	MD
cord-281487-x0a9qgjs	80	30	be	be	VB
cord-281487-x0a9qgjs	80	31	monitored	monitor	VBN
cord-281487-x0a9qgjs	80	32	once	once	RB
cord-281487-x0a9qgjs	80	33	or	or	CC
cord-281487-x0a9qgjs	80	34	twice	twice	RB
cord-281487-x0a9qgjs	80	35	daily	daily	RB
cord-281487-x0a9qgjs	80	36	in	in	IN
cord-281487-x0a9qgjs	80	37	patients	patient	NNS
cord-281487-x0a9qgjs	80	38	with	with	IN
cord-281487-x0a9qgjs	80	39	severe	severe	JJ
cord-281487-x0a9qgjs	80	40	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	80	41	[	[	-LRB-
cord-281487-x0a9qgjs	80	42	29	29	CD
cord-281487-x0a9qgjs	80	43	]	]	-RRB-
cord-281487-x0a9qgjs	80	44	.	.	.
cord-281487-x0a9qgjs	81	1	The	the	DT
cord-281487-x0a9qgjs	81	2	prevalence	prevalence	NN
cord-281487-x0a9qgjs	81	3	of	of	IN
cord-281487-x0a9qgjs	81	4	co	co	NN
cord-281487-x0a9qgjs	81	5	-	-	NN
cord-281487-x0a9qgjs	81	6	infection	infection	NN
cord-281487-x0a9qgjs	81	7	among	among	IN
cord-281487-x0a9qgjs	81	8	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	81	9	patients	patient	NNS
cord-281487-x0a9qgjs	81	10	ranges	range	VBZ
cord-281487-x0a9qgjs	81	11	from	from	IN
cord-281487-x0a9qgjs	81	12	0	0	CD
cord-281487-x0a9qgjs	81	13	%	%	NN
cord-281487-x0a9qgjs	81	14	to	to	TO
cord-281487-x0a9qgjs	81	15	45	45	CD
cord-281487-x0a9qgjs	81	16	%	%	NN
cord-281487-x0a9qgjs	81	17	overall	overall	JJ
cord-281487-x0a9qgjs	81	18	[	[	-LRB-
cord-281487-x0a9qgjs	81	19	42	42	CD
cord-281487-x0a9qgjs	81	20	]	]	-RRB-
cord-281487-x0a9qgjs	81	21	.	.	.
cord-281487-x0a9qgjs	82	1	In	in	IN
cord-281487-x0a9qgjs	82	2	a	a	DT
cord-281487-x0a9qgjs	82	3	report	report	NN
cord-281487-x0a9qgjs	82	4	by	by	IN
cord-281487-x0a9qgjs	82	5	Zhou	Zhou	NNP
cord-281487-x0a9qgjs	82	6	et	et	NNP
cord-281487-x0a9qgjs	82	7	al	al	NNP
cord-281487-x0a9qgjs	82	8	.	.	.
cord-281487-x0a9qgjs	83	1	,	,	,
cord-281487-x0a9qgjs	83	2	the	the	DT
cord-281487-x0a9qgjs	83	3	incidence	incidence	NN
cord-281487-x0a9qgjs	83	4	of	of	IN
cord-281487-x0a9qgjs	83	5	co	co	NN
cord-281487-x0a9qgjs	83	6	-	-	NN
cord-281487-x0a9qgjs	83	7	infection	infection	NN
cord-281487-x0a9qgjs	83	8	was	be	VBD
cord-281487-x0a9qgjs	83	9	50	50	CD
cord-281487-x0a9qgjs	83	10	%	%	NN
cord-281487-x0a9qgjs	83	11	in	in	IN
cord-281487-x0a9qgjs	83	12	non	non	NNS
cord-281487-x0a9qgjs	83	13	-	-	NNS
cord-281487-x0a9qgjs	83	14	survivors	survivor	NNS
cord-281487-x0a9qgjs	83	15	[	[	-LRB-
cord-281487-x0a9qgjs	83	16	30	30	CD
cord-281487-x0a9qgjs	83	17	]	]	-RRB-
cord-281487-x0a9qgjs	83	18	.	.	.
cord-281487-x0a9qgjs	84	1	Bacterial	bacterial	JJ
cord-281487-x0a9qgjs	84	2	,	,	,
cord-281487-x0a9qgjs	84	3	viral	viral	JJ
cord-281487-x0a9qgjs	84	4	and	and	CC
cord-281487-x0a9qgjs	84	5	fungal	fungal	JJ
cord-281487-x0a9qgjs	84	6	infections	infection	NNS
cord-281487-x0a9qgjs	84	7	have	have	VBP
cord-281487-x0a9qgjs	84	8	all	all	DT
cord-281487-x0a9qgjs	84	9	been	be	VBN
cord-281487-x0a9qgjs	84	10	documented	document	VBN
cord-281487-x0a9qgjs	84	11	and	and	CC
cord-281487-x0a9qgjs	84	12	may	may	MD
cord-281487-x0a9qgjs	84	13	need	need	VB
cord-281487-x0a9qgjs	84	14	specialized	specialized	JJ
cord-281487-x0a9qgjs	84	15	diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	84	16	microbiology	microbiology	NN
cord-281487-x0a9qgjs	84	17	to	to	TO
cord-281487-x0a9qgjs	84	18	identify	identify	VB
cord-281487-x0a9qgjs	84	19	these	these	DT
cord-281487-x0a9qgjs	84	20	serious	serious	JJ
cord-281487-x0a9qgjs	84	21	complications	complication	NNS
cord-281487-x0a9qgjs	84	22	[	[	-LRB-
cord-281487-x0a9qgjs	84	23	42	42	CD
cord-281487-x0a9qgjs	84	24	]	]	-RRB-
cord-281487-x0a9qgjs	84	25	.	.	.
cord-281487-x0a9qgjs	85	1	Most	Most	JJS
cord-281487-x0a9qgjs	85	2	co	co	NNS
cord-281487-x0a9qgjs	85	3	-	-	NNS
cord-281487-x0a9qgjs	85	4	infections	infection	NNS
cord-281487-x0a9qgjs	85	5	occurred	occur	VBD
cord-281487-x0a9qgjs	85	6	within	within	IN
cord-281487-x0a9qgjs	85	7	1−4	1−4	CD
cord-281487-x0a9qgjs	85	8	days	day	NNS
cord-281487-x0a9qgjs	85	9	of	of	IN
cord-281487-x0a9qgjs	85	10	onset	onset	NN
cord-281487-x0a9qgjs	85	11	of	of	IN
cord-281487-x0a9qgjs	85	12	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	85	13	disease	disease	NN
cord-281487-x0a9qgjs	85	14	[	[	-LRB-
cord-281487-x0a9qgjs	85	15	31	31	CD
cord-281487-x0a9qgjs	85	16	]	]	-RRB-
cord-281487-x0a9qgjs	85	17	.	.	.
cord-281487-x0a9qgjs	86	1	Generally	generally	RB
cord-281487-x0a9qgjs	86	2	,	,	,
cord-281487-x0a9qgjs	86	3	transplant	transplant	NN
cord-281487-x0a9qgjs	86	4	recipients	recipient	NNS
cord-281487-x0a9qgjs	86	5	experience	experience	NN
cord-281487-x0a9qgjs	86	6	co	co	NN
cord-281487-x0a9qgjs	86	7	-	-	NN
cord-281487-x0a9qgjs	86	8	infection	infection	NN
cord-281487-x0a9qgjs	86	9	more	more	RBR
cord-281487-x0a9qgjs	86	10	commonly	commonly	RB
cord-281487-x0a9qgjs	86	11	than	than	IN
cord-281487-x0a9qgjs	86	12	immunocompetent	immunocompetent	JJ
cord-281487-x0a9qgjs	86	13	individuals	individual	NNS
cord-281487-x0a9qgjs	86	14	[	[	-LRB-
cord-281487-x0a9qgjs	86	15	43	43	CD
cord-281487-x0a9qgjs	86	16	]	]	-RRB-
cord-281487-x0a9qgjs	86	17	.	.	.
cord-281487-x0a9qgjs	87	1	In	in	IN
cord-281487-x0a9qgjs	87	2	a	a	DT
cord-281487-x0a9qgjs	87	3	report	report	NN
cord-281487-x0a9qgjs	87	4	by	by	IN
cord-281487-x0a9qgjs	87	5	Roberts	Roberts	NNP
cord-281487-x0a9qgjs	87	6	et	et	NNP
cord-281487-x0a9qgjs	87	7	al	al	NNP
cord-281487-x0a9qgjs	87	8	.	.	.
cord-281487-x0a9qgjs	88	1	,	,	,
cord-281487-x0a9qgjs	88	2	co	co	NN
cord-281487-x0a9qgjs	88	3	-	-	NN
cord-281487-x0a9qgjs	88	4	infection	infection	NN
cord-281487-x0a9qgjs	88	5	was	be	VBD
cord-281487-x0a9qgjs	88	6	22	22	CD
cord-281487-x0a9qgjs	88	7	%	%	NN
cord-281487-x0a9qgjs	88	8	and	and	CC
cord-281487-x0a9qgjs	88	9	35	35	CD
cord-281487-x0a9qgjs	88	10	%	%	NN
cord-281487-x0a9qgjs	88	11	in	in	IN
cord-281487-x0a9qgjs	88	12	transplant	transplant	NN
cord-281487-x0a9qgjs	88	13	recipients	recipient	NNS
cord-281487-x0a9qgjs	88	14	with	with	IN
cord-281487-x0a9qgjs	88	15	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	88	16	and	and	CC
cord-281487-x0a9qgjs	88	17	those	those	DT
cord-281487-x0a9qgjs	88	18	admitted	admit	VBN
cord-281487-x0a9qgjs	88	19	to	to	IN
cord-281487-x0a9qgjs	88	20	ICU	ICU	NNP
cord-281487-x0a9qgjs	88	21	[	[	-LRB-
cord-281487-x0a9qgjs	88	22	12	12	CD
cord-281487-x0a9qgjs	88	23	]	]	-RRB-
cord-281487-x0a9qgjs	88	24	.	.	.
cord-281487-x0a9qgjs	89	1	Thus	thus	RB
cord-281487-x0a9qgjs	89	2	,	,	,
cord-281487-x0a9qgjs	89	3	transplant	transplant	NN
cord-281487-x0a9qgjs	89	4	recipients	recipient	NNS
cord-281487-x0a9qgjs	89	5	should	should	MD
cord-281487-x0a9qgjs	89	6	be	be	VB
cord-281487-x0a9qgjs	89	7	evaluated	evaluate	VBN
cord-281487-x0a9qgjs	89	8	for	for	IN
cord-281487-x0a9qgjs	89	9	Abbreviations	abbreviation	NNS
cord-281487-x0a9qgjs	89	10	:	:	:
cord-281487-x0a9qgjs	90	1	AST	AST	NNP
cord-281487-x0a9qgjs	90	2	,	,	,
cord-281487-x0a9qgjs	90	3	Aspartate	aspartate	JJ
cord-281487-x0a9qgjs	90	4	amino	amino	NN
cord-281487-x0a9qgjs	90	5	transferase	transferase	NN
cord-281487-x0a9qgjs	90	6	;	;	:
cord-281487-x0a9qgjs	90	7	ALT	ALT	NNP
cord-281487-x0a9qgjs	90	8	,	,	,
cord-281487-x0a9qgjs	90	9	Alanine	Alanine	NNP
cord-281487-x0a9qgjs	90	10	amino	amino	NN
cord-281487-x0a9qgjs	90	11	transferase	transferase	NN
cord-281487-x0a9qgjs	90	12	;	;	:
cord-281487-x0a9qgjs	90	13	BUN	bun	NN
cord-281487-x0a9qgjs	90	14	,	,	,
cord-281487-x0a9qgjs	90	15	blood	blood	NN
cord-281487-x0a9qgjs	90	16	urea	urea	NN
cord-281487-x0a9qgjs	90	17	nitrogen	nitrogen	NN
cord-281487-x0a9qgjs	90	18	;	;	:
cord-281487-x0a9qgjs	90	19	LDH	LDH	NNP
cord-281487-x0a9qgjs	90	20	,	,	,
cord-281487-x0a9qgjs	90	21	Lactate	Lactate	NNP
cord-281487-x0a9qgjs	90	22	dehydrogenase	dehydrogenase	NN
cord-281487-x0a9qgjs	90	23	;	;	:
cord-281487-x0a9qgjs	90	24	CPK	CPK	NNP
cord-281487-x0a9qgjs	90	25	,	,	,
cord-281487-x0a9qgjs	90	26	Creatinine	creatinine	NN
cord-281487-x0a9qgjs	90	27	phosphokinase	phosphokinase	NN
cord-281487-x0a9qgjs	90	28	;	;	:
cord-281487-x0a9qgjs	90	29	CRP	CRP	NNP
cord-281487-x0a9qgjs	90	30	,	,	,
cord-281487-x0a9qgjs	90	31	C	C	NNP
cord-281487-x0a9qgjs	90	32	-	-	HYPH
cord-281487-x0a9qgjs	90	33	reactive	reactive	JJ
cord-281487-x0a9qgjs	90	34	protein	protein	NN
cord-281487-x0a9qgjs	90	35	;	;	:
cord-281487-x0a9qgjs	90	36	IL-6	IL-6	NNP
cord-281487-x0a9qgjs	90	37	,	,	,
cord-281487-x0a9qgjs	90	38	interleukin-6	interleukin-6	NNP
cord-281487-x0a9qgjs	90	39	;	;	:
cord-281487-x0a9qgjs	90	40	CMV	CMV	NNP
cord-281487-x0a9qgjs	90	41	,	,	,
cord-281487-x0a9qgjs	90	42	cytomegalovirus	cytomegalovirus	NN
cord-281487-x0a9qgjs	90	43	;	;	:
cord-281487-x0a9qgjs	90	44	ECG	ECG	NNP
cord-281487-x0a9qgjs	90	45	,	,	,
cord-281487-x0a9qgjs	90	46	electrocardiogram	electrocardiogram	VB
cord-281487-x0a9qgjs	90	47	bacterial	bacterial	JJ
cord-281487-x0a9qgjs	90	48	and	and	CC
cord-281487-x0a9qgjs	90	49	opportunistic	opportunistic	JJ
cord-281487-x0a9qgjs	90	50	fungal	fungal	JJ
cord-281487-x0a9qgjs	90	51	infections	infection	NNS
cord-281487-x0a9qgjs	90	52	when	when	WRB
cord-281487-x0a9qgjs	90	53	diagnosed	diagnose	VBN
cord-281487-x0a9qgjs	90	54	with	with	IN
cord-281487-x0a9qgjs	90	55	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	90	56	.	.	.
cord-281487-x0a9qgjs	91	1	Cytomegalovirus	Cytomegalovirus	NNP
cord-281487-x0a9qgjs	91	2	(	(	-LRB-
cord-281487-x0a9qgjs	91	3	CMV	CMV	NNP
cord-281487-x0a9qgjs	91	4	)	)	-RRB-
cord-281487-x0a9qgjs	91	5	is	be	VBZ
cord-281487-x0a9qgjs	91	6	common	common	JJ
cord-281487-x0a9qgjs	91	7	in	in	IN
cord-281487-x0a9qgjs	91	8	transplant	transplant	NN
cord-281487-x0a9qgjs	91	9	recipients	recipient	NNS
cord-281487-x0a9qgjs	91	10	and	and	CC
cord-281487-x0a9qgjs	91	11	may	may	MD
cord-281487-x0a9qgjs	91	12	reactivate	reactivate	VB
cord-281487-x0a9qgjs	91	13	under	under	IN
cord-281487-x0a9qgjs	91	14	conditions	condition	NNS
cord-281487-x0a9qgjs	91	15	of	of	IN
cord-281487-x0a9qgjs	91	16	stress	stress	NN
cord-281487-x0a9qgjs	91	17	or	or	CC
cord-281487-x0a9qgjs	91	18	augmented	augment	VBN
cord-281487-x0a9qgjs	91	19	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	91	20	[	[	-LRB-
cord-281487-x0a9qgjs	91	21	43	43	CD
cord-281487-x0a9qgjs	91	22	]	]	-RRB-
cord-281487-x0a9qgjs	91	23	.	.	.
cord-281487-x0a9qgjs	92	1	Table	table	NN
cord-281487-x0a9qgjs	92	2	3	3	CD
cord-281487-x0a9qgjs	92	3	shows	show	VBZ
cord-281487-x0a9qgjs	92	4	tests	test	NNS
cord-281487-x0a9qgjs	92	5	that	that	IN
cord-281487-x0a9qgjs	92	6	the	the	DT
cord-281487-x0a9qgjs	92	7	JH	JH	NNP
cord-281487-x0a9qgjs	92	8	-	-	HYPH
cord-281487-x0a9qgjs	92	9	CTC	CTC	NNP
cord-281487-x0a9qgjs	92	10	examines	examine	VBZ
cord-281487-x0a9qgjs	92	11	:	:	:
cord-281487-x0a9qgjs	92	12	a	a	DT
cord-281487-x0a9qgjs	92	13	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	92	14	viral	viral	JJ
cord-281487-x0a9qgjs	92	15	panel	panel	NN
cord-281487-x0a9qgjs	92	16	,	,	,
cord-281487-x0a9qgjs	92	17	urine	urine	NN
cord-281487-x0a9qgjs	92	18	legionella	legionella	NN
cord-281487-x0a9qgjs	92	19	and	and	CC
cord-281487-x0a9qgjs	92	20	pneumococcal	pneumococcal	JJ
cord-281487-x0a9qgjs	92	21	antigen	antigen	NN
cord-281487-x0a9qgjs	92	22	,	,	,
cord-281487-x0a9qgjs	92	23	culture	culture	NN
cord-281487-x0a9qgjs	92	24	of	of	IN
cord-281487-x0a9qgjs	92	25	blood	blood	NN
cord-281487-x0a9qgjs	92	26	and	and	CC
cord-281487-x0a9qgjs	92	27	urine	urine	NN
cord-281487-x0a9qgjs	92	28	for	for	IN
cord-281487-x0a9qgjs	92	29	bacteria	bacteria	NNS
cord-281487-x0a9qgjs	92	30	and	and	CC
cord-281487-x0a9qgjs	92	31	fungi	fungus	NNS
cord-281487-x0a9qgjs	92	32	,	,	,
cord-281487-x0a9qgjs	92	33	CMV	CMV	NNP
cord-281487-x0a9qgjs	92	34	antigenemia	antigenemia	NN
cord-281487-x0a9qgjs	92	35	and	and	CC
cord-281487-x0a9qgjs	92	36	PCR	PCR	NNP
cord-281487-x0a9qgjs	92	37	,	,	,
cord-281487-x0a9qgjs	92	38	β	β	NN
cord-281487-x0a9qgjs	92	39	-	-	HYPH
cord-281487-x0a9qgjs	92	40	d	d	NN
cord-281487-x0a9qgjs	92	41	-	-	HYPH
cord-281487-x0a9qgjs	92	42	glucan	glucan	JJ
cord-281487-x0a9qgjs	92	43	and	and	CC
cord-281487-x0a9qgjs	92	44	galactomannan	galactomannan	NNP
cord-281487-x0a9qgjs	92	45	,	,	,
cord-281487-x0a9qgjs	92	46	cryptococcal	cryptococcal	JJ
cord-281487-x0a9qgjs	92	47	antigen	antigen	NN
cord-281487-x0a9qgjs	92	48	,	,	,
cord-281487-x0a9qgjs	92	49	histoplasma	histoplasma	NN
cord-281487-x0a9qgjs	92	50	antigen	antigen	NN
cord-281487-x0a9qgjs	92	51	in	in	IN
cord-281487-x0a9qgjs	92	52	serum	serum	NN
cord-281487-x0a9qgjs	92	53	and	and	CC
cord-281487-x0a9qgjs	92	54	urine	urine	NN
cord-281487-x0a9qgjs	92	55	,	,	,
cord-281487-x0a9qgjs	92	56	Clostridium	clostridium	NN
cord-281487-x0a9qgjs	92	57	difficile	difficile	NN
cord-281487-x0a9qgjs	92	58	toxin	toxin	NN
cord-281487-x0a9qgjs	92	59	assay	assay	NN
cord-281487-x0a9qgjs	92	60	.	.	.
cord-281487-x0a9qgjs	93	1	While	while	IN
cord-281487-x0a9qgjs	93	2	bronchoscopy	bronchoscopy	NN
cord-281487-x0a9qgjs	93	3	is	be	VBZ
cord-281487-x0a9qgjs	93	4	not	not	RB
cord-281487-x0a9qgjs	93	5	routinely	routinely	RB
cord-281487-x0a9qgjs	93	6	available	available	JJ
cord-281487-x0a9qgjs	93	7	,	,	,
cord-281487-x0a9qgjs	93	8	tracheal	tracheal	JJ
cord-281487-x0a9qgjs	93	9	aspirates	aspirate	NNS
cord-281487-x0a9qgjs	93	10	could	could	MD
cord-281487-x0a9qgjs	93	11	be	be	VB
cord-281487-x0a9qgjs	93	12	considered	consider	VBN
cord-281487-x0a9qgjs	93	13	for	for	IN
cord-281487-x0a9qgjs	93	14	intubated	intubate	VBN
cord-281487-x0a9qgjs	93	15	patients	patient	NNS
cord-281487-x0a9qgjs	93	16	to	to	TO
cord-281487-x0a9qgjs	93	17	obtain	obtain	VB
cord-281487-x0a9qgjs	93	18	microbiological	microbiological	JJ
cord-281487-x0a9qgjs	93	19	samples	sample	NNS
cord-281487-x0a9qgjs	93	20	.	.	.
cord-281487-x0a9qgjs	94	1	In	in	IN
cord-281487-x0a9qgjs	94	2	instances	instance	NNS
cord-281487-x0a9qgjs	94	3	where	where	WRB
cord-281487-x0a9qgjs	94	4	the	the	DT
cord-281487-x0a9qgjs	94	5	risk	risk	NN
cord-281487-x0a9qgjs	94	6	of	of	IN
cord-281487-x0a9qgjs	94	7	diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	94	8	procedures	procedure	NNS
cord-281487-x0a9qgjs	94	9	may	may	MD
cord-281487-x0a9qgjs	94	10	be	be	VB
cord-281487-x0a9qgjs	94	11	precluded	preclude	VBN
cord-281487-x0a9qgjs	94	12	sample	sample	NN
cord-281487-x0a9qgjs	94	13	collection	collection	NN
cord-281487-x0a9qgjs	94	14	,	,	,
cord-281487-x0a9qgjs	94	15	empiric	empiric	JJ
cord-281487-x0a9qgjs	94	16	antibiotics	antibiotic	NNS
cord-281487-x0a9qgjs	94	17	,	,	,
cord-281487-x0a9qgjs	94	18	anti	anti	NNS
cord-281487-x0a9qgjs	94	19	-	-	NNS
cord-281487-x0a9qgjs	94	20	fungals	fungal	NNS
cord-281487-x0a9qgjs	94	21	,	,	,
cord-281487-x0a9qgjs	94	22	or	or	CC
cord-281487-x0a9qgjs	94	23	anti	anti	NNS
cord-281487-x0a9qgjs	94	24	-	-	NNS
cord-281487-x0a9qgjs	94	25	virals	viral	NNS
cord-281487-x0a9qgjs	94	26	should	should	MD
cord-281487-x0a9qgjs	94	27	be	be	VB
cord-281487-x0a9qgjs	94	28	carefully	carefully	RB
cord-281487-x0a9qgjs	94	29	considered	consider	VBN
cord-281487-x0a9qgjs	94	30	based	base	VBN
cord-281487-x0a9qgjs	94	31	on	on	IN
cord-281487-x0a9qgjs	94	32	the	the	DT
cord-281487-x0a9qgjs	94	33	organ	organ	NN
cord-281487-x0a9qgjs	94	34	-	-	HYPH
cord-281487-x0a9qgjs	94	35	specific	specific	JJ
cord-281487-x0a9qgjs	94	36	pathogen	pathogen	NN
cord-281487-x0a9qgjs	94	37	risks	risk	NNS
cord-281487-x0a9qgjs	94	38	.	.	.
cord-281487-x0a9qgjs	95	1	An	an	DT
cord-281487-x0a9qgjs	95	2	increase	increase	NN
cord-281487-x0a9qgjs	95	3	of	of	IN
cord-281487-x0a9qgjs	95	4	the	the	DT
cord-281487-x0a9qgjs	95	5	procalcitonin	procalcitonin	JJ
cord-281487-x0a9qgjs	95	6	level	level	NN
cord-281487-x0a9qgjs	95	7	reflects	reflect	VBZ
cord-281487-x0a9qgjs	95	8	bacterial	bacterial	JJ
cord-281487-x0a9qgjs	95	9	coinfection	coinfection	NN
cord-281487-x0a9qgjs	95	10	and	and	CC
cord-281487-x0a9qgjs	95	11	predicts	predict	VBZ
cord-281487-x0a9qgjs	95	12	the	the	DT
cord-281487-x0a9qgjs	95	13	progression	progression	NN
cord-281487-x0a9qgjs	95	14	toward	toward	IN
cord-281487-x0a9qgjs	95	15	severe	severe	JJ
cord-281487-x0a9qgjs	95	16	disease	disease	NN
cord-281487-x0a9qgjs	95	17	[	[	-LRB-
cord-281487-x0a9qgjs	95	18	44	44	CD
cord-281487-x0a9qgjs	95	19	]	]	-RRB-
cord-281487-x0a9qgjs	95	20	.	.	.
cord-281487-x0a9qgjs	96	1	Previously	previously	RB
cord-281487-x0a9qgjs	96	2	published	publish	VBN
cord-281487-x0a9qgjs	96	3	literatures	literature	NNS
cord-281487-x0a9qgjs	96	4	suggest	suggest	VBP
cord-281487-x0a9qgjs	96	5	that	that	IN
cord-281487-x0a9qgjs	96	6	procalcitonin	procalcitonin	NNS
cord-281487-x0a9qgjs	96	7	levels	level	NNS
cord-281487-x0a9qgjs	96	8	may	may	MD
cord-281487-x0a9qgjs	96	9	be	be	VB
cord-281487-x0a9qgjs	96	10	comparatively	comparatively	RB
cord-281487-x0a9qgjs	96	11	higher	high	JJR
cord-281487-x0a9qgjs	96	12	in	in	IN
cord-281487-x0a9qgjs	96	13	transplant	transplant	NN
cord-281487-x0a9qgjs	96	14	recipients	recipient	NNS
cord-281487-x0a9qgjs	96	15	with	with	IN
cord-281487-x0a9qgjs	96	16	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	96	17	than	than	IN
cord-281487-x0a9qgjs	96	18	in	in	IN
cord-281487-x0a9qgjs	96	19	the	the	DT
cord-281487-x0a9qgjs	96	20	general	general	JJ
cord-281487-x0a9qgjs	96	21	population	population	NN
cord-281487-x0a9qgjs	96	22	with	with	IN
cord-281487-x0a9qgjs	96	23	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	96	24	(	(	-LRB-
cord-281487-x0a9qgjs	96	25	Table	table	NN
cord-281487-x0a9qgjs	96	26	2	2	CD
cord-281487-x0a9qgjs	96	27	)	)	-RRB-
cord-281487-x0a9qgjs	96	28	[	[	-LRB-
cord-281487-x0a9qgjs	96	29	11	11	CD
cord-281487-x0a9qgjs	96	30	,	,	,
cord-281487-x0a9qgjs	96	31	17	17	CD
cord-281487-x0a9qgjs	96	32	,	,	,
cord-281487-x0a9qgjs	96	33	18	18	CD
cord-281487-x0a9qgjs	96	34	,	,	,
cord-281487-x0a9qgjs	96	35	21	21	CD
cord-281487-x0a9qgjs	96	36	,	,	,
cord-281487-x0a9qgjs	96	37	23	23	CD
cord-281487-x0a9qgjs	96	38	,	,	,
cord-281487-x0a9qgjs	96	39	24	24	CD
cord-281487-x0a9qgjs	96	40	]	]	-RRB-
cord-281487-x0a9qgjs	96	41	.	.	.
cord-281487-x0a9qgjs	97	1	The	the	DT
cord-281487-x0a9qgjs	97	2	monitoring	monitoring	NN
cord-281487-x0a9qgjs	97	3	of	of	IN
cord-281487-x0a9qgjs	97	4	procalcitonin	procalcitonin	NNS
cord-281487-x0a9qgjs	97	5	may	may	MD
cord-281487-x0a9qgjs	97	6	play	play	VB
cord-281487-x0a9qgjs	97	7	a	a	DT
cord-281487-x0a9qgjs	97	8	role	role	NN
cord-281487-x0a9qgjs	97	9	in	in	IN
cord-281487-x0a9qgjs	97	10	predicting	predict	VBG
cord-281487-x0a9qgjs	97	11	bacterial	bacterial	JJ
cord-281487-x0a9qgjs	97	12	infection	infection	NN
cord-281487-x0a9qgjs	97	13	in	in	IN
cord-281487-x0a9qgjs	97	14	the	the	DT
cord-281487-x0a9qgjs	97	15	absence	absence	NN
cord-281487-x0a9qgjs	97	16	of	of	IN
cord-281487-x0a9qgjs	97	17	direct	direct	JJ
cord-281487-x0a9qgjs	97	18	microbiology	microbiology	NN
cord-281487-x0a9qgjs	97	19	.	.	.
cord-281487-x0a9qgjs	98	1	Chest	chest	NN
cord-281487-x0a9qgjs	98	2	radiography	radiography	NN
cord-281487-x0a9qgjs	98	3	plays	play	VBZ
cord-281487-x0a9qgjs	98	4	an	an	DT
cord-281487-x0a9qgjs	98	5	important	important	JJ
cord-281487-x0a9qgjs	98	6	role	role	NN
cord-281487-x0a9qgjs	98	7	in	in	IN
cord-281487-x0a9qgjs	98	8	the	the	DT
cord-281487-x0a9qgjs	98	9	diagnosis	diagnosis	NN
cord-281487-x0a9qgjs	98	10	of	of	IN
cord-281487-x0a9qgjs	98	11	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	98	12	.	.	.
cord-281487-x0a9qgjs	99	1	Abnormal	abnormal	JJ
cord-281487-x0a9qgjs	99	2	findings	finding	NNS
cord-281487-x0a9qgjs	99	3	on	on	IN
cord-281487-x0a9qgjs	99	4	chest	chest	NN
cord-281487-x0a9qgjs	99	5	radiography	radiography	NN
cord-281487-x0a9qgjs	99	6	were	be	VBD
cord-281487-x0a9qgjs	99	7	identified	identify	VBN
cord-281487-x0a9qgjs	99	8	in	in	IN
cord-281487-x0a9qgjs	99	9	up	up	IN
cord-281487-x0a9qgjs	99	10	to	to	TO
cord-281487-x0a9qgjs	99	11	76.5	76.5	CD
cord-281487-x0a9qgjs	99	12	%	%	NN
cord-281487-x0a9qgjs	99	13	of	of	IN
cord-281487-x0a9qgjs	99	14	individuals	individual	NNS
cord-281487-x0a9qgjs	99	15	,	,	,
cord-281487-x0a9qgjs	99	16	and	and	CC
cord-281487-x0a9qgjs	99	17	abnormalities	abnormality	NNS
cord-281487-x0a9qgjs	99	18	on	on	IN
cord-281487-x0a9qgjs	99	19	chest	chest	NN
cord-281487-x0a9qgjs	99	20	computed	compute	VBN
cord-281487-x0a9qgjs	99	21	tomography	tomography	NN
cord-281487-x0a9qgjs	99	22	(	(	-LRB-
cord-281487-x0a9qgjs	99	23	CT	CT	NNP
cord-281487-x0a9qgjs	99	24	)	)	-RRB-
cord-281487-x0a9qgjs	99	25	were	be	VBD
cord-281487-x0a9qgjs	99	26	84.4	84.4	CD
cord-281487-x0a9qgjs	99	27	%	%	NN
cord-281487-x0a9qgjs	99	28	and	and	CC
cord-281487-x0a9qgjs	99	29	94.6	94.6	CD
cord-281487-x0a9qgjs	99	30	%	%	NN
cord-281487-x0a9qgjs	99	31	among	among	IN
cord-281487-x0a9qgjs	99	32	patients	patient	NNS
cord-281487-x0a9qgjs	99	33	with	with	IN
cord-281487-x0a9qgjs	99	34	non	non	JJ
cord-281487-x0a9qgjs	99	35	-	-	JJ
cord-281487-x0a9qgjs	99	36	severe	severe	JJ
cord-281487-x0a9qgjs	99	37	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	99	38	and	and	CC
cord-281487-x0a9qgjs	99	39	patients	patient	NNS
cord-281487-x0a9qgjs	99	40	with	with	IN
cord-281487-x0a9qgjs	99	41	severe	severe	JJ
cord-281487-x0a9qgjs	99	42	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	99	43	,	,	,
cord-281487-x0a9qgjs	99	44	respectively	respectively	RB
cord-281487-x0a9qgjs	99	45	[	[	-LRB-
cord-281487-x0a9qgjs	99	46	14	14	CD
cord-281487-x0a9qgjs	99	47	]	]	-RRB-
cord-281487-x0a9qgjs	99	48	.	.	.
cord-281487-x0a9qgjs	100	1	Despite	despite	IN
cord-281487-x0a9qgjs	100	2	a	a	DT
cord-281487-x0a9qgjs	100	3	higher	high	JJR
cord-281487-x0a9qgjs	100	4	sensitivity	sensitivity	NN
cord-281487-x0a9qgjs	100	5	,	,	,
cord-281487-x0a9qgjs	100	6	the	the	DT
cord-281487-x0a9qgjs	100	7	infectious	infectious	JJ
cord-281487-x0a9qgjs	100	8	precautions	precaution	NNS
cord-281487-x0a9qgjs	100	9	needed	need	VBN
cord-281487-x0a9qgjs	100	10	to	to	TO
cord-281487-x0a9qgjs	100	11	safely	safely	RB
cord-281487-x0a9qgjs	100	12	transport	transport	VB
cord-281487-x0a9qgjs	100	13	patients	patient	NNS
cord-281487-x0a9qgjs	100	14	with	with	IN
cord-281487-x0a9qgjs	100	15	COVID-19	covid-19	VB
cord-281487-x0a9qgjs	100	16	and	and	CC
cord-281487-x0a9qgjs	100	17	decontaminate	decontaminate	VB
cord-281487-x0a9qgjs	100	18	equipment	equipment	NN
cord-281487-x0a9qgjs	100	19	necessitate	necessitate	VBP
cord-281487-x0a9qgjs	100	20	thoughtful	thoughtful	JJ
cord-281487-x0a9qgjs	100	21	consideration	consideration	NN
cord-281487-x0a9qgjs	100	22	of	of	IN
cord-281487-x0a9qgjs	100	23	the	the	DT
cord-281487-x0a9qgjs	100	24	optimal	optimal	JJ
cord-281487-x0a9qgjs	100	25	use	use	NN
cord-281487-x0a9qgjs	100	26	of	of	IN
cord-281487-x0a9qgjs	100	27	CT	CT	NNP
cord-281487-x0a9qgjs	100	28	[	[	-LRB-
cord-281487-x0a9qgjs	100	29	45	45	CD
cord-281487-x0a9qgjs	100	30	,	,	,
cord-281487-x0a9qgjs	100	31	46	46	CD
cord-281487-x0a9qgjs	100	32	]	]	-RRB-
cord-281487-x0a9qgjs	100	33	.	.	.
cord-281487-x0a9qgjs	101	1	Alternative	alternative	JJ
cord-281487-x0a9qgjs	101	2	modalities	modality	NNS
cord-281487-x0a9qgjs	101	3	such	such	JJ
cord-281487-x0a9qgjs	101	4	as	as	IN
cord-281487-x0a9qgjs	101	5	lung	lung	NN
cord-281487-x0a9qgjs	101	6	ultrasonography	ultrasonography	NN
cord-281487-x0a9qgjs	101	7	may	may	MD
cord-281487-x0a9qgjs	101	8	provide	provide	VB
cord-281487-x0a9qgjs	101	9	results	result	NNS
cord-281487-x0a9qgjs	101	10	similar	similar	JJ
cord-281487-x0a9qgjs	101	11	to	to	IN
cord-281487-x0a9qgjs	101	12	chest	chest	NN
cord-281487-x0a9qgjs	101	13	CT	CT	NNP
cord-281487-x0a9qgjs	101	14	to	to	TO
cord-281487-x0a9qgjs	101	15	assess	assess	VB
cord-281487-x0a9qgjs	101	16	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	101	17	and	and	CC
cord-281487-x0a9qgjs	101	18	reduce	reduce	VB
cord-281487-x0a9qgjs	101	19	staff	staff	NN
cord-281487-x0a9qgjs	101	20	/	/	SYM
cord-281487-x0a9qgjs	101	21	equipment	equipment	NN
cord-281487-x0a9qgjs	101	22	exposure	exposure	NN
cord-281487-x0a9qgjs	101	23	[	[	-LRB-
cord-281487-x0a9qgjs	101	24	46	46	CD
cord-281487-x0a9qgjs	101	25	]	]	-RRB-
cord-281487-x0a9qgjs	101	26	[	[	-LRB-
cord-281487-x0a9qgjs	101	27	47	47	CD
cord-281487-x0a9qgjs	101	28	]	]	-RRB-
cord-281487-x0a9qgjs	101	29	[	[	-LRB-
cord-281487-x0a9qgjs	101	30	48	48	CD
cord-281487-x0a9qgjs	101	31	]	]	-RRB-
cord-281487-x0a9qgjs	101	32	.	.	.
cord-281487-x0a9qgjs	102	1	However	however	RB
cord-281487-x0a9qgjs	102	2	,	,	,
cord-281487-x0a9qgjs	102	3	CT	CT	NNP
cord-281487-x0a9qgjs	102	4	may	may	MD
cord-281487-x0a9qgjs	102	5	still	still	RB
cord-281487-x0a9qgjs	102	6	have	have	VB
cord-281487-x0a9qgjs	102	7	a	a	DT
cord-281487-x0a9qgjs	102	8	valuable	valuable	JJ
cord-281487-x0a9qgjs	102	9	role	role	NN
cord-281487-x0a9qgjs	102	10	in	in	IN
cord-281487-x0a9qgjs	102	11	the	the	DT
cord-281487-x0a9qgjs	102	12	evaluation	evaluation	NN
cord-281487-x0a9qgjs	102	13	of	of	IN
cord-281487-x0a9qgjs	102	14	pulmonary	pulmonary	JJ
cord-281487-x0a9qgjs	102	15	emboli	emboli	NN
cord-281487-x0a9qgjs	102	16	and/or	and/or	CC
cord-281487-x0a9qgjs	102	17	diagnosis	diagnosis	NN
cord-281487-x0a9qgjs	102	18	of	of	IN
cord-281487-x0a9qgjs	102	19	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	102	20	when	when	WRB
cord-281487-x0a9qgjs	102	21	other	other	JJ
cord-281487-x0a9qgjs	102	22	modalities	modality	NNS
cord-281487-x0a9qgjs	102	23	are	be	VBP
cord-281487-x0a9qgjs	102	24	non	non	JJ
cord-281487-x0a9qgjs	102	25	-	-	JJ
cord-281487-x0a9qgjs	102	26	diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	102	27	.	.	.
cord-281487-x0a9qgjs	103	1	Further	further	JJ
cord-281487-x0a9qgjs	103	2	studies	study	NNS
cord-281487-x0a9qgjs	103	3	are	be	VBP
cord-281487-x0a9qgjs	103	4	required	require	VBN
cord-281487-x0a9qgjs	103	5	to	to	TO
cord-281487-x0a9qgjs	103	6	determine	determine	VB
cord-281487-x0a9qgjs	103	7	the	the	DT
cord-281487-x0a9qgjs	103	8	optimal	optimal	JJ
cord-281487-x0a9qgjs	103	9	use	use	NN
cord-281487-x0a9qgjs	103	10	of	of	IN
cord-281487-x0a9qgjs	103	11	imaging	imaging	NN
cord-281487-x0a9qgjs	103	12	in	in	IN
cord-281487-x0a9qgjs	103	13	managing	manage	VBG
cord-281487-x0a9qgjs	103	14	the	the	DT
cord-281487-x0a9qgjs	103	15	care	care	NN
cord-281487-x0a9qgjs	103	16	of	of	IN
cord-281487-x0a9qgjs	103	17	the	the	DT
cord-281487-x0a9qgjs	103	18	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	103	19	transplant	transplant	NN
cord-281487-x0a9qgjs	103	20	recipient	recipient	NN
cord-281487-x0a9qgjs	103	21	.	.	.
cord-281487-x0a9qgjs	104	1	Evolving	evolve	VBG
cord-281487-x0a9qgjs	104	2	knowledge	knowledge	NN
cord-281487-x0a9qgjs	104	3	of	of	IN
cord-281487-x0a9qgjs	104	4	viral	viral	JJ
cord-281487-x0a9qgjs	104	5	transmission	transmission	NN
cord-281487-x0a9qgjs	104	6	informs	inform	VBZ
cord-281487-x0a9qgjs	104	7	the	the	DT
cord-281487-x0a9qgjs	104	8	approach	approach	NN
cord-281487-x0a9qgjs	104	9	to	to	IN
cord-281487-x0a9qgjs	104	10	the	the	DT
cord-281487-x0a9qgjs	104	11	management	management	NN
cord-281487-x0a9qgjs	104	12	of	of	IN
cord-281487-x0a9qgjs	104	13	transplant	transplant	NN
cord-281487-x0a9qgjs	104	14	recipients	recipient	NNS
cord-281487-x0a9qgjs	104	15	with	with	IN
cord-281487-x0a9qgjs	104	16	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	104	17	.	.	.
cord-281487-x0a9qgjs	105	1	The	the	DT
cord-281487-x0a9qgjs	105	2	median	median	JJ
cord-281487-x0a9qgjs	105	3	incubation	incubation	NN
cord-281487-x0a9qgjs	105	4	period	period	NN
cord-281487-x0a9qgjs	105	5	of	of	IN
cord-281487-x0a9qgjs	105	6	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	105	7	is	be	VBZ
cord-281487-x0a9qgjs	105	8	estimated	estimate	VBN
cord-281487-x0a9qgjs	105	9	to	to	TO
cord-281487-x0a9qgjs	105	10	be	be	VB
cord-281487-x0a9qgjs	105	11	5.1	5.1	CD
cord-281487-x0a9qgjs	105	12	days	day	NNS
cord-281487-x0a9qgjs	105	13	and	and	CC
cord-281487-x0a9qgjs	105	14	the	the	DT
cord-281487-x0a9qgjs	105	15	majority	majority	NN
cord-281487-x0a9qgjs	105	16	of	of	IN
cord-281487-x0a9qgjs	105	17	symptomatic	symptomatic	JJ
cord-281487-x0a9qgjs	105	18	patients	patient	NNS
cord-281487-x0a9qgjs	105	19	develop	develop	VBP
cord-281487-x0a9qgjs	105	20	symptoms	symptom	NNS
cord-281487-x0a9qgjs	105	21	within	within	IN
cord-281487-x0a9qgjs	105	22	11	11	CD
cord-281487-x0a9qgjs	105	23	days	day	NNS
cord-281487-x0a9qgjs	105	24	[	[	-LRB-
cord-281487-x0a9qgjs	105	25	49	49	CD
cord-281487-x0a9qgjs	105	26	]	]	-RRB-
cord-281487-x0a9qgjs	105	27	.	.	.
cord-281487-x0a9qgjs	106	1	Moreover	moreover	RB
cord-281487-x0a9qgjs	106	2	,	,	,
cord-281487-x0a9qgjs	106	3	the	the	DT
cord-281487-x0a9qgjs	106	4	infectiousness	infectiousness	NN
cord-281487-x0a9qgjs	106	5	of	of	IN
cord-281487-x0a9qgjs	106	6	SARS	SARS	NNP
cord-281487-x0a9qgjs	106	7	-	-	HYPH
cord-281487-x0a9qgjs	106	8	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	106	9	starts	start	VBZ
cord-281487-x0a9qgjs	106	10	from	from	IN
cord-281487-x0a9qgjs	106	11	2.3	2.3	CD
cord-281487-x0a9qgjs	106	12	days	day	NNS
cord-281487-x0a9qgjs	106	13	before	before	IN
cord-281487-x0a9qgjs	106	14	symptom	symptom	NN
cord-281487-x0a9qgjs	106	15	onset	onset	NN
cord-281487-x0a9qgjs	106	16	and	and	CC
cord-281487-x0a9qgjs	106	17	up	up	IN
cord-281487-x0a9qgjs	106	18	to	to	TO
cord-281487-x0a9qgjs	106	19	10	10	CD
cord-281487-x0a9qgjs	106	20	days	day	NNS
cord-281487-x0a9qgjs	106	21	after	after	IN
cord-281487-x0a9qgjs	106	22	resolution	resolution	NN
cord-281487-x0a9qgjs	106	23	of	of	IN
cord-281487-x0a9qgjs	106	24	symptoms	symptom	NNS
cord-281487-x0a9qgjs	106	25	in	in	IN
cord-281487-x0a9qgjs	106	26	the	the	DT
cord-281487-x0a9qgjs	106	27	immunocompetent	immunocompetent	JJ
cord-281487-x0a9qgjs	106	28	host	host	NN
cord-281487-x0a9qgjs	106	29	,	,	,
cord-281487-x0a9qgjs	106	30	but	but	CC
cord-281487-x0a9qgjs	106	31	possibly	possibly	RB
cord-281487-x0a9qgjs	106	32	up	up	IN
cord-281487-x0a9qgjs	106	33	to	to	TO
cord-281487-x0a9qgjs	106	34	4	4	CD
cord-281487-x0a9qgjs	106	35	weeks	week	NNS
cord-281487-x0a9qgjs	106	36	in	in	IN
cord-281487-x0a9qgjs	106	37	immunocompromised	immunocompromised	JJ
cord-281487-x0a9qgjs	106	38	hosts	host	NNS
cord-281487-x0a9qgjs	106	39	.	.	.
cord-281487-x0a9qgjs	107	1	Unfortunately	unfortunately	RB
cord-281487-x0a9qgjs	107	2	,	,	,
cord-281487-x0a9qgjs	107	3	44	44	CD
cord-281487-x0a9qgjs	107	4	%	%	NN
cord-281487-x0a9qgjs	107	5	of	of	IN
cord-281487-x0a9qgjs	107	6	infection	infection	NN
cord-281487-x0a9qgjs	107	7	occurs	occur	VBZ
cord-281487-x0a9qgjs	107	8	at	at	IN
cord-281487-x0a9qgjs	107	9	the	the	DT
cord-281487-x0a9qgjs	107	10	pre	pre	JJ
cord-281487-x0a9qgjs	107	11	-	-	JJ
cord-281487-x0a9qgjs	107	12	symptomatic	symptomatic	JJ
cord-281487-x0a9qgjs	107	13	phase	phase	NN
cord-281487-x0a9qgjs	107	14	[	[	-LRB-
cord-281487-x0a9qgjs	107	15	50	50	CD
cord-281487-x0a9qgjs	107	16	]	]	-RRB-
cord-281487-x0a9qgjs	107	17	,	,	,
cord-281487-x0a9qgjs	107	18	and	and	CC
cord-281487-x0a9qgjs	107	19	due	due	IN
cord-281487-x0a9qgjs	107	20	to	to	IN
cord-281487-x0a9qgjs	107	21	its	-PRON-	PRP$
cord-281487-x0a9qgjs	107	22	high	high	JJ
cord-281487-x0a9qgjs	107	23	transmissibility	transmissibility	NN
cord-281487-x0a9qgjs	107	24	in	in	IN
cord-281487-x0a9qgjs	107	25	droplets	droplet	NNS
cord-281487-x0a9qgjs	107	26	,	,	,
cord-281487-x0a9qgjs	107	27	contact	contact	NN
cord-281487-x0a9qgjs	107	28	and	and	CC
cord-281487-x0a9qgjs	107	29	aerosols	aerosol	NNS
cord-281487-x0a9qgjs	107	30	,	,	,
cord-281487-x0a9qgjs	107	31	preventive	preventive	JJ
cord-281487-x0a9qgjs	107	32	precautions	precaution	NNS
cord-281487-x0a9qgjs	107	33	are	be	VBP
cord-281487-x0a9qgjs	107	34	critical	critical	JJ
cord-281487-x0a9qgjs	107	35	.	.	.
cord-281487-x0a9qgjs	108	1	Respiratory	respiratory	JJ
cord-281487-x0a9qgjs	108	2	droplets	droplet	NNS
cord-281487-x0a9qgjs	108	3	,	,	,
cord-281487-x0a9qgjs	108	4	the	the	DT
cord-281487-x0a9qgjs	108	5	most	most	RBS
cord-281487-x0a9qgjs	108	6	common	common	JJ
cord-281487-x0a9qgjs	108	7	mode	mode	NN
cord-281487-x0a9qgjs	108	8	of	of	IN
cord-281487-x0a9qgjs	108	9	transmission	transmission	NN
cord-281487-x0a9qgjs	108	10	,	,	,
cord-281487-x0a9qgjs	108	11	are	be	VBP
cord-281487-x0a9qgjs	108	12	formed	form	VBN
cord-281487-x0a9qgjs	108	13	when	when	WRB
cord-281487-x0a9qgjs	108	14	an	an	DT
cord-281487-x0a9qgjs	108	15	infected	infected	JJ
cord-281487-x0a9qgjs	108	16	patient	patient	NN
cord-281487-x0a9qgjs	108	17	sneezes	sneeze	VBZ
cord-281487-x0a9qgjs	108	18	,	,	,
cord-281487-x0a9qgjs	108	19	coughs	cough	NNS
cord-281487-x0a9qgjs	108	20	,	,	,
cord-281487-x0a9qgjs	108	21	or	or	CC
cord-281487-x0a9qgjs	108	22	even	even	RB
cord-281487-x0a9qgjs	108	23	talks	talk	NNS
cord-281487-x0a9qgjs	108	24	,	,	,
cord-281487-x0a9qgjs	108	25	and	and	CC
cord-281487-x0a9qgjs	108	26	viral	viral	JJ
cord-281487-x0a9qgjs	108	27	particles	particle	NNS
cord-281487-x0a9qgjs	108	28	are	be	VBP
cord-281487-x0a9qgjs	108	29	directly	directly	RB
cord-281487-x0a9qgjs	108	30	inhaled	inhale	VBN
cord-281487-x0a9qgjs	108	31	,	,	,
cord-281487-x0a9qgjs	108	32	or	or	CC
cord-281487-x0a9qgjs	108	33	when	when	WRB
cord-281487-x0a9qgjs	108	34	an	an	DT
cord-281487-x0a9qgjs	108	35	uninfected	uninfected	JJ
cord-281487-x0a9qgjs	108	36	individual	individual	NN
cord-281487-x0a9qgjs	108	37	touches	touch	VBZ
cord-281487-x0a9qgjs	108	38	a	a	DT
cord-281487-x0a9qgjs	108	39	contaminated	contaminate	VBN
cord-281487-x0a9qgjs	108	40	surface	surface	NN
cord-281487-x0a9qgjs	108	41	and	and	CC
cord-281487-x0a9qgjs	108	42	subsequently	subsequently	RB
cord-281487-x0a9qgjs	108	43	their	-PRON-	PRP$
cord-281487-x0a9qgjs	108	44	mucous	mucous	JJ
cord-281487-x0a9qgjs	108	45	membranes	membrane	NNS
cord-281487-x0a9qgjs	108	46	[	[	-LRB-
cord-281487-x0a9qgjs	108	47	51	51	CD
cord-281487-x0a9qgjs	108	48	]	]	-RRB-
cord-281487-x0a9qgjs	108	49	.	.	.
cord-281487-x0a9qgjs	109	1	Transmission	transmission	NN
cord-281487-x0a9qgjs	109	2	through	through	IN
cord-281487-x0a9qgjs	109	3	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	109	4	droplet	droplet	NN
cord-281487-x0a9qgjs	109	5	may	may	MD
cord-281487-x0a9qgjs	109	6	be	be	VB
cord-281487-x0a9qgjs	109	7	reduced	reduce	VBN
cord-281487-x0a9qgjs	109	8	with	with	IN
cord-281487-x0a9qgjs	109	9	the	the	DT
cord-281487-x0a9qgjs	109	10	use	use	NN
cord-281487-x0a9qgjs	109	11	of	of	IN
cord-281487-x0a9qgjs	109	12	surgical	surgical	JJ
cord-281487-x0a9qgjs	109	13	or	or	CC
cord-281487-x0a9qgjs	109	14	cloth	cloth	JJ
cord-281487-x0a9qgjs	109	15	masks	mask	NNS
cord-281487-x0a9qgjs	109	16	,	,	,
cord-281487-x0a9qgjs	109	17	and	and	CC
cord-281487-x0a9qgjs	109	18	thus	thus	RB
cord-281487-x0a9qgjs	109	19	transplant	transplant	NN
cord-281487-x0a9qgjs	109	20	recipients	recipient	NNS
cord-281487-x0a9qgjs	109	21	should	should	MD
cord-281487-x0a9qgjs	109	22	ensure	ensure	VB
cord-281487-x0a9qgjs	109	23	that	that	IN
cord-281487-x0a9qgjs	109	24	they	-PRON-	PRP
cord-281487-x0a9qgjs	109	25	and	and	CC
cord-281487-x0a9qgjs	109	26	all	all	DT
cord-281487-x0a9qgjs	109	27	individuals	individual	NNS
cord-281487-x0a9qgjs	109	28	outside	outside	IN
cord-281487-x0a9qgjs	109	29	of	of	IN
cord-281487-x0a9qgjs	109	30	their	-PRON-	PRP$
cord-281487-x0a9qgjs	109	31	household	household	NN
cord-281487-x0a9qgjs	109	32	are	be	VBP
cord-281487-x0a9qgjs	109	33	wearing	wear	VBG
cord-281487-x0a9qgjs	109	34	masks	mask	NNS
cord-281487-x0a9qgjs	109	35	during	during	IN
cord-281487-x0a9qgjs	109	36	an	an	DT
cord-281487-x0a9qgjs	109	37	in	in	IN
cord-281487-x0a9qgjs	109	38	-	-	HYPH
cord-281487-x0a9qgjs	109	39	person	person	NN
cord-281487-x0a9qgjs	109	40	encounter	encounter	NN
cord-281487-x0a9qgjs	109	41	[	[	-LRB-
cord-281487-x0a9qgjs	109	42	52	52	CD
cord-281487-x0a9qgjs	109	43	]	]	-RRB-
cord-281487-x0a9qgjs	109	44	.	.	.
cord-281487-x0a9qgjs	110	1	Further	further	RB
cord-281487-x0a9qgjs	110	2	,	,	,
cord-281487-x0a9qgjs	110	3	hand	hand	NN
cord-281487-x0a9qgjs	110	4	hygiene	hygiene	NN
cord-281487-x0a9qgjs	110	5	is	be	VBZ
cord-281487-x0a9qgjs	110	6	essential	essential	JJ
cord-281487-x0a9qgjs	110	7	to	to	TO
cord-281487-x0a9qgjs	110	8	reduce	reduce	VB
cord-281487-x0a9qgjs	110	9	transmission	transmission	NN
cord-281487-x0a9qgjs	110	10	from	from	IN
cord-281487-x0a9qgjs	110	11	contact	contact	NN
cord-281487-x0a9qgjs	110	12	surfaces	surface	NNS
cord-281487-x0a9qgjs	110	13	,	,	,
cord-281487-x0a9qgjs	110	14	as	as	IN
cord-281487-x0a9qgjs	110	15	SARS	SARS	NNP
cord-281487-x0a9qgjs	110	16	-	-	HYPH
cord-281487-x0a9qgjs	110	17	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	110	18	can	can	MD
cord-281487-x0a9qgjs	110	19	be	be	VB
cord-281487-x0a9qgjs	110	20	detectable	detectable	JJ
cord-281487-x0a9qgjs	110	21	on	on	IN
cord-281487-x0a9qgjs	110	22	the	the	DT
cord-281487-x0a9qgjs	110	23	surface	surface	NN
cord-281487-x0a9qgjs	110	24	of	of	IN
cord-281487-x0a9qgjs	110	25	the	the	DT
cord-281487-x0a9qgjs	110	26	plastic	plastic	NN
cord-281487-x0a9qgjs	110	27	and	and	CC
cord-281487-x0a9qgjs	110	28	stainless	stainless	JJ
cord-281487-x0a9qgjs	110	29	steel	steel	NN
cord-281487-x0a9qgjs	110	30	up	up	IN
cord-281487-x0a9qgjs	110	31	to	to	TO
cord-281487-x0a9qgjs	110	32	72	72	CD
cord-281487-x0a9qgjs	110	33	h	h	NN
cord-281487-x0a9qgjs	110	34	[	[	-LRB-
cord-281487-x0a9qgjs	110	35	52	52	CD
cord-281487-x0a9qgjs	110	36	]	]	-RRB-
cord-281487-x0a9qgjs	110	37	.	.	.
cord-281487-x0a9qgjs	111	1	Given	give	VBN
cord-281487-x0a9qgjs	111	2	the	the	DT
cord-281487-x0a9qgjs	111	3	higher	high	JJR
cord-281487-x0a9qgjs	111	4	risk	risk	NN
cord-281487-x0a9qgjs	111	5	of	of	IN
cord-281487-x0a9qgjs	111	6	serious	serious	JJ
cord-281487-x0a9qgjs	111	7	complications	complication	NNS
cord-281487-x0a9qgjs	111	8	from	from	IN
cord-281487-x0a9qgjs	111	9	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	111	10	,	,	,
cord-281487-x0a9qgjs	111	11	we	-PRON-	PRP
cord-281487-x0a9qgjs	111	12	recommend	recommend	VBP
cord-281487-x0a9qgjs	111	13	that	that	IN
cord-281487-x0a9qgjs	111	14	patients	patient	NNS
cord-281487-x0a9qgjs	111	15	and	and	CC
cord-281487-x0a9qgjs	111	16	household	household	NN
cord-281487-x0a9qgjs	111	17	contacts	contact	NNS
cord-281487-x0a9qgjs	111	18	receive	receive	VBP
cord-281487-x0a9qgjs	111	19	ongoing	ongoing	JJ
cord-281487-x0a9qgjs	111	20	education	education	NN
cord-281487-x0a9qgjs	111	21	:	:	:
cord-281487-x0a9qgjs	111	22	the	the	DT
cord-281487-x0a9qgjs	111	23	importance	importance	NN
cord-281487-x0a9qgjs	111	24	of	of	IN
cord-281487-x0a9qgjs	111	25	exposure	exposure	NN
cord-281487-x0a9qgjs	111	26	prevention	prevention	NN
cord-281487-x0a9qgjs	111	27	and	and	CC
cord-281487-x0a9qgjs	111	28	risk	risk	NN
cord-281487-x0a9qgjs	111	29	reduction	reduction	NN
cord-281487-x0a9qgjs	111	30	measures	measure	NNS
cord-281487-x0a9qgjs	111	31	,	,	,
cord-281487-x0a9qgjs	111	32	as	as	IN
cord-281487-x0a9qgjs	111	33	these	these	DT
cord-281487-x0a9qgjs	111	34	behaviors	behavior	NNS
cord-281487-x0a9qgjs	111	35	may	may	MD
cord-281487-x0a9qgjs	111	36	erode	erode	VB
cord-281487-x0a9qgjs	111	37	over	over	IN
cord-281487-x0a9qgjs	111	38	time	time	NN
cord-281487-x0a9qgjs	111	39	.	.	.
cord-281487-x0a9qgjs	112	1	The	the	DT
cord-281487-x0a9qgjs	112	2	complexity	complexity	NN
cord-281487-x0a9qgjs	112	3	of	of	IN
cord-281487-x0a9qgjs	112	4	routine	routine	JJ
cord-281487-x0a9qgjs	112	5	transplant	transplant	NN
cord-281487-x0a9qgjs	112	6	care	care	NN
cord-281487-x0a9qgjs	112	7	in	in	IN
cord-281487-x0a9qgjs	112	8	monitoring	monitor	VBG
cord-281487-x0a9qgjs	112	9	allograft	allograft	NN
cord-281487-x0a9qgjs	112	10	function	function	NN
cord-281487-x0a9qgjs	112	11	,	,	,
cord-281487-x0a9qgjs	112	12	toxicities	toxicity	NNS
cord-281487-x0a9qgjs	112	13	,	,	,
cord-281487-x0a9qgjs	112	14	and	and	CC
cord-281487-x0a9qgjs	112	15	general	general	JJ
cord-281487-x0a9qgjs	112	16	health	health	NN
cord-281487-x0a9qgjs	112	17	has	have	VBZ
cord-281487-x0a9qgjs	112	18	necessitated	necessitate	VBN
cord-281487-x0a9qgjs	112	19	a	a	DT
cord-281487-x0a9qgjs	112	20	reimagining	reimagining	NN
cord-281487-x0a9qgjs	112	21	of	of	IN
cord-281487-x0a9qgjs	112	22	health	health	NN
cord-281487-x0a9qgjs	112	23	care	care	NN
cord-281487-x0a9qgjs	112	24	delivery	delivery	NN
cord-281487-x0a9qgjs	112	25	during	during	IN
cord-281487-x0a9qgjs	112	26	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	112	27	pandemic	pandemic	NN
cord-281487-x0a9qgjs	112	28	.	.	.
cord-281487-x0a9qgjs	113	1	In	in	IN
cord-281487-x0a9qgjs	113	2	this	this	DT
cord-281487-x0a9qgjs	113	3	regard	regard	NN
cord-281487-x0a9qgjs	113	4	,	,	,
cord-281487-x0a9qgjs	113	5	centers	center	NNS
cord-281487-x0a9qgjs	113	6	have	have	VBP
cord-281487-x0a9qgjs	113	7	instituted	institute	VBN
cord-281487-x0a9qgjs	113	8	telemedicine	telemedicine	NN
cord-281487-x0a9qgjs	113	9	,	,	,
cord-281487-x0a9qgjs	113	10	limited	limit	VBN
cord-281487-x0a9qgjs	113	11	in	in	IN
cord-281487-x0a9qgjs	113	12	-	-	HYPH
cord-281487-x0a9qgjs	113	13	person	person	NN
cord-281487-x0a9qgjs	113	14	visits	visit	NNS
cord-281487-x0a9qgjs	113	15	,	,	,
cord-281487-x0a9qgjs	113	16	and	and	CC
cord-281487-x0a9qgjs	113	17	increased	increase	VBN
cord-281487-x0a9qgjs	113	18	remote	remote	JJ
cord-281487-x0a9qgjs	113	19	monitoring	monitoring	NN
cord-281487-x0a9qgjs	113	20	allows	allow	VBZ
cord-281487-x0a9qgjs	113	21	uninterrupted	uninterrupted	JJ
cord-281487-x0a9qgjs	113	22	outpatient	outpatient	NN
cord-281487-x0a9qgjs	113	23	care	care	NN
cord-281487-x0a9qgjs	113	24	while	while	IN
cord-281487-x0a9qgjs	113	25	limiting	limit	VBG
cord-281487-x0a9qgjs	113	26	direct	direct	JJ
cord-281487-x0a9qgjs	113	27	patient	patient	NN
cord-281487-x0a9qgjs	113	28	contact	contact	NN
cord-281487-x0a9qgjs	113	29	to	to	IN
cord-281487-x0a9qgjs	113	30	highest	high	JJS
cord-281487-x0a9qgjs	113	31	priority	priority	NN
cord-281487-x0a9qgjs	113	32	individuals	individual	NNS
cord-281487-x0a9qgjs	113	33	.	.	.
cord-281487-x0a9qgjs	114	1	With	with	IN
cord-281487-x0a9qgjs	114	2	these	these	DT
cord-281487-x0a9qgjs	114	3	tools	tool	NNS
cord-281487-x0a9qgjs	114	4	,	,	,
cord-281487-x0a9qgjs	114	5	limited	limited	JJ
cord-281487-x0a9qgjs	114	6	ambulatory	ambulatory	JJ
cord-281487-x0a9qgjs	114	7	care	care	NN
cord-281487-x0a9qgjs	114	8	then	then	RB
cord-281487-x0a9qgjs	114	9	ideally	ideally	RB
cord-281487-x0a9qgjs	114	10	be	be	VB
cord-281487-x0a9qgjs	114	11	provided	provide	VBN
cord-281487-x0a9qgjs	114	12	in	in	IN
cord-281487-x0a9qgjs	114	13	social	social	JJ
cord-281487-x0a9qgjs	114	14	distanced	distance	VBN
cord-281487-x0a9qgjs	114	15	settings	setting	NNS
cord-281487-x0a9qgjs	114	16	with	with	IN
cord-281487-x0a9qgjs	114	17	appropriate	appropriate	JJ
cord-281487-x0a9qgjs	114	18	COVID−19	COVID−19	NNP
cord-281487-x0a9qgjs	114	19	screening	screening	NN
cord-281487-x0a9qgjs	114	20	to	to	TO
cord-281487-x0a9qgjs	114	21	reduce	reduce	VB
cord-281487-x0a9qgjs	114	22	nosocomial	nosocomial	JJ
cord-281487-x0a9qgjs	114	23	transmission	transmission	NN
cord-281487-x0a9qgjs	114	24	risk	risk	NN
cord-281487-x0a9qgjs	114	25	[	[	-LRB-
cord-281487-x0a9qgjs	114	26	53	53	CD
cord-281487-x0a9qgjs	114	27	]	]	-RRB-
cord-281487-x0a9qgjs	114	28	.	.	.
cord-281487-x0a9qgjs	115	1	Telemedicine	telemedicine	NN
cord-281487-x0a9qgjs	115	2	can	can	MD
cord-281487-x0a9qgjs	115	3	be	be	VB
cord-281487-x0a9qgjs	115	4	performed	perform	VBN
cord-281487-x0a9qgjs	115	5	using	use	VBG
cord-281487-x0a9qgjs	115	6	a	a	DT
cord-281487-x0a9qgjs	115	7	combination	combination	NN
cord-281487-x0a9qgjs	115	8	of	of	IN
cord-281487-x0a9qgjs	115	9	synchronous	synchronous	JJ
cord-281487-x0a9qgjs	115	10	,	,	,
cord-281487-x0a9qgjs	115	11	asynchronous	asynchronous	JJ
cord-281487-x0a9qgjs	115	12	,	,	,
cord-281487-x0a9qgjs	115	13	or	or	CC
cord-281487-x0a9qgjs	115	14	remote	remote	JJ
cord-281487-x0a9qgjs	115	15	monitoring	monitoring	NN
cord-281487-x0a9qgjs	115	16	.	.	.
cord-281487-x0a9qgjs	116	1	Synchronous	synchronous	JJ
cord-281487-x0a9qgjs	116	2	refers	refer	VBZ
cord-281487-x0a9qgjs	116	3	to	to	IN
cord-281487-x0a9qgjs	116	4	real	real	JJ
cord-281487-x0a9qgjs	116	5	-	-	HYPH
cord-281487-x0a9qgjs	116	6	time	time	NN
cord-281487-x0a9qgjs	116	7	encounters	encounter	NNS
cord-281487-x0a9qgjs	116	8	via	via	IN
cord-281487-x0a9qgjs	116	9	telephone	telephone	NN
cord-281487-x0a9qgjs	116	10	or	or	CC
cord-281487-x0a9qgjs	116	11	audio	audio	JJ
cord-281487-x0a9qgjs	116	12	-	-	HYPH
cord-281487-x0a9qgjs	116	13	video	video	NN
cord-281487-x0a9qgjs	116	14	interaction	interaction	NN
cord-281487-x0a9qgjs	116	15	.	.	.
cord-281487-x0a9qgjs	117	1	Asynchronous	asynchronous	JJ
cord-281487-x0a9qgjs	117	2	telemedicine	telemedicine	NN
cord-281487-x0a9qgjs	117	3	is	be	VBZ
cord-281487-x0a9qgjs	117	4	a	a	DT
cord-281487-x0a9qgjs	117	5	"	"	``
cord-281487-x0a9qgjs	117	6	store	store	NN
cord-281487-x0a9qgjs	117	7	-	-	HYPH
cord-281487-x0a9qgjs	117	8	and	and	CC
cord-281487-x0a9qgjs	117	9	-	-	HYPH
cord-281487-x0a9qgjs	117	10	forward	forward	NN
cord-281487-x0a9qgjs	117	11	"	"	''
cord-281487-x0a9qgjs	117	12	technique	technique	NN
cord-281487-x0a9qgjs	117	13	that	that	WDT
cord-281487-x0a9qgjs	117	14	sends	send	VBZ
cord-281487-x0a9qgjs	117	15	the	the	DT
cord-281487-x0a9qgjs	117	16	collected	collect	VBN
cord-281487-x0a9qgjs	117	17	data	datum	NNS
cord-281487-x0a9qgjs	117	18	and	and	CC
cord-281487-x0a9qgjs	117	19	images	image	NNS
cord-281487-x0a9qgjs	117	20	to	to	IN
cord-281487-x0a9qgjs	117	21	clinicians	clinician	NNS
cord-281487-x0a9qgjs	117	22	.	.	.
cord-281487-x0a9qgjs	118	1	Remote	remote	JJ
cord-281487-x0a9qgjs	118	2	patient	patient	NN
cord-281487-x0a9qgjs	118	3	monitoring	monitoring	NN
cord-281487-x0a9qgjs	118	4	refers	refer	VBZ
cord-281487-x0a9qgjs	118	5	to	to	IN
cord-281487-x0a9qgjs	118	6	the	the	DT
cord-281487-x0a9qgjs	118	7	direct	direct	JJ
cord-281487-x0a9qgjs	118	8	transmission	transmission	NN
cord-281487-x0a9qgjs	118	9	of	of	IN
cord-281487-x0a9qgjs	118	10	a	a	DT
cord-281487-x0a9qgjs	118	11	patient	patient	NN
cord-281487-x0a9qgjs	118	12	's	's	POS
cord-281487-x0a9qgjs	118	13	clinical	clinical	JJ
cord-281487-x0a9qgjs	118	14	measurements	measurement	NNS
cord-281487-x0a9qgjs	118	15	to	to	IN
cord-281487-x0a9qgjs	118	16	their	-PRON-	PRP$
cord-281487-x0a9qgjs	118	17	healthcare	healthcare	NN
cord-281487-x0a9qgjs	118	18	provider	provider	NN
cord-281487-x0a9qgjs	118	19	[	[	-LRB-
cord-281487-x0a9qgjs	118	20	52	52	CD
cord-281487-x0a9qgjs	118	21	]	]	-RRB-
cord-281487-x0a9qgjs	118	22	.	.	.
cord-281487-x0a9qgjs	119	1	Telemedicine	telemedicine	NN
cord-281487-x0a9qgjs	119	2	may	may	MD
cord-281487-x0a9qgjs	119	3	also	also	RB
cord-281487-x0a9qgjs	119	4	be	be	VB
cord-281487-x0a9qgjs	119	5	an	an	DT
cord-281487-x0a9qgjs	119	6	important	important	JJ
cord-281487-x0a9qgjs	119	7	component	component	NN
cord-281487-x0a9qgjs	119	8	of	of	IN
cord-281487-x0a9qgjs	119	9	preparation	preparation	NN
cord-281487-x0a9qgjs	119	10	for	for	IN
cord-281487-x0a9qgjs	119	11	in	in	IN
cord-281487-x0a9qgjs	119	12	-	-	HYPH
cord-281487-x0a9qgjs	119	13	person	person	NN
cord-281487-x0a9qgjs	119	14	encounters	encounter	VBZ
cord-281487-x0a9qgjs	119	15	to	to	TO
cord-281487-x0a9qgjs	119	16	reduce	reduce	VB
cord-281487-x0a9qgjs	119	17	the	the	DT
cord-281487-x0a9qgjs	119	18	amount	amount	NN
cord-281487-x0a9qgjs	119	19	of	of	IN
cord-281487-x0a9qgjs	119	20	time	time	NN
cord-281487-x0a9qgjs	119	21	spent	spend	VBN
cord-281487-x0a9qgjs	119	22	in	in	IN
cord-281487-x0a9qgjs	119	23	direct	direct	JJ
cord-281487-x0a9qgjs	119	24	patient	patient	NN
cord-281487-x0a9qgjs	119	25	contact	contact	NN
cord-281487-x0a9qgjs	119	26	and	and	CC
cord-281487-x0a9qgjs	119	27	to	to	TO
cord-281487-x0a9qgjs	119	28	conduct	conduct	VB
cord-281487-x0a9qgjs	119	29	necessary	necessary	JJ
cord-281487-x0a9qgjs	119	30	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	119	31	symptom	symptom	NN
cord-281487-x0a9qgjs	119	32	and	and	CC
cord-281487-x0a9qgjs	119	33	behavior	behavior	NN
cord-281487-x0a9qgjs	119	34	risk	risk	NN
cord-281487-x0a9qgjs	119	35	screening	screening	NN
cord-281487-x0a9qgjs	119	36	(	(	-LRB-
cord-281487-x0a9qgjs	119	37	Fig	Fig	NNP
cord-281487-x0a9qgjs	119	38	.	.	.
cord-281487-x0a9qgjs	119	39	1	1	CD
cord-281487-x0a9qgjs	119	40	)	)	-RRB-
cord-281487-x0a9qgjs	119	41	[	[	-LRB-
cord-281487-x0a9qgjs	119	42	54	54	CD
cord-281487-x0a9qgjs	119	43	,	,	,
cord-281487-x0a9qgjs	119	44	55	55	CD
cord-281487-x0a9qgjs	119	45	]	]	-RRB-
cord-281487-x0a9qgjs	119	46	.	.	.
cord-281487-x0a9qgjs	120	1	For	for	IN
cord-281487-x0a9qgjs	120	2	maximum	maximum	JJ
cord-281487-x0a9qgjs	120	3	utility	utility	NN
cord-281487-x0a9qgjs	120	4	,	,	,
cord-281487-x0a9qgjs	120	5	transplant	transplant	NN
cord-281487-x0a9qgjs	120	6	centers	center	NNS
cord-281487-x0a9qgjs	120	7	may	may	MD
cord-281487-x0a9qgjs	120	8	need	need	VB
cord-281487-x0a9qgjs	120	9	to	to	TO
cord-281487-x0a9qgjs	120	10	invest	invest	VB
cord-281487-x0a9qgjs	120	11	in	in	IN
cord-281487-x0a9qgjs	120	12	resources	resource	NNS
cord-281487-x0a9qgjs	120	13	for	for	IN
cord-281487-x0a9qgjs	120	14	patient	patient	JJ
cord-281487-x0a9qgjs	120	15	self	self	NN
cord-281487-x0a9qgjs	120	16	-	-	HYPH
cord-281487-x0a9qgjs	120	17	monitoring	monitoring	NN
cord-281487-x0a9qgjs	120	18	,	,	,
cord-281487-x0a9qgjs	120	19	including	include	VBG
cord-281487-x0a9qgjs	120	20	tools	tool	NNS
cord-281487-x0a9qgjs	120	21	for	for	IN
cord-281487-x0a9qgjs	120	22	vital	vital	JJ
cord-281487-x0a9qgjs	120	23	signs	sign	NNS
cord-281487-x0a9qgjs	120	24	monitoring	monitor	VBG
cord-281487-x0a9qgjs	120	25	,	,	,
cord-281487-x0a9qgjs	120	26	technology	technology	NN
cord-281487-x0a9qgjs	120	27	platforms	platform	NNS
cord-281487-x0a9qgjs	120	28	,	,	,
cord-281487-x0a9qgjs	120	29	and	and	CC
cord-281487-x0a9qgjs	120	30	resources	resource	NNS
cord-281487-x0a9qgjs	120	31	to	to	TO
cord-281487-x0a9qgjs	120	32	document	document	VB
cord-281487-x0a9qgjs	120	33	objective	objective	JJ
cord-281487-x0a9qgjs	120	34	findings	finding	NNS
cord-281487-x0a9qgjs	120	35	.	.	.
cord-281487-x0a9qgjs	121	1	The	the	DT
cord-281487-x0a9qgjs	121	2	frequency	frequency	NN
cord-281487-x0a9qgjs	121	3	of	of	IN
cord-281487-x0a9qgjs	121	4	routine	routine	JJ
cord-281487-x0a9qgjs	121	5	laboratory	laboratory	NN
cord-281487-x0a9qgjs	121	6	testing	testing	NN
cord-281487-x0a9qgjs	121	7	,	,	,
cord-281487-x0a9qgjs	121	8	routine	routine	JJ
cord-281487-x0a9qgjs	121	9	health	health	NN
cord-281487-x0a9qgjs	121	10	maintenance	maintenance	NN
cord-281487-x0a9qgjs	121	11	tests	test	NNS
cord-281487-x0a9qgjs	121	12	,	,	,
cord-281487-x0a9qgjs	121	13	and	and	CC
cord-281487-x0a9qgjs	121	14	cancer	cancer	NN
cord-281487-x0a9qgjs	121	15	screening	screening	NN
cord-281487-x0a9qgjs	121	16	should	should	MD
cord-281487-x0a9qgjs	121	17	be	be	VB
cord-281487-x0a9qgjs	121	18	considered	consider	VBN
cord-281487-x0a9qgjs	121	19	to	to	TO
cord-281487-x0a9qgjs	121	20	balance	balance	VB
cord-281487-x0a9qgjs	121	21	the	the	DT
cord-281487-x0a9qgjs	121	22	infection	infection	NN
cord-281487-x0a9qgjs	121	23	risk	risk	NN
cord-281487-x0a9qgjs	121	24	of	of	IN
cord-281487-x0a9qgjs	121	25	SARS	SARS	NNP
cord-281487-x0a9qgjs	121	26	-	-	HYPH
cord-281487-x0a9qgjs	121	27	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	121	28	with	with	IN
cord-281487-x0a9qgjs	121	29	the	the	DT
cord-281487-x0a9qgjs	121	30	risk	risk	NN
cord-281487-x0a9qgjs	121	31	to	to	TO
cord-281487-x0a9qgjs	121	32	health	health	VB
cord-281487-x0a9qgjs	121	33	if	if	IN
cord-281487-x0a9qgjs	121	34	these	these	DT
cord-281487-x0a9qgjs	121	35	diagnostics	diagnostic	NNS
cord-281487-x0a9qgjs	121	36	are	be	VBP
cord-281487-x0a9qgjs	121	37	deferred	defer	VBN
cord-281487-x0a9qgjs	121	38	.	.	.
cord-281487-x0a9qgjs	122	1	Ideally	ideally	RB
cord-281487-x0a9qgjs	122	2	,	,	,
cord-281487-x0a9qgjs	122	3	when	when	WRB
cord-281487-x0a9qgjs	122	4	required	require	VBN
cord-281487-x0a9qgjs	122	5	,	,	,
cord-281487-x0a9qgjs	122	6	diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	122	7	tests	test	NNS
cord-281487-x0a9qgjs	122	8	should	should	MD
cord-281487-x0a9qgjs	122	9	be	be	VB
cord-281487-x0a9qgjs	122	10	performed	perform	VBN
cord-281487-x0a9qgjs	122	11	at	at	IN
cord-281487-x0a9qgjs	122	12	a	a	DT
cord-281487-x0a9qgjs	122	13	facility	facility	NN
cord-281487-x0a9qgjs	122	14	that	that	WDT
cord-281487-x0a9qgjs	122	15	practices	practice	VBZ
cord-281487-x0a9qgjs	122	16	mitigation	mitigation	NN
cord-281487-x0a9qgjs	122	17	behaviors	behavior	NNS
cord-281487-x0a9qgjs	122	18	such	such	JJ
cord-281487-x0a9qgjs	122	19	as	as	IN
cord-281487-x0a9qgjs	122	20	a	a	DT
cord-281487-x0a9qgjs	122	21	restricted	restricted	JJ
cord-281487-x0a9qgjs	122	22	number	number	NN
cord-281487-x0a9qgjs	122	23	of	of	IN
cord-281487-x0a9qgjs	122	24	persons	person	NNS
cord-281487-x0a9qgjs	122	25	in	in	IN
cord-281487-x0a9qgjs	122	26	waiting	wait	VBG
cord-281487-x0a9qgjs	122	27	rooms	room	NNS
cord-281487-x0a9qgjs	122	28	,	,	,
cord-281487-x0a9qgjs	122	29	scheduled	schedule	VBN
cord-281487-x0a9qgjs	122	30	appointments	appointment	NNS
cord-281487-x0a9qgjs	122	31	,	,	,
cord-281487-x0a9qgjs	122	32	and	and	CC
cord-281487-x0a9qgjs	122	33	strict	strict	JJ
cord-281487-x0a9qgjs	122	34	screening	screening	NN
cord-281487-x0a9qgjs	122	35	of	of	IN
cord-281487-x0a9qgjs	122	36	patients	patient	NNS
cord-281487-x0a9qgjs	122	37	for	for	IN
cord-281487-x0a9qgjs	122	38	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	122	39	.	.	.
cord-281487-x0a9qgjs	122	40	Collaboration	collaboration	NN
cord-281487-x0a9qgjs	122	41	between	between	IN
cord-281487-x0a9qgjs	122	42	transplantation	transplantation	NN
cord-281487-x0a9qgjs	122	43	specialists	specialist	NNS
cord-281487-x0a9qgjs	122	44	,	,	,
cord-281487-x0a9qgjs	122	45	monitoring	monitoring	NN
cord-281487-x0a9qgjs	122	46	of	of	IN
cord-281487-x0a9qgjs	122	47	local	local	JJ
cord-281487-x0a9qgjs	122	48	COVID	covid	JJ
cord-281487-x0a9qgjs	122	49	infection	infection	NN
cord-281487-x0a9qgjs	122	50	rates	rate	NNS
cord-281487-x0a9qgjs	122	51	,	,	,
cord-281487-x0a9qgjs	122	52	and	and	CC
cord-281487-x0a9qgjs	122	53	the	the	DT
cord-281487-x0a9qgjs	122	54	local	local	JJ
cord-281487-x0a9qgjs	122	55	health	health	NN
cord-281487-x0a9qgjs	122	56	care	care	NN
cord-281487-x0a9qgjs	122	57	provider	provider	NN
cord-281487-x0a9qgjs	122	58	may	may	MD
cord-281487-x0a9qgjs	122	59	be	be	VB
cord-281487-x0a9qgjs	122	60	required	require	VBN
cord-281487-x0a9qgjs	122	61	[	[	-LRB-
cord-281487-x0a9qgjs	122	62	54	54	CD
cord-281487-x0a9qgjs	122	63	,	,	,
cord-281487-x0a9qgjs	122	64	56	56	CD
cord-281487-x0a9qgjs	122	65	]	]	-RRB-
cord-281487-x0a9qgjs	122	66	.	.	.
cord-281487-x0a9qgjs	123	1	The	the	DT
cord-281487-x0a9qgjs	123	2	frequency	frequency	NN
cord-281487-x0a9qgjs	123	3	of	of	IN
cord-281487-x0a9qgjs	123	4	allograft	allograft	NN
cord-281487-x0a9qgjs	123	5	surveillance	surveillance	NN
cord-281487-x0a9qgjs	123	6	biopsies	biopsy	NNS
cord-281487-x0a9qgjs	123	7	should	should	MD
cord-281487-x0a9qgjs	123	8	be	be	VB
cord-281487-x0a9qgjs	123	9	determined	determine	VBN
cord-281487-x0a9qgjs	123	10	to	to	TO
cord-281487-x0a9qgjs	123	11	take	take	VB
cord-281487-x0a9qgjs	123	12	into	into	IN
cord-281487-x0a9qgjs	123	13	account	account	NN
cord-281487-x0a9qgjs	123	14	the	the	DT
cord-281487-x0a9qgjs	123	15	individual	individual	JJ
cord-281487-x0a9qgjs	123	16	risks	risk	NNS
cord-281487-x0a9qgjs	123	17	and	and	CC
cord-281487-x0a9qgjs	123	18	benefits	benefit	NNS
cord-281487-x0a9qgjs	123	19	,	,	,
cord-281487-x0a9qgjs	123	20	especially	especially	RB
cord-281487-x0a9qgjs	123	21	during	during	IN
cord-281487-x0a9qgjs	123	22	this	this	DT
cord-281487-x0a9qgjs	123	23	epidemic	epidemic	NN
cord-281487-x0a9qgjs	123	24	period	period	NN
cord-281487-x0a9qgjs	123	25	.	.	.
cord-281487-x0a9qgjs	124	1	When	when	WRB
cord-281487-x0a9qgjs	124	2	available	available	JJ
cord-281487-x0a9qgjs	124	3	,	,	,
cord-281487-x0a9qgjs	124	4	non	non	JJ
cord-281487-x0a9qgjs	124	5	-	-	JJ
cord-281487-x0a9qgjs	124	6	invasive	invasive	JJ
cord-281487-x0a9qgjs	124	7	technologies	technology	NNS
cord-281487-x0a9qgjs	124	8	such	such	JJ
cord-281487-x0a9qgjs	124	9	as	as	IN
cord-281487-x0a9qgjs	124	10	donor	donor	NN
cord-281487-x0a9qgjs	124	11	-	-	HYPH
cord-281487-x0a9qgjs	124	12	derived	derive	VBN
cord-281487-x0a9qgjs	124	13	cell	cell	NN
cord-281487-x0a9qgjs	124	14	-	-	HYPH
cord-281487-x0a9qgjs	124	15	free	free	JJ
cord-281487-x0a9qgjs	124	16	DNA	dna	NN
cord-281487-x0a9qgjs	124	17	(	(	-LRB-
cord-281487-x0a9qgjs	124	18	dd	dd	NN
cord-281487-x0a9qgjs	124	19	-	-	HYPH
cord-281487-x0a9qgjs	124	20	cfDNA	cfdna	RBS
cord-281487-x0a9qgjs	124	21	)	)	-RRB-
cord-281487-x0a9qgjs	124	22	,	,	,
cord-281487-x0a9qgjs	124	23	gene	gene	NN
cord-281487-x0a9qgjs	124	24	expression	expression	NN
cord-281487-x0a9qgjs	124	25	profiles	profile	NNS
cord-281487-x0a9qgjs	124	26	,	,	,
cord-281487-x0a9qgjs	124	27	and	and	CC
cord-281487-x0a9qgjs	124	28	home	home	NN
cord-281487-x0a9qgjs	124	29	spirometry	spirometry	NN
cord-281487-x0a9qgjs	124	30	may	may	MD
cord-281487-x0a9qgjs	124	31	allow	allow	VB
cord-281487-x0a9qgjs	124	32	transplant	transplant	NN
cord-281487-x0a9qgjs	124	33	recipients	recipient	NNS
cord-281487-x0a9qgjs	124	34	to	to	TO
cord-281487-x0a9qgjs	124	35	reduce	reduce	VB
cord-281487-x0a9qgjs	124	36	invasive	invasive	JJ
cord-281487-x0a9qgjs	124	37	procedures	procedure	NNS
cord-281487-x0a9qgjs	124	38	for	for	IN
cord-281487-x0a9qgjs	124	39	rejection	rejection	NN
cord-281487-x0a9qgjs	124	40	monitoring	monitoring	NN
cord-281487-x0a9qgjs	124	41	.	.	.
cord-281487-x0a9qgjs	125	1	In	in	IN
cord-281487-x0a9qgjs	125	2	KT	KT	NNP
cord-281487-x0a9qgjs	125	3	recipients	recipient	NNS
cord-281487-x0a9qgjs	125	4	,	,	,
cord-281487-x0a9qgjs	125	5	the	the	DT
cord-281487-x0a9qgjs	125	6	negative	negative	JJ
cord-281487-x0a9qgjs	125	7	predictive	predictive	JJ
cord-281487-x0a9qgjs	125	8	value	value	NN
cord-281487-x0a9qgjs	125	9	of	of	IN
cord-281487-x0a9qgjs	125	10	dd	dd	NN
cord-281487-x0a9qgjs	125	11	-	-	HYPH
cord-281487-x0a9qgjs	125	12	cfDNA	cfdna	JJ
cord-281487-x0a9qgjs	125	13	for	for	IN
cord-281487-x0a9qgjs	125	14	any	any	DT
cord-281487-x0a9qgjs	125	15	active	active	JJ
cord-281487-x0a9qgjs	125	16	rejection	rejection	NN
cord-281487-x0a9qgjs	125	17	at	at	IN
cord-281487-x0a9qgjs	125	18	a	a	DT
cord-281487-x0a9qgjs	125	19	cutoff	cutoff	NN
cord-281487-x0a9qgjs	125	20	of	of	IN
cord-281487-x0a9qgjs	125	21	1.0	1.0	CD
cord-281487-x0a9qgjs	125	22	%	%	NN
cord-281487-x0a9qgjs	125	23	was	be	VBD
cord-281487-x0a9qgjs	125	24	84	84	CD
cord-281487-x0a9qgjs	125	25	%	%	NN
cord-281487-x0a9qgjs	125	26	,	,	,
cord-281487-x0a9qgjs	125	27	and	and	CC
cord-281487-x0a9qgjs	125	28	thus	thus	RB
cord-281487-x0a9qgjs	125	29	may	may	MD
cord-281487-x0a9qgjs	125	30	be	be	VB
cord-281487-x0a9qgjs	125	31	a	a	DT
cord-281487-x0a9qgjs	125	32	good	good	JJ
cord-281487-x0a9qgjs	125	33	non	non	JJ
cord-281487-x0a9qgjs	125	34	-	-	JJ
cord-281487-x0a9qgjs	125	35	invasive	invasive	JJ
cord-281487-x0a9qgjs	125	36	marker	marker	NN
cord-281487-x0a9qgjs	125	37	of	of	IN
cord-281487-x0a9qgjs	125	38	allograft	allograft	NN
cord-281487-x0a9qgjs	125	39	surveillance	surveillance	NN
cord-281487-x0a9qgjs	125	40	[	[	-LRB-
cord-281487-x0a9qgjs	125	41	57	57	CD
cord-281487-x0a9qgjs	125	42	]	]	-RRB-
cord-281487-x0a9qgjs	125	43	.	.	.
cord-281487-x0a9qgjs	126	1	While	while	IN
cord-281487-x0a9qgjs	126	2	its	-PRON-	PRP$
cord-281487-x0a9qgjs	126	3	role	role	NN
cord-281487-x0a9qgjs	126	4	in	in	IN
cord-281487-x0a9qgjs	126	5	other	other	JJ
cord-281487-x0a9qgjs	126	6	solid	solid	JJ
cord-281487-x0a9qgjs	126	7	organ	organ	NN
cord-281487-x0a9qgjs	126	8	transplants	transplant	NNS
cord-281487-x0a9qgjs	126	9	is	be	VBZ
cord-281487-x0a9qgjs	126	10	still	still	RB
cord-281487-x0a9qgjs	126	11	being	be	VBG
cord-281487-x0a9qgjs	126	12	defined	define	VBN
cord-281487-x0a9qgjs	126	13	,	,	,
cord-281487-x0a9qgjs	126	14	peripheral	peripheral	JJ
cord-281487-x0a9qgjs	126	15	gene	gene	NN
cord-281487-x0a9qgjs	126	16	expression	expression	NN
cord-281487-x0a9qgjs	126	17	tests	test	NNS
cord-281487-x0a9qgjs	126	18	may	may	MD
cord-281487-x0a9qgjs	126	19	also	also	RB
cord-281487-x0a9qgjs	126	20	be	be	VB
cord-281487-x0a9qgjs	126	21	helpful	helpful	JJ
cord-281487-x0a9qgjs	126	22	for	for	IN
cord-281487-x0a9qgjs	126	23	surveillance	surveillance	NN
cord-281487-x0a9qgjs	126	24	for	for	IN
cord-281487-x0a9qgjs	126	25	cardiac	cardiac	JJ
cord-281487-x0a9qgjs	126	26	allograft	allograft	NN
cord-281487-x0a9qgjs	126	27	rejection	rejection	NN
cord-281487-x0a9qgjs	126	28	to	to	TO
cord-281487-x0a9qgjs	126	29	reduce	reduce	VB
cord-281487-x0a9qgjs	126	30	need	need	NN
cord-281487-x0a9qgjs	126	31	for	for	IN
cord-281487-x0a9qgjs	126	32	invasive	invasive	JJ
cord-281487-x0a9qgjs	126	33	biopsies	biopsy	NNS
cord-281487-x0a9qgjs	126	34	[	[	-LRB-
cord-281487-x0a9qgjs	126	35	54	54	CD
cord-281487-x0a9qgjs	126	36	]	]	-RRB-
cord-281487-x0a9qgjs	126	37	.	.	.
cord-281487-x0a9qgjs	127	1	The	the	DT
cord-281487-x0a9qgjs	127	2	emotional	emotional	JJ
cord-281487-x0a9qgjs	127	3	toll	toll	NN
cord-281487-x0a9qgjs	127	4	of	of	IN
cord-281487-x0a9qgjs	127	5	the	the	DT
cord-281487-x0a9qgjs	127	6	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	127	7	pandemic	pandemic	NN
cord-281487-x0a9qgjs	127	8	should	should	MD
cord-281487-x0a9qgjs	127	9	be	be	VB
cord-281487-x0a9qgjs	127	10	recognized	recognize	VBN
cord-281487-x0a9qgjs	127	11	and	and	CC
cord-281487-x0a9qgjs	127	12	addressed	address	VBN
cord-281487-x0a9qgjs	127	13	with	with	IN
cord-281487-x0a9qgjs	127	14	patients	patient	NNS
cord-281487-x0a9qgjs	127	15	.	.	.
cord-281487-x0a9qgjs	128	1	Fear	fear	NN
cord-281487-x0a9qgjs	128	2	of	of	IN
cord-281487-x0a9qgjs	128	3	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	128	4	and	and	CC
cord-281487-x0a9qgjs	128	5	health	health	NN
cord-281487-x0a9qgjs	128	6	recommendations	recommendation	NNS
cord-281487-x0a9qgjs	128	7	to	to	IN
cord-281487-x0a9qgjs	128	8	transplant	transplant	NN
cord-281487-x0a9qgjs	128	9	recipients	recipient	NNS
cord-281487-x0a9qgjs	128	10	to	to	TO
cord-281487-x0a9qgjs	128	11	shelter	shelter	VB
cord-281487-x0a9qgjs	128	12	in	in	IN
cord-281487-x0a9qgjs	128	13	place	place	NN
cord-281487-x0a9qgjs	128	14	when	when	WRB
cord-281487-x0a9qgjs	128	15	there	there	EX
cord-281487-x0a9qgjs	128	16	is	be	VBZ
cord-281487-x0a9qgjs	128	17	significant	significant	JJ
cord-281487-x0a9qgjs	128	18	community	community	NN
cord-281487-x0a9qgjs	128	19	spread	spread	VBN
cord-281487-x0a9qgjs	128	20	may	may	MD
cord-281487-x0a9qgjs	128	21	worsen	worsen	VB
cord-281487-x0a9qgjs	128	22	anxiety	anxiety	NN
cord-281487-x0a9qgjs	128	23	,	,	,
cord-281487-x0a9qgjs	128	24	and/or	and/or	CC
cord-281487-x0a9qgjs	128	25	cause	cause	VB
cord-281487-x0a9qgjs	128	26	patients	patient	NNS
cord-281487-x0a9qgjs	128	27	to	to	TO
cord-281487-x0a9qgjs	128	28	defer	defer	VB
cord-281487-x0a9qgjs	128	29	essential	essential	JJ
cord-281487-x0a9qgjs	128	30	health	health	NN
cord-281487-x0a9qgjs	128	31	care	care	NN
cord-281487-x0a9qgjs	128	32	.	.	.
cord-281487-x0a9qgjs	129	1	The	the	DT
cord-281487-x0a9qgjs	129	2	emotional	emotional	JJ
cord-281487-x0a9qgjs	129	3	toll	toll	NN
cord-281487-x0a9qgjs	129	4	of	of	IN
cord-281487-x0a9qgjs	129	5	social	social	JJ
cord-281487-x0a9qgjs	129	6	isolation	isolation	NN
cord-281487-x0a9qgjs	129	7	may	may	MD
cord-281487-x0a9qgjs	129	8	lead	lead	VB
cord-281487-x0a9qgjs	129	9	transplant	transplant	NN
cord-281487-x0a9qgjs	129	10	recipients	recipient	NNS
cord-281487-x0a9qgjs	129	11	to	to	TO
cord-281487-x0a9qgjs	129	12	engage	engage	VB
cord-281487-x0a9qgjs	129	13	in	in	IN
cord-281487-x0a9qgjs	129	14	behaviors	behavior	NNS
cord-281487-x0a9qgjs	129	15	that	that	WDT
cord-281487-x0a9qgjs	129	16	increase	increase	VBP
cord-281487-x0a9qgjs	129	17	their	-PRON-	PRP$
cord-281487-x0a9qgjs	129	18	risk	risk	NN
cord-281487-x0a9qgjs	129	19	of	of	IN
cord-281487-x0a9qgjs	129	20	exposure	exposure	NN
cord-281487-x0a9qgjs	129	21	to	to	IN
cord-281487-x0a9qgjs	129	22	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	129	23	.	.	.
cord-281487-x0a9qgjs	130	1	Thus	thus	RB
cord-281487-x0a9qgjs	130	2	,	,	,
cord-281487-x0a9qgjs	130	3	the	the	DT
cord-281487-x0a9qgjs	130	4	transplant	transplant	NN
cord-281487-x0a9qgjs	130	5	team	team	NN
cord-281487-x0a9qgjs	130	6	should	should	MD
cord-281487-x0a9qgjs	130	7	assess	assess	VB
cord-281487-x0a9qgjs	130	8	mental	mental	JJ
cord-281487-x0a9qgjs	130	9	health	health	NN
cord-281487-x0a9qgjs	130	10	during	during	IN
cord-281487-x0a9qgjs	130	11	their	-PRON-	PRP$
cord-281487-x0a9qgjs	130	12	patient	patient	JJ
cord-281487-x0a9qgjs	130	13	encounters	encounter	NNS
cord-281487-x0a9qgjs	130	14	and	and	CC
cord-281487-x0a9qgjs	130	15	provide	provide	VB
cord-281487-x0a9qgjs	130	16	referrals	referral	NNS
cord-281487-x0a9qgjs	130	17	or	or	CC
cord-281487-x0a9qgjs	130	18	interventions	intervention	NNS
cord-281487-x0a9qgjs	130	19	as	as	IN
cord-281487-x0a9qgjs	130	20	appropriate	appropriate	JJ
cord-281487-x0a9qgjs	130	21	during	during	IN
cord-281487-x0a9qgjs	130	22	this	this	DT
cord-281487-x0a9qgjs	130	23	unprecedented	unprecedented	JJ
cord-281487-x0a9qgjs	130	24	challenge	challenge	NN
cord-281487-x0a9qgjs	130	25	.	.	.
cord-281487-x0a9qgjs	131	1	In	in	IN
cord-281487-x0a9qgjs	131	2	transplant	transplant	NN
cord-281487-x0a9qgjs	131	3	recipients	recipient	NNS
cord-281487-x0a9qgjs	131	4	with	with	IN
cord-281487-x0a9qgjs	131	5	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	131	6	,	,	,
cord-281487-x0a9qgjs	131	7	depression	depression	NN
cord-281487-x0a9qgjs	131	8	,	,	,
cord-281487-x0a9qgjs	131	9	anxiety	anxiety	NN
cord-281487-x0a9qgjs	131	10	,	,	,
cord-281487-x0a9qgjs	131	11	and	and	CC
cord-281487-x0a9qgjs	131	12	sleep	sleep	NN
cord-281487-x0a9qgjs	131	13	disturbances	disturbance	NNS
cord-281487-x0a9qgjs	131	14	associated	associate	VBN
cord-281487-x0a9qgjs	131	15	with	with	IN
cord-281487-x0a9qgjs	131	16	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	131	17	can	can	MD
cord-281487-x0a9qgjs	131	18	worsen	worsen	VB
cord-281487-x0a9qgjs	131	19	non	non	JJ
cord-281487-x0a9qgjs	131	20	-	-	JJ
cord-281487-x0a9qgjs	131	21	adherence	adherence	JJ
cord-281487-x0a9qgjs	131	22	to	to	IN
cord-281487-x0a9qgjs	131	23	immunosuppressive	immunosuppressive	JJ
cord-281487-x0a9qgjs	131	24	therapy	therapy	NN
cord-281487-x0a9qgjs	131	25	and	and	CC
cord-281487-x0a9qgjs	131	26	increase	increase	VB
cord-281487-x0a9qgjs	131	27	the	the	DT
cord-281487-x0a9qgjs	131	28	risk	risk	NN
cord-281487-x0a9qgjs	131	29	of	of	IN
cord-281487-x0a9qgjs	131	30	allograft	allograft	NN
cord-281487-x0a9qgjs	131	31	rejection	rejection	NN
cord-281487-x0a9qgjs	131	32	[	[	-LRB-
cord-281487-x0a9qgjs	131	33	58	58	CD
cord-281487-x0a9qgjs	131	34	]	]	-RRB-
cord-281487-x0a9qgjs	131	35	.	.	.
cord-281487-x0a9qgjs	132	1	Melatonin	melatonin	NN
cord-281487-x0a9qgjs	132	2	is	be	VBZ
cord-281487-x0a9qgjs	132	3	an	an	DT
cord-281487-x0a9qgjs	132	4	effective	effective	JJ
cord-281487-x0a9qgjs	132	5	drug	drug	NN
cord-281487-x0a9qgjs	132	6	for	for	IN
cord-281487-x0a9qgjs	132	7	anxiety	anxiety	NN
cord-281487-x0a9qgjs	132	8	and	and	CC
cord-281487-x0a9qgjs	132	9	sleep	sleep	NN
cord-281487-x0a9qgjs	132	10	disturbances	disturbance	NNS
cord-281487-x0a9qgjs	132	11	,	,	,
cord-281487-x0a9qgjs	132	12	which	which	WDT
cord-281487-x0a9qgjs	132	13	might	may	MD
cord-281487-x0a9qgjs	132	14	also	also	RB
cord-281487-x0a9qgjs	132	15	be	be	VB
cord-281487-x0a9qgjs	132	16	beneficial	beneficial	JJ
cord-281487-x0a9qgjs	132	17	for	for	IN
cord-281487-x0a9qgjs	132	18	clinical	clinical	JJ
cord-281487-x0a9qgjs	132	19	outcomes	outcome	NNS
cord-281487-x0a9qgjs	132	20	of	of	IN
cord-281487-x0a9qgjs	132	21	patients	patient	NNS
cord-281487-x0a9qgjs	132	22	with	with	IN
cord-281487-x0a9qgjs	132	23	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	132	24	due	due	IN
cord-281487-x0a9qgjs	132	25	to	to	IN
cord-281487-x0a9qgjs	132	26	its	-PRON-	PRP$
cord-281487-x0a9qgjs	132	27	anti	anti	JJ
cord-281487-x0a9qgjs	132	28	-	-	JJ
cord-281487-x0a9qgjs	132	29	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	132	30	and	and	CC
cord-281487-x0a9qgjs	132	31	anti	anti	JJ
cord-281487-x0a9qgjs	132	32	-	-	JJ
cord-281487-x0a9qgjs	132	33	oxidant	oxidant	JJ
cord-281487-x0a9qgjs	132	34	properties	property	NNS
cord-281487-x0a9qgjs	132	35	[	[	-LRB-
cord-281487-x0a9qgjs	132	36	59	59	CD
cord-281487-x0a9qgjs	132	37	,	,	,
cord-281487-x0a9qgjs	132	38	60	60	CD
cord-281487-x0a9qgjs	132	39	]	]	-RRB-
cord-281487-x0a9qgjs	132	40	.	.	.
cord-281487-x0a9qgjs	133	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	133	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	133	3	with	with	IN
cord-281487-x0a9qgjs	133	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	133	5	can	can	MD
cord-281487-x0a9qgjs	133	6	progress	progress	VB
cord-281487-x0a9qgjs	133	7	rapidly	rapidly	RB
cord-281487-x0a9qgjs	133	8	and	and	CC
cord-281487-x0a9qgjs	133	9	seriously	seriously	RB
cord-281487-x0a9qgjs	133	10	.	.	.
cord-281487-x0a9qgjs	134	1	They	-PRON-	PRP
cord-281487-x0a9qgjs	134	2	should	should	MD
cord-281487-x0a9qgjs	134	3	be	be	VB
cord-281487-x0a9qgjs	134	4	monitored	monitor	VBN
cord-281487-x0a9qgjs	134	5	and	and	CC
cord-281487-x0a9qgjs	134	6	managed	manage	VBN
cord-281487-x0a9qgjs	134	7	through	through	IN
cord-281487-x0a9qgjs	134	8	frequent	frequent	JJ
cord-281487-x0a9qgjs	134	9	communication	communication	NN
cord-281487-x0a9qgjs	134	10	between	between	IN
cord-281487-x0a9qgjs	134	11	the	the	DT
cord-281487-x0a9qgjs	134	12	transplant	transplant	NN
cord-281487-x0a9qgjs	134	13	team	team	NN
cord-281487-x0a9qgjs	134	14	and	and	CC
cord-281487-x0a9qgjs	134	15	patients	patient	NNS
cord-281487-x0a9qgjs	134	16	.	.	.
cord-281487-x0a9qgjs	135	1	Figure	figure	NN
cord-281487-x0a9qgjs	135	2	1	1	CD
cord-281487-x0a9qgjs	135	3	shows	show	VBZ
cord-281487-x0a9qgjs	135	4	a	a	DT
cord-281487-x0a9qgjs	135	5	model	model	NN
cord-281487-x0a9qgjs	135	6	for	for	IN
cord-281487-x0a9qgjs	135	7	the	the	DT
cord-281487-x0a9qgjs	135	8	management	management	NN
cord-281487-x0a9qgjs	135	9	of	of	IN
cord-281487-x0a9qgjs	135	10	solid	solid	JJ
cord-281487-x0a9qgjs	135	11	organ	organ	NN
cord-281487-x0a9qgjs	135	12	transplant	transplant	NN
cord-281487-x0a9qgjs	135	13	recipients	recipient	NNS
cord-281487-x0a9qgjs	135	14	during	during	IN
cord-281487-x0a9qgjs	135	15	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	135	16	pandemic	pandemic	NN
cord-281487-x0a9qgjs	135	17	,	,	,
cord-281487-x0a9qgjs	135	18	based	base	VBN
cord-281487-x0a9qgjs	135	19	on	on	IN
cord-281487-x0a9qgjs	135	20	recommendations	recommendation	NNS
cord-281487-x0a9qgjs	135	21	of	of	IN
cord-281487-x0a9qgjs	135	22	the	the	DT
cord-281487-x0a9qgjs	135	23	Centers	Centers	NNPS
cord-281487-x0a9qgjs	135	24	for	for	IN
cord-281487-x0a9qgjs	135	25	Disease	Disease	NNP
cord-281487-x0a9qgjs	135	26	Control	Control	NNP
cord-281487-x0a9qgjs	135	27	and	and	CC
cord-281487-x0a9qgjs	135	28	Prevention	Prevention	NNP
cord-281487-x0a9qgjs	135	29	(	(	-LRB-
cord-281487-x0a9qgjs	135	30	CDC	CDC	NNP
cord-281487-x0a9qgjs	135	31	)	)	-RRB-
cord-281487-x0a9qgjs	135	32	and	and	CC
cord-281487-x0a9qgjs	135	33	the	the	DT
cord-281487-x0a9qgjs	135	34	American	American	NNP
cord-281487-x0a9qgjs	135	35	Society	Society	NNP
cord-281487-x0a9qgjs	135	36	of	of	IN
cord-281487-x0a9qgjs	135	37	Transplantation	Transplantation	NNP
cord-281487-x0a9qgjs	135	38	(	(	-LRB-
cord-281487-x0a9qgjs	135	39	AST	ast	NN
cord-281487-x0a9qgjs	135	40	)	)	-RRB-
cord-281487-x0a9qgjs	136	1	[	[	-LRB-
cord-281487-x0a9qgjs	136	2	52	52	CD
cord-281487-x0a9qgjs	136	3	,	,	,
cord-281487-x0a9qgjs	136	4	61	61	CD
cord-281487-x0a9qgjs	136	5	]	]	-RRB-
cord-281487-x0a9qgjs	136	6	.	.	.
cord-281487-x0a9qgjs	137	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	137	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	137	3	with	with	IN
cord-281487-x0a9qgjs	137	4	direct	direct	JJ
cord-281487-x0a9qgjs	137	5	contact	contact	NN
cord-281487-x0a9qgjs	137	6	(	(	-LRB-
cord-281487-x0a9qgjs	137	7	<	<	NNP
cord-281487-x0a9qgjs	137	8	6	6	CD
cord-281487-x0a9qgjs	137	9	ft	ft	NN
cord-281487-x0a9qgjs	137	10	for	for	IN
cord-281487-x0a9qgjs	137	11	≥	≥	CD
cord-281487-x0a9qgjs	137	12	15	15	CD
cord-281487-x0a9qgjs	137	13	min	min	NNP
cord-281487-x0a9qgjs	137	14	)	)	-RRB-
cord-281487-x0a9qgjs	137	15	with	with	IN
cord-281487-x0a9qgjs	137	16	a	a	DT
cord-281487-x0a9qgjs	137	17	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	137	18	infected	infected	JJ
cord-281487-x0a9qgjs	137	19	individual	individual	NN
cord-281487-x0a9qgjs	137	20	should	should	MD
cord-281487-x0a9qgjs	137	21	be	be	VB
cord-281487-x0a9qgjs	137	22	quarantined	quarantine	VBN
cord-281487-x0a9qgjs	137	23	for	for	IN
cord-281487-x0a9qgjs	137	24	14	14	CD
cord-281487-x0a9qgjs	137	25	days	day	NNS
cord-281487-x0a9qgjs	137	26	and	and	CC
cord-281487-x0a9qgjs	137	27	consider	consider	VB
cord-281487-x0a9qgjs	137	28	testing	test	VBG
cord-281487-x0a9qgjs	137	29	for	for	IN
cord-281487-x0a9qgjs	137	30	SARS	SARS	NNP
cord-281487-x0a9qgjs	137	31	-	-	HYPH
cord-281487-x0a9qgjs	137	32	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	137	33	after	after	IN
cord-281487-x0a9qgjs	137	34	exposure	exposure	NN
cord-281487-x0a9qgjs	137	35	or	or	CC
cord-281487-x0a9qgjs	137	36	if	if	IN
cord-281487-x0a9qgjs	137	37	they	-PRON-	PRP
cord-281487-x0a9qgjs	137	38	develop	develop	VBP
cord-281487-x0a9qgjs	137	39	symptoms	symptom	NNS
cord-281487-x0a9qgjs	137	40	[	[	-LRB-
cord-281487-x0a9qgjs	137	41	49	49	CD
cord-281487-x0a9qgjs	137	42	,	,	,
cord-281487-x0a9qgjs	137	43	52	52	CD
cord-281487-x0a9qgjs	137	44	]	]	-RRB-
cord-281487-x0a9qgjs	137	45	.	.	.
cord-281487-x0a9qgjs	138	1	Patients	patient	NNS
cord-281487-x0a9qgjs	138	2	with	with	IN
cord-281487-x0a9qgjs	138	3	confirmed	confirm	VBN
cord-281487-x0a9qgjs	138	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	138	5	should	should	MD
cord-281487-x0a9qgjs	138	6	check	check	VB
cord-281487-x0a9qgjs	138	7	their	-PRON-	PRP$
cord-281487-x0a9qgjs	138	8	temperature	temperature	NN
cord-281487-x0a9qgjs	138	9	and	and	CC
cord-281487-x0a9qgjs	138	10	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	138	11	rate	rate	NN
cord-281487-x0a9qgjs	138	12	(	(	-LRB-
cord-281487-x0a9qgjs	138	13	RR	RR	NNP
cord-281487-x0a9qgjs	138	14	)	)	-RRB-
cord-281487-x0a9qgjs	138	15	,	,	,
cord-281487-x0a9qgjs	138	16	oxygen	oxygen	NN
cord-281487-x0a9qgjs	138	17	saturation	saturation	NN
cord-281487-x0a9qgjs	138	18	,	,	,
cord-281487-x0a9qgjs	138	19	and	and	CC
cord-281487-x0a9qgjs	138	20	symptoms	symptom	NNS
cord-281487-x0a9qgjs	138	21	.	.	.
cord-281487-x0a9qgjs	139	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	139	2	centers	center	NNS
cord-281487-x0a9qgjs	139	3	should	should	MD
cord-281487-x0a9qgjs	139	4	consider	consider	VB
cord-281487-x0a9qgjs	139	5	assistance	assistance	NN
cord-281487-x0a9qgjs	139	6	for	for	IN
cord-281487-x0a9qgjs	139	7	pulse	pulse	NN
cord-281487-x0a9qgjs	139	8	oximeters	oximeter	NNS
cord-281487-x0a9qgjs	139	9	if	if	IN
cord-281487-x0a9qgjs	139	10	patients	patient	NNS
cord-281487-x0a9qgjs	139	11	experience	experience	VBP
cord-281487-x0a9qgjs	139	12	hardship	hardship	NN
cord-281487-x0a9qgjs	139	13	in	in	IN
cord-281487-x0a9qgjs	139	14	obtaining	obtain	VBG
cord-281487-x0a9qgjs	139	15	these	these	DT
cord-281487-x0a9qgjs	139	16	devices	device	NNS
cord-281487-x0a9qgjs	139	17	.	.	.
cord-281487-x0a9qgjs	140	1	If	if	IN
cord-281487-x0a9qgjs	140	2	they	-PRON-	PRP
cord-281487-x0a9qgjs	140	3	have	have	VBP
cord-281487-x0a9qgjs	140	4	dyspnea	dyspnea	NN
cord-281487-x0a9qgjs	140	5	or	or	CC
cord-281487-x0a9qgjs	140	6	RR	rr	NN
cord-281487-x0a9qgjs	140	7	≥	≥	CD
cord-281487-x0a9qgjs	140	8	24	24	CD
cord-281487-x0a9qgjs	140	9	per	per	IN
cord-281487-x0a9qgjs	140	10	minute	minute	NN
cord-281487-x0a9qgjs	140	11	,	,	,
cord-281487-x0a9qgjs	140	12	oxygen	oxygen	NN
cord-281487-x0a9qgjs	140	13	saturation	saturation	NN
cord-281487-x0a9qgjs	141	1	<	<	NNP
cord-281487-x0a9qgjs	141	2	94	94	CD
cord-281487-x0a9qgjs	141	3	%	%	NN
cord-281487-x0a9qgjs	141	4	,	,	,
cord-281487-x0a9qgjs	141	5	persistent	persistent	JJ
cord-281487-x0a9qgjs	141	6	or	or	CC
cord-281487-x0a9qgjs	141	7	high	high	JJ
cord-281487-x0a9qgjs	141	8	fever	fever	NN
cord-281487-x0a9qgjs	141	9	,	,	,
cord-281487-x0a9qgjs	141	10	difficulty	difficulty	NN
cord-281487-x0a9qgjs	141	11	eating	eat	VBG
cord-281487-x0a9qgjs	141	12	foods	food	NNS
cord-281487-x0a9qgjs	141	13	with	with	IN
cord-281487-x0a9qgjs	141	14	predominant	predominant	JJ
cord-281487-x0a9qgjs	141	15	gastrointestinal	gastrointestinal	JJ
cord-281487-x0a9qgjs	141	16	symptoms	symptom	NNS
cord-281487-x0a9qgjs	141	17	,	,	,
cord-281487-x0a9qgjs	141	18	low	low	JJ
cord-281487-x0a9qgjs	141	19	urine	urine	NN
cord-281487-x0a9qgjs	141	20	volume	volume	NN
cord-281487-x0a9qgjs	141	21	(	(	-LRB-
cord-281487-x0a9qgjs	141	22	<	<	NN
cord-281487-x0a9qgjs	141	23	400	400	CD
cord-281487-x0a9qgjs	141	24	mL	ml	NN
cord-281487-x0a9qgjs	141	25	per	per	IN
cord-281487-x0a9qgjs	141	26	day	day	NN
cord-281487-x0a9qgjs	141	27	)	)	-RRB-
cord-281487-x0a9qgjs	141	28	,	,	,
cord-281487-x0a9qgjs	141	29	or	or	CC
cord-281487-x0a9qgjs	141	30	worsening	worsening	NN
cord-281487-x0a9qgjs	141	31	of	of	IN
cord-281487-x0a9qgjs	141	32	general	general	JJ
cord-281487-x0a9qgjs	141	33	conditions	condition	NNS
cord-281487-x0a9qgjs	141	34	,	,	,
cord-281487-x0a9qgjs	141	35	they	-PRON-	PRP
cord-281487-x0a9qgjs	141	36	should	should	MD
cord-281487-x0a9qgjs	141	37	plan	plan	VB
cord-281487-x0a9qgjs	141	38	for	for	IN
cord-281487-x0a9qgjs	141	39	hospitalization	hospitalization	NN
cord-281487-x0a9qgjs	142	1	(	(	-LRB-
cord-281487-x0a9qgjs	142	2	Fig	Fig	NNP
cord-281487-x0a9qgjs	142	3	.	.	.
cord-281487-x0a9qgjs	142	4	1	1	CD
cord-281487-x0a9qgjs	142	5	)	)	-RRB-
cord-281487-x0a9qgjs	142	6	[	[	-LRB-
cord-281487-x0a9qgjs	142	7	52	52	CD
cord-281487-x0a9qgjs	142	8	,	,	,
cord-281487-x0a9qgjs	142	9	54	54	CD
cord-281487-x0a9qgjs	142	10	]	]	-RRB-
cord-281487-x0a9qgjs	142	11	.	.	.
cord-281487-x0a9qgjs	143	1	The	the	DT
cord-281487-x0a9qgjs	143	2	determination	determination	NN
cord-281487-x0a9qgjs	143	3	of	of	IN
cord-281487-x0a9qgjs	143	4	when	when	WRB
cord-281487-x0a9qgjs	143	5	a	a	DT
cord-281487-x0a9qgjs	143	6	transplant	transplant	NN
cord-281487-x0a9qgjs	143	7	recipient	recipient	NN
cord-281487-x0a9qgjs	143	8	is	be	VBZ
cord-281487-x0a9qgjs	143	9	no	no	DT
cord-281487-x0a9qgjs	143	10	longer	long	RBR
cord-281487-x0a9qgjs	143	11	infectious	infectious	JJ
cord-281487-x0a9qgjs	143	12	is	be	VBZ
cord-281487-x0a9qgjs	143	13	evolving	evolve	VBG
cord-281487-x0a9qgjs	143	14	.	.	.
cord-281487-x0a9qgjs	144	1	Immunocompromised	immunocompromise	VBN
cord-281487-x0a9qgjs	144	2	patients	patient	NNS
cord-281487-x0a9qgjs	144	3	may	may	MD
cord-281487-x0a9qgjs	144	4	have	have	VB
cord-281487-x0a9qgjs	144	5	prolonged	prolong	VBN
cord-281487-x0a9qgjs	144	6	viral	viral	JJ
cord-281487-x0a9qgjs	144	7	shedding	shedding	NN
cord-281487-x0a9qgjs	144	8	,	,	,
cord-281487-x0a9qgjs	144	9	and	and	CC
cord-281487-x0a9qgjs	144	10	further	further	JJ
cord-281487-x0a9qgjs	144	11	research	research	NN
cord-281487-x0a9qgjs	144	12	is	be	VBZ
cord-281487-x0a9qgjs	144	13	needed	need	VBN
cord-281487-x0a9qgjs	144	14	to	to	TO
cord-281487-x0a9qgjs	144	15	determine	determine	VB
cord-281487-x0a9qgjs	144	16	the	the	DT
cord-281487-x0a9qgjs	144	17	timeframe	timeframe	NN
cord-281487-x0a9qgjs	144	18	of	of	IN
cord-281487-x0a9qgjs	144	19	infectivity	infectivity	NN
cord-281487-x0a9qgjs	144	20	in	in	IN
cord-281487-x0a9qgjs	144	21	this	this	DT
cord-281487-x0a9qgjs	144	22	population	population	NN
cord-281487-x0a9qgjs	144	23	[	[	-LRB-
cord-281487-x0a9qgjs	144	24	62	62	CD
cord-281487-x0a9qgjs	144	25	,	,	,
cord-281487-x0a9qgjs	144	26	63	63	CD
cord-281487-x0a9qgjs	144	27	]	]	-RRB-
cord-281487-x0a9qgjs	144	28	.	.	.
cord-281487-x0a9qgjs	145	1	The	the	DT
cord-281487-x0a9qgjs	145	2	AST	AST	NNP
cord-281487-x0a9qgjs	145	3	recommends	recommend	VBZ
cord-281487-x0a9qgjs	145	4	a	a	DT
cord-281487-x0a9qgjs	145	5	28-day	28-day	CD
cord-281487-x0a9qgjs	145	6	time	time	NN
cord-281487-x0a9qgjs	145	7	-	-	HYPH
cord-281487-x0a9qgjs	145	8	frame	frame	NN
cord-281487-x0a9qgjs	145	9	because	because	IN
cord-281487-x0a9qgjs	145	10	the	the	DT
cord-281487-x0a9qgjs	145	11	shedding	shedding	NN
cord-281487-x0a9qgjs	145	12	of	of	IN
cord-281487-x0a9qgjs	145	13	the	the	DT
cord-281487-x0a9qgjs	145	14	virus	virus	NN
cord-281487-x0a9qgjs	145	15	can	can	MD
cord-281487-x0a9qgjs	145	16	be	be	VB
cord-281487-x0a9qgjs	145	17	prolonged	prolong	VBN
cord-281487-x0a9qgjs	145	18	in	in	IN
cord-281487-x0a9qgjs	145	19	transplant	transplant	NN
cord-281487-x0a9qgjs	145	20	recipients	recipient	NNS
cord-281487-x0a9qgjs	145	21	,	,	,
cord-281487-x0a9qgjs	145	22	although	although	IN
cord-281487-x0a9qgjs	145	23	infectivity	infectivity	NN
cord-281487-x0a9qgjs	145	24	is	be	VBZ
cord-281487-x0a9qgjs	145	25	unclear	unclear	JJ
cord-281487-x0a9qgjs	145	26	[	[	-LRB-
cord-281487-x0a9qgjs	145	27	61	61	CD
cord-281487-x0a9qgjs	145	28	]	]	-RRB-
cord-281487-x0a9qgjs	145	29	.	.	.
cord-281487-x0a9qgjs	146	1	This	this	DT
cord-281487-x0a9qgjs	146	2	is	be	VBZ
cord-281487-x0a9qgjs	146	3	different	different	JJ
cord-281487-x0a9qgjs	146	4	from	from	IN
cord-281487-x0a9qgjs	146	5	recommendations	recommendation	NNS
cord-281487-x0a9qgjs	146	6	for	for	IN
cord-281487-x0a9qgjs	146	7	immunocompetent	immunocompetent	JJ
cord-281487-x0a9qgjs	146	8	hosts	host	NNS
cord-281487-x0a9qgjs	146	9	and	and	CC
cord-281487-x0a9qgjs	146	10	should	should	MD
cord-281487-x0a9qgjs	146	11	be	be	VB
cord-281487-x0a9qgjs	146	12	communicated	communicate	VBN
cord-281487-x0a9qgjs	146	13	to	to	IN
cord-281487-x0a9qgjs	146	14	health	health	NN
cord-281487-x0a9qgjs	146	15	care	care	NN
cord-281487-x0a9qgjs	146	16	providers	provider	NNS
cord-281487-x0a9qgjs	146	17	and	and	CC
cord-281487-x0a9qgjs	146	18	COVID-19	covid-19	VB
cord-281487-x0a9qgjs	146	19	infected	infected	JJ
cord-281487-x0a9qgjs	146	20	transplant	transplant	NN
cord-281487-x0a9qgjs	146	21	recipients	recipient	NNS
cord-281487-x0a9qgjs	146	22	.	.	.
cord-281487-x0a9qgjs	147	1	Alternatively	alternatively	RB
cord-281487-x0a9qgjs	147	2	,	,	,
cord-281487-x0a9qgjs	147	3	a	a	DT
cord-281487-x0a9qgjs	147	4	test	test	NN
cord-281487-x0a9qgjs	147	5	-	-	HYPH
cord-281487-x0a9qgjs	147	6	based	base	VBN
cord-281487-x0a9qgjs	147	7	strategy	strategy	NN
cord-281487-x0a9qgjs	147	8	has	have	VBZ
cord-281487-x0a9qgjs	147	9	also	also	RB
cord-281487-x0a9qgjs	147	10	been	be	VBN
cord-281487-x0a9qgjs	147	11	used	use	VBN
cord-281487-x0a9qgjs	147	12	with	with	IN
cord-281487-x0a9qgjs	147	13	the	the	DT
cord-281487-x0a9qgjs	147	14	use	use	NN
cord-281487-x0a9qgjs	147	15	of	of	IN
cord-281487-x0a9qgjs	147	16	negative	negative	JJ
cord-281487-x0a9qgjs	147	17	results	result	NNS
cord-281487-x0a9qgjs	147	18	of	of	IN
cord-281487-x0a9qgjs	147	19	RNA	RNA	NNP
cord-281487-x0a9qgjs	147	20	PCR	PCR	NNP
cord-281487-x0a9qgjs	147	21	tests	test	NNS
cord-281487-x0a9qgjs	147	22	from	from	IN
cord-281487-x0a9qgjs	147	23	at	at	RB
cord-281487-x0a9qgjs	147	24	least	least	RBS
cord-281487-x0a9qgjs	147	25	two	two	CD
cord-281487-x0a9qgjs	147	26	consecutive	consecutive	JJ
cord-281487-x0a9qgjs	147	27	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	147	28	specimens	specimen	NNS
cord-281487-x0a9qgjs	147	29	≥	≥	CD
cord-281487-x0a9qgjs	147	30	24	24	CD
cord-281487-x0a9qgjs	147	31	h	h	NN
cord-281487-x0a9qgjs	147	32	apart	apart	RB
cord-281487-x0a9qgjs	147	33	as	as	RB
cord-281487-x0a9qgjs	147	34	well	well	RB
cord-281487-x0a9qgjs	147	35	as	as	IN
cord-281487-x0a9qgjs	147	36	recovery	recovery	NN
cord-281487-x0a9qgjs	147	37	of	of	IN
cord-281487-x0a9qgjs	147	38	symptoms	symptom	NNS
cord-281487-x0a9qgjs	147	39	.	.	.
cord-281487-x0a9qgjs	148	1	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	148	2	progresses	progress	VBZ
cord-281487-x0a9qgjs	148	3	through	through	IN
cord-281487-x0a9qgjs	148	4	syndrome	syndrome	NN
cord-281487-x0a9qgjs	148	5	phases	phase	NNS
cord-281487-x0a9qgjs	148	6	that	that	WDT
cord-281487-x0a9qgjs	148	7	include	include	VBP
cord-281487-x0a9qgjs	148	8	:	:	:
cord-281487-x0a9qgjs	148	9	the	the	DT
cord-281487-x0a9qgjs	148	10	early	early	JJ
cord-281487-x0a9qgjs	148	11	infection	infection	NN
cord-281487-x0a9qgjs	148	12	phase	phase	NN
cord-281487-x0a9qgjs	148	13	,	,	,
cord-281487-x0a9qgjs	148	14	the	the	DT
cord-281487-x0a9qgjs	148	15	pulmonary	pulmonary	JJ
cord-281487-x0a9qgjs	148	16	phase	phase	NN
cord-281487-x0a9qgjs	148	17	,	,	,
cord-281487-x0a9qgjs	148	18	and	and	CC
cord-281487-x0a9qgjs	148	19	the	the	DT
cord-281487-x0a9qgjs	148	20	hyperinflammation	hyperinflammation	NN
cord-281487-x0a9qgjs	148	21	phase	phase	NN
cord-281487-x0a9qgjs	148	22	[	[	-LRB-
cord-281487-x0a9qgjs	148	23	64	64	CD
cord-281487-x0a9qgjs	148	24	]	]	-RRB-
cord-281487-x0a9qgjs	148	25	.	.	.
cord-281487-x0a9qgjs	149	1	The	the	DT
cord-281487-x0a9qgjs	149	2	early	early	JJ
cord-281487-x0a9qgjs	149	3	infection	infection	NN
cord-281487-x0a9qgjs	149	4	phase	phase	NN
cord-281487-x0a9qgjs	149	5	is	be	VBZ
cord-281487-x0a9qgjs	149	6	triggered	trigger	VBN
cord-281487-x0a9qgjs	149	7	by	by	IN
cord-281487-x0a9qgjs	149	8	the	the	DT
cord-281487-x0a9qgjs	149	9	virus	virus	NN
cord-281487-x0a9qgjs	149	10	itself	-PRON-	PRP
cord-281487-x0a9qgjs	149	11	and	and	CC
cord-281487-x0a9qgjs	149	12	the	the	DT
cord-281487-x0a9qgjs	149	13	hyperinflammation	hyperinflammation	NN
cord-281487-x0a9qgjs	149	14	phase	phase	NN
cord-281487-x0a9qgjs	149	15	is	be	VBZ
cord-281487-x0a9qgjs	149	16	developed	develop	VBN
cord-281487-x0a9qgjs	149	17	by	by	IN
cord-281487-x0a9qgjs	149	18	the	the	DT
cord-281487-x0a9qgjs	149	19	host	host	NN
cord-281487-x0a9qgjs	149	20	response	response	NN
cord-281487-x0a9qgjs	149	21	.	.	.
cord-281487-x0a9qgjs	150	1	At	at	IN
cord-281487-x0a9qgjs	150	2	the	the	DT
cord-281487-x0a9qgjs	150	3	initial	initial	JJ
cord-281487-x0a9qgjs	150	4	stage	stage	NN
cord-281487-x0a9qgjs	150	5	or	or	CC
cord-281487-x0a9qgjs	150	6	infection	infection	NN
cord-281487-x0a9qgjs	150	7	,	,	,
cord-281487-x0a9qgjs	150	8	most	most	JJS
cord-281487-x0a9qgjs	150	9	patients	patient	NNS
cord-281487-x0a9qgjs	150	10	have	have	VBP
cord-281487-x0a9qgjs	150	11	mild	mild	JJ
cord-281487-x0a9qgjs	150	12	,	,	,
cord-281487-x0a9qgjs	150	13	non	non	JJ
cord-281487-x0a9qgjs	150	14	-	-	JJ
cord-281487-x0a9qgjs	150	15	specific	specific	JJ
cord-281487-x0a9qgjs	150	16	symptoms	symptom	NNS
cord-281487-x0a9qgjs	150	17	.	.	.
cord-281487-x0a9qgjs	151	1	Because	because	IN
cord-281487-x0a9qgjs	151	2	SARS	SARS	NNP
cord-281487-x0a9qgjs	151	3	-	-	HYPH
cord-281487-x0a9qgjs	151	4	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	151	5	multiplies	multiply	VBZ
cord-281487-x0a9qgjs	151	6	and	and	CC
cord-281487-x0a9qgjs	151	7	establishes	establish	VBZ
cord-281487-x0a9qgjs	151	8	residence	residence	NN
cord-281487-x0a9qgjs	151	9	in	in	IN
cord-281487-x0a9qgjs	151	10	the	the	DT
cord-281487-x0a9qgjs	151	11	host	host	NN
cord-281487-x0a9qgjs	151	12	during	during	IN
cord-281487-x0a9qgjs	151	13	this	this	DT
cord-281487-x0a9qgjs	151	14	period	period	NN
cord-281487-x0a9qgjs	151	15	,	,	,
cord-281487-x0a9qgjs	151	16	the	the	DT
cord-281487-x0a9qgjs	151	17	reduction	reduction	NN
cord-281487-x0a9qgjs	151	18	of	of	IN
cord-281487-x0a9qgjs	151	19	immunosuppressive	immunosuppressive	JJ
cord-281487-x0a9qgjs	151	20	agents	agent	NNS
cord-281487-x0a9qgjs	151	21	should	should	MD
cord-281487-x0a9qgjs	151	22	be	be	VB
cord-281487-x0a9qgjs	151	23	considered	consider	VBN
cord-281487-x0a9qgjs	151	24	to	to	TO
cord-281487-x0a9qgjs	151	25	enhance	enhance	VB
cord-281487-x0a9qgjs	151	26	viral	viral	JJ
cord-281487-x0a9qgjs	151	27	clearance	clearance	NN
cord-281487-x0a9qgjs	151	28	[	[	-LRB-
cord-281487-x0a9qgjs	151	29	64	64	CD
cord-281487-x0a9qgjs	151	30	]	]	-RRB-
cord-281487-x0a9qgjs	151	31	.	.	.
cord-281487-x0a9qgjs	152	1	At	at	IN
cord-281487-x0a9qgjs	152	2	the	the	DT
cord-281487-x0a9qgjs	152	3	JH	JH	NNP
cord-281487-x0a9qgjs	152	4	-	-	HYPH
cord-281487-x0a9qgjs	152	5	CTC	CTC	NNP
cord-281487-x0a9qgjs	152	6	,	,	,
cord-281487-x0a9qgjs	152	7	it	-PRON-	PRP
cord-281487-x0a9qgjs	152	8	is	be	VBZ
cord-281487-x0a9qgjs	152	9	recommended	recommend	VBN
cord-281487-x0a9qgjs	152	10	that	that	IN
cord-281487-x0a9qgjs	152	11	mycophenolate	mycophenolate	NNP
cord-281487-x0a9qgjs	152	12	be	be	VB
cord-281487-x0a9qgjs	152	13	preemptively	preemptively	RB
cord-281487-x0a9qgjs	152	14	discontinued	discontinue	VBN
cord-281487-x0a9qgjs	152	15	if	if	IN
cord-281487-x0a9qgjs	152	16	the	the	DT
cord-281487-x0a9qgjs	152	17	absolute	absolute	JJ
cord-281487-x0a9qgjs	152	18	lymphocyte	lymphocyte	NN
cord-281487-x0a9qgjs	152	19	count	count	NN
cord-281487-x0a9qgjs	152	20	(	(	-LRB-
cord-281487-x0a9qgjs	152	21	ALC	ALC	NNP
cord-281487-x0a9qgjs	152	22	)	)	-RRB-
cord-281487-x0a9qgjs	152	23	were	be	VBD
cord-281487-x0a9qgjs	152	24	<	<	XX
cord-281487-x0a9qgjs	152	25	700	700	CD
cord-281487-x0a9qgjs	152	26	cells	cell	NNS
cord-281487-x0a9qgjs	152	27	/	/	SYM
cord-281487-x0a9qgjs	152	28	mL	ml	NN
cord-281487-x0a9qgjs	152	29	and	and	CC
cord-281487-x0a9qgjs	152	30	reduced	reduce	VBN
cord-281487-x0a9qgjs	152	31	if	if	IN
cord-281487-x0a9qgjs	152	32	the	the	DT
cord-281487-x0a9qgjs	152	33	ALC	ALC	NNP
cord-281487-x0a9qgjs	152	34	was	be	VBD
cord-281487-x0a9qgjs	152	35	700	700	CD
cord-281487-x0a9qgjs	152	36	-	-	SYM
cord-281487-x0a9qgjs	152	37	1000	1000	CD
cord-281487-x0a9qgjs	152	38	cells	cell	NNS
cord-281487-x0a9qgjs	152	39	/	/	SYM
cord-281487-x0a9qgjs	152	40	mL.	mL.	NNS
cord-281487-x0a9qgjs	153	1	Because	because	IN
cord-281487-x0a9qgjs	153	2	calcineurin	calcineurin	NNP
cord-281487-x0a9qgjs	153	3	inhibitors	inhibitor	NNS
cord-281487-x0a9qgjs	153	4	(	(	-LRB-
cord-281487-x0a9qgjs	153	5	CNIs	CNIs	NNP
cord-281487-x0a9qgjs	153	6	)	)	-RRB-
cord-281487-x0a9qgjs	153	7	block	block	NN
cord-281487-x0a9qgjs	153	8	nuclear	nuclear	JJ
cord-281487-x0a9qgjs	153	9	factor	factor	NN
cord-281487-x0a9qgjs	153	10	of	of	IN
cord-281487-x0a9qgjs	153	11	activated	activate	VBN
cord-281487-x0a9qgjs	153	12	T	T	NNP
cord-281487-x0a9qgjs	153	13	cells	cell	NNS
cord-281487-x0a9qgjs	153	14	(	(	-LRB-
cord-281487-x0a9qgjs	153	15	NFAT	NFAT	NNP
cord-281487-x0a9qgjs	153	16	)	)	-RRB-
cord-281487-x0a9qgjs	153	17	and	and	CC
cord-281487-x0a9qgjs	153	18	thus	thus	RB
cord-281487-x0a9qgjs	153	19	transcription	transcription	NN
cord-281487-x0a9qgjs	153	20	of	of	IN
cord-281487-x0a9qgjs	153	21	downstream	downstream	JJ
cord-281487-x0a9qgjs	153	22	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	153	23	cytokines	cytokine	NNS
cord-281487-x0a9qgjs	153	24	,	,	,
cord-281487-x0a9qgjs	153	25	we	-PRON-	PRP
cord-281487-x0a9qgjs	153	26	do	do	VBP
cord-281487-x0a9qgjs	153	27	not	not	RB
cord-281487-x0a9qgjs	153	28	recommend	recommend	VB
cord-281487-x0a9qgjs	153	29	reducing	reduce	VBG
cord-281487-x0a9qgjs	153	30	the	the	DT
cord-281487-x0a9qgjs	153	31	CNIs	cni	NNS
cord-281487-x0a9qgjs	153	32	and	and	CC
cord-281487-x0a9qgjs	153	33	maintain	maintain	VB
cord-281487-x0a9qgjs	153	34	tacrolimus	tacrolimus	NN
cord-281487-x0a9qgjs	153	35	levels	level	NNS
cord-281487-x0a9qgjs	153	36	between	between	IN
cord-281487-x0a9qgjs	153	37	5	5	CD
cord-281487-x0a9qgjs	153	38	and	and	CC
cord-281487-x0a9qgjs	153	39	10	10	CD
cord-281487-x0a9qgjs	153	40	ng	ng	NN
cord-281487-x0a9qgjs	153	41	/	/	SYM
cord-281487-x0a9qgjs	153	42	mL.	mL.	NNP
cord-281487-x0a9qgjs	153	43	Clinical	clinical	JJ
cord-281487-x0a9qgjs	153	44	trials	trial	NNS
cord-281487-x0a9qgjs	153	45	of	of	IN
cord-281487-x0a9qgjs	153	46	therapies	therapy	NNS
cord-281487-x0a9qgjs	153	47	to	to	TO
cord-281487-x0a9qgjs	153	48	enhance	enhance	VB
cord-281487-x0a9qgjs	153	49	viral	viral	JJ
cord-281487-x0a9qgjs	153	50	clearance	clearance	NN
cord-281487-x0a9qgjs	153	51	,	,	,
cord-281487-x0a9qgjs	153	52	such	such	JJ
cord-281487-x0a9qgjs	153	53	convalescent	convalescent	JJ
cord-281487-x0a9qgjs	153	54	plasma	plasma	NN
cord-281487-x0a9qgjs	153	55	may	may	MD
cord-281487-x0a9qgjs	153	56	be	be	VB
cord-281487-x0a9qgjs	153	57	offered	offer	VBN
cord-281487-x0a9qgjs	153	58	at	at	IN
cord-281487-x0a9qgjs	153	59	this	this	DT
cord-281487-x0a9qgjs	153	60	stage	stage	NN
cord-281487-x0a9qgjs	153	61	.	.	.
cord-281487-x0a9qgjs	154	1	In	in	IN
cord-281487-x0a9qgjs	154	2	the	the	DT
cord-281487-x0a9qgjs	154	3	second	second	JJ
cord-281487-x0a9qgjs	154	4	stage	stage	NN
cord-281487-x0a9qgjs	154	5	,	,	,
cord-281487-x0a9qgjs	154	6	viral	viral	JJ
cord-281487-x0a9qgjs	154	7	multiplication	multiplication	NN
cord-281487-x0a9qgjs	154	8	and	and	CC
cord-281487-x0a9qgjs	154	9	localized	localized	JJ
cord-281487-x0a9qgjs	154	10	lung	lung	NN
cord-281487-x0a9qgjs	154	11	inflammation	inflammation	NN
cord-281487-x0a9qgjs	154	12	occur	occur	VBP
cord-281487-x0a9qgjs	154	13	[	[	-LRB-
cord-281487-x0a9qgjs	154	14	64	64	CD
cord-281487-x0a9qgjs	154	15	]	]	-RRB-
cord-281487-x0a9qgjs	154	16	.	.	.
cord-281487-x0a9qgjs	155	1	Markers	marker	NNS
cord-281487-x0a9qgjs	155	2	of	of	IN
cord-281487-x0a9qgjs	155	3	systemic	systemic	JJ
cord-281487-x0a9qgjs	155	4	inflammation	inflammation	NN
cord-281487-x0a9qgjs	155	5	may	may	MD
cord-281487-x0a9qgjs	155	6	be	be	VB
cord-281487-x0a9qgjs	155	7	elevated	elevate	VBN
cord-281487-x0a9qgjs	155	8	.	.	.
cord-281487-x0a9qgjs	156	1	Anti	anti	JJ
cord-281487-x0a9qgjs	156	2	-	-	JJ
cord-281487-x0a9qgjs	156	3	viral	viral	JJ
cord-281487-x0a9qgjs	156	4	therapies	therapy	NNS
cord-281487-x0a9qgjs	156	5	,	,	,
cord-281487-x0a9qgjs	156	6	as	as	IN
cord-281487-x0a9qgjs	156	7	discussed	discuss	VBN
cord-281487-x0a9qgjs	156	8	in	in	IN
cord-281487-x0a9qgjs	156	9	a	a	DT
cord-281487-x0a9qgjs	156	10	separate	separate	JJ
cord-281487-x0a9qgjs	156	11	article	article	NN
cord-281487-x0a9qgjs	156	12	of	of	IN
cord-281487-x0a9qgjs	156	13	this	this	DT
cord-281487-x0a9qgjs	156	14	issue	issue	NN
cord-281487-x0a9qgjs	156	15	,	,	,
cord-281487-x0a9qgjs	156	16	may	may	MD
cord-281487-x0a9qgjs	156	17	be	be	VB
cord-281487-x0a9qgjs	156	18	indicated	indicate	VBN
cord-281487-x0a9qgjs	156	19	for	for	IN
cord-281487-x0a9qgjs	156	20	patients	patient	NNS
cord-281487-x0a9qgjs	156	21	with	with	IN
cord-281487-x0a9qgjs	156	22	hypoxia	hypoxia	NN
cord-281487-x0a9qgjs	156	23	,	,	,
cord-281487-x0a9qgjs	156	24	and	and	CC
cord-281487-x0a9qgjs	156	25	investigational	investigational	JJ
cord-281487-x0a9qgjs	156	26	agents	agent	NNS
cord-281487-x0a9qgjs	156	27	may	may	MD
cord-281487-x0a9qgjs	156	28	be	be	VB
cord-281487-x0a9qgjs	156	29	considered	consider	VBN
cord-281487-x0a9qgjs	156	30	.	.	.
cord-281487-x0a9qgjs	157	1	A	a	DT
cord-281487-x0a9qgjs	157	2	minority	minority	NN
cord-281487-x0a9qgjs	157	3	of	of	IN
cord-281487-x0a9qgjs	157	4	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	157	5	patients	patient	NNS
cord-281487-x0a9qgjs	157	6	progress	progress	VBP
cord-281487-x0a9qgjs	157	7	into	into	IN
cord-281487-x0a9qgjs	157	8	the	the	DT
cord-281487-x0a9qgjs	157	9	hyperinflammation	hyperinflammation	NN
cord-281487-x0a9qgjs	157	10	phase	phase	NN
cord-281487-x0a9qgjs	157	11	.	.	.
cord-281487-x0a9qgjs	158	1	In	in	IN
cord-281487-x0a9qgjs	158	2	this	this	DT
cord-281487-x0a9qgjs	158	3	stage	stage	NN
cord-281487-x0a9qgjs	158	4	,	,	,
cord-281487-x0a9qgjs	158	5	markers	marker	NNS
cord-281487-x0a9qgjs	158	6	of	of	IN
cord-281487-x0a9qgjs	158	7	systemic	systemic	JJ
cord-281487-x0a9qgjs	158	8	inflammation	inflammation	NN
cord-281487-x0a9qgjs	158	9	are	be	VBP
cord-281487-x0a9qgjs	158	10	elevated	elevated	JJ
cord-281487-x0a9qgjs	158	11	and	and	CC
cord-281487-x0a9qgjs	158	12	systemic	systemic	JJ
cord-281487-x0a9qgjs	158	13	organs	organ	NNS
cord-281487-x0a9qgjs	158	14	would	would	MD
cord-281487-x0a9qgjs	158	15	be	be	VB
cord-281487-x0a9qgjs	158	16	involved	involve	VBN
cord-281487-x0a9qgjs	158	17	[	[	-LRB-
cord-281487-x0a9qgjs	158	18	64	64	CD
cord-281487-x0a9qgjs	158	19	]	]	-RRB-
cord-281487-x0a9qgjs	158	20	.	.	.
cord-281487-x0a9qgjs	159	1	Immunomodulatory	immunomodulatory	JJ
cord-281487-x0a9qgjs	159	2	agents	agent	NNS
cord-281487-x0a9qgjs	159	3	have	have	VBP
cord-281487-x0a9qgjs	159	4	been	be	VBN
cord-281487-x0a9qgjs	159	5	studied	study	VBN
cord-281487-x0a9qgjs	159	6	and	and	CC
cord-281487-x0a9qgjs	159	7	applied	apply	VBN
cord-281487-x0a9qgjs	159	8	to	to	TO
cord-281487-x0a9qgjs	159	9	reduce	reduce	VB
cord-281487-x0a9qgjs	159	10	systemic	systemic	JJ
cord-281487-x0a9qgjs	159	11	inflammation	inflammation	NN
cord-281487-x0a9qgjs	159	12	to	to	TO
cord-281487-x0a9qgjs	159	13	try	try	VB
cord-281487-x0a9qgjs	159	14	and	and	CC
cord-281487-x0a9qgjs	159	15	prevent	prevent	VB
cord-281487-x0a9qgjs	159	16	multiorgan	multiorgan	NNP
cord-281487-x0a9qgjs	159	17	dysfunction	dysfunction	NN
cord-281487-x0a9qgjs	159	18	,	,	,
cord-281487-x0a9qgjs	159	19	but	but	CC
cord-281487-x0a9qgjs	159	20	with	with	IN
cord-281487-x0a9qgjs	159	21	exception	exception	NN
cord-281487-x0a9qgjs	159	22	of	of	IN
cord-281487-x0a9qgjs	159	23	dexamethasone	dexamethasone	NN
cord-281487-x0a9qgjs	159	24	,	,	,
cord-281487-x0a9qgjs	159	25	remain	remain	VBP
cord-281487-x0a9qgjs	159	26	under	under	IN
cord-281487-x0a9qgjs	159	27	off	off	IN
cord-281487-x0a9qgjs	159	28	-	-	HYPH
cord-281487-x0a9qgjs	159	29	label	label	NN
cord-281487-x0a9qgjs	159	30	or	or	CC
cord-281487-x0a9qgjs	159	31	investigational	investigational	JJ
cord-281487-x0a9qgjs	159	32	use	use	NN
cord-281487-x0a9qgjs	159	33	.	.	.
cord-281487-x0a9qgjs	160	1	Supportive	supportive	JJ
cord-281487-x0a9qgjs	160	2	therapy	therapy	NN
cord-281487-x0a9qgjs	160	3	includes	include	VBZ
cord-281487-x0a9qgjs	160	4	management	management	NN
cord-281487-x0a9qgjs	160	5	of	of	IN
cord-281487-x0a9qgjs	160	6	hypoxia	hypoxia	NN
cord-281487-x0a9qgjs	160	7	,	,	,
cord-281487-x0a9qgjs	160	8	fluid	fluid	JJ
cord-281487-x0a9qgjs	160	9	therapy	therapy	NN
cord-281487-x0a9qgjs	160	10	,	,	,
cord-281487-x0a9qgjs	160	11	medication	medication	NN
cord-281487-x0a9qgjs	160	12	adjustments	adjustment	NNS
cord-281487-x0a9qgjs	160	13	,	,	,
cord-281487-x0a9qgjs	160	14	and	and	CC
cord-281487-x0a9qgjs	160	15	control	control	NN
cord-281487-x0a9qgjs	160	16	of	of	IN
cord-281487-x0a9qgjs	160	17	symptoms	symptom	NNS
cord-281487-x0a9qgjs	160	18	such	such	JJ
cord-281487-x0a9qgjs	160	19	as	as	IN
cord-281487-x0a9qgjs	160	20	fever	fever	NN
cord-281487-x0a9qgjs	160	21	,	,	,
cord-281487-x0a9qgjs	160	22	cough	cough	NN
cord-281487-x0a9qgjs	160	23	,	,	,
cord-281487-x0a9qgjs	160	24	and	and	CC
cord-281487-x0a9qgjs	160	25	diarrhea	diarrhea	NN
cord-281487-x0a9qgjs	160	26	.	.	.
cord-281487-x0a9qgjs	161	1	Considering	consider	VBG
cord-281487-x0a9qgjs	161	2	that	that	DT
cord-281487-x0a9qgjs	161	3	acute	acute	JJ
cord-281487-x0a9qgjs	161	4	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	161	5	distress	distress	NN
cord-281487-x0a9qgjs	161	6	syndrome	syndrome	NN
cord-281487-x0a9qgjs	161	7	(	(	-LRB-
cord-281487-x0a9qgjs	161	8	ARDS	ARDS	NNP
cord-281487-x0a9qgjs	161	9	)	)	-RRB-
cord-281487-x0a9qgjs	161	10	is	be	VBZ
cord-281487-x0a9qgjs	161	11	one	one	CD
cord-281487-x0a9qgjs	161	12	of	of	IN
cord-281487-x0a9qgjs	161	13	the	the	DT
cord-281487-x0a9qgjs	161	14	most	most	RBS
cord-281487-x0a9qgjs	161	15	severe	severe	JJ
cord-281487-x0a9qgjs	161	16	complications	complication	NNS
cord-281487-x0a9qgjs	161	17	in	in	IN
cord-281487-x0a9qgjs	161	18	patients	patient	NNS
cord-281487-x0a9qgjs	161	19	with	with	IN
cord-281487-x0a9qgjs	161	20	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	161	21	and	and	CC
cord-281487-x0a9qgjs	161	22	a	a	DT
cord-281487-x0a9qgjs	161	23	leading	leading	JJ
cord-281487-x0a9qgjs	161	24	cause	cause	NN
cord-281487-x0a9qgjs	161	25	of	of	IN
cord-281487-x0a9qgjs	161	26	death	death	NN
cord-281487-x0a9qgjs	161	27	(	(	-LRB-
cord-281487-x0a9qgjs	161	28	Table	table	NN
cord-281487-x0a9qgjs	161	29	2	2	CD
cord-281487-x0a9qgjs	161	30	)	)	-RRB-
cord-281487-x0a9qgjs	161	31	[	[	-LRB-
cord-281487-x0a9qgjs	161	32	65	65	CD
cord-281487-x0a9qgjs	161	33	]	]	-RRB-
cord-281487-x0a9qgjs	161	34	,	,	,
cord-281487-x0a9qgjs	161	35	patients	patient	NNS
cord-281487-x0a9qgjs	161	36	requiring	require	VBG
cord-281487-x0a9qgjs	161	37	mechanical	mechanical	JJ
cord-281487-x0a9qgjs	161	38	ventilation	ventilation	NN
cord-281487-x0a9qgjs	161	39	should	should	MD
cord-281487-x0a9qgjs	161	40	be	be	VB
cord-281487-x0a9qgjs	161	41	managed	manage	VBN
cord-281487-x0a9qgjs	161	42	per	per	IN
cord-281487-x0a9qgjs	161	43	standard	standard	NN
cord-281487-x0a9qgjs	161	44	of	of	IN
cord-281487-x0a9qgjs	161	45	care	care	NN
cord-281487-x0a9qgjs	161	46	practices	practice	NNS
cord-281487-x0a9qgjs	161	47	for	for	IN
cord-281487-x0a9qgjs	161	48	ARDS	ARDS	NNP
cord-281487-x0a9qgjs	161	49	.	.	.
cord-281487-x0a9qgjs	162	1	Proning	Proning	NNP
cord-281487-x0a9qgjs	162	2	may	may	MD
cord-281487-x0a9qgjs	162	3	be	be	VB
cord-281487-x0a9qgjs	162	4	required	require	VBN
cord-281487-x0a9qgjs	162	5	due	due	IN
cord-281487-x0a9qgjs	162	6	to	to	IN
cord-281487-x0a9qgjs	162	7	the	the	DT
cord-281487-x0a9qgjs	162	8	distribution	distribution	NN
cord-281487-x0a9qgjs	162	9	of	of	IN
cord-281487-x0a9qgjs	162	10	parenchymal	parenchymal	NN
cord-281487-x0a9qgjs	162	11	changes	change	NNS
cord-281487-x0a9qgjs	162	12	,	,	,
cord-281487-x0a9qgjs	162	13	and	and	CC
cord-281487-x0a9qgjs	162	14	in	in	IN
cord-281487-x0a9qgjs	162	15	some	some	DT
cord-281487-x0a9qgjs	162	16	centers	center	NNS
cord-281487-x0a9qgjs	162	17	is	be	VBZ
cord-281487-x0a9qgjs	162	18	initiated	initiate	VBN
cord-281487-x0a9qgjs	162	19	prior	prior	RB
cord-281487-x0a9qgjs	162	20	to	to	IN
cord-281487-x0a9qgjs	162	21	intubation	intubation	NN
cord-281487-x0a9qgjs	162	22	[	[	-LRB-
cord-281487-x0a9qgjs	162	23	66	66	CD
cord-281487-x0a9qgjs	162	24	]	]	-RRB-
cord-281487-x0a9qgjs	162	25	.	.	.
cord-281487-x0a9qgjs	163	1	The	the	DT
cord-281487-x0a9qgjs	163	2	optimal	optimal	JJ
cord-281487-x0a9qgjs	163	3	fluid	fluid	NN
cord-281487-x0a9qgjs	163	4	therapy	therapy	NN
cord-281487-x0a9qgjs	163	5	for	for	IN
cord-281487-x0a9qgjs	163	6	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	163	7	patients	patient	NNS
cord-281487-x0a9qgjs	163	8	has	have	VBZ
cord-281487-x0a9qgjs	163	9	not	not	RB
cord-281487-x0a9qgjs	163	10	been	be	VBN
cord-281487-x0a9qgjs	163	11	established	establish	VBN
cord-281487-x0a9qgjs	163	12	but	but	CC
cord-281487-x0a9qgjs	163	13	may	may	MD
cord-281487-x0a9qgjs	163	14	need	need	VB
cord-281487-x0a9qgjs	163	15	to	to	TO
cord-281487-x0a9qgjs	163	16	be	be	VB
cord-281487-x0a9qgjs	163	17	individualized	individualize	VBN
cord-281487-x0a9qgjs	163	18	based	base	VBN
cord-281487-x0a9qgjs	163	19	on	on	IN
cord-281487-x0a9qgjs	163	20	the	the	DT
cord-281487-x0a9qgjs	163	21	presence	presence	NN
cord-281487-x0a9qgjs	163	22	of	of	IN
cord-281487-x0a9qgjs	163	23	AKI	AKI	NNP
cord-281487-x0a9qgjs	163	24	,	,	,
cord-281487-x0a9qgjs	163	25	Sepsis	sepsis	NN
cord-281487-x0a9qgjs	163	26	,	,	,
cord-281487-x0a9qgjs	163	27	or	or	CC
cord-281487-x0a9qgjs	163	28	ARDS	ARDS	NNP
cord-281487-x0a9qgjs	163	29	[	[	-LRB-
cord-281487-x0a9qgjs	163	30	37	37	CD
cord-281487-x0a9qgjs	163	31	,	,	,
cord-281487-x0a9qgjs	163	32	67	67	CD
cord-281487-x0a9qgjs	163	33	]	]	-RRB-
cord-281487-x0a9qgjs	163	34	.	.	.
cord-281487-x0a9qgjs	164	1	As	as	IN
cord-281487-x0a9qgjs	164	2	the	the	DT
cord-281487-x0a9qgjs	164	3	risk	risk	NN
cord-281487-x0a9qgjs	164	4	of	of	IN
cord-281487-x0a9qgjs	164	5	AKI	AKI	NNP
cord-281487-x0a9qgjs	164	6	is	be	VBZ
cord-281487-x0a9qgjs	164	7	high	high	JJ
cord-281487-x0a9qgjs	164	8	in	in	IN
cord-281487-x0a9qgjs	164	9	patients	patient	NNS
cord-281487-x0a9qgjs	164	10	transplant	transplant	NN
cord-281487-x0a9qgjs	164	11	recipients	recipient	NNS
cord-281487-x0a9qgjs	164	12	with	with	IN
cord-281487-x0a9qgjs	164	13	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	164	14	,	,	,
cord-281487-x0a9qgjs	164	15	avoidance	avoidance	NN
cord-281487-x0a9qgjs	164	16	of	of	IN
cord-281487-x0a9qgjs	164	17	non	non	JJ
cord-281487-x0a9qgjs	164	18	-	-	JJ
cord-281487-x0a9qgjs	164	19	essential	essential	JJ
cord-281487-x0a9qgjs	164	20	nephrotoxic	nephrotoxic	JJ
cord-281487-x0a9qgjs	164	21	agents	agent	NNS
cord-281487-x0a9qgjs	164	22	may	may	MD
cord-281487-x0a9qgjs	164	23	also	also	RB
cord-281487-x0a9qgjs	164	24	be	be	VB
cord-281487-x0a9qgjs	164	25	advisable	advisable	JJ
cord-281487-x0a9qgjs	164	26	[	[	-LRB-
cord-281487-x0a9qgjs	164	27	21	21	CD
cord-281487-x0a9qgjs	164	28	,	,	,
cord-281487-x0a9qgjs	164	29	30	30	CD
cord-281487-x0a9qgjs	164	30	]	]	-RRB-
cord-281487-x0a9qgjs	164	31	.	.	.
cord-281487-x0a9qgjs	165	1	The	the	DT
cord-281487-x0a9qgjs	165	2	use	use	NN
cord-281487-x0a9qgjs	165	3	of	of	IN
cord-281487-x0a9qgjs	165	4	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	165	5	-	-	HYPH
cord-281487-x0a9qgjs	165	6	converting	convert	VBG
cord-281487-x0a9qgjs	165	7	enzyme	enzyme	NN
cord-281487-x0a9qgjs	165	8	inhibitors	inhibitor	NNS
cord-281487-x0a9qgjs	165	9	and	and	CC
cord-281487-x0a9qgjs	165	10	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	165	11	receptor	receptor	NN
cord-281487-x0a9qgjs	165	12	blockers	blocker	NNS
cord-281487-x0a9qgjs	165	13	(	(	-LRB-
cord-281487-x0a9qgjs	165	14	ACEI	ACEI	NNP
cord-281487-x0a9qgjs	165	15	/	/	SYM
cord-281487-x0a9qgjs	165	16	ARBs	arb	NNS
cord-281487-x0a9qgjs	165	17	)	)	-RRB-
cord-281487-x0a9qgjs	165	18	has	have	VBZ
cord-281487-x0a9qgjs	165	19	been	be	VBN
cord-281487-x0a9qgjs	165	20	controversial	controversial	JJ
cord-281487-x0a9qgjs	165	21	due	due	IN
cord-281487-x0a9qgjs	165	22	to	to	IN
cord-281487-x0a9qgjs	165	23	concerns	concern	NNS
cord-281487-x0a9qgjs	165	24	that	that	WDT
cord-281487-x0a9qgjs	165	25	may	may	MD
cord-281487-x0a9qgjs	165	26	increase	increase	VB
cord-281487-x0a9qgjs	165	27	susceptibility	susceptibility	NN
cord-281487-x0a9qgjs	165	28	to	to	IN
cord-281487-x0a9qgjs	165	29	the	the	DT
cord-281487-x0a9qgjs	165	30	SARS	SARS	NNP
cord-281487-x0a9qgjs	165	31	-	-	HYPH
cord-281487-x0a9qgjs	165	32	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	165	33	[	[	-LRB-
cord-281487-x0a9qgjs	165	34	6	6	CD
cord-281487-x0a9qgjs	165	35	]	]	-RRB-
cord-281487-x0a9qgjs	165	36	.	.	.
cord-281487-x0a9qgjs	166	1	In	in	IN
cord-281487-x0a9qgjs	166	2	recently	recently	RB
cord-281487-x0a9qgjs	166	3	published	publish	VBN
cord-281487-x0a9qgjs	166	4	studies	study	NNS
cord-281487-x0a9qgjs	166	5	,	,	,
cord-281487-x0a9qgjs	166	6	use	use	NN
cord-281487-x0a9qgjs	166	7	of	of	IN
cord-281487-x0a9qgjs	166	8	ACEI	ACEI	NNP
cord-281487-x0a9qgjs	166	9	/	/	SYM
cord-281487-x0a9qgjs	166	10	ARBs	arb	NNS
cord-281487-x0a9qgjs	166	11	before	before	IN
cord-281487-x0a9qgjs	166	12	or	or	CC
cord-281487-x0a9qgjs	166	13	during	during	IN
cord-281487-x0a9qgjs	166	14	hospitalization	hospitalization	NN
cord-281487-x0a9qgjs	166	15	was	be	VBD
cord-281487-x0a9qgjs	166	16	not	not	RB
cord-281487-x0a9qgjs	166	17	associated	associate	VBN
cord-281487-x0a9qgjs	166	18	with	with	IN
cord-281487-x0a9qgjs	166	19	mortality	mortality	NN
cord-281487-x0a9qgjs	166	20	among	among	IN
cord-281487-x0a9qgjs	166	21	hypertensive	hypertensive	JJ
cord-281487-x0a9qgjs	166	22	patients	patient	NNS
cord-281487-x0a9qgjs	166	23	with	with	IN
cord-281487-x0a9qgjs	166	24	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	166	25	[	[	-LRB-
cord-281487-x0a9qgjs	166	26	68	68	CD
cord-281487-x0a9qgjs	166	27	,	,	,
cord-281487-x0a9qgjs	166	28	69	69	CD
cord-281487-x0a9qgjs	166	29	]	]	-RRB-
cord-281487-x0a9qgjs	166	30	,	,	,
cord-281487-x0a9qgjs	166	31	and	and	CC
cord-281487-x0a9qgjs	166	32	thus	thus	RB
cord-281487-x0a9qgjs	166	33	should	should	MD
cord-281487-x0a9qgjs	166	34	be	be	VB
cord-281487-x0a9qgjs	166	35	maintained	maintain	VBN
cord-281487-x0a9qgjs	166	36	as	as	RB
cord-281487-x0a9qgjs	166	37	clinically	clinically	RB
cord-281487-x0a9qgjs	166	38	indicated	indicate	VBN
cord-281487-x0a9qgjs	166	39	.	.	.
cord-281487-x0a9qgjs	167	1	The	the	DT
cord-281487-x0a9qgjs	167	2	ISTH	ISTH	NNP
cord-281487-x0a9qgjs	167	3	recommends	recommend	VBZ
cord-281487-x0a9qgjs	167	4	prophylactic	prophylactic	JJ
cord-281487-x0a9qgjs	167	5	dose	dose	NN
cord-281487-x0a9qgjs	167	6	low	low	JJ
cord-281487-x0a9qgjs	167	7	molecular	molecular	JJ
cord-281487-x0a9qgjs	167	8	weight	weight	NN
cord-281487-x0a9qgjs	167	9	heparin	heparin	NN
cord-281487-x0a9qgjs	167	10	in	in	IN
cord-281487-x0a9qgjs	167	11	patients	patient	NNS
cord-281487-x0a9qgjs	167	12	with	with	IN
cord-281487-x0a9qgjs	167	13	coagulopathy	coagulopathy	NN
cord-281487-x0a9qgjs	167	14	(	(	-LRB-
cord-281487-x0a9qgjs	167	15	D	d	NN
cord-281487-x0a9qgjs	167	16	-	-	HYPH
cord-281487-x0a9qgjs	167	17	dimer	dimer	NN
cord-281487-x0a9qgjs	167	18	>	>	XX
cord-281487-x0a9qgjs	168	1	3	3	CD
cord-281487-x0a9qgjs	168	2	to	to	IN
cord-281487-x0a9qgjs	168	3	4	4	CD
cord-281487-x0a9qgjs	168	4	times	time	NNS
cord-281487-x0a9qgjs	168	5	,	,	,
cord-281487-x0a9qgjs	168	6	prolonged	prolonged	JJ
cord-281487-x0a9qgjs	168	7	prothrombin	prothrombin	NN
cord-281487-x0a9qgjs	168	8	time	time	NN
cord-281487-x0a9qgjs	168	9	,	,	,
cord-281487-x0a9qgjs	168	10	platelet	platelet	NN
cord-281487-x0a9qgjs	168	11	count	count	VBP
cord-281487-x0a9qgjs	168	12	<	<	XX
cord-281487-x0a9qgjs	168	13	100	100	CD
cord-281487-x0a9qgjs	168	14	×	×	NN
cord-281487-x0a9qgjs	168	15	10	10	CD
cord-281487-x0a9qgjs	168	16	3	3	CD
cord-281487-x0a9qgjs	168	17	/μL	/μl	CD
cord-281487-x0a9qgjs	168	18	,	,	,
cord-281487-x0a9qgjs	168	19	or	or	CC
cord-281487-x0a9qgjs	168	20	fibrinogen	fibrinogen	NN
cord-281487-x0a9qgjs	168	21	<	<	XX
cord-281487-x0a9qgjs	168	22	2.0	2.0	CD
cord-281487-x0a9qgjs	168	23	g	g	NN
cord-281487-x0a9qgjs	168	24	/	/	SYM
cord-281487-x0a9qgjs	168	25	L	L	NNP
cord-281487-x0a9qgjs	168	26	)	)	-RRB-
cord-281487-x0a9qgjs	168	27	and	and	CC
cord-281487-x0a9qgjs	168	28	patients	patient	NNS
cord-281487-x0a9qgjs	168	29	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	168	30	for	for	IN
cord-281487-x0a9qgjs	168	31	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	168	32	in	in	IN
cord-281487-x0a9qgjs	168	33	the	the	DT
cord-281487-x0a9qgjs	168	34	absence	absence	NN
cord-281487-x0a9qgjs	168	35	of	of	IN
cord-281487-x0a9qgjs	168	36	any	any	DT
cord-281487-x0a9qgjs	168	37	bleeding	bleeding	NN
cord-281487-x0a9qgjs	168	38	or	or	CC
cord-281487-x0a9qgjs	168	39	thrombocytopenia	thrombocytopenia	NN
cord-281487-x0a9qgjs	168	40	[	[	-LRB-
cord-281487-x0a9qgjs	168	41	29	29	CD
cord-281487-x0a9qgjs	168	42	,	,	,
cord-281487-x0a9qgjs	168	43	40	40	CD
cord-281487-x0a9qgjs	168	44	]	]	-RRB-
cord-281487-x0a9qgjs	168	45	.	.	.
cord-281487-x0a9qgjs	169	1	A	a	DT
cord-281487-x0a9qgjs	169	2	study	study	NN
cord-281487-x0a9qgjs	169	3	demonstrated	demonstrate	VBD
cord-281487-x0a9qgjs	169	4	that	that	IN
cord-281487-x0a9qgjs	169	5	the	the	DT
cord-281487-x0a9qgjs	169	6	use	use	NN
cord-281487-x0a9qgjs	169	7	of	of	IN
cord-281487-x0a9qgjs	169	8	prophylactic	prophylactic	JJ
cord-281487-x0a9qgjs	169	9	LMWH	LMWH	NNP
cord-281487-x0a9qgjs	169	10	was	be	VBD
cord-281487-x0a9qgjs	169	11	associated	associate	VBN
cord-281487-x0a9qgjs	169	12	with	with	IN
cord-281487-x0a9qgjs	169	13	low	low	JJ
cord-281487-x0a9qgjs	169	14	mortality	mortality	NN
cord-281487-x0a9qgjs	169	15	in	in	IN
cord-281487-x0a9qgjs	169	16	patients	patient	NNS
cord-281487-x0a9qgjs	169	17	with	with	IN
cord-281487-x0a9qgjs	169	18	severe	severe	JJ
cord-281487-x0a9qgjs	169	19	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	169	20	.	.	.
cord-281487-x0a9qgjs	170	1	The	the	DT
cord-281487-x0a9qgjs	170	2	optimal	optimal	JJ
cord-281487-x0a9qgjs	170	3	regulation	regulation	NN
cord-281487-x0a9qgjs	170	4	of	of	IN
cord-281487-x0a9qgjs	170	5	transplant	transplant	NN
cord-281487-x0a9qgjs	170	6	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	170	7	in	in	IN
cord-281487-x0a9qgjs	170	8	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	170	9	remains	remain	VBZ
cord-281487-x0a9qgjs	170	10	a	a	DT
cord-281487-x0a9qgjs	170	11	challenging	challenging	JJ
cord-281487-x0a9qgjs	170	12	question	question	NN
cord-281487-x0a9qgjs	170	13	,	,	,
cord-281487-x0a9qgjs	170	14	with	with	IN
cord-281487-x0a9qgjs	170	15	a	a	DT
cord-281487-x0a9qgjs	170	16	paucity	paucity	NN
cord-281487-x0a9qgjs	170	17	of	of	IN
cord-281487-x0a9qgjs	170	18	clinical	clinical	JJ
cord-281487-x0a9qgjs	170	19	data	datum	NNS
cord-281487-x0a9qgjs	170	20	for	for	IN
cord-281487-x0a9qgjs	170	21	guidance	guidance	NN
cord-281487-x0a9qgjs	170	22	.	.	.
cord-281487-x0a9qgjs	171	1	Immunosuppressive	immunosuppressive	JJ
cord-281487-x0a9qgjs	171	2	drugs	drug	NNS
cord-281487-x0a9qgjs	171	3	may	may	MD
cord-281487-x0a9qgjs	171	4	prolong	prolong	VB
cord-281487-x0a9qgjs	171	5	viral	viral	JJ
cord-281487-x0a9qgjs	171	6	shedding	shedding	NN
cord-281487-x0a9qgjs	171	7	,	,	,
cord-281487-x0a9qgjs	171	8	have	have	VBP
cord-281487-x0a9qgjs	171	9	beneficial	beneficial	JJ
cord-281487-x0a9qgjs	171	10	anti	anti	JJ
cord-281487-x0a9qgjs	171	11	-	-	JJ
cord-281487-x0a9qgjs	171	12	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	171	13	effects	effect	NNS
cord-281487-x0a9qgjs	171	14	,	,	,
cord-281487-x0a9qgjs	171	15	or	or	CC
cord-281487-x0a9qgjs	171	16	even	even	RB
cord-281487-x0a9qgjs	171	17	have	have	VBP
cord-281487-x0a9qgjs	171	18	anti	anti	JJ
cord-281487-x0a9qgjs	171	19	-	-	JJ
cord-281487-x0a9qgjs	171	20	viral	viral	JJ
cord-281487-x0a9qgjs	171	21	properties	property	NNS
cord-281487-x0a9qgjs	171	22	[	[	-LRB-
cord-281487-x0a9qgjs	171	23	70	70	CD
cord-281487-x0a9qgjs	171	24	]	]	-RRB-
cord-281487-x0a9qgjs	171	25	.	.	.
cord-281487-x0a9qgjs	172	1	Little	little	JJ
cord-281487-x0a9qgjs	172	2	is	be	VBZ
cord-281487-x0a9qgjs	172	3	known	know	VBN
cord-281487-x0a9qgjs	172	4	about	about	IN
cord-281487-x0a9qgjs	172	5	the	the	DT
cord-281487-x0a9qgjs	172	6	exact	exact	JJ
cord-281487-x0a9qgjs	172	7	role	role	NN
cord-281487-x0a9qgjs	172	8	of	of	IN
cord-281487-x0a9qgjs	172	9	cyclophilin	cyclophilin	NNP
cord-281487-x0a9qgjs	172	10	in	in	IN
cord-281487-x0a9qgjs	172	11	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	172	12	replication	replication	NN
cord-281487-x0a9qgjs	172	13	,	,	,
cord-281487-x0a9qgjs	172	14	but	but	CC
cord-281487-x0a9qgjs	172	15	it	-PRON-	PRP
cord-281487-x0a9qgjs	172	16	has	have	VBZ
cord-281487-x0a9qgjs	172	17	been	be	VBN
cord-281487-x0a9qgjs	172	18	reported	report	VBN
cord-281487-x0a9qgjs	172	19	that	that	IN
cord-281487-x0a9qgjs	172	20	cyclosporine	cyclosporine	NN
cord-281487-x0a9qgjs	172	21	,	,	,
cord-281487-x0a9qgjs	172	22	which	which	WDT
cord-281487-x0a9qgjs	172	23	also	also	RB
cord-281487-x0a9qgjs	172	24	binds	bind	VBZ
cord-281487-x0a9qgjs	172	25	cyclophilin	cyclophilin	NNP
cord-281487-x0a9qgjs	172	26	,	,	,
cord-281487-x0a9qgjs	172	27	may	may	MD
cord-281487-x0a9qgjs	172	28	inhibit	inhibit	VB
cord-281487-x0a9qgjs	172	29	the	the	DT
cord-281487-x0a9qgjs	172	30	replication	replication	NN
cord-281487-x0a9qgjs	172	31	of	of	IN
cord-281487-x0a9qgjs	172	32	coronaviruses	coronaviruse	NNS
cord-281487-x0a9qgjs	172	33	at	at	IN
cord-281487-x0a9qgjs	172	34	noncytotoxic	noncytotoxic	NNP
cord-281487-x0a9qgjs	172	35	concentrations	concentration	NNS
cord-281487-x0a9qgjs	172	36	[	[	-LRB-
cord-281487-x0a9qgjs	172	37	71	71	CD
cord-281487-x0a9qgjs	172	38	,	,	,
cord-281487-x0a9qgjs	172	39	72	72	CD
cord-281487-x0a9qgjs	172	40	]	]	-RRB-
cord-281487-x0a9qgjs	172	41	.	.	.
cord-281487-x0a9qgjs	173	1	In	in	IN
cord-281487-x0a9qgjs	173	2	vitro	vitro	FW
cord-281487-x0a9qgjs	173	3	,	,	,
cord-281487-x0a9qgjs	173	4	tacrolimus	tacrolimus	NNP
cord-281487-x0a9qgjs	173	5	inhibited	inhibit	VBD
cord-281487-x0a9qgjs	173	6	the	the	DT
cord-281487-x0a9qgjs	173	7	replication	replication	NN
cord-281487-x0a9qgjs	173	8	of	of	IN
cord-281487-x0a9qgjs	173	9	SARS	SARS	NNP
cord-281487-x0a9qgjs	173	10	-	-	HYPH
cord-281487-x0a9qgjs	173	11	CoV	CoV	NNP
cord-281487-x0a9qgjs	173	12	,	,	,
cord-281487-x0a9qgjs	173	13	suggesting	suggest	VBG
cord-281487-x0a9qgjs	173	14	the	the	DT
cord-281487-x0a9qgjs	173	15	requirement	requirement	NN
cord-281487-x0a9qgjs	173	16	of	of	IN
cord-281487-x0a9qgjs	173	17	FK506-binding	fk506-binde	VBG
cord-281487-x0a9qgjs	173	18	proteins	protein	NNS
cord-281487-x0a9qgjs	173	19	for	for	IN
cord-281487-x0a9qgjs	173	20	virus	virus	NN
cord-281487-x0a9qgjs	173	21	growth	growth	NN
cord-281487-x0a9qgjs	173	22	[	[	-LRB-
cord-281487-x0a9qgjs	173	23	73	73	CD
cord-281487-x0a9qgjs	173	24	]	]	-RRB-
cord-281487-x0a9qgjs	173	25	.	.	.
cord-281487-x0a9qgjs	174	1	Further	further	RB
cord-281487-x0a9qgjs	174	2	,	,	,
cord-281487-x0a9qgjs	174	3	CNIs	cni	NNS
cord-281487-x0a9qgjs	174	4	may	may	MD
cord-281487-x0a9qgjs	174	5	be	be	VB
cord-281487-x0a9qgjs	174	6	capable	capable	JJ
cord-281487-x0a9qgjs	174	7	of	of	IN
cord-281487-x0a9qgjs	174	8	reducing	reduce	VBG
cord-281487-x0a9qgjs	174	9	the	the	DT
cord-281487-x0a9qgjs	174	10	frequency	frequency	NN
cord-281487-x0a9qgjs	174	11	of	of	IN
cord-281487-x0a9qgjs	174	12	cytokine	cytokine	NN
cord-281487-x0a9qgjs	174	13	release	release	NN
cord-281487-x0a9qgjs	174	14	syndrome	syndrome	NN
cord-281487-x0a9qgjs	174	15	through	through	IN
cord-281487-x0a9qgjs	174	16	inhibition	inhibition	NN
cord-281487-x0a9qgjs	174	17	of	of	IN
cord-281487-x0a9qgjs	174	18	NFAT	NFAT	NNP
cord-281487-x0a9qgjs	174	19	.	.	.
cord-281487-x0a9qgjs	175	1	However	however	RB
cord-281487-x0a9qgjs	175	2	,	,	,
cord-281487-x0a9qgjs	175	3	the	the	DT
cord-281487-x0a9qgjs	175	4	exact	exact	JJ
cord-281487-x0a9qgjs	175	5	role	role	NN
cord-281487-x0a9qgjs	175	6	of	of	IN
cord-281487-x0a9qgjs	175	7	these	these	DT
cord-281487-x0a9qgjs	175	8	agents	agent	NNS
cord-281487-x0a9qgjs	175	9	for	for	IN
cord-281487-x0a9qgjs	175	10	enhancing	enhance	VBG
cord-281487-x0a9qgjs	175	11	viral	viral	JJ
cord-281487-x0a9qgjs	175	12	clearance	clearance	NN
cord-281487-x0a9qgjs	175	13	in	in	IN
cord-281487-x0a9qgjs	175	14	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	175	15	is	be	VBZ
cord-281487-x0a9qgjs	175	16	unknown	unknown	JJ
cord-281487-x0a9qgjs	175	17	and	and	CC
cord-281487-x0a9qgjs	175	18	merits	merit	NNS
cord-281487-x0a9qgjs	175	19	further	further	JJ
cord-281487-x0a9qgjs	175	20	investigation	investigation	NN
cord-281487-x0a9qgjs	175	21	.	.	.
cord-281487-x0a9qgjs	176	1	Given	give	VBN
cord-281487-x0a9qgjs	176	2	these	these	DT
cord-281487-x0a9qgjs	176	3	in	in	IN
cord-281487-x0a9qgjs	176	4	vitro	vitro	FW
cord-281487-x0a9qgjs	176	5	effects	effect	NNS
cord-281487-x0a9qgjs	176	6	and	and	CC
cord-281487-x0a9qgjs	176	7	the	the	DT
cord-281487-x0a9qgjs	176	8	need	need	NN
cord-281487-x0a9qgjs	176	9	to	to	TO
cord-281487-x0a9qgjs	176	10	maintain	maintain	VB
cord-281487-x0a9qgjs	176	11	some	some	DT
cord-281487-x0a9qgjs	176	12	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	176	13	to	to	TO
cord-281487-x0a9qgjs	176	14	prevent	prevent	VB
cord-281487-x0a9qgjs	176	15	allograft	allograft	NN
cord-281487-x0a9qgjs	176	16	rejection	rejection	NN
cord-281487-x0a9qgjs	176	17	,	,	,
cord-281487-x0a9qgjs	176	18	many	many	JJ
cord-281487-x0a9qgjs	176	19	centers	center	NNS
cord-281487-x0a9qgjs	176	20	,	,	,
cord-281487-x0a9qgjs	176	21	including	include	VBG
cord-281487-x0a9qgjs	176	22	ours	-PRON-	PRP
cord-281487-x0a9qgjs	176	23	,	,	,
cord-281487-x0a9qgjs	176	24	have	have	VBP
cord-281487-x0a9qgjs	176	25	implemented	implement	VBN
cord-281487-x0a9qgjs	176	26	reduction	reduction	NN
cord-281487-x0a9qgjs	176	27	or	or	CC
cord-281487-x0a9qgjs	176	28	holding	holding	NN
cord-281487-x0a9qgjs	176	29	antimetabolite	antimetabolite	NN
cord-281487-x0a9qgjs	176	30	and	and	CC
cord-281487-x0a9qgjs	176	31	continuing	continue	VBG
cord-281487-x0a9qgjs	176	32	the	the	DT
cord-281487-x0a9qgjs	176	33	CNIs	cni	NNS
cord-281487-x0a9qgjs	176	34	and	and	CC
cord-281487-x0a9qgjs	176	35	glucocorticoids	glucocorticoid	NNS
cord-281487-x0a9qgjs	176	36	in	in	IN
cord-281487-x0a9qgjs	176	37	transplant	transplant	NN
cord-281487-x0a9qgjs	176	38	recipients	recipient	NNS
cord-281487-x0a9qgjs	176	39	with	with	IN
cord-281487-x0a9qgjs	176	40	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	176	41	.	.	.
cord-281487-x0a9qgjs	177	1	Others	other	NNS
cord-281487-x0a9qgjs	177	2	have	have	VBP
cord-281487-x0a9qgjs	177	3	recommended	recommend	VBN
cord-281487-x0a9qgjs	177	4	that	that	IN
cord-281487-x0a9qgjs	177	5	CNIs	cni	NNS
cord-281487-x0a9qgjs	177	6	and	and	CC
cord-281487-x0a9qgjs	177	7	the	the	DT
cord-281487-x0a9qgjs	177	8	antimetabolite	antimetabolite	NN
cord-281487-x0a9qgjs	177	9	be	be	VB
cord-281487-x0a9qgjs	177	10	immediately	immediately	RB
cord-281487-x0a9qgjs	177	11	withdrawn	withdraw	VBN
cord-281487-x0a9qgjs	177	12	and	and	CC
cord-281487-x0a9qgjs	177	13	the	the	DT
cord-281487-x0a9qgjs	177	14	glucocorticoid	glucocorticoid	NN
cord-281487-x0a9qgjs	177	15	dosage	dosage	NN
cord-281487-x0a9qgjs	177	16	increased	increase	VBD
cord-281487-x0a9qgjs	177	17	in	in	IN
cord-281487-x0a9qgjs	177	18	KT	KT	NNP
cord-281487-x0a9qgjs	177	19	recipients	recipient	NNS
cord-281487-x0a9qgjs	177	20	with	with	IN
cord-281487-x0a9qgjs	177	21	severe	severe	JJ
cord-281487-x0a9qgjs	177	22	or	or	CC
cord-281487-x0a9qgjs	177	23	rapidly	rapidly	RB
cord-281487-x0a9qgjs	177	24	progressing	progress	VBG
cord-281487-x0a9qgjs	177	25	COVID-19	covid-19	VB
cord-281487-x0a9qgjs	177	26	[	[	-LRB-
cord-281487-x0a9qgjs	177	27	54	54	CD
cord-281487-x0a9qgjs	177	28	,	,	,
cord-281487-x0a9qgjs	177	29	74	74	CD
cord-281487-x0a9qgjs	177	30	]	]	-RRB-
cord-281487-x0a9qgjs	177	31	.	.	.
cord-281487-x0a9qgjs	178	1	However	however	RB
cord-281487-x0a9qgjs	178	2	,	,	,
cord-281487-x0a9qgjs	178	3	we	-PRON-	PRP
cord-281487-x0a9qgjs	178	4	remain	remain	VBP
cord-281487-x0a9qgjs	178	5	hesitant	hesitant	JJ
cord-281487-x0a9qgjs	178	6	to	to	TO
cord-281487-x0a9qgjs	178	7	recommend	recommend	VB
cord-281487-x0a9qgjs	178	8	complete	complete	JJ
cord-281487-x0a9qgjs	178	9	cessation	cessation	NN
cord-281487-x0a9qgjs	178	10	of	of	IN
cord-281487-x0a9qgjs	178	11	CNIs	cni	NNS
cord-281487-x0a9qgjs	178	12	without	without	IN
cord-281487-x0a9qgjs	178	13	further	further	JJ
cord-281487-x0a9qgjs	178	14	clinical	clinical	JJ
cord-281487-x0a9qgjs	178	15	data	datum	NNS
cord-281487-x0a9qgjs	178	16	to	to	TO
cord-281487-x0a9qgjs	178	17	support	support	VB
cord-281487-x0a9qgjs	178	18	the	the	DT
cord-281487-x0a9qgjs	178	19	safety	safety	NN
cord-281487-x0a9qgjs	178	20	of	of	IN
cord-281487-x0a9qgjs	178	21	this	this	DT
cord-281487-x0a9qgjs	178	22	practice	practice	NN
cord-281487-x0a9qgjs	178	23	.	.	.
cord-281487-x0a9qgjs	179	1	While	while	IN
cord-281487-x0a9qgjs	179	2	there	there	EX
cord-281487-x0a9qgjs	179	3	is	be	VBZ
cord-281487-x0a9qgjs	179	4	literature	literature	NN
cord-281487-x0a9qgjs	179	5	in	in	IN
cord-281487-x0a9qgjs	179	6	the	the	DT
cord-281487-x0a9qgjs	179	7	general	general	JJ
cord-281487-x0a9qgjs	179	8	population	population	NN
cord-281487-x0a9qgjs	179	9	to	to	TO
cord-281487-x0a9qgjs	179	10	support	support	VB
cord-281487-x0a9qgjs	179	11	the	the	DT
cord-281487-x0a9qgjs	179	12	use	use	NN
cord-281487-x0a9qgjs	179	13	of	of	IN
cord-281487-x0a9qgjs	179	14	augmented	augment	VBN
cord-281487-x0a9qgjs	179	15	dexamethasone	dexamethasone	NN
cord-281487-x0a9qgjs	179	16	in	in	IN
cord-281487-x0a9qgjs	179	17	severely	severely	RB
cord-281487-x0a9qgjs	179	18	ill	ill	JJ
cord-281487-x0a9qgjs	180	1	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	180	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	180	3	,	,	,
cord-281487-x0a9qgjs	180	4	these	these	DT
cord-281487-x0a9qgjs	180	5	studies	study	NNS
cord-281487-x0a9qgjs	180	6	have	have	VBP
cord-281487-x0a9qgjs	180	7	not	not	RB
cord-281487-x0a9qgjs	180	8	reported	report	VBN
cord-281487-x0a9qgjs	180	9	the	the	DT
cord-281487-x0a9qgjs	180	10	outcomes	outcome	NNS
cord-281487-x0a9qgjs	180	11	of	of	IN
cord-281487-x0a9qgjs	180	12	this	this	DT
cord-281487-x0a9qgjs	180	13	augmentation	augmentation	NN
cord-281487-x0a9qgjs	180	14	in	in	IN
cord-281487-x0a9qgjs	180	15	immunocompromised	immunocompromised	JJ
cord-281487-x0a9qgjs	180	16	individuals	individual	NNS
cord-281487-x0a9qgjs	180	17	.	.	.
cord-281487-x0a9qgjs	181	1	In	in	IN
cord-281487-x0a9qgjs	181	2	a	a	DT
cord-281487-x0a9qgjs	181	3	preliminary	preliminary	JJ
cord-281487-x0a9qgjs	181	4	report	report	NN
cord-281487-x0a9qgjs	181	5	by	by	IN
cord-281487-x0a9qgjs	181	6	Horby	Horby	NNP
cord-281487-x0a9qgjs	181	7	et	et	NNP
cord-281487-x0a9qgjs	181	8	al	al	NNP
cord-281487-x0a9qgjs	181	9	.	.	.
cord-281487-x0a9qgjs	182	1	,	,	,
cord-281487-x0a9qgjs	182	2	dexamethasone	dexamethasone	NNP
cord-281487-x0a9qgjs	182	3	(	(	-LRB-
cord-281487-x0a9qgjs	182	4	6	6	CD
cord-281487-x0a9qgjs	182	5	mg	mg	NNP
cord-281487-x0a9qgjs	182	6	daily	daily	RB
cord-281487-x0a9qgjs	182	7	for	for	IN
cord-281487-x0a9qgjs	182	8	up	up	IN
cord-281487-x0a9qgjs	182	9	to	to	TO
cord-281487-x0a9qgjs	182	10	10	10	CD
cord-281487-x0a9qgjs	182	11	days	day	NNS
cord-281487-x0a9qgjs	182	12	)	)	-RRB-
cord-281487-x0a9qgjs	182	13	reduced	reduce	VBN
cord-281487-x0a9qgjs	182	14	mortality	mortality	NN
cord-281487-x0a9qgjs	182	15	among	among	IN
cord-281487-x0a9qgjs	182	16	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	182	17	patients	patient	NNS
cord-281487-x0a9qgjs	182	18	receiving	receive	VBG
cord-281487-x0a9qgjs	182	19	mechanical	mechanical	JJ
cord-281487-x0a9qgjs	182	20	ventilation	ventilation	NN
cord-281487-x0a9qgjs	182	21	or	or	CC
cord-281487-x0a9qgjs	182	22	oxygen	oxygen	NN
cord-281487-x0a9qgjs	182	23	[	[	-LRB-
cord-281487-x0a9qgjs	182	24	75	75	CD
cord-281487-x0a9qgjs	182	25	]	]	-RRB-
cord-281487-x0a9qgjs	182	26	,	,	,
cord-281487-x0a9qgjs	182	27	and	and	CC
cord-281487-x0a9qgjs	182	28	this	this	DT
cord-281487-x0a9qgjs	182	29	has	have	VBZ
cord-281487-x0a9qgjs	182	30	been	be	VBN
cord-281487-x0a9qgjs	182	31	incorporated	incorporate	VBN
cord-281487-x0a9qgjs	182	32	into	into	IN
cord-281487-x0a9qgjs	182	33	routine	routine	JJ
cord-281487-x0a9qgjs	182	34	practice	practice	NN
cord-281487-x0a9qgjs	182	35	.	.	.
cord-281487-x0a9qgjs	183	1	However	however	RB
cord-281487-x0a9qgjs	183	2	,	,	,
cord-281487-x0a9qgjs	183	3	optimal	optimal	JJ
cord-281487-x0a9qgjs	183	4	adjustment	adjustment	NN
cord-281487-x0a9qgjs	183	5	of	of	IN
cord-281487-x0a9qgjs	183	6	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	183	7	and	and	CC
cord-281487-x0a9qgjs	183	8	return	return	VB
cord-281487-x0a9qgjs	183	9	to	to	IN
cord-281487-x0a9qgjs	183	10	maintenance	maintenance	NN
cord-281487-x0a9qgjs	183	11	dosing	dosing	NN
cord-281487-x0a9qgjs	183	12	remains	remain	VBZ
cord-281487-x0a9qgjs	183	13	unknown	unknown	JJ
cord-281487-x0a9qgjs	183	14	.	.	.
cord-281487-x0a9qgjs	184	1	As	as	IN
cord-281487-x0a9qgjs	184	2	we	-PRON-	PRP
cord-281487-x0a9qgjs	184	3	have	have	VBP
cord-281487-x0a9qgjs	184	4	previously	previously	RB
cord-281487-x0a9qgjs	184	5	reported	report	VBN
cord-281487-x0a9qgjs	184	6	,	,	,
cord-281487-x0a9qgjs	184	7	permanent	permanent	JJ
cord-281487-x0a9qgjs	184	8	discontinuation	discontinuation	NN
cord-281487-x0a9qgjs	184	9	of	of	IN
cord-281487-x0a9qgjs	184	10	the	the	DT
cord-281487-x0a9qgjs	184	11	antimetabolite	antimetabolite	NN
cord-281487-x0a9qgjs	184	12	in	in	IN
cord-281487-x0a9qgjs	184	13	KT	KT	NNP
cord-281487-x0a9qgjs	184	14	patients	patient	NNS
cord-281487-x0a9qgjs	184	15	with	with	IN
cord-281487-x0a9qgjs	184	16	a	a	DT
cord-281487-x0a9qgjs	184	17	severe	severe	JJ
cord-281487-x0a9qgjs	184	18	viral	viral	JJ
cord-281487-x0a9qgjs	184	19	infection	infection	NN
cord-281487-x0a9qgjs	184	20	such	such	JJ
cord-281487-x0a9qgjs	184	21	as	as	IN
cord-281487-x0a9qgjs	184	22	CMV	CMV	NNP
cord-281487-x0a9qgjs	184	23	and	and	CC
cord-281487-x0a9qgjs	184	24	BK	BK	NNP
cord-281487-x0a9qgjs	184	25	virus	virus	NN
cord-281487-x0a9qgjs	184	26	is	be	VBZ
cord-281487-x0a9qgjs	184	27	safe	safe	JJ
cord-281487-x0a9qgjs	184	28	and	and	CC
cord-281487-x0a9qgjs	184	29	effective	effective	JJ
cord-281487-x0a9qgjs	184	30	[	[	-LRB-
cord-281487-x0a9qgjs	184	31	76	76	CD
cord-281487-x0a9qgjs	184	32	,	,	,
cord-281487-x0a9qgjs	184	33	77	77	CD
cord-281487-x0a9qgjs	184	34	]	]	-RRB-
cord-281487-x0a9qgjs	184	35	.	.	.
cord-281487-x0a9qgjs	185	1	However	however	RB
cord-281487-x0a9qgjs	185	2	,	,	,
cord-281487-x0a9qgjs	185	3	there	there	EX
cord-281487-x0a9qgjs	185	4	are	be	VBP
cord-281487-x0a9qgjs	185	5	less	less	JJR
cord-281487-x0a9qgjs	185	6	data	datum	NNS
cord-281487-x0a9qgjs	185	7	about	about	IN
cord-281487-x0a9qgjs	185	8	the	the	DT
cord-281487-x0a9qgjs	185	9	safety	safety	NN
cord-281487-x0a9qgjs	185	10	of	of	IN
cord-281487-x0a9qgjs	185	11	the	the	DT
cord-281487-x0a9qgjs	185	12	prolonged	prolong	VBN
cord-281487-x0a9qgjs	185	13	cessation	cessation	NN
cord-281487-x0a9qgjs	185	14	of	of	IN
cord-281487-x0a9qgjs	185	15	antimetabolites	antimetabolite	NNS
cord-281487-x0a9qgjs	185	16	in	in	IN
cord-281487-x0a9qgjs	185	17	other	other	JJ
cord-281487-x0a9qgjs	185	18	organ	organ	NN
cord-281487-x0a9qgjs	185	19	transplants	transplant	NNS
cord-281487-x0a9qgjs	185	20	,	,	,
cord-281487-x0a9qgjs	185	21	particularly	particularly	RB
cord-281487-x0a9qgjs	185	22	for	for	IN
cord-281487-x0a9qgjs	185	23	viruses	virus	NNS
cord-281487-x0a9qgjs	185	24	in	in	IN
cord-281487-x0a9qgjs	185	25	whom	whom	WP
cord-281487-x0a9qgjs	185	26	the	the	DT
cord-281487-x0a9qgjs	185	27	disease	disease	NN
cord-281487-x0a9qgjs	185	28	severity	severity	NN
cord-281487-x0a9qgjs	185	29	is	be	VBZ
cord-281487-x0a9qgjs	185	30	characterized	characterize	VBN
cord-281487-x0a9qgjs	185	31	by	by	IN
cord-281487-x0a9qgjs	185	32	a	a	DT
cord-281487-x0a9qgjs	185	33	hyperactive	hyperactive	JJ
cord-281487-x0a9qgjs	185	34	immune	immune	JJ
cord-281487-x0a9qgjs	185	35	response	response	NN
cord-281487-x0a9qgjs	185	36	,	,	,
cord-281487-x0a9qgjs	185	37	or	or	CC
cord-281487-x0a9qgjs	185	38	for	for	IN
cord-281487-x0a9qgjs	185	39	conditions	condition	NNS
cord-281487-x0a9qgjs	185	40	such	such	JJ
cord-281487-x0a9qgjs	185	41	as	as	IN
cord-281487-x0a9qgjs	185	42	in	in	IN
cord-281487-x0a9qgjs	185	43	thoracic	thoracic	JJ
cord-281487-x0a9qgjs	185	44	transplant	transplant	NN
cord-281487-x0a9qgjs	185	45	where	where	WRB
cord-281487-x0a9qgjs	185	46	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	185	47	viral	viral	JJ
cord-281487-x0a9qgjs	185	48	infections	infection	NNS
cord-281487-x0a9qgjs	185	49	have	have	VBP
cord-281487-x0a9qgjs	185	50	been	be	VBN
cord-281487-x0a9qgjs	185	51	shown	show	VBN
cord-281487-x0a9qgjs	185	52	to	to	TO
cord-281487-x0a9qgjs	185	53	trigger	trigger	VB
cord-281487-x0a9qgjs	185	54	immune	immune	JJ
cord-281487-x0a9qgjs	185	55	responses	response	NNS
cord-281487-x0a9qgjs	185	56	that	that	WDT
cord-281487-x0a9qgjs	185	57	induce	induce	VBP
cord-281487-x0a9qgjs	185	58	chronic	chronic	JJ
cord-281487-x0a9qgjs	185	59	allograft	allograft	NN
cord-281487-x0a9qgjs	185	60	dysfunction	dysfunction	NN
cord-281487-x0a9qgjs	185	61	[	[	-LRB-
cord-281487-x0a9qgjs	185	62	78	78	CD
cord-281487-x0a9qgjs	185	63	]	]	-RRB-
cord-281487-x0a9qgjs	185	64	[	[	-LRB-
cord-281487-x0a9qgjs	185	65	79	79	CD
cord-281487-x0a9qgjs	185	66	]	]	-RRB-
cord-281487-x0a9qgjs	185	67	[	[	-LRB-
cord-281487-x0a9qgjs	185	68	80	80	CD
cord-281487-x0a9qgjs	185	69	]	]	-RRB-
cord-281487-x0a9qgjs	185	70	[	[	-LRB-
cord-281487-x0a9qgjs	185	71	81	81	CD
cord-281487-x0a9qgjs	185	72	]	]	-RRB-
cord-281487-x0a9qgjs	185	73	.	.	.
cord-281487-x0a9qgjs	186	1	There	there	EX
cord-281487-x0a9qgjs	186	2	has	have	VBZ
cord-281487-x0a9qgjs	186	3	been	be	VBN
cord-281487-x0a9qgjs	186	4	much	much	JJ
cord-281487-x0a9qgjs	186	5	interest	interest	NN
cord-281487-x0a9qgjs	186	6	in	in	IN
cord-281487-x0a9qgjs	186	7	supplements	supplement	NNS
cord-281487-x0a9qgjs	186	8	such	such	JJ
cord-281487-x0a9qgjs	186	9	as	as	IN
cord-281487-x0a9qgjs	186	10	vitamin	vitamin	NN
cord-281487-x0a9qgjs	186	11	D	d	NN
cord-281487-x0a9qgjs	186	12	and	and	CC
cord-281487-x0a9qgjs	186	13	melatonin	melatonin	NN
cord-281487-x0a9qgjs	186	14	in	in	IN
cord-281487-x0a9qgjs	186	15	adjunctive	adjunctive	JJ
cord-281487-x0a9qgjs	186	16	therapy	therapy	NN
cord-281487-x0a9qgjs	186	17	for	for	IN
cord-281487-x0a9qgjs	186	18	patients	patient	NNS
cord-281487-x0a9qgjs	186	19	with	with	IN
cord-281487-x0a9qgjs	186	20	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	186	21	due	due	IN
cord-281487-x0a9qgjs	186	22	to	to	IN
cord-281487-x0a9qgjs	186	23	their	-PRON-	PRP$
cord-281487-x0a9qgjs	186	24	anti	anti	JJ
cord-281487-x0a9qgjs	186	25	-	-	JJ
cord-281487-x0a9qgjs	186	26	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	186	27	and	and	CC
cord-281487-x0a9qgjs	186	28	anti	anti	JJ
cord-281487-x0a9qgjs	186	29	-	-	JJ
cord-281487-x0a9qgjs	186	30	oxidant	oxidant	JJ
cord-281487-x0a9qgjs	186	31	properties	property	NNS
cord-281487-x0a9qgjs	186	32	and	and	CC
cord-281487-x0a9qgjs	186	33	low	low	JJ
cord-281487-x0a9qgjs	186	34	risk	risk	NN
cord-281487-x0a9qgjs	186	35	of	of	IN
cord-281487-x0a9qgjs	186	36	harm	harm	NN
cord-281487-x0a9qgjs	186	37	.	.	.
cord-281487-x0a9qgjs	187	1	Inadequate	inadequate	JJ
cord-281487-x0a9qgjs	187	2	vitamin	vitamin	NN
cord-281487-x0a9qgjs	187	3	D	d	NN
cord-281487-x0a9qgjs	187	4	levels	level	NNS
cord-281487-x0a9qgjs	187	5	have	have	VBP
cord-281487-x0a9qgjs	187	6	been	be	VBN
cord-281487-x0a9qgjs	187	7	found	find	VBN
cord-281487-x0a9qgjs	187	8	in	in	IN
cord-281487-x0a9qgjs	187	9	>	>	$
cord-281487-x0a9qgjs	187	10	70	70	CD
cord-281487-x0a9qgjs	187	11	%	%	NN
cord-281487-x0a9qgjs	187	12	abdominal	abdominal	JJ
cord-281487-x0a9qgjs	187	13	transplant	transplant	NN
cord-281487-x0a9qgjs	187	14	recipients	recipient	NNS
cord-281487-x0a9qgjs	187	15	[	[	-LRB-
cord-281487-x0a9qgjs	187	16	82	82	CD
cord-281487-x0a9qgjs	187	17	]	]	-RRB-
cord-281487-x0a9qgjs	187	18	and	and	CC
cord-281487-x0a9qgjs	187	19	may	may	MD
cord-281487-x0a9qgjs	187	20	be	be	VB
cord-281487-x0a9qgjs	187	21	exacerbated	exacerbate	VBN
cord-281487-x0a9qgjs	187	22	by	by	IN
cord-281487-x0a9qgjs	187	23	glucocorticoids	glucocorticoid	NNS
cord-281487-x0a9qgjs	187	24	,	,	,
cord-281487-x0a9qgjs	187	25	CNIs	cni	NNS
cord-281487-x0a9qgjs	187	26	,	,	,
cord-281487-x0a9qgjs	187	27	low	low	JJ
cord-281487-x0a9qgjs	187	28	sun	sun	NN
cord-281487-x0a9qgjs	187	29	exposure	exposure	NN
cord-281487-x0a9qgjs	187	30	,	,	,
cord-281487-x0a9qgjs	187	31	and	and	CC
cord-281487-x0a9qgjs	187	32	inadequate	inadequate	JJ
cord-281487-x0a9qgjs	187	33	dietary	dietary	JJ
cord-281487-x0a9qgjs	187	34	intake	intake	NN
cord-281487-x0a9qgjs	187	35	[	[	-LRB-
cord-281487-x0a9qgjs	187	36	83	83	CD
cord-281487-x0a9qgjs	187	37	]	]	-RRB-
cord-281487-x0a9qgjs	187	38	.	.	.
cord-281487-x0a9qgjs	188	1	Low	low	JJ
cord-281487-x0a9qgjs	188	2	vitamin	vitamin	NN
cord-281487-x0a9qgjs	188	3	D	d	NN
cord-281487-x0a9qgjs	188	4	levels	level	NNS
cord-281487-x0a9qgjs	188	5	have	have	VBP
cord-281487-x0a9qgjs	188	6	been	be	VBN
cord-281487-x0a9qgjs	188	7	associated	associate	VBN
cord-281487-x0a9qgjs	188	8	with	with	IN
cord-281487-x0a9qgjs	188	9	a	a	DT
cord-281487-x0a9qgjs	188	10	high	high	JJ
cord-281487-x0a9qgjs	188	11	risk	risk	NN
cord-281487-x0a9qgjs	188	12	of	of	IN
cord-281487-x0a9qgjs	188	13	CMV	CMV	NNP
cord-281487-x0a9qgjs	188	14	infection	infection	NN
cord-281487-x0a9qgjs	188	15	and	and	CC
cord-281487-x0a9qgjs	188	16	overall	overall	JJ
cord-281487-x0a9qgjs	188	17	infection	infection	NN
cord-281487-x0a9qgjs	188	18	in	in	IN
cord-281487-x0a9qgjs	188	19	transplant	transplant	NN
cord-281487-x0a9qgjs	188	20	recipients	recipient	NNS
cord-281487-x0a9qgjs	188	21	[	[	-LRB-
cord-281487-x0a9qgjs	188	22	84	84	CD
cord-281487-x0a9qgjs	188	23	,	,	,
cord-281487-x0a9qgjs	188	24	85	85	CD
cord-281487-x0a9qgjs	188	25	]	]	-RRB-
cord-281487-x0a9qgjs	188	26	.	.	.
cord-281487-x0a9qgjs	189	1	Further	further	JJ
cord-281487-x0a9qgjs	189	2	meta	meta	NNP
cord-281487-x0a9qgjs	189	3	-	-	HYPH
cord-281487-x0a9qgjs	189	4	analyses	analysis	NNS
cord-281487-x0a9qgjs	189	5	of	of	IN
cord-281487-x0a9qgjs	189	6	RCT	RCT	NNP
cord-281487-x0a9qgjs	189	7	data	datum	NNS
cord-281487-x0a9qgjs	189	8	have	have	VBP
cord-281487-x0a9qgjs	189	9	demonstrated	demonstrate	VBN
cord-281487-x0a9qgjs	189	10	that	that	IN
cord-281487-x0a9qgjs	189	11	vitamin	vitamin	NN
cord-281487-x0a9qgjs	189	12	D	d	NN
cord-281487-x0a9qgjs	189	13	has	have	VBZ
cord-281487-x0a9qgjs	189	14	a	a	DT
cord-281487-x0a9qgjs	189	15	protective	protective	JJ
cord-281487-x0a9qgjs	189	16	effect	effect	NN
cord-281487-x0a9qgjs	189	17	against	against	IN
cord-281487-x0a9qgjs	189	18	acute	acute	JJ
cord-281487-x0a9qgjs	189	19	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	189	20	tract	tract	NN
cord-281487-x0a9qgjs	189	21	infection	infection	NN
cord-281487-x0a9qgjs	189	22	and	and	CC
cord-281487-x0a9qgjs	189	23	with	with	IN
cord-281487-x0a9qgjs	189	24	even	even	RB
cord-281487-x0a9qgjs	189	25	further	further	JJ
cord-281487-x0a9qgjs	189	26	risk	risk	NN
cord-281487-x0a9qgjs	189	27	in	in	IN
cord-281487-x0a9qgjs	189	28	subjects	subject	NNS
cord-281487-x0a9qgjs	189	29	who	who	WP
cord-281487-x0a9qgjs	189	30	concentrations	concentration	NNS
cord-281487-x0a9qgjs	189	31	of	of	IN
cord-281487-x0a9qgjs	189	32	25-hydroxyvitamin	25-hydroxyvitamin	CD
cord-281487-x0a9qgjs	189	33	D	d	NN
cord-281487-x0a9qgjs	189	34	(	(	-LRB-
cord-281487-x0a9qgjs	189	35	25[OH]D	25[oh]d	CD
cord-281487-x0a9qgjs	189	36	)	)	-RRB-
cord-281487-x0a9qgjs	189	37	below	below	IN
cord-281487-x0a9qgjs	189	38	37.5	37.5	CD
cord-281487-x0a9qgjs	189	39	nmol	nmol	NNP
cord-281487-x0a9qgjs	189	40	/	/	SYM
cord-281487-x0a9qgjs	189	41	L	L	NNP
cord-281487-x0a9qgjs	189	42	[	[	-LRB-
cord-281487-x0a9qgjs	189	43	86	86	CD
cord-281487-x0a9qgjs	189	44	]	]	-RRB-
cord-281487-x0a9qgjs	189	45	.	.	.
cord-281487-x0a9qgjs	190	1	In	in	IN
cord-281487-x0a9qgjs	190	2	these	these	DT
cord-281487-x0a9qgjs	190	3	studies	study	NNS
cord-281487-x0a9qgjs	190	4	,	,	,
cord-281487-x0a9qgjs	190	5	once	once	IN
cord-281487-x0a9qgjs	190	6	daily	daily	RB
cord-281487-x0a9qgjs	190	7	dosing	dose	VBG
cord-281487-x0a9qgjs	190	8	at	at	IN
cord-281487-x0a9qgjs	190	9	modest	modest	JJ
cord-281487-x0a9qgjs	190	10	doses	dose	NNS
cord-281487-x0a9qgjs	190	11	(	(	-LRB-
cord-281487-x0a9qgjs	190	12	400	400	CD
cord-281487-x0a9qgjs	190	13	-	-	SYM
cord-281487-x0a9qgjs	190	14	4000	4000	CD
cord-281487-x0a9qgjs	190	15	IU	IU	NNP
cord-281487-x0a9qgjs	190	16	/	/	SYM
cord-281487-x0a9qgjs	190	17	day	day	NN
cord-281487-x0a9qgjs	190	18	)	)	-RRB-
cord-281487-x0a9qgjs	190	19	appeared	appear	VBD
cord-281487-x0a9qgjs	190	20	to	to	TO
cord-281487-x0a9qgjs	190	21	confer	confer	VB
cord-281487-x0a9qgjs	190	22	benefit	benefit	NN
cord-281487-x0a9qgjs	190	23	,	,	,
cord-281487-x0a9qgjs	190	24	particularly	particularly	RB
cord-281487-x0a9qgjs	190	25	when	when	WRB
cord-281487-x0a9qgjs	190	26	Vitamin	vitamin	NN
cord-281487-x0a9qgjs	190	27	D	d	NN
cord-281487-x0a9qgjs	190	28	levels	level	NNS
cord-281487-x0a9qgjs	190	29	were	be	VBD
cord-281487-x0a9qgjs	190	30	low	low	JJ
cord-281487-x0a9qgjs	190	31	.	.	.
cord-281487-x0a9qgjs	191	1	The	the	DT
cord-281487-x0a9qgjs	191	2	prevalence	prevalence	NN
cord-281487-x0a9qgjs	191	3	of	of	IN
cord-281487-x0a9qgjs	191	4	vitamin	vitamin	NN
cord-281487-x0a9qgjs	191	5	D	d	NN
cord-281487-x0a9qgjs	191	6	deficiency	deficiency	NN
cord-281487-x0a9qgjs	191	7	is	be	VBZ
cord-281487-x0a9qgjs	191	8	40−70	40−70	CD
cord-281487-x0a9qgjs	191	9	%	%	NN
cord-281487-x0a9qgjs	191	10	in	in	IN
cord-281487-x0a9qgjs	191	11	the	the	DT
cord-281487-x0a9qgjs	191	12	intensive	intensive	JJ
cord-281487-x0a9qgjs	191	13	care	care	NN
cord-281487-x0a9qgjs	191	14	unit	unit	NN
cord-281487-x0a9qgjs	191	15	and	and	CC
cord-281487-x0a9qgjs	191	16	circulating	circulate	VBG
cord-281487-x0a9qgjs	191	17	25(OH)D	25(oh)d	CD
cord-281487-x0a9qgjs	191	18	concentrations	concentration	NNS
cord-281487-x0a9qgjs	191	19	may	may	MD
cord-281487-x0a9qgjs	191	20	drop	drop	VB
cord-281487-x0a9qgjs	191	21	rapidly	rapidly	RB
cord-281487-x0a9qgjs	191	22	in	in	IN
cord-281487-x0a9qgjs	191	23	the	the	DT
cord-281487-x0a9qgjs	191	24	early	early	JJ
cord-281487-x0a9qgjs	191	25	illness	illness	NN
cord-281487-x0a9qgjs	191	26	[	[	-LRB-
cord-281487-x0a9qgjs	191	27	87	87	CD
cord-281487-x0a9qgjs	191	28	]	]	-RRB-
cord-281487-x0a9qgjs	191	29	.	.	.
cord-281487-x0a9qgjs	192	1	However	however	RB
cord-281487-x0a9qgjs	192	2	,	,	,
cord-281487-x0a9qgjs	192	3	in	in	IN
cord-281487-x0a9qgjs	192	4	multi	multi	JJ
cord-281487-x0a9qgjs	192	5	-	-	JJ
cord-281487-x0a9qgjs	192	6	center	center	JJ
cord-281487-x0a9qgjs	192	7	RCTs	rct	NNS
cord-281487-x0a9qgjs	192	8	of	of	IN
cord-281487-x0a9qgjs	192	9	critically	critically	RB
cord-281487-x0a9qgjs	192	10	ill	ill	JJ
cord-281487-x0a9qgjs	192	11	patients	patient	NNS
cord-281487-x0a9qgjs	192	12	,	,	,
cord-281487-x0a9qgjs	192	13	a	a	DT
cord-281487-x0a9qgjs	192	14	single	single	JJ
cord-281487-x0a9qgjs	192	15	dose	dose	NN
cord-281487-x0a9qgjs	192	16	of	of	IN
cord-281487-x0a9qgjs	192	17	540,000	540,000	CD
cord-281487-x0a9qgjs	192	18	IU	IU	NNP
cord-281487-x0a9qgjs	192	19	or	or	CC
cord-281487-x0a9qgjs	192	20	short	short	JJ
cord-281487-x0a9qgjs	192	21	term	term	NN
cord-281487-x0a9qgjs	192	22	therapy	therapy	NN
cord-281487-x0a9qgjs	192	23	(	(	-LRB-
cord-281487-x0a9qgjs	192	24	50,000	50,000	CD
cord-281487-x0a9qgjs	192	25	IU	IU	NNP
cord-281487-x0a9qgjs	192	26	or	or	CC
cord-281487-x0a9qgjs	192	27	100,000	100,000	CD
cord-281487-x0a9qgjs	192	28	IU	IU	NNP
cord-281487-x0a9qgjs	192	29	for	for	IN
cord-281487-x0a9qgjs	192	30	5	5	CD
cord-281487-x0a9qgjs	192	31	days	day	NNS
cord-281487-x0a9qgjs	192	32	)	)	-RRB-
cord-281487-x0a9qgjs	192	33	did	do	VBD
cord-281487-x0a9qgjs	192	34	not	not	RB
cord-281487-x0a9qgjs	192	35	show	show	VB
cord-281487-x0a9qgjs	192	36	mortality	mortality	NN
cord-281487-x0a9qgjs	192	37	benefit	benefit	NN
cord-281487-x0a9qgjs	192	38	[	[	-LRB-
cord-281487-x0a9qgjs	192	39	88	88	CD
cord-281487-x0a9qgjs	192	40	,	,	,
cord-281487-x0a9qgjs	192	41	89	89	CD
cord-281487-x0a9qgjs	192	42	]	]	-RRB-
cord-281487-x0a9qgjs	192	43	.	.	.
cord-281487-x0a9qgjs	193	1	As	as	IN
cord-281487-x0a9qgjs	193	2	the	the	DT
cord-281487-x0a9qgjs	193	3	relationship	relationship	NN
cord-281487-x0a9qgjs	193	4	between	between	IN
cord-281487-x0a9qgjs	193	5	vitamin	vitamin	NN
cord-281487-x0a9qgjs	193	6	D	d	NN
cord-281487-x0a9qgjs	193	7	supplementation	supplementation	NN
cord-281487-x0a9qgjs	193	8	and	and	CC
cord-281487-x0a9qgjs	193	9	improvement	improvement	NN
cord-281487-x0a9qgjs	193	10	in	in	IN
cord-281487-x0a9qgjs	193	11	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	193	12	outcomes	outcome	NNS
cord-281487-x0a9qgjs	193	13	has	have	VBZ
cord-281487-x0a9qgjs	193	14	not	not	RB
cord-281487-x0a9qgjs	193	15	yet	yet	RB
cord-281487-x0a9qgjs	193	16	been	be	VBN
cord-281487-x0a9qgjs	193	17	established	establish	VBN
cord-281487-x0a9qgjs	193	18	,	,	,
cord-281487-x0a9qgjs	193	19	measurement	measurement	NN
cord-281487-x0a9qgjs	193	20	of	of	IN
cord-281487-x0a9qgjs	193	21	Vitamin	vitamin	NN
cord-281487-x0a9qgjs	193	22	D	d	NN
cord-281487-x0a9qgjs	193	23	levels	level	NNS
cord-281487-x0a9qgjs	193	24	may	may	MD
cord-281487-x0a9qgjs	193	25	be	be	VB
cord-281487-x0a9qgjs	193	26	a	a	DT
cord-281487-x0a9qgjs	193	27	reasonable	reasonable	JJ
cord-281487-x0a9qgjs	193	28	strategy	strategy	NN
cord-281487-x0a9qgjs	193	29	to	to	TO
cord-281487-x0a9qgjs	193	30	guide	guide	VB
cord-281487-x0a9qgjs	193	31	supplementation	supplementation	NN
cord-281487-x0a9qgjs	193	32	using	use	VBG
cord-281487-x0a9qgjs	193	33	modest	modest	JJ
cord-281487-x0a9qgjs	193	34	daily	daily	JJ
cord-281487-x0a9qgjs	193	35	dosing	dosing	NN
cord-281487-x0a9qgjs	193	36	until	until	IN
cord-281487-x0a9qgjs	193	37	further	further	JJ
cord-281487-x0a9qgjs	193	38	data	data	NN
cord-281487-x0a9qgjs	193	39	is	be	VBZ
cord-281487-x0a9qgjs	193	40	available	available	JJ
cord-281487-x0a9qgjs	193	41	.	.	.
cord-281487-x0a9qgjs	194	1	In	in	IN
cord-281487-x0a9qgjs	194	2	KT	KT	NNP
cord-281487-x0a9qgjs	194	3	recipients	recipient	NNS
cord-281487-x0a9qgjs	194	4	,	,	,
cord-281487-x0a9qgjs	194	5	we	-PRON-	PRP
cord-281487-x0a9qgjs	194	6	routinely	routinely	RB
cord-281487-x0a9qgjs	194	7	give	give	VBP
cord-281487-x0a9qgjs	194	8	ergocalciferol	ergocalciferol	JJ
cord-281487-x0a9qgjs	194	9	50,000	50,000	CD
cord-281487-x0a9qgjs	194	10	units	unit	NNS
cord-281487-x0a9qgjs	194	11	orally	orally	RB
cord-281487-x0a9qgjs	194	12	daily	daily	RB
cord-281487-x0a9qgjs	194	13	for	for	IN
cord-281487-x0a9qgjs	194	14	5	5	CD
cord-281487-x0a9qgjs	194	15	days	day	NNS
cord-281487-x0a9qgjs	194	16	at	at	IN
cord-281487-x0a9qgjs	194	17	the	the	DT
cord-281487-x0a9qgjs	194	18	time	time	NN
cord-281487-x0a9qgjs	194	19	of	of	IN
cord-281487-x0a9qgjs	194	20	transplant	transplant	NN
cord-281487-x0a9qgjs	194	21	and	and	CC
cord-281487-x0a9qgjs	194	22	upon	upon	IN
cord-281487-x0a9qgjs	194	23	a	a	DT
cord-281487-x0a9qgjs	194	24	positive	positive	JJ
cord-281487-x0a9qgjs	194	25	COVID-19	COVID-19	,
cord-281487-x0a9qgjs	194	26	PCR	PCR	NNP
cord-281487-x0a9qgjs	194	27	.	.	.
cord-281487-x0a9qgjs	195	1	Melatonin	melatonin	NN
cord-281487-x0a9qgjs	195	2	lowers	lower	VBZ
cord-281487-x0a9qgjs	195	3	the	the	DT
cord-281487-x0a9qgjs	195	4	levels	level	NNS
cord-281487-x0a9qgjs	195	5	of	of	IN
cord-281487-x0a9qgjs	195	6	circulating	circulate	VBG
cord-281487-x0a9qgjs	195	7	cytokines	cytokine	NNS
cord-281487-x0a9qgjs	195	8	and	and	CC
cord-281487-x0a9qgjs	195	9	may	may	MD
cord-281487-x0a9qgjs	195	10	reduce	reduce	VB
cord-281487-x0a9qgjs	195	11	pro	pro	JJ
cord-281487-x0a9qgjs	195	12	-	-	JJ
cord-281487-x0a9qgjs	195	13	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	195	14	cytokine	cytokine	NN
cord-281487-x0a9qgjs	195	15	levels	level	NNS
cord-281487-x0a9qgjs	195	16	in	in	IN
cord-281487-x0a9qgjs	195	17	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	195	18	patients	patient	NNS
cord-281487-x0a9qgjs	195	19	[	[	-LRB-
cord-281487-x0a9qgjs	195	20	60	60	CD
cord-281487-x0a9qgjs	195	21	]	]	-RRB-
cord-281487-x0a9qgjs	195	22	.	.	.
cord-281487-x0a9qgjs	196	1	Further	further	RB
cord-281487-x0a9qgjs	196	2	,	,	,
cord-281487-x0a9qgjs	196	3	stress	stress	NN
cord-281487-x0a9qgjs	196	4	and	and	CC
cord-281487-x0a9qgjs	196	5	sleep	sleep	NN
cord-281487-x0a9qgjs	196	6	deprivation	deprivation	NN
cord-281487-x0a9qgjs	196	7	induce	induce	VBP
cord-281487-x0a9qgjs	196	8	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	196	9	.	.	.
cord-281487-x0a9qgjs	197	1	These	these	DT
cord-281487-x0a9qgjs	197	2	negative	negative	JJ
cord-281487-x0a9qgjs	197	3	effects	effect	NNS
cord-281487-x0a9qgjs	197	4	on	on	IN
cord-281487-x0a9qgjs	197	5	immunity	immunity	NN
cord-281487-x0a9qgjs	197	6	may	may	MD
cord-281487-x0a9qgjs	197	7	be	be	VB
cord-281487-x0a9qgjs	197	8	alleviated	alleviate	VBN
cord-281487-x0a9qgjs	197	9	by	by	IN
cord-281487-x0a9qgjs	197	10	restoring	restore	VBG
cord-281487-x0a9qgjs	197	11	sleep	sleep	NN
cord-281487-x0a9qgjs	197	12	disorder	disorder	NN
cord-281487-x0a9qgjs	197	13	and	and	CC
cord-281487-x0a9qgjs	197	14	reducing	reduce	VBG
cord-281487-x0a9qgjs	197	15	anxiety	anxiety	NN
cord-281487-x0a9qgjs	197	16	through	through	IN
cord-281487-x0a9qgjs	197	17	melatonin	melatonin	NN
cord-281487-x0a9qgjs	197	18	[	[	-LRB-
cord-281487-x0a9qgjs	197	19	90	90	CD
cord-281487-x0a9qgjs	197	20	]	]	-RRB-
cord-281487-x0a9qgjs	197	21	.	.	.
cord-281487-x0a9qgjs	198	1	So	so	RB
cord-281487-x0a9qgjs	198	2	far	far	RB
cord-281487-x0a9qgjs	198	3	,	,	,
cord-281487-x0a9qgjs	198	4	the	the	DT
cord-281487-x0a9qgjs	198	5	direct	direct	JJ
cord-281487-x0a9qgjs	198	6	evidence	evidence	NN
cord-281487-x0a9qgjs	198	7	of	of	IN
cord-281487-x0a9qgjs	198	8	melatonin	melatonin	NN
cord-281487-x0a9qgjs	198	9	application	application	NN
cord-281487-x0a9qgjs	198	10	in	in	IN
cord-281487-x0a9qgjs	198	11	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	198	12	is	be	VBZ
cord-281487-x0a9qgjs	198	13	unclear	unclear	JJ
cord-281487-x0a9qgjs	198	14	.	.	.
cord-281487-x0a9qgjs	199	1	Further	further	JJ
cord-281487-x0a9qgjs	199	2	research	research	NN
cord-281487-x0a9qgjs	199	3	is	be	VBZ
cord-281487-x0a9qgjs	199	4	needed	need	VBN
cord-281487-x0a9qgjs	199	5	to	to	TO
cord-281487-x0a9qgjs	199	6	determine	determine	VB
cord-281487-x0a9qgjs	199	7	if	if	IN
cord-281487-x0a9qgjs	199	8	it	-PRON-	PRP
cord-281487-x0a9qgjs	199	9	has	have	VBZ
cord-281487-x0a9qgjs	199	10	a	a	DT
cord-281487-x0a9qgjs	199	11	COVID	covid	JJ
cord-281487-x0a9qgjs	199	12	specific	specific	JJ
cord-281487-x0a9qgjs	199	13	application	application	NN
cord-281487-x0a9qgjs	199	14	outside	outside	IN
cord-281487-x0a9qgjs	199	15	of	of	IN
cord-281487-x0a9qgjs	199	16	generalized	generalized	JJ
cord-281487-x0a9qgjs	199	17	sleep	sleep	NN
cord-281487-x0a9qgjs	199	18	and	and	CC
cord-281487-x0a9qgjs	199	19	anxiety	anxiety	NN
cord-281487-x0a9qgjs	199	20	disorders	disorder	NNS
cord-281487-x0a9qgjs	199	21	.	.	.
cord-281487-x0a9qgjs	200	1	Cytokine	cytokine	NN
cord-281487-x0a9qgjs	200	2	release	release	NN
cord-281487-x0a9qgjs	200	3	syndrome	syndrome	NN
cord-281487-x0a9qgjs	200	4	(	(	-LRB-
cord-281487-x0a9qgjs	200	5	CRS	CRS	NNP
cord-281487-x0a9qgjs	200	6	)	)	-RRB-
cord-281487-x0a9qgjs	200	7	,	,	,
cord-281487-x0a9qgjs	200	8	characterized	characterize	VBN
cord-281487-x0a9qgjs	200	9	by	by	IN
cord-281487-x0a9qgjs	200	10	a	a	DT
cord-281487-x0a9qgjs	200	11	systemic	systemic	JJ
cord-281487-x0a9qgjs	200	12	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	200	13	response	response	NN
cord-281487-x0a9qgjs	200	14	resulting	result	VBG
cord-281487-x0a9qgjs	200	15	from	from	IN
cord-281487-x0a9qgjs	200	16	the	the	DT
cord-281487-x0a9qgjs	200	17	release	release	NN
cord-281487-x0a9qgjs	200	18	of	of	IN
cord-281487-x0a9qgjs	200	19	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	200	20	cytokines	cytokine	NNS
cord-281487-x0a9qgjs	200	21	including	include	VBG
cord-281487-x0a9qgjs	200	22	IL-6	IL-6	NNP
cord-281487-x0a9qgjs	200	23	,	,	,
cord-281487-x0a9qgjs	200	24	is	be	VBZ
cord-281487-x0a9qgjs	200	25	a	a	DT
cord-281487-x0a9qgjs	200	26	hallmark	hallmark	NN
cord-281487-x0a9qgjs	200	27	of	of	IN
cord-281487-x0a9qgjs	200	28	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	200	29	progression	progression	NN
cord-281487-x0a9qgjs	200	30	[	[	-LRB-
cord-281487-x0a9qgjs	200	31	91	91	CD
cord-281487-x0a9qgjs	200	32	]	]	-RRB-
cord-281487-x0a9qgjs	200	33	.	.	.
cord-281487-x0a9qgjs	201	1	Although	although	IN
cord-281487-x0a9qgjs	201	2	immunomodulatory	immunomodulatory	JJ
cord-281487-x0a9qgjs	201	3	therapy	therapy	NN
cord-281487-x0a9qgjs	201	4	is	be	VBZ
cord-281487-x0a9qgjs	201	5	discussed	discuss	VBN
cord-281487-x0a9qgjs	201	6	separately	separately	RB
cord-281487-x0a9qgjs	201	7	,	,	,
cord-281487-x0a9qgjs	201	8	we	-PRON-	PRP
cord-281487-x0a9qgjs	201	9	note	note	VBP
cord-281487-x0a9qgjs	201	10	that	that	IN
cord-281487-x0a9qgjs	201	11	blocking	blocking	NN
cord-281487-x0a9qgjs	201	12	of	of	IN
cord-281487-x0a9qgjs	201	13	the	the	DT
cord-281487-x0a9qgjs	201	14	catecholamine	catecholamine	NN
cord-281487-x0a9qgjs	201	15	pathway	pathway	NN
cord-281487-x0a9qgjs	201	16	with	with	IN
cord-281487-x0a9qgjs	201	17	alpha-1	alpha-1	JJ
cord-281487-x0a9qgjs	201	18	adrenergic	adrenergic	JJ
cord-281487-x0a9qgjs	201	19	receptor	receptor	NN
cord-281487-x0a9qgjs	201	20	antagonists	antagonist	NNS
cord-281487-x0a9qgjs	201	21	(	(	-LRB-
cord-281487-x0a9qgjs	201	22	⍺	⍺	VBZ
cord-281487-x0a9qgjs	201	23	-blockers	-blocker	NNS
cord-281487-x0a9qgjs	201	24	)	)	-RRB-
cord-281487-x0a9qgjs	201	25	may	may	MD
cord-281487-x0a9qgjs	201	26	reduce	reduce	VB
cord-281487-x0a9qgjs	201	27	cytokine	cytokine	NN
cord-281487-x0a9qgjs	201	28	storms	storm	NNS
cord-281487-x0a9qgjs	201	29	[	[	-LRB-
cord-281487-x0a9qgjs	201	30	92	92	CD
cord-281487-x0a9qgjs	201	31	]	]	-RRB-
cord-281487-x0a9qgjs	201	32	.	.	.
cord-281487-x0a9qgjs	202	1	In	in	IN
cord-281487-x0a9qgjs	202	2	a	a	DT
cord-281487-x0a9qgjs	202	3	retrospective	retrospective	JJ
cord-281487-x0a9qgjs	202	4	study	study	NN
cord-281487-x0a9qgjs	202	5	,	,	,
cord-281487-x0a9qgjs	202	6	Vogelstein	Vogelstein	NNP
cord-281487-x0a9qgjs	202	7	et	et	NNP
cord-281487-x0a9qgjs	202	8	al	al	NNP
cord-281487-x0a9qgjs	202	9	.	.	.
cord-281487-x0a9qgjs	203	1	found	find	VBD
cord-281487-x0a9qgjs	203	2	that	that	IN
cord-281487-x0a9qgjs	203	3	the	the	DT
cord-281487-x0a9qgjs	203	4	use	use	NN
cord-281487-x0a9qgjs	203	5	of	of	IN
cord-281487-x0a9qgjs	203	6	αblockers	αblocker	NNS
cord-281487-x0a9qgjs	203	7	was	be	VBD
cord-281487-x0a9qgjs	203	8	associated	associate	VBN
cord-281487-x0a9qgjs	203	9	with	with	IN
cord-281487-x0a9qgjs	203	10	reduced	reduce	VBN
cord-281487-x0a9qgjs	203	11	ARDS	ARDS	NNP
cord-281487-x0a9qgjs	203	12	and	and	CC
cord-281487-x0a9qgjs	203	13	death	death	NN
cord-281487-x0a9qgjs	203	14	from	from	IN
cord-281487-x0a9qgjs	203	15	CRS	CRS	NNP
cord-281487-x0a9qgjs	203	16	[	[	-LRB-
cord-281487-x0a9qgjs	203	17	93	93	CD
cord-281487-x0a9qgjs	203	18	]	]	-RRB-
cord-281487-x0a9qgjs	203	19	.	.	.
cord-281487-x0a9qgjs	204	1	As	as	IN
cord-281487-x0a9qgjs	204	2	such	such	JJ
cord-281487-x0a9qgjs	204	3	,	,	,
cord-281487-x0a9qgjs	204	4	prospective	prospective	JJ
cord-281487-x0a9qgjs	204	5	clinical	clinical	JJ
cord-281487-x0a9qgjs	204	6	trials	trial	NNS
cord-281487-x0a9qgjs	204	7	are	be	VBP
cord-281487-x0a9qgjs	204	8	underway	underway	JJ
cord-281487-x0a9qgjs	204	9	to	to	TO
cord-281487-x0a9qgjs	204	10	determine	determine	VB
cord-281487-x0a9qgjs	204	11	whether	whether	IN
cord-281487-x0a9qgjs	204	12	these	these	DT
cord-281487-x0a9qgjs	204	13	agents	agent	NNS
cord-281487-x0a9qgjs	204	14	can	can	MD
cord-281487-x0a9qgjs	204	15	pre	pre	VB
cord-281487-x0a9qgjs	204	16	-	-	VB
cord-281487-x0a9qgjs	204	17	emptively	emptively	RB
cord-281487-x0a9qgjs	204	18	reduce	reduce	VB
cord-281487-x0a9qgjs	204	19	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	204	20	disease	disease	NN
cord-281487-x0a9qgjs	204	21	progression	progression	NN
cord-281487-x0a9qgjs	204	22	[	[	-LRB-
cord-281487-x0a9qgjs	204	23	94	94	CD
cord-281487-x0a9qgjs	204	24	]	]	-RRB-
cord-281487-x0a9qgjs	204	25	.	.	.
cord-281487-x0a9qgjs	205	1	Patients	patient	NNS
cord-281487-x0a9qgjs	205	2	can	can	MD
cord-281487-x0a9qgjs	205	3	be	be	VB
cord-281487-x0a9qgjs	205	4	discharged	discharge	VBN
cord-281487-x0a9qgjs	205	5	from	from	IN
cord-281487-x0a9qgjs	205	6	the	the	DT
cord-281487-x0a9qgjs	205	7	hospital	hospital	NN
cord-281487-x0a9qgjs	205	8	when	when	WRB
cord-281487-x0a9qgjs	205	9	clinically	clinically	RB
cord-281487-x0a9qgjs	205	10	indicated	indicate	VBN
cord-281487-x0a9qgjs	205	11	.	.	.
cord-281487-x0a9qgjs	206	1	Isolation	isolation	NN
cord-281487-x0a9qgjs	206	2	should	should	MD
cord-281487-x0a9qgjs	206	3	be	be	VB
cord-281487-x0a9qgjs	206	4	maintained	maintain	VBN
cord-281487-x0a9qgjs	206	5	if	if	IN
cord-281487-x0a9qgjs	206	6	the	the	DT
cord-281487-x0a9qgjs	206	7	patients	patient	NNS
cord-281487-x0a9qgjs	206	8	are	be	VBP
cord-281487-x0a9qgjs	206	9	discharged	discharge	VBN
cord-281487-x0a9qgjs	206	10	to	to	IN
cord-281487-x0a9qgjs	206	11	home	home	NN
cord-281487-x0a9qgjs	206	12	or	or	CC
cord-281487-x0a9qgjs	206	13	long	long	JJ
cord-281487-x0a9qgjs	206	14	-	-	HYPH
cord-281487-x0a9qgjs	206	15	term	term	NN
cord-281487-x0a9qgjs	206	16	care	care	NN
cord-281487-x0a9qgjs	206	17	facility	facility	NN
cord-281487-x0a9qgjs	206	18	before	before	IN
cord-281487-x0a9qgjs	206	19	discontinuation	discontinuation	NN
cord-281487-x0a9qgjs	206	20	of	of	IN
cord-281487-x0a9qgjs	206	21	isolation	isolation	NN
cord-281487-x0a9qgjs	206	22	and	and	CC
cord-281487-x0a9qgjs	206	23	may	may	MD
cord-281487-x0a9qgjs	206	24	pose	pose	VB
cord-281487-x0a9qgjs	206	25	a	a	DT
cord-281487-x0a9qgjs	206	26	challenge	challenge	NN
cord-281487-x0a9qgjs	206	27	in	in	IN
cord-281487-x0a9qgjs	206	28	a	a	DT
cord-281487-x0a9qgjs	206	29	safe	safe	JJ
cord-281487-x0a9qgjs	206	30	return	return	NN
cord-281487-x0a9qgjs	206	31	to	to	IN
cord-281487-x0a9qgjs	206	32	a	a	DT
cord-281487-x0a9qgjs	206	33	home	home	NN
cord-281487-x0a9qgjs	206	34	environment	environment	NN
cord-281487-x0a9qgjs	206	35	if	if	IN
cord-281487-x0a9qgjs	206	36	there	there	EX
cord-281487-x0a9qgjs	206	37	are	be	VBP
cord-281487-x0a9qgjs	206	38	uninfected	uninfected	JJ
cord-281487-x0a9qgjs	206	39	individuals	individual	NNS
cord-281487-x0a9qgjs	206	40	in	in	IN
cord-281487-x0a9qgjs	206	41	the	the	DT
cord-281487-x0a9qgjs	206	42	home	home	NN
cord-281487-x0a9qgjs	206	43	.	.	.
cord-281487-x0a9qgjs	207	1	Long	long	JJ
cord-281487-x0a9qgjs	207	2	-	-	HYPH
cord-281487-x0a9qgjs	207	3	term	term	NN
cord-281487-x0a9qgjs	207	4	care	care	NN
cord-281487-x0a9qgjs	207	5	facilities	facility	NNS
cord-281487-x0a9qgjs	207	6	should	should	MD
cord-281487-x0a9qgjs	207	7	follow	follow	VB
cord-281487-x0a9qgjs	207	8	infection	infection	NN
cord-281487-x0a9qgjs	207	9	prevention	prevention	NN
cord-281487-x0a9qgjs	207	10	and	and	CC
cord-281487-x0a9qgjs	207	11	control	control	NN
cord-281487-x0a9qgjs	207	12	recommendations	recommendation	NNS
cord-281487-x0a9qgjs	207	13	for	for	IN
cord-281487-x0a9qgjs	207	14	the	the	DT
cord-281487-x0a9qgjs	207	15	care	care	NN
cord-281487-x0a9qgjs	207	16	of	of	IN
cord-281487-x0a9qgjs	207	17	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	207	18	patients	patient	NNS
cord-281487-x0a9qgjs	207	19	[	[	-LRB-
cord-281487-x0a9qgjs	207	20	52	52	CD
cord-281487-x0a9qgjs	207	21	]	]	-RRB-
cord-281487-x0a9qgjs	207	22	.	.	.
cord-281487-x0a9qgjs	208	1	As	as	IN
cord-281487-x0a9qgjs	208	2	there	there	EX
cord-281487-x0a9qgjs	208	3	is	be	VBZ
cord-281487-x0a9qgjs	208	4	a	a	DT
cord-281487-x0a9qgjs	208	5	paucity	paucity	NN
cord-281487-x0a9qgjs	208	6	of	of	IN
cord-281487-x0a9qgjs	208	7	high	high	JJ
cord-281487-x0a9qgjs	208	8	-	-	HYPH
cord-281487-x0a9qgjs	208	9	quality	quality	NN
cord-281487-x0a9qgjs	208	10	evidence	evidence	NN
cord-281487-x0a9qgjs	208	11	to	to	TO
cord-281487-x0a9qgjs	208	12	guide	guide	VB
cord-281487-x0a9qgjs	208	13	management	management	NN
cord-281487-x0a9qgjs	208	14	of	of	IN
cord-281487-x0a9qgjs	208	15	the	the	DT
cord-281487-x0a9qgjs	208	16	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	208	17	infected	infected	JJ
cord-281487-x0a9qgjs	208	18	transplant	transplant	NN
cord-281487-x0a9qgjs	208	19	recipient	recipient	NN
cord-281487-x0a9qgjs	208	20	,	,	,
cord-281487-x0a9qgjs	208	21	many	many	JJ
cord-281487-x0a9qgjs	208	22	centers	center	NNS
cord-281487-x0a9qgjs	208	23	have	have	VBP
cord-281487-x0a9qgjs	208	24	implemented	implement	VBN
cord-281487-x0a9qgjs	208	25	practices	practice	NNS
cord-281487-x0a9qgjs	208	26	based	base	VBN
cord-281487-x0a9qgjs	208	27	on	on	IN
cord-281487-x0a9qgjs	208	28	biological	biological	JJ
cord-281487-x0a9qgjs	208	29	plausibility	plausibility	NN
cord-281487-x0a9qgjs	208	30	and	and	CC
cord-281487-x0a9qgjs	208	31	extrapolation	extrapolation	NN
cord-281487-x0a9qgjs	208	32	from	from	IN
cord-281487-x0a9qgjs	208	33	scenarios	scenario	NNS
cord-281487-x0a9qgjs	208	34	which	which	WDT
cord-281487-x0a9qgjs	208	35	share	share	VBP
cord-281487-x0a9qgjs	208	36	common	common	JJ
cord-281487-x0a9qgjs	208	37	features	feature	NNS
cord-281487-x0a9qgjs	208	38	with	with	IN
cord-281487-x0a9qgjs	208	39	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	208	40	.	.	.
cord-281487-x0a9qgjs	209	1	At	at	IN
cord-281487-x0a9qgjs	209	2	our	-PRON-	PRP$
cord-281487-x0a9qgjs	209	3	institution	institution	NN
cord-281487-x0a9qgjs	209	4	,	,	,
cord-281487-x0a9qgjs	209	5	we	-PRON-	PRP
cord-281487-x0a9qgjs	209	6	have	have	VBP
cord-281487-x0a9qgjs	209	7	noted	note	VBN
cord-281487-x0a9qgjs	209	8	markedly	markedly	RB
cord-281487-x0a9qgjs	209	9	low	low	JJ
cord-281487-x0a9qgjs	209	10	mortality	mortality	NN
cord-281487-x0a9qgjs	209	11	of	of	IN
cord-281487-x0a9qgjs	209	12	3.7	3.7	CD
cord-281487-x0a9qgjs	209	13	%	%	NN
cord-281487-x0a9qgjs	209	14	in	in	IN
cord-281487-x0a9qgjs	209	15	the	the	DT
cord-281487-x0a9qgjs	209	16	1st	1st	JJ
cord-281487-x0a9qgjs	209	17	27	27	CD
cord-281487-x0a9qgjs	209	18	solid	solid	JJ
cord-281487-x0a9qgjs	209	19	organ	organ	NN
cord-281487-x0a9qgjs	209	20	transplant	transplant	NN
cord-281487-x0a9qgjs	209	21	recipients	recipient	NNS
cord-281487-x0a9qgjs	209	22	cared	care	VBN
cord-281487-x0a9qgjs	209	23	by	by	IN
cord-281487-x0a9qgjs	209	24	our	-PRON-	PRP$
cord-281487-x0a9qgjs	209	25	providers	provider	NNS
cord-281487-x0a9qgjs	209	26	between	between	IN
cord-281487-x0a9qgjs	209	27	March	March	NNP
cord-281487-x0a9qgjs	209	28	15	15	CD
cord-281487-x0a9qgjs	209	29	,	,	,
cord-281487-x0a9qgjs	209	30	2020	2020	CD
cord-281487-x0a9qgjs	209	31	and	and	CC
cord-281487-x0a9qgjs	209	32	May	May	NNP
cord-281487-x0a9qgjs	209	33	22	22	CD
cord-281487-x0a9qgjs	209	34	,	,	,
cord-281487-x0a9qgjs	209	35	2020	2020	CD
cord-281487-x0a9qgjs	209	36	,	,	,
cord-281487-x0a9qgjs	209	37	compared	compare	VBN
cord-281487-x0a9qgjs	209	38	to	to	IN
cord-281487-x0a9qgjs	209	39	reports	report	NNS
cord-281487-x0a9qgjs	209	40	from	from	IN
cord-281487-x0a9qgjs	209	41	other	other	JJ
cord-281487-x0a9qgjs	209	42	institutions	institution	NNS
cord-281487-x0a9qgjs	209	43	in	in	IN
cord-281487-x0a9qgjs	209	44	similar	similar	JJ
cord-281487-x0a9qgjs	209	45	time	time	NN
cord-281487-x0a9qgjs	209	46	periods	period	NNS
cord-281487-x0a9qgjs	209	47	(	(	-LRB-
cord-281487-x0a9qgjs	209	48	Table	table	NN
cord-281487-x0a9qgjs	209	49	2	2	CD
cord-281487-x0a9qgjs	209	50	)	)	-RRB-
cord-281487-x0a9qgjs	209	51	.	.	.
cord-281487-x0a9qgjs	210	1	While	while	IN
cord-281487-x0a9qgjs	210	2	we	-PRON-	PRP
cord-281487-x0a9qgjs	210	3	can	can	MD
cord-281487-x0a9qgjs	210	4	not	not	RB
cord-281487-x0a9qgjs	210	5	yet	yet	RB
cord-281487-x0a9qgjs	210	6	definitely	definitely	RB
cord-281487-x0a9qgjs	210	7	determine	determine	VB
cord-281487-x0a9qgjs	210	8	which	which	WDT
cord-281487-x0a9qgjs	210	9	of	of	IN
cord-281487-x0a9qgjs	210	10	our	-PRON-	PRP$
cord-281487-x0a9qgjs	210	11	practices	practice	NNS
cord-281487-x0a9qgjs	210	12	contributed	contribute	VBD
cord-281487-x0a9qgjs	210	13	to	to	IN
cord-281487-x0a9qgjs	210	14	this	this	DT
cord-281487-x0a9qgjs	210	15	excellent	excellent	JJ
cord-281487-x0a9qgjs	210	16	outcome	outcome	NN
cord-281487-x0a9qgjs	210	17	,	,	,
cord-281487-x0a9qgjs	210	18	we	-PRON-	PRP
cord-281487-x0a9qgjs	210	19	have	have	VBP
cord-281487-x0a9qgjs	210	20	in	in	IN
cord-281487-x0a9qgjs	210	21	this	this	DT
cord-281487-x0a9qgjs	210	22	section	section	NN
cord-281487-x0a9qgjs	210	23	,	,	,
cord-281487-x0a9qgjs	210	24	detailed	detail	VBN
cord-281487-x0a9qgjs	210	25	our	-PRON-	PRP$
cord-281487-x0a9qgjs	210	26	center	center	NN
cord-281487-x0a9qgjs	210	27	's	's	POS
cord-281487-x0a9qgjs	210	28	specific	specific	JJ
cord-281487-x0a9qgjs	210	29	practices	practice	NNS
cord-281487-x0a9qgjs	210	30	(	(	-LRB-
cord-281487-x0a9qgjs	210	31	Fig	fig	NN
cord-281487-x0a9qgjs	210	32	.	.	NNP
cord-281487-x0a9qgjs	210	33	1	1	CD
cord-281487-x0a9qgjs	210	34	)	)	-RRB-
cord-281487-x0a9qgjs	210	35	,	,	,
cord-281487-x0a9qgjs	210	36	and	and	CC
cord-281487-x0a9qgjs	210	37	look	look	VB
cord-281487-x0a9qgjs	210	38	forward	forward	RB
cord-281487-x0a9qgjs	210	39	to	to	IN
cord-281487-x0a9qgjs	210	40	further	further	JJ
cord-281487-x0a9qgjs	210	41	science	science	NN
cord-281487-x0a9qgjs	210	42	to	to	TO
cord-281487-x0a9qgjs	210	43	refine	refine	VB
cord-281487-x0a9qgjs	210	44	these	these	DT
cord-281487-x0a9qgjs	210	45	clinical	clinical	JJ
cord-281487-x0a9qgjs	210	46	algorithms	algorithm	NNS
cord-281487-x0a9qgjs	210	47	.	.	.
cord-281487-x0a9qgjs	211	1	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	211	2	is	be	VBZ
cord-281487-x0a9qgjs	211	3	an	an	DT
cord-281487-x0a9qgjs	211	4	unprecedented	unprecedented	JJ
cord-281487-x0a9qgjs	211	5	worldwide	worldwide	JJ
cord-281487-x0a9qgjs	211	6	challenge	challenge	NN
cord-281487-x0a9qgjs	211	7	,	,	,
cord-281487-x0a9qgjs	211	8	that	that	RB
cord-281487-x0a9qgjs	211	9	is	is	RB
cord-281487-x0a9qgjs	211	10	,	,	,
cord-281487-x0a9qgjs	211	11	heightened	heighten	VBN
cord-281487-x0a9qgjs	211	12	in	in	IN
cord-281487-x0a9qgjs	211	13	solid	solid	JJ
cord-281487-x0a9qgjs	211	14	organ	organ	NN
cord-281487-x0a9qgjs	211	15	transplant	transplant	NN
cord-281487-x0a9qgjs	211	16	recipients	recipient	NNS
cord-281487-x0a9qgjs	211	17	.	.	.
cord-281487-x0a9qgjs	212	1	While	while	IN
cord-281487-x0a9qgjs	212	2	a	a	DT
cord-281487-x0a9qgjs	212	3	worldwide	worldwide	JJ
cord-281487-x0a9qgjs	212	4	effort	effort	NN
cord-281487-x0a9qgjs	212	5	is	be	VBZ
cord-281487-x0a9qgjs	212	6	underway	underway	JJ
cord-281487-x0a9qgjs	212	7	to	to	TO
cord-281487-x0a9qgjs	212	8	identify	identify	VB
cord-281487-x0a9qgjs	212	9	the	the	DT
cord-281487-x0a9qgjs	212	10	best	good	JJS
cord-281487-x0a9qgjs	212	11	therapeutics	therapeutic	NNS
cord-281487-x0a9qgjs	212	12	and	and	CC
cord-281487-x0a9qgjs	212	13	vaccines	vaccine	NNS
cord-281487-x0a9qgjs	212	14	,	,	,
cord-281487-x0a9qgjs	212	15	their	-PRON-	PRP$
cord-281487-x0a9qgjs	212	16	risk	risk	NN
cord-281487-x0a9qgjs	212	17	and	and	CC
cord-281487-x0a9qgjs	212	18	benefit	benefit	NN
cord-281487-x0a9qgjs	212	19	in	in	IN
cord-281487-x0a9qgjs	212	20	transplant	transplant	NN
cord-281487-x0a9qgjs	212	21	recipients	recipient	NNS
cord-281487-x0a9qgjs	212	22	remain	remain	VBP
cord-281487-x0a9qgjs	212	23	undetermined	undetermined	JJ
cord-281487-x0a9qgjs	212	24	.	.	.
cord-281487-x0a9qgjs	213	1	Thus	thus	RB
cord-281487-x0a9qgjs	213	2	,	,	,
cord-281487-x0a9qgjs	213	3	it	-PRON-	PRP
cord-281487-x0a9qgjs	213	4	is	be	VBZ
cord-281487-x0a9qgjs	213	5	critical	critical	JJ
cord-281487-x0a9qgjs	213	6	to	to	TO
cord-281487-x0a9qgjs	213	7	reinforce	reinforce	VB
cord-281487-x0a9qgjs	213	8	to	to	IN
cord-281487-x0a9qgjs	213	9	transplant	transplant	NN
cord-281487-x0a9qgjs	213	10	households	household	NNS
cord-281487-x0a9qgjs	213	11	to	to	TO
cord-281487-x0a9qgjs	213	12	strictly	strictly	RB
cord-281487-x0a9qgjs	213	13	adhere	adhere	VB
cord-281487-x0a9qgjs	213	14	to	to	IN
cord-281487-x0a9qgjs	213	15	infection	infection	NN
cord-281487-x0a9qgjs	213	16	prevention	prevention	NN
cord-281487-x0a9qgjs	213	17	measures	measure	NNS
cord-281487-x0a9qgjs	213	18	.	.	.
cord-281487-x0a9qgjs	214	1	Transplant	transplant	NN
cord-281487-x0a9qgjs	214	2	recipients	recipient	NNS
cord-281487-x0a9qgjs	214	3	should	should	MD
cord-281487-x0a9qgjs	214	4	remain	remain	VB
cord-281487-x0a9qgjs	214	5	in	in	IN
cord-281487-x0a9qgjs	214	6	close	close	JJ
cord-281487-x0a9qgjs	214	7	communication	communication	NN
cord-281487-x0a9qgjs	214	8	with	with	IN
cord-281487-x0a9qgjs	214	9	their	-PRON-	PRP$
cord-281487-x0a9qgjs	214	10	health	health	NN
cord-281487-x0a9qgjs	214	11	team	team	NN
cord-281487-x0a9qgjs	214	12	to	to	TO
cord-281487-x0a9qgjs	214	13	monitor	monitor	VB
cord-281487-x0a9qgjs	214	14	their	-PRON-	PRP$
cord-281487-x0a9qgjs	214	15	overall	overall	JJ
cord-281487-x0a9qgjs	214	16	health	health	NN
cord-281487-x0a9qgjs	214	17	,	,	,
cord-281487-x0a9qgjs	214	18	manage	manage	VB
cord-281487-x0a9qgjs	214	19	comorbidities	comorbiditie	NNS
cord-281487-x0a9qgjs	214	20	and	and	CC
cord-281487-x0a9qgjs	214	21	identify	identify	VB
cord-281487-x0a9qgjs	214	22	any	any	DT
cord-281487-x0a9qgjs	214	23	new	new	JJ
cord-281487-x0a9qgjs	214	24	findings	finding	NNS
cord-281487-x0a9qgjs	214	25	that	that	WDT
cord-281487-x0a9qgjs	214	26	may	may	MD
cord-281487-x0a9qgjs	214	27	confer	confer	VB
cord-281487-x0a9qgjs	214	28	risk	risk	NN
cord-281487-x0a9qgjs	214	29	of	of	IN
cord-281487-x0a9qgjs	214	30	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	214	31	.	.	.
cord-281487-x0a9qgjs	215	1	Finally	finally	RB
cord-281487-x0a9qgjs	215	2	,	,	,
cord-281487-x0a9qgjs	215	3	understanding	understanding	NN
cord-281487-x0a9qgjs	215	4	of	of	IN
cord-281487-x0a9qgjs	215	5	the	the	DT
cord-281487-x0a9qgjs	215	6	transplant	transplant	NN
cord-281487-x0a9qgjs	215	7	specific	specific	JJ
cord-281487-x0a9qgjs	215	8	pathophysiology	pathophysiology	NN
cord-281487-x0a9qgjs	215	9	,	,	,
cord-281487-x0a9qgjs	215	10	effective	effective	JJ
cord-281487-x0a9qgjs	215	11	treatments	treatment	NNS
cord-281487-x0a9qgjs	215	12	,	,	,
cord-281487-x0a9qgjs	215	13	and	and	CC
cord-281487-x0a9qgjs	215	14	adjunctive	adjunctive	JJ
cord-281487-x0a9qgjs	215	15	practices	practice	NNS
cord-281487-x0a9qgjs	215	16	for	for	IN
cord-281487-x0a9qgjs	215	17	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	215	18	should	should	MD
cord-281487-x0a9qgjs	215	19	be	be	VB
cord-281487-x0a9qgjs	215	20	prioritized	prioritize	VBN
cord-281487-x0a9qgjs	215	21	as	as	IN
cord-281487-x0a9qgjs	215	22	part	part	NN
cord-281487-x0a9qgjs	215	23	of	of	IN
cord-281487-x0a9qgjs	215	24	a	a	DT
cord-281487-x0a9qgjs	215	25	comprehensive	comprehensive	JJ
cord-281487-x0a9qgjs	215	26	research	research	NN
cord-281487-x0a9qgjs	215	27	strategy	strategy	NN
cord-281487-x0a9qgjs	215	28	to	to	TO
cord-281487-x0a9qgjs	215	29	optimize	optimize	VB
cord-281487-x0a9qgjs	215	30	outcomes	outcome	NNS
cord-281487-x0a9qgjs	215	31	.	.	.
cord-281487-x0a9qgjs	216	1	Global	global	JJ
cord-281487-x0a9qgjs	216	2	transplantation	transplantation	NN
cord-281487-x0a9qgjs	216	3	COVID	COVID	NNP
cord-281487-x0a9qgjs	216	4	report	report	NN
cord-281487-x0a9qgjs	216	5	Early	early	JJ
cord-281487-x0a9qgjs	216	6	impact	impact	NN
cord-281487-x0a9qgjs	216	7	of	of	IN
cord-281487-x0a9qgjs	216	8	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	216	9	on	on	IN
cord-281487-x0a9qgjs	216	10	transplant	transplant	NN
cord-281487-x0a9qgjs	216	11	center	center	NN
cord-281487-x0a9qgjs	216	12	practices	practice	NNS
cord-281487-x0a9qgjs	216	13	and	and	CC
cord-281487-x0a9qgjs	216	14	policies	policy	NNS
cord-281487-x0a9qgjs	216	15	in	in	IN
cord-281487-x0a9qgjs	216	16	the	the	DT
cord-281487-x0a9qgjs	216	17	United	United	NNP
cord-281487-x0a9qgjs	216	18	States	States	NNP
cord-281487-x0a9qgjs	217	1	The	the	DT
cord-281487-x0a9qgjs	217	2	impact	impact	NN
cord-281487-x0a9qgjs	217	3	of	of	IN
cord-281487-x0a9qgjs	217	4	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	217	5	on	on	IN
cord-281487-x0a9qgjs	217	6	the	the	DT
cord-281487-x0a9qgjs	217	7	state	state	NN
cord-281487-x0a9qgjs	217	8	of	of	IN
cord-281487-x0a9qgjs	217	9	clinical	clinical	JJ
cord-281487-x0a9qgjs	217	10	and	and	CC
cord-281487-x0a9qgjs	217	11	laboratory	laboratory	NN
cord-281487-x0a9qgjs	217	12	research	research	NN
cord-281487-x0a9qgjs	217	13	globally	globally	RB
cord-281487-x0a9qgjs	217	14	in	in	IN
cord-281487-x0a9qgjs	217	15	transplantation	transplantation	NN
cord-281487-x0a9qgjs	217	16	in	in	IN
cord-281487-x0a9qgjs	217	17	Kidney	kidney	NN
cord-281487-x0a9qgjs	217	18	diseases	disease	NNS
cord-281487-x0a9qgjs	217	19	in	in	IN
cord-281487-x0a9qgjs	217	20	the	the	DT
cord-281487-x0a9qgjs	217	21	time	time	NN
cord-281487-x0a9qgjs	217	22	of	of	IN
cord-281487-x0a9qgjs	217	23	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	217	24	:	:	:
cord-281487-x0a9qgjs	217	25	major	major	JJ
cord-281487-x0a9qgjs	217	26	challenges	challenge	NNS
cord-281487-x0a9qgjs	217	27	to	to	TO
cord-281487-x0a9qgjs	217	28	patient	patient	NN
cord-281487-x0a9qgjs	217	29	care	care	NN
cord-281487-x0a9qgjs	217	30	Identifying	identify	VBG
cord-281487-x0a9qgjs	217	31	scenarios	scenario	NNS
cord-281487-x0a9qgjs	217	32	of	of	IN
cord-281487-x0a9qgjs	217	33	benefit	benefit	NN
cord-281487-x0a9qgjs	217	34	or	or	CC
cord-281487-x0a9qgjs	217	35	harm	harm	NN
cord-281487-x0a9qgjs	217	36	from	from	IN
cord-281487-x0a9qgjs	217	37	kidney	kidney	NN
cord-281487-x0a9qgjs	217	38	transplantation	transplantation	NN
cord-281487-x0a9qgjs	217	39	during	during	IN
cord-281487-x0a9qgjs	217	40	the	the	DT
cord-281487-x0a9qgjs	217	41	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	217	42	pandemic	pandemic	NN
cord-281487-x0a9qgjs	217	43	:	:	:
cord-281487-x0a9qgjs	217	44	a	a	DT
cord-281487-x0a9qgjs	217	45	stochastic	stochastic	JJ
cord-281487-x0a9qgjs	217	46	simulation	simulation	NN
cord-281487-x0a9qgjs	217	47	and	and	CC
cord-281487-x0a9qgjs	217	48	machine	machine	NN
cord-281487-x0a9qgjs	217	49	learning	learning	NN
cord-281487-x0a9qgjs	217	50	study	study	NN
cord-281487-x0a9qgjs	217	51	Angiotensin	Angiotensin	NNP
cord-281487-x0a9qgjs	217	52	-	-	HYPH
cord-281487-x0a9qgjs	217	53	converting	convert	VBG
cord-281487-x0a9qgjs	217	54	enzyme	enzyme	NN
cord-281487-x0a9qgjs	217	55	2	2	CD
cord-281487-x0a9qgjs	217	56	and	and	CC
cord-281487-x0a9qgjs	217	57	antihypertensives	antihypertensives	NNP
cord-281487-x0a9qgjs	217	58	(	(	-LRB-
cord-281487-x0a9qgjs	217	59	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	217	60	receptor	receptor	NN
cord-281487-x0a9qgjs	217	61	blockers	blocker	NNS
cord-281487-x0a9qgjs	217	62	and	and	CC
cord-281487-x0a9qgjs	217	63	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	217	64	-	-	HYPH
cord-281487-x0a9qgjs	217	65	converting	convert	VBG
cord-281487-x0a9qgjs	217	66	enzyme	enzyme	NN
cord-281487-x0a9qgjs	217	67	inhibitors	inhibitor	NNS
cord-281487-x0a9qgjs	217	68	)	)	-RRB-
cord-281487-x0a9qgjs	217	69	in	in	IN
cord-281487-x0a9qgjs	217	70	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	217	71	disease	disease	NN
cord-281487-x0a9qgjs	218	1	2019	2019	CD
cord-281487-x0a9qgjs	218	2	Controversies	controversy	NNS
cord-281487-x0a9qgjs	218	3	of	of	IN
cord-281487-x0a9qgjs	218	4	renin	renin	NN
cord-281487-x0a9qgjs	218	5	-	-	HYPH
cord-281487-x0a9qgjs	218	6	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	218	7	system	system	NN
cord-281487-x0a9qgjs	218	8	inhibition	inhibition	NN
cord-281487-x0a9qgjs	218	9	during	during	IN
cord-281487-x0a9qgjs	218	10	the	the	DT
cord-281487-x0a9qgjs	218	11	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	218	12	pandemic	pandemic	NN
cord-281487-x0a9qgjs	218	13	Acute	acute	JJ
cord-281487-x0a9qgjs	218	14	kidney	kidney	NN
cord-281487-x0a9qgjs	218	15	injury	injury	NN
cord-281487-x0a9qgjs	218	16	in	in	IN
cord-281487-x0a9qgjs	218	17	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	218	18	:	:	:
cord-281487-x0a9qgjs	218	19	emerging	emerge	VBG
cord-281487-x0a9qgjs	218	20	evidence	evidence	NN
cord-281487-x0a9qgjs	218	21	of	of	IN
cord-281487-x0a9qgjs	218	22	a	a	DT
cord-281487-x0a9qgjs	218	23	distinct	distinct	JJ
cord-281487-x0a9qgjs	218	24	pathophysiology	pathophysiology	NN
cord-281487-x0a9qgjs	218	25	Features	feature	NNS
cord-281487-x0a9qgjs	218	26	of	of	IN
cord-281487-x0a9qgjs	218	27	20	20	CD
cord-281487-x0a9qgjs	218	28	133	133	CD
cord-281487-x0a9qgjs	218	29	UK	UK	NNP
cord-281487-x0a9qgjs	218	30	patients	patient	NNS
cord-281487-x0a9qgjs	218	31	in	in	IN
cord-281487-x0a9qgjs	218	32	hospital	hospital	NN
cord-281487-x0a9qgjs	218	33	with	with	IN
cord-281487-x0a9qgjs	218	34	covid-19	covid-19	NNP
cord-281487-x0a9qgjs	218	35	using	use	VBG
cord-281487-x0a9qgjs	218	36	the	the	DT
cord-281487-x0a9qgjs	218	37	ISARIC	ISARIC	NNP
cord-281487-x0a9qgjs	218	38	WHO	WHO	NNP
cord-281487-x0a9qgjs	218	39	Clinical	Clinical	NNP
cord-281487-x0a9qgjs	218	40	Characterisation	Characterisation	NNP
cord-281487-x0a9qgjs	218	41	Protocol	Protocol	NNP
cord-281487-x0a9qgjs	218	42	:	:	:
cord-281487-x0a9qgjs	218	43	prospective	prospective	JJ
cord-281487-x0a9qgjs	218	44	observational	observational	JJ
cord-281487-x0a9qgjs	218	45	cohort	cohort	NN
cord-281487-x0a9qgjs	218	46	study	study	NN
cord-281487-x0a9qgjs	218	47	Infection	Infection	NNP
cord-281487-x0a9qgjs	218	48	in	in	IN
cord-281487-x0a9qgjs	218	49	organ	organ	NN
cord-281487-x0a9qgjs	218	50	transplantation	transplantation	NN
cord-281487-x0a9qgjs	218	51	Clinical	clinical	JJ
cord-281487-x0a9qgjs	218	52	characteristics	characteristic	NNS
cord-281487-x0a9qgjs	218	53	and	and	CC
cord-281487-x0a9qgjs	218	54	outcomes	outcome	NNS
cord-281487-x0a9qgjs	218	55	of	of	IN
cord-281487-x0a9qgjs	218	56	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	218	57	in	in	IN
cord-281487-x0a9qgjs	218	58	solid	solid	JJ
cord-281487-x0a9qgjs	218	59	organ	organ	NN
cord-281487-x0a9qgjs	218	60	transplant	transplant	NN
cord-281487-x0a9qgjs	218	61	recipients	recipient	NNS
cord-281487-x0a9qgjs	218	62	:	:	:
cord-281487-x0a9qgjs	218	63	a	a	DT
cord-281487-x0a9qgjs	218	64	case	case	NN
cord-281487-x0a9qgjs	218	65	-	-	HYPH
cord-281487-x0a9qgjs	218	66	control	control	NN
cord-281487-x0a9qgjs	218	67	study	study	NN
cord-281487-x0a9qgjs	218	68	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	218	69	in	in	IN
cord-281487-x0a9qgjs	218	70	solid	solid	JJ
cord-281487-x0a9qgjs	218	71	organ	organ	NN
cord-281487-x0a9qgjs	218	72	transplant	transplant	NN
cord-281487-x0a9qgjs	218	73	recipients	recipient	NNS
cord-281487-x0a9qgjs	218	74	:	:	:
cord-281487-x0a9qgjs	218	75	dynamics	dynamic	NNS
cord-281487-x0a9qgjs	218	76	of	of	IN
cord-281487-x0a9qgjs	218	77	disease	disease	NN
cord-281487-x0a9qgjs	218	78	progression	progression	NN
cord-281487-x0a9qgjs	218	79	and	and	CC
cord-281487-x0a9qgjs	218	80	inflammatory	inflammatory	JJ
cord-281487-x0a9qgjs	218	81	markers	marker	NNS
cord-281487-x0a9qgjs	218	82	in	in	IN
cord-281487-x0a9qgjs	218	83	ICU	ICU	NNP
cord-281487-x0a9qgjs	218	84	and	and	CC
cord-281487-x0a9qgjs	218	85	non	non	JJ
cord-281487-x0a9qgjs	218	86	-	-	JJ
cord-281487-x0a9qgjs	218	87	ICU	ICU	NNP
cord-281487-x0a9qgjs	218	88	admitted	admit	VBD
cord-281487-x0a9qgjs	218	89	patients	patient	NNS
cord-281487-x0a9qgjs	218	90	COVID-19	covid-19	VBP
cord-281487-x0a9qgjs	218	91	in	in	IN
cord-281487-x0a9qgjs	218	92	solid	solid	JJ
cord-281487-x0a9qgjs	218	93	organ	organ	NN
cord-281487-x0a9qgjs	218	94	transplant	transplant	NN
cord-281487-x0a9qgjs	218	95	:	:	:
cord-281487-x0a9qgjs	219	1	a	a	DT
cord-281487-x0a9qgjs	219	2	multicenter	multicenter	JJ
cord-281487-x0a9qgjs	219	3	cohort	cohort	NN
cord-281487-x0a9qgjs	219	4	study	study	NN
cord-281487-x0a9qgjs	219	5	Clinical	clinical	JJ
cord-281487-x0a9qgjs	219	6	characteristics	characteristic	NNS
cord-281487-x0a9qgjs	219	7	of	of	IN
cord-281487-x0a9qgjs	219	8	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	219	9	disease	disease	NN
cord-281487-x0a9qgjs	219	10	2019	2019	CD
cord-281487-x0a9qgjs	219	11	in	in	IN
cord-281487-x0a9qgjs	219	12	China	China	NNP
cord-281487-x0a9qgjs	219	13	RNA	RNA	NNP
cord-281487-x0a9qgjs	219	14	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	219	15	viral	viral	JJ
cord-281487-x0a9qgjs	219	16	infections	infection	NNS
cord-281487-x0a9qgjs	219	17	in	in	IN
cord-281487-x0a9qgjs	219	18	solid	solid	JJ
cord-281487-x0a9qgjs	219	19	organ	organ	NN
cord-281487-x0a9qgjs	219	20	transplant	transplant	NN
cord-281487-x0a9qgjs	219	21	recipients	recipient	NNS
cord-281487-x0a9qgjs	219	22	:	:	:
cord-281487-x0a9qgjs	220	1	guidelines	guideline	NNS
cord-281487-x0a9qgjs	220	2	from	from	IN
cord-281487-x0a9qgjs	220	3	the	the	DT
cord-281487-x0a9qgjs	220	4	American	American	NNP
cord-281487-x0a9qgjs	220	5	Society	Society	NNP
cord-281487-x0a9qgjs	220	6	of	of	IN
cord-281487-x0a9qgjs	220	7	Transplantation	Transplantation	NNP
cord-281487-x0a9qgjs	220	8	Infectious	Infectious	NNP
cord-281487-x0a9qgjs	220	9	Diseases	Diseases	NNPS
cord-281487-x0a9qgjs	220	10	Community	Community	NNP
cord-281487-x0a9qgjs	220	11	of	of	IN
cord-281487-x0a9qgjs	220	12	Practice	Practice	NNP
cord-281487-x0a9qgjs	220	13	Impact	Impact	NNP
cord-281487-x0a9qgjs	220	14	of	of	IN
cord-281487-x0a9qgjs	220	15	solid	solid	JJ
cord-281487-x0a9qgjs	220	16	organ	organ	NN
cord-281487-x0a9qgjs	220	17	transplantation	transplantation	NN
cord-281487-x0a9qgjs	220	18	and	and	CC
cord-281487-x0a9qgjs	220	19	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	220	20	on	on	IN
cord-281487-x0a9qgjs	220	21	fever	fever	NN
cord-281487-x0a9qgjs	220	22	,	,	,
cord-281487-x0a9qgjs	220	23	leukocytosis	leukocytosis	NN
cord-281487-x0a9qgjs	220	24	,	,	,
cord-281487-x0a9qgjs	220	25	and	and	CC
cord-281487-x0a9qgjs	220	26	physiologic	physiologic	JJ
cord-281487-x0a9qgjs	220	27	response	response	NN
cord-281487-x0a9qgjs	220	28	during	during	IN
cord-281487-x0a9qgjs	220	29	bacterial	bacterial	JJ
cord-281487-x0a9qgjs	220	30	and	and	CC
cord-281487-x0a9qgjs	220	31	fungal	fungal	JJ
cord-281487-x0a9qgjs	220	32	infections	infection	NNS
cord-281487-x0a9qgjs	220	33	Covid-19	covid-19	VBP
cord-281487-x0a9qgjs	220	34	and	and	CC
cord-281487-x0a9qgjs	220	35	kidney	kidney	NN
cord-281487-x0a9qgjs	220	36	transplantation	transplantation	NN
cord-281487-x0a9qgjs	220	37	COVID-19	covid-19	VBP
cord-281487-x0a9qgjs	220	38	in	in	IN
cord-281487-x0a9qgjs	220	39	solid	solid	JJ
cord-281487-x0a9qgjs	220	40	organ	organ	NN
cord-281487-x0a9qgjs	220	41	transplant	transplant	NN
cord-281487-x0a9qgjs	220	42	recipients	recipient	NNS
cord-281487-x0a9qgjs	220	43	:	:	:
cord-281487-x0a9qgjs	220	44	initial	initial	JJ
cord-281487-x0a9qgjs	220	45	report	report	NN
cord-281487-x0a9qgjs	220	46	from	from	IN
cord-281487-x0a9qgjs	220	47	the	the	DT
cord-281487-x0a9qgjs	220	48	US	US	NNP
cord-281487-x0a9qgjs	220	49	epicenter	epicenter	NN
cord-281487-x0a9qgjs	220	50	Early	early	JJ
cord-281487-x0a9qgjs	220	51	experience	experience	NN
cord-281487-x0a9qgjs	220	52	with	with	IN
cord-281487-x0a9qgjs	220	53	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	220	54	and	and	CC
cord-281487-x0a9qgjs	220	55	solid	solid	JJ
cord-281487-x0a9qgjs	220	56	organ	organ	NN
cord-281487-x0a9qgjs	220	57	transplantation	transplantation	NN
cord-281487-x0a9qgjs	220	58	at	at	IN
cord-281487-x0a9qgjs	220	59	a	a	DT
cord-281487-x0a9qgjs	220	60	US	US	NNP
cord-281487-x0a9qgjs	220	61	high	high	JJ
cord-281487-x0a9qgjs	220	62	-	-	HYPH
cord-281487-x0a9qgjs	220	63	volume	volume	NN
cord-281487-x0a9qgjs	220	64	transplant	transplant	NN
cord-281487-x0a9qgjs	220	65	center	center	NN
cord-281487-x0a9qgjs	220	66	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	220	67	in	in	IN
cord-281487-x0a9qgjs	220	68	solid	solid	JJ
cord-281487-x0a9qgjs	220	69	organ	organ	NN
cord-281487-x0a9qgjs	220	70	transplant	transplant	NN
cord-281487-x0a9qgjs	220	71	recipients	recipient	NNS
cord-281487-x0a9qgjs	220	72	:	:	:
cord-281487-x0a9qgjs	220	73	a	a	DT
cord-281487-x0a9qgjs	220	74	single	single	JJ
cord-281487-x0a9qgjs	220	75	-	-	HYPH
cord-281487-x0a9qgjs	220	76	center	center	NN
cord-281487-x0a9qgjs	220	77	case	case	NN
cord-281487-x0a9qgjs	220	78	series	series	NN
cord-281487-x0a9qgjs	220	79	from	from	IN
cord-281487-x0a9qgjs	220	80	Spain	Spain	NNP
cord-281487-x0a9qgjs	220	81	Early	early	JJ
cord-281487-x0a9qgjs	220	82	description	description	NN
cord-281487-x0a9qgjs	220	83	of	of	IN
cord-281487-x0a9qgjs	220	84	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	220	85	2019	2019	CD
cord-281487-x0a9qgjs	220	86	disease	disease	NN
cord-281487-x0a9qgjs	220	87	in	in	IN
cord-281487-x0a9qgjs	220	88	kidney	kidney	NN
cord-281487-x0a9qgjs	220	89	transplant	transplant	NN
cord-281487-x0a9qgjs	220	90	recipients	recipient	NNS
cord-281487-x0a9qgjs	220	91	in	in	IN
cord-281487-x0a9qgjs	220	92	New	New	NNP
cord-281487-x0a9qgjs	220	93	York	York	NNP
cord-281487-x0a9qgjs	220	94	First	first	JJ
cord-281487-x0a9qgjs	220	95	experience	experience	NN
cord-281487-x0a9qgjs	220	96	of	of	IN
cord-281487-x0a9qgjs	220	97	SARS	SARS	NNP
cord-281487-x0a9qgjs	220	98	-	-	HYPH
cord-281487-x0a9qgjs	220	99	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	220	100	infections	infection	NNS
cord-281487-x0a9qgjs	220	101	in	in	IN
cord-281487-x0a9qgjs	220	102	solid	solid	JJ
cord-281487-x0a9qgjs	220	103	organ	organ	NN
cord-281487-x0a9qgjs	220	104	transplant	transplant	NN
cord-281487-x0a9qgjs	220	105	recipients	recipient	NNS
cord-281487-x0a9qgjs	220	106	in	in	IN
cord-281487-x0a9qgjs	220	107	the	the	DT
cord-281487-x0a9qgjs	220	108	Swiss	swiss	JJ
cord-281487-x0a9qgjs	220	109	transplant	transplant	NN
cord-281487-x0a9qgjs	220	110	cohort	cohort	NN
cord-281487-x0a9qgjs	220	111	study	study	NN
cord-281487-x0a9qgjs	220	112	A	a	DT
cord-281487-x0a9qgjs	220	113	single	single	JJ
cord-281487-x0a9qgjs	220	114	center	center	NN
cord-281487-x0a9qgjs	220	115	observational	observational	JJ
cord-281487-x0a9qgjs	220	116	study	study	NN
cord-281487-x0a9qgjs	220	117	of	of	IN
cord-281487-x0a9qgjs	220	118	the	the	DT
cord-281487-x0a9qgjs	220	119	clinical	clinical	JJ
cord-281487-x0a9qgjs	220	120	characteristics	characteristic	NNS
cord-281487-x0a9qgjs	220	121	and	and	CC
cord-281487-x0a9qgjs	220	122	short	short	JJ
cord-281487-x0a9qgjs	220	123	-	-	HYPH
cord-281487-x0a9qgjs	220	124	term	term	NN
cord-281487-x0a9qgjs	220	125	outcome	outcome	NN
cord-281487-x0a9qgjs	220	126	of	of	IN
cord-281487-x0a9qgjs	220	127	20	20	CD
cord-281487-x0a9qgjs	220	128	kidney	kidney	NN
cord-281487-x0a9qgjs	220	129	transplant	transplant	NN
cord-281487-x0a9qgjs	220	130	patients	patient	NNS
cord-281487-x0a9qgjs	220	131	admitted	admit	VBN
cord-281487-x0a9qgjs	220	132	for	for	IN
cord-281487-x0a9qgjs	220	133	SARS	SARS	NNP
cord-281487-x0a9qgjs	220	134	-	-	HYPH
cord-281487-x0a9qgjs	220	135	CoV2	CoV2	NNP
cord-281487-x0a9qgjs	220	136	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	220	137	Clinical	clinical	JJ
cord-281487-x0a9qgjs	220	138	features	feature	NNS
cord-281487-x0a9qgjs	220	139	of	of	IN
cord-281487-x0a9qgjs	220	140	69	69	CD
cord-281487-x0a9qgjs	220	141	cases	case	NNS
cord-281487-x0a9qgjs	220	142	with	with	IN
cord-281487-x0a9qgjs	220	143	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	220	144	disease	disease	NN
cord-281487-x0a9qgjs	220	145	Radiological	radiological	JJ
cord-281487-x0a9qgjs	220	146	findings	finding	NNS
cord-281487-x0a9qgjs	220	147	from	from	IN
cord-281487-x0a9qgjs	220	148	81	81	CD
cord-281487-x0a9qgjs	220	149	patients	patient	NNS
cord-281487-x0a9qgjs	220	150	with	with	IN
cord-281487-x0a9qgjs	220	151	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	220	152	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	220	153	in	in	IN
cord-281487-x0a9qgjs	220	154	Wuhan	Wuhan	NNP
cord-281487-x0a9qgjs	220	155	,	,	,
cord-281487-x0a9qgjs	220	156	China	China	NNP
cord-281487-x0a9qgjs	220	157	:	:	:
cord-281487-x0a9qgjs	220	158	a	a	DT
cord-281487-x0a9qgjs	220	159	descriptive	descriptive	JJ
cord-281487-x0a9qgjs	220	160	study	study	NN
cord-281487-x0a9qgjs	220	161	Clinical	clinical	JJ
cord-281487-x0a9qgjs	220	162	and	and	CC
cord-281487-x0a9qgjs	220	163	immunological	immunological	JJ
cord-281487-x0a9qgjs	220	164	features	feature	NNS
cord-281487-x0a9qgjs	220	165	of	of	IN
cord-281487-x0a9qgjs	220	166	severe	severe	JJ
cord-281487-x0a9qgjs	220	167	and	and	CC
cord-281487-x0a9qgjs	220	168	moderate	moderate	JJ
cord-281487-x0a9qgjs	220	169	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	220	170	disease	disease	NN
cord-281487-x0a9qgjs	220	171	2019	2019	CD
cord-281487-x0a9qgjs	220	172	Prediction	Prediction	NNP
cord-281487-x0a9qgjs	220	173	for	for	IN
cord-281487-x0a9qgjs	220	174	progression	progression	NN
cord-281487-x0a9qgjs	220	175	risk	risk	NN
cord-281487-x0a9qgjs	220	176	in	in	IN
cord-281487-x0a9qgjs	220	177	patients	patient	NNS
cord-281487-x0a9qgjs	220	178	with	with	IN
cord-281487-x0a9qgjs	220	179	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	220	180	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	220	181	:	:	:
cord-281487-x0a9qgjs	220	182	the	the	DT
cord-281487-x0a9qgjs	220	183	CALL	call	NN
cord-281487-x0a9qgjs	220	184	score	score	NN
cord-281487-x0a9qgjs	220	185	Prognostic	prognostic	JJ
cord-281487-x0a9qgjs	220	186	value	value	NN
cord-281487-x0a9qgjs	220	187	of	of	IN
cord-281487-x0a9qgjs	220	188	interleukin-6	interleukin-6	NNP
cord-281487-x0a9qgjs	220	189	,	,	,
cord-281487-x0a9qgjs	220	190	C	C	NNP
cord-281487-x0a9qgjs	220	191	-	-	HYPH
cord-281487-x0a9qgjs	220	192	reactive	reactive	JJ
cord-281487-x0a9qgjs	220	193	protein	protein	NN
cord-281487-x0a9qgjs	220	194	,	,	,
cord-281487-x0a9qgjs	220	195	and	and	CC
cord-281487-x0a9qgjs	220	196	procalcitonin	procalcitonin	NNS
cord-281487-x0a9qgjs	220	197	in	in	IN
cord-281487-x0a9qgjs	220	198	patients	patient	NNS
cord-281487-x0a9qgjs	220	199	with	with	IN
cord-281487-x0a9qgjs	220	200	COVID-19	covid-19	DT
cord-281487-x0a9qgjs	220	201	ISTH	ISTH	NNP
cord-281487-x0a9qgjs	220	202	interim	interim	JJ
cord-281487-x0a9qgjs	220	203	guidance	guidance	NN
cord-281487-x0a9qgjs	220	204	on	on	IN
cord-281487-x0a9qgjs	220	205	recognition	recognition	NN
cord-281487-x0a9qgjs	220	206	and	and	CC
cord-281487-x0a9qgjs	220	207	management	management	NN
cord-281487-x0a9qgjs	220	208	of	of	IN
cord-281487-x0a9qgjs	220	209	coagulopathy	coagulopathy	NN
cord-281487-x0a9qgjs	220	210	in	in	IN
cord-281487-x0a9qgjs	220	211	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	220	212	Clinical	Clinical	NNP
cord-281487-x0a9qgjs	220	213	course	course	NN
cord-281487-x0a9qgjs	220	214	and	and	CC
cord-281487-x0a9qgjs	220	215	risk	risk	NN
cord-281487-x0a9qgjs	220	216	factors	factor	NNS
cord-281487-x0a9qgjs	220	217	for	for	IN
cord-281487-x0a9qgjs	220	218	mortality	mortality	NN
cord-281487-x0a9qgjs	220	219	of	of	IN
cord-281487-x0a9qgjs	220	220	adult	adult	NN
cord-281487-x0a9qgjs	220	221	inpatients	inpatient	NNS
cord-281487-x0a9qgjs	220	222	with	with	IN
cord-281487-x0a9qgjs	220	223	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	220	224	in	in	IN
cord-281487-x0a9qgjs	220	225	Wuhan	Wuhan	NNP
cord-281487-x0a9qgjs	220	226	,	,	,
cord-281487-x0a9qgjs	220	227	China	China	NNP
cord-281487-x0a9qgjs	220	228	:	:	:
cord-281487-x0a9qgjs	221	1	a	a	DT
cord-281487-x0a9qgjs	221	2	retrospective	retrospective	JJ
cord-281487-x0a9qgjs	221	3	cohort	cohort	NN
cord-281487-x0a9qgjs	221	4	study	study	NN
cord-281487-x0a9qgjs	221	5	Co	co	NN
cord-281487-x0a9qgjs	221	6	-	-	NN
cord-281487-x0a9qgjs	221	7	infection	infection	NN
cord-281487-x0a9qgjs	221	8	with	with	IN
cord-281487-x0a9qgjs	221	9	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	221	10	pathogens	pathogen	NNS
cord-281487-x0a9qgjs	221	11	among	among	IN
cord-281487-x0a9qgjs	221	12	COVID-2019	COVID-2019	NNP
cord-281487-x0a9qgjs	221	13	cases	case	NNS
cord-281487-x0a9qgjs	221	14	guidance	guidance	NN
cord-281487-x0a9qgjs	221	15	for	for	IN
cord-281487-x0a9qgjs	221	16	the	the	DT
cord-281487-x0a9qgjs	221	17	diagnosis	diagnosis	NN
cord-281487-x0a9qgjs	221	18	and	and	CC
cord-281487-x0a9qgjs	221	19	management	management	NN
cord-281487-x0a9qgjs	221	20	of	of	IN
cord-281487-x0a9qgjs	221	21	CV	CV	NNP
cord-281487-x0a9qgjs	221	22	disease	disease	NN
cord-281487-x0a9qgjs	221	23	during	during	IN
cord-281487-x0a9qgjs	221	24	the	the	DT
cord-281487-x0a9qgjs	221	25	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	221	26	pandemic	pandemic	NN
cord-281487-x0a9qgjs	221	27	A	a	DT
cord-281487-x0a9qgjs	221	28	clinical	clinical	JJ
cord-281487-x0a9qgjs	221	29	risk	risk	NN
cord-281487-x0a9qgjs	221	30	score	score	NN
cord-281487-x0a9qgjs	221	31	to	to	TO
cord-281487-x0a9qgjs	221	32	identify	identify	VB
cord-281487-x0a9qgjs	221	33	patients	patient	NNS
cord-281487-x0a9qgjs	221	34	with	with	IN
cord-281487-x0a9qgjs	221	35	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	221	36	at	at	IN
cord-281487-x0a9qgjs	221	37	high	high	JJ
cord-281487-x0a9qgjs	221	38	risk	risk	NN
cord-281487-x0a9qgjs	221	39	of	of	IN
cord-281487-x0a9qgjs	221	40	critical	critical	JJ
cord-281487-x0a9qgjs	221	41	care	care	NN
cord-281487-x0a9qgjs	221	42	admission	admission	NN
cord-281487-x0a9qgjs	221	43	or	or	CC
cord-281487-x0a9qgjs	221	44	death	death	NN
cord-281487-x0a9qgjs	221	45	:	:	:
cord-281487-x0a9qgjs	222	1	An	an	DT
cord-281487-x0a9qgjs	222	2	observational	observational	JJ
cord-281487-x0a9qgjs	222	3	cohort	cohort	NN
cord-281487-x0a9qgjs	222	4	study	study	NN
cord-281487-x0a9qgjs	222	5	Clinical	clinical	JJ
cord-281487-x0a9qgjs	222	6	best	good	JJS
cord-281487-x0a9qgjs	222	7	practice	practice	NN
cord-281487-x0a9qgjs	222	8	advice	advice	NN
cord-281487-x0a9qgjs	222	9	for	for	IN
cord-281487-x0a9qgjs	222	10	hepatology	hepatology	NN
cord-281487-x0a9qgjs	222	11	and	and	CC
cord-281487-x0a9qgjs	222	12	liver	liver	NN
cord-281487-x0a9qgjs	222	13	transplant	transplant	NN
cord-281487-x0a9qgjs	222	14	providers	provider	NNS
cord-281487-x0a9qgjs	222	15	during	during	IN
cord-281487-x0a9qgjs	222	16	the	the	DT
cord-281487-x0a9qgjs	222	17	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	222	18	pandemic	pandemic	NN
cord-281487-x0a9qgjs	222	19	:	:	:
cord-281487-x0a9qgjs	223	1	AASLD	AASLD	NNP
cord-281487-x0a9qgjs	223	2	Expert	Expert	NNP
cord-281487-x0a9qgjs	223	3	Panel	Panel	NNP
cord-281487-x0a9qgjs	223	4	Consensus	Consensus	NNP
cord-281487-x0a9qgjs	223	5	Statement	Statement	NNP
cord-281487-x0a9qgjs	224	1	COVID-19	covid-19	VB
cord-281487-x0a9qgjs	224	2	:	:	:
cord-281487-x0a9qgjs	224	3	abnormal	abnormal	JJ
cord-281487-x0a9qgjs	224	4	liver	liver	NN
cord-281487-x0a9qgjs	224	5	function	function	NN
cord-281487-x0a9qgjs	224	6	tests	test	VBZ
cord-281487-x0a9qgjs	224	7	Kidney	kidney	NN
cord-281487-x0a9qgjs	224	8	disease	disease	NN
cord-281487-x0a9qgjs	224	9	is	be	VBZ
cord-281487-x0a9qgjs	224	10	associated	associate	VBN
cord-281487-x0a9qgjs	224	11	with	with	IN
cord-281487-x0a9qgjs	224	12	in	in	IN
cord-281487-x0a9qgjs	224	13	-	-	HYPH
cord-281487-x0a9qgjs	224	14	hospital	hospital	NN
cord-281487-x0a9qgjs	224	15	death	death	NN
cord-281487-x0a9qgjs	224	16	of	of	IN
cord-281487-x0a9qgjs	224	17	patients	patient	NNS
cord-281487-x0a9qgjs	224	18	with	with	IN
cord-281487-x0a9qgjs	224	19	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	224	20	Management	Management	NNP
cord-281487-x0a9qgjs	224	21	of	of	IN
cord-281487-x0a9qgjs	224	22	acute	acute	JJ
cord-281487-x0a9qgjs	224	23	kidney	kidney	NN
cord-281487-x0a9qgjs	224	24	injury	injury	NN
cord-281487-x0a9qgjs	224	25	in	in	IN
cord-281487-x0a9qgjs	224	26	patients	patient	NNS
cord-281487-x0a9qgjs	224	27	with	with	IN
cord-281487-x0a9qgjs	224	28	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	224	29	Is	be	VBZ
cord-281487-x0a9qgjs	224	30	the	the	DT
cord-281487-x0a9qgjs	224	31	kidney	kidney	NN
cord-281487-x0a9qgjs	224	32	a	a	DT
cord-281487-x0a9qgjs	224	33	target	target	NN
cord-281487-x0a9qgjs	224	34	of	of	IN
cord-281487-x0a9qgjs	224	35	SARS	SARS	NNP
cord-281487-x0a9qgjs	224	36	-	-	HYPH
cord-281487-x0a9qgjs	224	37	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	224	38	?	?	.
cord-281487-x0a9qgjs	225	1	Incidence	incidence	NN
cord-281487-x0a9qgjs	225	2	of	of	IN
cord-281487-x0a9qgjs	225	3	thrombotic	thrombotic	JJ
cord-281487-x0a9qgjs	225	4	complications	complication	NNS
cord-281487-x0a9qgjs	225	5	in	in	IN
cord-281487-x0a9qgjs	225	6	critically	critically	RB
cord-281487-x0a9qgjs	225	7	ill	ill	JJ
cord-281487-x0a9qgjs	225	8	ICU	ICU	NNP
cord-281487-x0a9qgjs	225	9	patients	patient	NNS
cord-281487-x0a9qgjs	225	10	with	with	IN
cord-281487-x0a9qgjs	225	11	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	225	12	Coagulation	Coagulation	NNP
cord-281487-x0a9qgjs	225	13	abnormalities	abnormality	NNS
cord-281487-x0a9qgjs	225	14	and	and	CC
cord-281487-x0a9qgjs	225	15	thrombosis	thrombosis	NN
cord-281487-x0a9qgjs	225	16	in	in	IN
cord-281487-x0a9qgjs	225	17	patients	patient	NNS
cord-281487-x0a9qgjs	225	18	with	with	IN
cord-281487-x0a9qgjs	225	19	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	225	20	Renal	Renal	NNP
cord-281487-x0a9qgjs	225	21	histopathological	histopathological	NNP
cord-281487-x0a9qgjs	225	22	analysis	analysis	NN
cord-281487-x0a9qgjs	225	23	of	of	IN
cord-281487-x0a9qgjs	225	24	26	26	CD
cord-281487-x0a9qgjs	225	25	postmortem	postmortem	JJ
cord-281487-x0a9qgjs	225	26	findings	finding	NNS
cord-281487-x0a9qgjs	225	27	of	of	IN
cord-281487-x0a9qgjs	225	28	patients	patient	NNS
cord-281487-x0a9qgjs	225	29	with	with	IN
cord-281487-x0a9qgjs	225	30	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	225	31	in	in	IN
cord-281487-x0a9qgjs	225	32	China	China	NNP
cord-281487-x0a9qgjs	225	33	Co	Co	NNS
cord-281487-x0a9qgjs	225	34	-	-	NNS
cord-281487-x0a9qgjs	225	35	infections	infection	NNS
cord-281487-x0a9qgjs	225	36	among	among	IN
cord-281487-x0a9qgjs	225	37	patients	patient	NNS
cord-281487-x0a9qgjs	225	38	with	with	IN
cord-281487-x0a9qgjs	225	39	COVID-19	covid-19	CD
cord-281487-x0a9qgjs	225	40	:	:	:
cord-281487-x0a9qgjs	225	41	the	the	DT
cord-281487-x0a9qgjs	225	42	need	need	NN
cord-281487-x0a9qgjs	225	43	for	for	IN
cord-281487-x0a9qgjs	225	44	combination	combination	NN
cord-281487-x0a9qgjs	225	45	therapy	therapy	NN
cord-281487-x0a9qgjs	225	46	with	with	IN
cord-281487-x0a9qgjs	225	47	non	non	JJ
cord-281487-x0a9qgjs	225	48	-	-	JJ
cord-281487-x0a9qgjs	225	49	anti	anti	JJ
cord-281487-x0a9qgjs	225	50	-	-	JJ
cord-281487-x0a9qgjs	225	51	SARS	SARS	NNP
cord-281487-x0a9qgjs	225	52	-	-	HYPH
cord-281487-x0a9qgjs	225	53	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	225	54	agents	agent	NNS
cord-281487-x0a9qgjs	225	55	?	?	.
cord-281487-x0a9qgjs	226	1	Diagnostic	diagnostic	JJ
cord-281487-x0a9qgjs	226	2	and	and	CC
cord-281487-x0a9qgjs	226	3	therapeutic	therapeutic	JJ
cord-281487-x0a9qgjs	226	4	approach	approach	NN
cord-281487-x0a9qgjs	226	5	to	to	IN
cord-281487-x0a9qgjs	226	6	infectious	infectious	JJ
cord-281487-x0a9qgjs	226	7	diseases	disease	NNS
cord-281487-x0a9qgjs	226	8	in	in	IN
cord-281487-x0a9qgjs	226	9	solid	solid	JJ
cord-281487-x0a9qgjs	226	10	organ	organ	NN
cord-281487-x0a9qgjs	226	11	transplant	transplant	NN
cord-281487-x0a9qgjs	226	12	recipients	recipient	NNS
cord-281487-x0a9qgjs	226	13	Procalcitonin	Procalcitonin	NNP
cord-281487-x0a9qgjs	226	14	in	in	IN
cord-281487-x0a9qgjs	226	15	patients	patient	NNS
cord-281487-x0a9qgjs	226	16	with	with	IN
cord-281487-x0a9qgjs	226	17	severe	severe	JJ
cord-281487-x0a9qgjs	226	18	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	226	19	disease	disease	NN
cord-281487-x0a9qgjs	226	20	2019	2019	CD
cord-281487-x0a9qgjs	226	21	(	(	-LRB-
cord-281487-x0a9qgjs	226	22	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	226	23	)	)	-RRB-
cord-281487-x0a9qgjs	226	24	:	:	:
cord-281487-x0a9qgjs	226	25	a	a	DT
cord-281487-x0a9qgjs	226	26	meta	meta	JJ
cord-281487-x0a9qgjs	226	27	-	-	HYPH
cord-281487-x0a9qgjs	226	28	analysis	analysis	NN
cord-281487-x0a9qgjs	226	29	Disposable	disposable	JJ
cord-281487-x0a9qgjs	226	30	isolation	isolation	NN
cord-281487-x0a9qgjs	226	31	device	device	NN
cord-281487-x0a9qgjs	226	32	to	to	TO
cord-281487-x0a9qgjs	226	33	reduce	reduce	VB
cord-281487-x0a9qgjs	226	34	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	226	35	contamination	contamination	NN
cord-281487-x0a9qgjs	226	36	during	during	IN
cord-281487-x0a9qgjs	226	37	CT	CT	NNP
cord-281487-x0a9qgjs	226	38	scanning	scanning	NN
cord-281487-x0a9qgjs	226	39	Findings	Findings	NNP
cord-281487-x0a9qgjs	226	40	of	of	IN
cord-281487-x0a9qgjs	226	41	lung	lung	NN
cord-281487-x0a9qgjs	226	42	ultrasonography	ultrasonography	NN
cord-281487-x0a9qgjs	226	43	of	of	IN
cord-281487-x0a9qgjs	226	44	novel	novel	NNP
cord-281487-x0a9qgjs	226	45	corona	corona	NNP
cord-281487-x0a9qgjs	226	46	virus	virus	NN
cord-281487-x0a9qgjs	226	47	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	226	48	during	during	IN
cord-281487-x0a9qgjs	226	49	the	the	DT
cord-281487-x0a9qgjs	226	50	2019	2019	CD
cord-281487-x0a9qgjs	226	51	-	-	SYM
cord-281487-x0a9qgjs	226	52	2020	2020	CD
cord-281487-x0a9qgjs	226	53	epidemic	epidemic	NN
cord-281487-x0a9qgjs	226	54	Thoracic	thoracic	JJ
cord-281487-x0a9qgjs	226	55	ultrasonography	ultrasonography	NN
cord-281487-x0a9qgjs	226	56	:	:	:
cord-281487-x0a9qgjs	226	57	a	a	DT
cord-281487-x0a9qgjs	226	58	narrative	narrative	NN
cord-281487-x0a9qgjs	226	59	review	review	NN
cord-281487-x0a9qgjs	226	60	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	226	61	diagnosis	diagnosis	NN
cord-281487-x0a9qgjs	226	62	and	and	CC
cord-281487-x0a9qgjs	226	63	management	management	NN
cord-281487-x0a9qgjs	226	64	:	:	:
cord-281487-x0a9qgjs	226	65	a	a	DT
cord-281487-x0a9qgjs	226	66	comprehensive	comprehensive	JJ
cord-281487-x0a9qgjs	226	67	review	review	NN
cord-281487-x0a9qgjs	227	1	The	the	DT
cord-281487-x0a9qgjs	227	2	incubation	incubation	NN
cord-281487-x0a9qgjs	227	3	period	period	NN
cord-281487-x0a9qgjs	227	4	of	of	IN
cord-281487-x0a9qgjs	227	5	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	227	6	disease	disease	NN
cord-281487-x0a9qgjs	227	7	2019	2019	CD
cord-281487-x0a9qgjs	227	8	(	(	-LRB-
cord-281487-x0a9qgjs	227	9	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	10	)	)	-RRB-
cord-281487-x0a9qgjs	227	11	from	from	IN
cord-281487-x0a9qgjs	227	12	publicly	publicly	RB
cord-281487-x0a9qgjs	227	13	reported	report	VBN
cord-281487-x0a9qgjs	227	14	confirmed	confirm	VBN
cord-281487-x0a9qgjs	227	15	cases	case	NNS
cord-281487-x0a9qgjs	227	16	:	:	:
cord-281487-x0a9qgjs	227	17	estimation	estimation	NN
cord-281487-x0a9qgjs	227	18	and	and	CC
cord-281487-x0a9qgjs	227	19	application	application	VB
cord-281487-x0a9qgjs	227	20	Temporal	temporal	JJ
cord-281487-x0a9qgjs	227	21	dynamics	dynamic	NNS
cord-281487-x0a9qgjs	227	22	in	in	IN
cord-281487-x0a9qgjs	227	23	viral	viral	JJ
cord-281487-x0a9qgjs	227	24	shedding	shedding	NN
cord-281487-x0a9qgjs	227	25	and	and	CC
cord-281487-x0a9qgjs	227	26	transmissibility	transmissibility	NN
cord-281487-x0a9qgjs	227	27	of	of	IN
cord-281487-x0a9qgjs	227	28	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	29	Diagnosis	Diagnosis	NNP
cord-281487-x0a9qgjs	227	30	and	and	CC
cord-281487-x0a9qgjs	227	31	treatment	treatment	NN
cord-281487-x0a9qgjs	227	32	of	of	IN
cord-281487-x0a9qgjs	227	33	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	227	34	disease	disease	NN
cord-281487-x0a9qgjs	227	35	2019	2019	CD
cord-281487-x0a9qgjs	227	36	(	(	-LRB-
cord-281487-x0a9qgjs	227	37	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	38	)	)	-RRB-
cord-281487-x0a9qgjs	227	39	:	:	:
cord-281487-x0a9qgjs	227	40	laboratory	laboratory	NN
cord-281487-x0a9qgjs	227	41	,	,	,
cord-281487-x0a9qgjs	227	42	PCR	PCR	NNP
cord-281487-x0a9qgjs	227	43	,	,	,
cord-281487-x0a9qgjs	227	44	and	and	CC
cord-281487-x0a9qgjs	227	45	chest	chest	NN
cord-281487-x0a9qgjs	227	46	CT	CT	NNP
cord-281487-x0a9qgjs	227	47	imaging	imaging	NN
cord-281487-x0a9qgjs	227	48	findings	finding	NNS
cord-281487-x0a9qgjs	227	49	Telemedicine	Telemedicine	NNP
cord-281487-x0a9qgjs	227	50	for	for	IN
cord-281487-x0a9qgjs	227	51	outpatient	outpatient	NN
cord-281487-x0a9qgjs	227	52	neurosurgical	neurosurgical	JJ
cord-281487-x0a9qgjs	227	53	oncology	oncology	NN
cord-281487-x0a9qgjs	227	54	care	care	NN
cord-281487-x0a9qgjs	227	55	:	:	:
cord-281487-x0a9qgjs	227	56	lessons	lesson	NNS
cord-281487-x0a9qgjs	227	57	learned	learn	VBN
cord-281487-x0a9qgjs	227	58	for	for	IN
cord-281487-x0a9qgjs	227	59	the	the	DT
cord-281487-x0a9qgjs	227	60	future	future	NN
cord-281487-x0a9qgjs	227	61	during	during	IN
cord-281487-x0a9qgjs	227	62	the	the	DT
cord-281487-x0a9qgjs	227	63	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	64	pandemic	pandemic	NN
cord-281487-x0a9qgjs	227	65	Outpatient	Outpatient	NNP
cord-281487-x0a9qgjs	227	66	Management	Management	NNP
cord-281487-x0a9qgjs	227	67	of	of	IN
cord-281487-x0a9qgjs	227	68	the	the	DT
cord-281487-x0a9qgjs	227	69	Kidney	Kidney	NNP
cord-281487-x0a9qgjs	227	70	Transplant	Transplant	NNP
cord-281487-x0a9qgjs	227	71	Recipient	Recipient	NNP
cord-281487-x0a9qgjs	227	72	during	during	IN
cord-281487-x0a9qgjs	227	73	the	the	DT
cord-281487-x0a9qgjs	227	74	SARS	SARS	NNP
cord-281487-x0a9qgjs	227	75	-	-	HYPH
cord-281487-x0a9qgjs	227	76	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	227	77	virus	virus	NN
cord-281487-x0a9qgjs	227	78	pandemic	pandemic	NN
cord-281487-x0a9qgjs	227	79	Out	out	IN
cord-281487-x0a9qgjs	227	80	patient	patient	NN
cord-281487-x0a9qgjs	227	81	department	department	NN
cord-281487-x0a9qgjs	227	82	practices	practice	NNS
cord-281487-x0a9qgjs	227	83	in	in	IN
cord-281487-x0a9qgjs	227	84	orthopaedics	orthopaedic	NNS
cord-281487-x0a9qgjs	227	85	amidst	amidst	IN
cord-281487-x0a9qgjs	227	86	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	87	:	:	:
cord-281487-x0a9qgjs	227	88	the	the	DT
cord-281487-x0a9qgjs	227	89	evolving	evolve	VBG
cord-281487-x0a9qgjs	227	90	model	model	NN
cord-281487-x0a9qgjs	227	91	Care	Care	NNP
cord-281487-x0a9qgjs	227	92	of	of	IN
cord-281487-x0a9qgjs	227	93	patients	patient	NNS
cord-281487-x0a9qgjs	227	94	with	with	IN
cord-281487-x0a9qgjs	227	95	liver	liver	NN
cord-281487-x0a9qgjs	227	96	disease	disease	NN
cord-281487-x0a9qgjs	227	97	during	during	IN
cord-281487-x0a9qgjs	227	98	the	the	DT
cord-281487-x0a9qgjs	227	99	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	100	pandemic	pandemic	NN
cord-281487-x0a9qgjs	227	101	:	:	:
cord-281487-x0a9qgjs	227	102	EASL	EASL	NNP
cord-281487-x0a9qgjs	227	103	-	-	HYPH
cord-281487-x0a9qgjs	227	104	ESCMID	ESCMID	NNP
cord-281487-x0a9qgjs	227	105	position	position	NN
cord-281487-x0a9qgjs	227	106	paper	paper	NN
cord-281487-x0a9qgjs	227	107	Cell	cell	NN
cord-281487-x0a9qgjs	227	108	-	-	HYPH
cord-281487-x0a9qgjs	227	109	free	free	JJ
cord-281487-x0a9qgjs	227	110	DNA	dna	NN
cord-281487-x0a9qgjs	227	111	and	and	CC
cord-281487-x0a9qgjs	227	112	active	active	JJ
cord-281487-x0a9qgjs	227	113	rejection	rejection	NN
cord-281487-x0a9qgjs	227	114	in	in	IN
cord-281487-x0a9qgjs	227	115	kidney	kidney	NN
cord-281487-x0a9qgjs	227	116	allografts	allograft	NNS
cord-281487-x0a9qgjs	227	117	Psychological	psychological	JJ
cord-281487-x0a9qgjs	227	118	and	and	CC
cord-281487-x0a9qgjs	227	119	psychopathological	psychopathological	JJ
cord-281487-x0a9qgjs	227	120	aspects	aspect	NNS
cord-281487-x0a9qgjs	227	121	of	of	IN
cord-281487-x0a9qgjs	227	122	kidney	kidney	NN
cord-281487-x0a9qgjs	227	123	transplantation	transplantation	NN
cord-281487-x0a9qgjs	227	124	:	:	:
cord-281487-x0a9qgjs	227	125	a	a	DT
cord-281487-x0a9qgjs	227	126	systematic	systematic	JJ
cord-281487-x0a9qgjs	227	127	review	review	NN
cord-281487-x0a9qgjs	227	128	Therapeutic	therapeutic	JJ
cord-281487-x0a9qgjs	227	129	algorithm	algorithm	NN
cord-281487-x0a9qgjs	227	130	for	for	IN
cord-281487-x0a9qgjs	227	131	use	use	NN
cord-281487-x0a9qgjs	227	132	of	of	IN
cord-281487-x0a9qgjs	227	133	melatonin	melatonin	NN
cord-281487-x0a9qgjs	227	134	in	in	IN
cord-281487-x0a9qgjs	227	135	patients	patient	NNS
cord-281487-x0a9qgjs	227	136	with	with	IN
cord-281487-x0a9qgjs	227	137	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	138	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	227	139	:	:	:
cord-281487-x0a9qgjs	227	140	melatonin	melatonin	NN
cord-281487-x0a9qgjs	227	141	as	as	IN
cord-281487-x0a9qgjs	227	142	a	a	DT
cord-281487-x0a9qgjs	227	143	potential	potential	JJ
cord-281487-x0a9qgjs	227	144	adjuvant	adjuvant	NN
cord-281487-x0a9qgjs	227	145	treatment	treatment	NN
cord-281487-x0a9qgjs	227	146	AST	AST	NNP
cord-281487-x0a9qgjs	227	147	.	.	.
cord-281487-x0a9qgjs	228	1	2019-nCoV	2019-ncov	CD
cord-281487-x0a9qgjs	229	1	(	(	-LRB-
cord-281487-x0a9qgjs	229	2	Coronavirus	Coronavirus	NNP
cord-281487-x0a9qgjs	229	3	)	)	-RRB-
cord-281487-x0a9qgjs	229	4	:	:	:
cord-281487-x0a9qgjs	230	1	Recommendations	recommendation	NNS
cord-281487-x0a9qgjs	230	2	and	and	CC
cord-281487-x0a9qgjs	230	3	guidance	guidance	NN
cord-281487-x0a9qgjs	230	4	for	for	IN
cord-281487-x0a9qgjs	230	5	organ	organ	NN
cord-281487-x0a9qgjs	230	6	donor	donor	NN
cord-281487-x0a9qgjs	230	7	testing	test	VBG
cord-281487-x0a9qgjs	230	8	Coronavirus	Coronavirus	NNP
cord-281487-x0a9qgjs	230	9	disease	disease	NN
cord-281487-x0a9qgjs	231	1	2019	2019	CD
cord-281487-x0a9qgjs	231	2	pneumonia	pneumonia	NN
cord-281487-x0a9qgjs	231	3	in	in	IN
cord-281487-x0a9qgjs	231	4	immunosuppressed	immunosuppressed	JJ
cord-281487-x0a9qgjs	231	5	renal	renal	JJ
cord-281487-x0a9qgjs	231	6	transplant	transplant	NN
cord-281487-x0a9qgjs	231	7	recipients	recipient	NNS
cord-281487-x0a9qgjs	231	8	:	:	:
cord-281487-x0a9qgjs	231	9	a	a	DT
cord-281487-x0a9qgjs	231	10	summary	summary	NN
cord-281487-x0a9qgjs	231	11	of	of	IN
cord-281487-x0a9qgjs	231	12	10	10	CD
cord-281487-x0a9qgjs	231	13	confirmed	confirm	VBN
cord-281487-x0a9qgjs	231	14	cases	case	NNS
cord-281487-x0a9qgjs	231	15	in	in	IN
cord-281487-x0a9qgjs	231	16	Wuhan	Wuhan	NNP
cord-281487-x0a9qgjs	231	17	,	,	,
cord-281487-x0a9qgjs	231	18	China	China	NNP
cord-281487-x0a9qgjs	232	1	The	the	DT
cord-281487-x0a9qgjs	232	2	natural	natural	JJ
cord-281487-x0a9qgjs	232	3	history	history	NN
cord-281487-x0a9qgjs	232	4	of	of	IN
cord-281487-x0a9qgjs	232	5	influenza	influenza	NN
cord-281487-x0a9qgjs	232	6	infection	infection	NN
cord-281487-x0a9qgjs	232	7	in	in	IN
cord-281487-x0a9qgjs	232	8	the	the	DT
cord-281487-x0a9qgjs	232	9	severely	severely	RB
cord-281487-x0a9qgjs	232	10	immunocompromised	immunocompromised	JJ
cord-281487-x0a9qgjs	232	11	vs	vs	IN
cord-281487-x0a9qgjs	232	12	nonimmunocompromised	nonimmunocompromised	JJ
cord-281487-x0a9qgjs	232	13	hosts	host	NNS
cord-281487-x0a9qgjs	232	14	COVID-19	covid-19	VBP
cord-281487-x0a9qgjs	232	15	illness	illness	NN
cord-281487-x0a9qgjs	232	16	in	in	IN
cord-281487-x0a9qgjs	232	17	native	native	JJ
cord-281487-x0a9qgjs	232	18	and	and	CC
cord-281487-x0a9qgjs	232	19	immunosuppressed	immunosuppressed	JJ
cord-281487-x0a9qgjs	232	20	states	state	NNS
cord-281487-x0a9qgjs	232	21	:	:	:
cord-281487-x0a9qgjs	232	22	a	a	DT
cord-281487-x0a9qgjs	232	23	clinical	clinical	JJ
cord-281487-x0a9qgjs	232	24	-	-	HYPH
cord-281487-x0a9qgjs	232	25	therapeutic	therapeutic	JJ
cord-281487-x0a9qgjs	232	26	staging	staging	NN
cord-281487-x0a9qgjs	232	27	proposal	proposal	NN
cord-281487-x0a9qgjs	232	28	Clinical	clinical	JJ
cord-281487-x0a9qgjs	232	29	predictors	predictor	NNS
cord-281487-x0a9qgjs	232	30	of	of	IN
cord-281487-x0a9qgjs	232	31	mortality	mortality	NN
cord-281487-x0a9qgjs	232	32	due	due	IN
cord-281487-x0a9qgjs	232	33	to	to	IN
cord-281487-x0a9qgjs	232	34	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	232	35	based	base	VBN
cord-281487-x0a9qgjs	232	36	on	on	IN
cord-281487-x0a9qgjs	232	37	an	an	DT
cord-281487-x0a9qgjs	232	38	analysis	analysis	NN
cord-281487-x0a9qgjs	232	39	of	of	IN
cord-281487-x0a9qgjs	232	40	data	datum	NNS
cord-281487-x0a9qgjs	232	41	of	of	IN
cord-281487-x0a9qgjs	232	42	150	150	CD
cord-281487-x0a9qgjs	232	43	patients	patient	NNS
cord-281487-x0a9qgjs	232	44	from	from	IN
cord-281487-x0a9qgjs	232	45	Wuhan	Wuhan	NNP
cord-281487-x0a9qgjs	232	46	,	,	,
cord-281487-x0a9qgjs	232	47	China	China	NNP
cord-281487-x0a9qgjs	232	48	Intensive	Intensive	NNP
cord-281487-x0a9qgjs	232	49	care	care	NN
cord-281487-x0a9qgjs	232	50	management	management	NN
cord-281487-x0a9qgjs	232	51	of	of	IN
cord-281487-x0a9qgjs	232	52	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	232	53	disease	disease	NNP
cord-281487-x0a9qgjs	232	54	2019	2019	CD
cord-281487-x0a9qgjs	232	55	(	(	-LRB-
cord-281487-x0a9qgjs	232	56	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	232	57	)	)	-RRB-
cord-281487-x0a9qgjs	232	58	:	:	:
cord-281487-x0a9qgjs	232	59	challenges	challenge	NNS
cord-281487-x0a9qgjs	232	60	and	and	CC
cord-281487-x0a9qgjs	232	61	recommendations	recommendation	NNS
cord-281487-x0a9qgjs	233	1	Novel	novel	JJ
cord-281487-x0a9qgjs	233	2	2019	2019	CD
cord-281487-x0a9qgjs	233	3	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	233	4	SARS	SARS	NNP
cord-281487-x0a9qgjs	233	5	-	-	HYPH
cord-281487-x0a9qgjs	233	6	CoV-2	CoV-2	NNP
cord-281487-x0a9qgjs	233	7	(	(	-LRB-
cord-281487-x0a9qgjs	233	8	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	233	9	)	)	-RRB-
cord-281487-x0a9qgjs	233	10	:	:	:
cord-281487-x0a9qgjs	234	1	an	an	DT
cord-281487-x0a9qgjs	234	2	updated	update	VBN
cord-281487-x0a9qgjs	234	3	overview	overview	NN
cord-281487-x0a9qgjs	234	4	for	for	IN
cord-281487-x0a9qgjs	234	5	emergency	emergency	NN
cord-281487-x0a9qgjs	234	6	clinicians	clinicians	NNPS
cord-281487-x0a9qgjs	234	7	Association	Association	NNP
cord-281487-x0a9qgjs	234	8	of	of	IN
cord-281487-x0a9qgjs	234	9	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	234	10	-	-	HYPH
cord-281487-x0a9qgjs	234	11	converting	convert	VBG
cord-281487-x0a9qgjs	234	12	enzyme	enzyme	NN
cord-281487-x0a9qgjs	234	13	inhibitor	inhibitor	NN
cord-281487-x0a9qgjs	234	14	or	or	CC
cord-281487-x0a9qgjs	234	15	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	234	16	receptor	receptor	NN
cord-281487-x0a9qgjs	234	17	blocker	blocker	NN
cord-281487-x0a9qgjs	234	18	use	use	NN
cord-281487-x0a9qgjs	234	19	with	with	IN
cord-281487-x0a9qgjs	234	20	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	234	21	diagnosis	diagnosis	NN
cord-281487-x0a9qgjs	234	22	and	and	CC
cord-281487-x0a9qgjs	234	23	mortality	mortality	NN
cord-281487-x0a9qgjs	234	24	Association	Association	NNP
cord-281487-x0a9qgjs	234	25	of	of	IN
cord-281487-x0a9qgjs	234	26	Inpatient	Inpatient	NNP
cord-281487-x0a9qgjs	234	27	use	use	NN
cord-281487-x0a9qgjs	234	28	of	of	IN
cord-281487-x0a9qgjs	234	29	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	234	30	-	-	HYPH
cord-281487-x0a9qgjs	234	31	converting	convert	VBG
cord-281487-x0a9qgjs	234	32	enzyme	enzyme	NN
cord-281487-x0a9qgjs	234	33	inhibitors	inhibitor	NNS
cord-281487-x0a9qgjs	234	34	and	and	CC
cord-281487-x0a9qgjs	234	35	angiotensin	angiotensin	NN
cord-281487-x0a9qgjs	234	36	II	ii	CD
cord-281487-x0a9qgjs	234	37	receptor	receptor	NN
cord-281487-x0a9qgjs	234	38	blockers	blocker	NNS
cord-281487-x0a9qgjs	234	39	with	with	IN
cord-281487-x0a9qgjs	234	40	mortality	mortality	NN
cord-281487-x0a9qgjs	234	41	among	among	IN
cord-281487-x0a9qgjs	234	42	patients	patient	NNS
cord-281487-x0a9qgjs	234	43	with	with	IN
cord-281487-x0a9qgjs	234	44	hypertension	hypertension	NN
cord-281487-x0a9qgjs	234	45	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	234	46	with	with	IN
cord-281487-x0a9qgjs	234	47	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	234	48	Effect	Effect	NNP
cord-281487-x0a9qgjs	234	49	of	of	IN
cord-281487-x0a9qgjs	234	50	maintenance	maintenance	NN
cord-281487-x0a9qgjs	234	51	immunosuppressive	immunosuppressive	JJ
cord-281487-x0a9qgjs	234	52	drugs	drug	NNS
cord-281487-x0a9qgjs	234	53	on	on	IN
cord-281487-x0a9qgjs	234	54	virus	virus	NN
cord-281487-x0a9qgjs	234	55	pathobiology	pathobiology	NN
cord-281487-x0a9qgjs	234	56	:	:	:
cord-281487-x0a9qgjs	234	57	evidence	evidence	NN
cord-281487-x0a9qgjs	234	58	and	and	CC
cord-281487-x0a9qgjs	234	59	potential	potential	JJ
cord-281487-x0a9qgjs	234	60	mechanisms	mechanism	NNS
cord-281487-x0a9qgjs	234	61	Suppression	suppression	NN
cord-281487-x0a9qgjs	234	62	of	of	IN
cord-281487-x0a9qgjs	234	63	coronavirus	coronavirus	NN
cord-281487-x0a9qgjs	234	64	replication	replication	NN
cord-281487-x0a9qgjs	234	65	by	by	IN
cord-281487-x0a9qgjs	234	66	cyclophilin	cyclophilin	NNP
cord-281487-x0a9qgjs	234	67	inhibitors	inhibitors	NNP
cord-281487-x0a9qgjs	234	68	COVID-19	covid-19	VBP
cord-281487-x0a9qgjs	234	69	and	and	CC
cord-281487-x0a9qgjs	234	70	calcineurin	calcineurin	NNP
cord-281487-x0a9qgjs	234	71	inhibitors	inhibitor	NNS
cord-281487-x0a9qgjs	234	72	:	:	:
cord-281487-x0a9qgjs	234	73	should	should	MD
cord-281487-x0a9qgjs	234	74	they	-PRON-	PRP
cord-281487-x0a9qgjs	234	75	get	get	VB
cord-281487-x0a9qgjs	234	76	left	leave	VBN
cord-281487-x0a9qgjs	234	77	out	out	RP
cord-281487-x0a9qgjs	234	78	in	in	IN
cord-281487-x0a9qgjs	234	79	the	the	DT
cord-281487-x0a9qgjs	234	80	storm	storm	NN
cord-281487-x0a9qgjs	234	81	?	?	.
cord-281487-x0a9qgjs	235	1	Replication	replication	NN
cord-281487-x0a9qgjs	235	2	of	of	IN
cord-281487-x0a9qgjs	235	3	human	human	JJ
cord-281487-x0a9qgjs	235	4	coronaviruses	coronaviruse	NNS
cord-281487-x0a9qgjs	235	5	SARS	SARS	NNP
cord-281487-x0a9qgjs	235	6	-	-	HYPH
cord-281487-x0a9qgjs	235	7	CoV	CoV	NNP
cord-281487-x0a9qgjs	235	8	,	,	,
cord-281487-x0a9qgjs	235	9	HCoV	HCoV	NNP
cord-281487-x0a9qgjs	235	10	-	-	HYPH
cord-281487-x0a9qgjs	235	11	NL63	NL63	NNP
cord-281487-x0a9qgjs	235	12	and	and	CC
cord-281487-x0a9qgjs	235	13	HCoV-229E	HCoV-229E	NNP
cord-281487-x0a9qgjs	235	14	is	be	VBZ
cord-281487-x0a9qgjs	235	15	inhibited	inhibit	VBN
cord-281487-x0a9qgjs	235	16	by	by	IN
cord-281487-x0a9qgjs	235	17	the	the	DT
cord-281487-x0a9qgjs	235	18	drug	drug	NN
cord-281487-x0a9qgjs	235	19	FK506	fk506	XX
cord-281487-x0a9qgjs	235	20	COVID-19	covid-19	NN
cord-281487-x0a9qgjs	235	21	:	:	:
cord-281487-x0a9qgjs	235	22	implications	implication	NNS
cord-281487-x0a9qgjs	235	23	for	for	IN
cord-281487-x0a9qgjs	235	24	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	235	25	in	in	IN
cord-281487-x0a9qgjs	235	26	kidney	kidney	NN
cord-281487-x0a9qgjs	235	27	disease	disease	NN
cord-281487-x0a9qgjs	235	28	and	and	CC
cord-281487-x0a9qgjs	235	29	transplantation	transplantation	NN
cord-281487-x0a9qgjs	235	30	Dexamethasone	Dexamethasone	NNP
cord-281487-x0a9qgjs	235	31	in	in	IN
cord-281487-x0a9qgjs	235	32	hospitalized	hospitalize	VBN
cord-281487-x0a9qgjs	235	33	patients	patient	NNS
cord-281487-x0a9qgjs	235	34	with	with	IN
cord-281487-x0a9qgjs	235	35	Covid-19-preliminary	Covid-19-preliminary	NNP
cord-281487-x0a9qgjs	235	36	report	report	NN
cord-281487-x0a9qgjs	235	37	Impact	Impact	NNP
cord-281487-x0a9qgjs	235	38	of	of	IN
cord-281487-x0a9qgjs	235	39	prophylactic	prophylactic	JJ
cord-281487-x0a9qgjs	235	40	versus	versus	IN
cord-281487-x0a9qgjs	235	41	preemptive	preemptive	JJ
cord-281487-x0a9qgjs	235	42	valganciclovir	valganciclovir	NN
cord-281487-x0a9qgjs	235	43	on	on	IN
cord-281487-x0a9qgjs	235	44	long	long	JJ
cord-281487-x0a9qgjs	235	45	-	-	HYPH
cord-281487-x0a9qgjs	235	46	term	term	NN
cord-281487-x0a9qgjs	235	47	renal	renal	JJ
cord-281487-x0a9qgjs	235	48	allograft	allograft	NN
cord-281487-x0a9qgjs	235	49	outcomes	outcome	NNS
cord-281487-x0a9qgjs	235	50	Prevention	Prevention	NNP
cord-281487-x0a9qgjs	235	51	and	and	CC
cord-281487-x0a9qgjs	235	52	management	management	NN
cord-281487-x0a9qgjs	235	53	of	of	IN
cord-281487-x0a9qgjs	235	54	cytomegalovirus	cytomegalovirus	JJ
cord-281487-x0a9qgjs	235	55	infection	infection	NN
cord-281487-x0a9qgjs	235	56	in	in	IN
cord-281487-x0a9qgjs	235	57	solid	solid	JJ
cord-281487-x0a9qgjs	235	58	-	-	HYPH
cord-281487-x0a9qgjs	235	59	organ	organ	NN
cord-281487-x0a9qgjs	235	60	transplantation	transplantation	NN
cord-281487-x0a9qgjs	235	61	Community	community	NN
cord-281487-x0a9qgjs	235	62	-	-	HYPH
cord-281487-x0a9qgjs	235	63	acquired	acquire	VBN
cord-281487-x0a9qgjs	235	64	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	235	65	viruses	virus	NNS
cord-281487-x0a9qgjs	235	66	are	be	VBP
cord-281487-x0a9qgjs	235	67	a	a	DT
cord-281487-x0a9qgjs	235	68	risk	risk	NN
cord-281487-x0a9qgjs	235	69	factor	factor	NN
cord-281487-x0a9qgjs	235	70	for	for	IN
cord-281487-x0a9qgjs	235	71	chronic	chronic	JJ
cord-281487-x0a9qgjs	235	72	lung	lung	NN
cord-281487-x0a9qgjs	235	73	allograft	allograft	NN
cord-281487-x0a9qgjs	235	74	dysfunction	dysfunction	NN
cord-281487-x0a9qgjs	235	75	Respiratory	respiratory	JJ
cord-281487-x0a9qgjs	235	76	viral	viral	JJ
cord-281487-x0a9qgjs	235	77	infection	infection	NN
cord-281487-x0a9qgjs	235	78	in	in	IN
cord-281487-x0a9qgjs	235	79	lung	lung	NN
cord-281487-x0a9qgjs	235	80	transplantation	transplantation	NN
cord-281487-x0a9qgjs	235	81	induces	induce	VBZ
cord-281487-x0a9qgjs	235	82	exosomes	exosome	NNS
cord-281487-x0a9qgjs	235	83	that	that	IN
cord-281487-x0a9qgjs	235	84	trigger	trigger	NN
cord-281487-x0a9qgjs	235	85	chronic	chronic	JJ
cord-281487-x0a9qgjs	235	86	rejection	rejection	NN
cord-281487-x0a9qgjs	235	87	Polyomavirus	Polyomavirus	NNP
cord-281487-x0a9qgjs	235	88	reactivation	reactivation	NN
cord-281487-x0a9qgjs	235	89	and	and	CC
cord-281487-x0a9qgjs	235	90	immune	immune	JJ
cord-281487-x0a9qgjs	235	91	responses	response	NNS
cord-281487-x0a9qgjs	235	92	to	to	IN
cord-281487-x0a9qgjs	235	93	kidney	kidney	NN
cord-281487-x0a9qgjs	235	94	-	-	HYPH
cord-281487-x0a9qgjs	235	95	specific	specific	JJ
cord-281487-x0a9qgjs	235	96	self	self	NN
cord-281487-x0a9qgjs	235	97	-	-	HYPH
cord-281487-x0a9qgjs	235	98	antigens	antigen	NNS
cord-281487-x0a9qgjs	235	99	in	in	IN
cord-281487-x0a9qgjs	236	1	transplantation	transplantation	NNP
cord-281487-x0a9qgjs	236	2	BKvirus	BKvirus	NNP
cord-281487-x0a9qgjs	236	3	and	and	CC
cord-281487-x0a9qgjs	236	4	the	the	DT
cord-281487-x0a9qgjs	236	5	impact	impact	NN
cord-281487-x0a9qgjs	236	6	of	of	IN
cord-281487-x0a9qgjs	236	7	pre	pre	JJ
cord-281487-x0a9qgjs	236	8	-	-	JJ
cord-281487-x0a9qgjs	236	9	emptive	emptive	JJ
cord-281487-x0a9qgjs	236	10	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	236	11	reduction	reduction	NN
cord-281487-x0a9qgjs	236	12	:	:	:
cord-281487-x0a9qgjs	237	1	5-year	5-year	CD
cord-281487-x0a9qgjs	237	2	results	result	NNS
cord-281487-x0a9qgjs	238	1	Serum	serum	NN
cord-281487-x0a9qgjs	238	2	vitamin	vitamin	NN
cord-281487-x0a9qgjs	238	3	D	d	NN
cord-281487-x0a9qgjs	238	4	levels	level	NNS
cord-281487-x0a9qgjs	238	5	in	in	IN
cord-281487-x0a9qgjs	238	6	kidney	kidney	NN
cord-281487-x0a9qgjs	238	7	transplant	transplant	NN
cord-281487-x0a9qgjs	238	8	recipients	recipient	NNS
cord-281487-x0a9qgjs	238	9	:	:	:
cord-281487-x0a9qgjs	238	10	the	the	DT
cord-281487-x0a9qgjs	238	11	importance	importance	NN
cord-281487-x0a9qgjs	238	12	of	of	IN
cord-281487-x0a9qgjs	238	13	an	an	DT
cord-281487-x0a9qgjs	238	14	immunosuppression	immunosuppression	NN
cord-281487-x0a9qgjs	238	15	regimen	regimen	NN
cord-281487-x0a9qgjs	238	16	and	and	CC
cord-281487-x0a9qgjs	238	17	sun	sun	NN
cord-281487-x0a9qgjs	238	18	exposure	exposure	NN
cord-281487-x0a9qgjs	239	1	Current	current	JJ
cord-281487-x0a9qgjs	239	2	evidence	evidence	NN
cord-281487-x0a9qgjs	239	3	on	on	IN
cord-281487-x0a9qgjs	239	4	vitamin	vitamin	NN
cord-281487-x0a9qgjs	239	5	D	d	NN
cord-281487-x0a9qgjs	239	6	deficiency	deficiency	NN
cord-281487-x0a9qgjs	239	7	and	and	CC
cord-281487-x0a9qgjs	239	8	kidney	kidney	NN
cord-281487-x0a9qgjs	239	9	transplant	transplant	NN
cord-281487-x0a9qgjs	239	10	:	:	:
cord-281487-x0a9qgjs	239	11	what	what	WP
cord-281487-x0a9qgjs	239	12	's	be	VBZ
cord-281487-x0a9qgjs	239	13	new	new	JJ
cord-281487-x0a9qgjs	239	14	?	?	.
cord-281487-x0a9qgjs	240	1	Low	low	JJ
cord-281487-x0a9qgjs	240	2	vitamin	vitamin	NN
cord-281487-x0a9qgjs	240	3	D	d	NN
cord-281487-x0a9qgjs	240	4	exposure	exposure	NN
cord-281487-x0a9qgjs	240	5	is	be	VBZ
cord-281487-x0a9qgjs	240	6	associated	associate	VBN
cord-281487-x0a9qgjs	240	7	with	with	IN
cord-281487-x0a9qgjs	240	8	higher	high	JJR
cord-281487-x0a9qgjs	240	9	risk	risk	NN
cord-281487-x0a9qgjs	240	10	of	of	IN
cord-281487-x0a9qgjs	240	11	infection	infection	NN
cord-281487-x0a9qgjs	240	12	in	in	IN
cord-281487-x0a9qgjs	240	13	renal	renal	JJ
cord-281487-x0a9qgjs	240	14	transplant	transplant	NN
cord-281487-x0a9qgjs	240	15	recipients	recipient	NNS
cord-281487-x0a9qgjs	241	1	The	the	DT
cord-281487-x0a9qgjs	241	2	association	association	NN
cord-281487-x0a9qgjs	241	3	of	of	IN
cord-281487-x0a9qgjs	241	4	25-hydroxyvitamin	25-hydroxyvitamin	CD
cord-281487-x0a9qgjs	241	5	D	D	NNP
cord-281487-x0a9qgjs	241	6	levels	level	NNS
cord-281487-x0a9qgjs	241	7	with	with	IN
cord-281487-x0a9qgjs	241	8	late	late	JJ
cord-281487-x0a9qgjs	241	9	cytomegalovirus	cytomegalovirus	JJ
cord-281487-x0a9qgjs	241	10	infection	infection	NN
cord-281487-x0a9qgjs	241	11	in	in	IN
cord-281487-x0a9qgjs	241	12	kidney	kidney	NN
cord-281487-x0a9qgjs	241	13	transplant	transplant	NN
cord-281487-x0a9qgjs	241	14	recipients	recipient	NNS
cord-281487-x0a9qgjs	241	15	:	:	:
cord-281487-x0a9qgjs	241	16	the	the	DT
cord-281487-x0a9qgjs	241	17	Wisconsin	Wisconsin	NNP
cord-281487-x0a9qgjs	241	18	Allograft	Allograft	NNP
cord-281487-x0a9qgjs	241	19	Recipient	Recipient	NNP
cord-281487-x0a9qgjs	241	20	Database	Database	NNP
cord-281487-x0a9qgjs	241	21	Acute	acute	JJ
cord-281487-x0a9qgjs	241	22	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	241	23	tract	tract	NN
cord-281487-x0a9qgjs	241	24	infection	infection	NN
cord-281487-x0a9qgjs	241	25	and	and	CC
cord-281487-x0a9qgjs	241	26	25-hydroxyvitamin	25-hydroxyvitamin	CD
cord-281487-x0a9qgjs	241	27	D	d	NN
cord-281487-x0a9qgjs	241	28	concentration	concentration	NN
cord-281487-x0a9qgjs	241	29	:	:	:
cord-281487-x0a9qgjs	241	30	a	a	DT
cord-281487-x0a9qgjs	241	31	systematic	systematic	JJ
cord-281487-x0a9qgjs	241	32	review	review	NN
cord-281487-x0a9qgjs	241	33	and	and	CC
cord-281487-x0a9qgjs	241	34	meta	meta	NNP
cord-281487-x0a9qgjs	241	35	-	-	HYPH
cord-281487-x0a9qgjs	241	36	analysis	analysis	NN
cord-281487-x0a9qgjs	241	37	Vitamin	vitamin	NN
cord-281487-x0a9qgjs	241	38	D	d	NN
cord-281487-x0a9qgjs	241	39	and	and	CC
cord-281487-x0a9qgjs	241	40	critical	critical	JJ
cord-281487-x0a9qgjs	241	41	illness	illness	NN
cord-281487-x0a9qgjs	241	42	:	:	:
cord-281487-x0a9qgjs	241	43	what	what	WP
cord-281487-x0a9qgjs	241	44	endocrinology	endocrinology	NN
cord-281487-x0a9qgjs	241	45	can	can	MD
cord-281487-x0a9qgjs	241	46	learn	learn	VB
cord-281487-x0a9qgjs	241	47	from	from	IN
cord-281487-x0a9qgjs	241	48	intensive	intensive	JJ
cord-281487-x0a9qgjs	241	49	care	care	NN
cord-281487-x0a9qgjs	241	50	and	and	CC
cord-281487-x0a9qgjs	241	51	vice	vice	NN
cord-281487-x0a9qgjs	241	52	versa	versa	RB
cord-281487-x0a9qgjs	241	53	High	high	JJ
cord-281487-x0a9qgjs	241	54	dose	dose	NN
cord-281487-x0a9qgjs	241	55	vitamin	vitamin	NN
cord-281487-x0a9qgjs	241	56	D	D	NNP
cord-281487-x0a9qgjs	241	57	administration	administration	NN
cord-281487-x0a9qgjs	241	58	in	in	IN
cord-281487-x0a9qgjs	241	59	ventilated	ventilate	VBN
cord-281487-x0a9qgjs	241	60	intensive	intensive	JJ
cord-281487-x0a9qgjs	241	61	care	care	NN
cord-281487-x0a9qgjs	241	62	unit	unit	NN
cord-281487-x0a9qgjs	241	63	patients	patient	NNS
cord-281487-x0a9qgjs	241	64	:	:	:
cord-281487-x0a9qgjs	241	65	a	a	DT
cord-281487-x0a9qgjs	241	66	pilot	pilot	NN
cord-281487-x0a9qgjs	241	67	double	double	JJ
cord-281487-x0a9qgjs	241	68	blind	blind	JJ
cord-281487-x0a9qgjs	241	69	randomized	randomized	JJ
cord-281487-x0a9qgjs	241	70	controlled	control	VBN
cord-281487-x0a9qgjs	241	71	trial	trial	NN
cord-281487-x0a9qgjs	241	72	Early	early	JJ
cord-281487-x0a9qgjs	241	73	high	high	JJ
cord-281487-x0a9qgjs	241	74	-	-	HYPH
cord-281487-x0a9qgjs	241	75	dose	dose	NN
cord-281487-x0a9qgjs	241	76	vitamin	vitamin	NN
cord-281487-x0a9qgjs	241	77	D(3	d(3	NN
cord-281487-x0a9qgjs	241	78	)	)	-RRB-
cord-281487-x0a9qgjs	241	79	for	for	IN
cord-281487-x0a9qgjs	241	80	critically	critically	RB
cord-281487-x0a9qgjs	241	81	ill	ill	JJ
cord-281487-x0a9qgjs	241	82	,	,	,
cord-281487-x0a9qgjs	241	83	vitamin	vitamin	NN
cord-281487-x0a9qgjs	241	84	D	d	NN
cord-281487-x0a9qgjs	241	85	-	-	HYPH
cord-281487-x0a9qgjs	241	86	deficient	deficient	JJ
cord-281487-x0a9qgjs	241	87	patients	patient	NNS
cord-281487-x0a9qgjs	241	88	Can	Can	MD
cord-281487-x0a9qgjs	241	89	melatonin	melatonin	NN
cord-281487-x0a9qgjs	241	90	reduce	reduce	VB
cord-281487-x0a9qgjs	241	91	the	the	DT
cord-281487-x0a9qgjs	241	92	severity	severity	NN
cord-281487-x0a9qgjs	241	93	of	of	IN
cord-281487-x0a9qgjs	241	94	COVID-19	covid-19	JJ
cord-281487-x0a9qgjs	241	95	pandemic	pandemic	NN
cord-281487-x0a9qgjs	241	96	?	?	.
cord-281487-x0a9qgjs	242	1	Current	current	JJ
cord-281487-x0a9qgjs	242	2	approaches	approach	NNS
cord-281487-x0a9qgjs	242	3	in	in	IN
cord-281487-x0a9qgjs	242	4	the	the	DT
cord-281487-x0a9qgjs	242	5	grading	grading	NN
cord-281487-x0a9qgjs	242	6	and	and	CC
cord-281487-x0a9qgjs	242	7	management	management	NN
cord-281487-x0a9qgjs	242	8	of	of	IN
cord-281487-x0a9qgjs	242	9	cytokine	cytokine	NN
cord-281487-x0a9qgjs	242	10	release	release	NN
cord-281487-x0a9qgjs	242	11	syndrome	syndrome	NN
cord-281487-x0a9qgjs	242	12	after	after	IN
cord-281487-x0a9qgjs	242	13	chimeric	chimeric	JJ
cord-281487-x0a9qgjs	242	14	antigen	antigen	NN
cord-281487-x0a9qgjs	242	15	receptor	receptor	NN
cord-281487-x0a9qgjs	242	16	T	t	NN
cord-281487-x0a9qgjs	242	17	-	-	HYPH
cord-281487-x0a9qgjs	242	18	cell	cell	NN
cord-281487-x0a9qgjs	242	19	therapy	therapy	NN
cord-281487-x0a9qgjs	242	20	Disruption	disruption	NN
cord-281487-x0a9qgjs	242	21	of	of	IN
cord-281487-x0a9qgjs	242	22	a	a	DT
cord-281487-x0a9qgjs	242	23	self	self	NN
cord-281487-x0a9qgjs	242	24	-	-	HYPH
cord-281487-x0a9qgjs	242	25	amplifying	amplify	VBG
cord-281487-x0a9qgjs	242	26	catecholamine	catecholamine	NN
cord-281487-x0a9qgjs	242	27	loop	loop	NN
cord-281487-x0a9qgjs	242	28	reduces	reduce	VBZ
cord-281487-x0a9qgjs	242	29	cytokine	cytokine	NN
cord-281487-x0a9qgjs	242	30	release	release	NN
cord-281487-x0a9qgjs	242	31	syndrome	syndrome	NN
cord-281487-x0a9qgjs	242	32	Alpha-1	alpha-1	JJ
cord-281487-x0a9qgjs	242	33	adrenergic	adrenergic	JJ
cord-281487-x0a9qgjs	242	34	receptor	receptor	NN
cord-281487-x0a9qgjs	242	35	antagonists	antagonist	NNS
cord-281487-x0a9qgjs	242	36	for	for	IN
cord-281487-x0a9qgjs	242	37	preventing	prevent	VBG
cord-281487-x0a9qgjs	242	38	acute	acute	JJ
cord-281487-x0a9qgjs	242	39	respiratory	respiratory	JJ
cord-281487-x0a9qgjs	242	40	distress	distress	NN
cord-281487-x0a9qgjs	242	41	syndrome	syndrome	NN
cord-281487-x0a9qgjs	242	42	and	and	CC
cord-281487-x0a9qgjs	242	43	death	death	NN
cord-281487-x0a9qgjs	242	44	from	from	IN
cord-281487-x0a9qgjs	242	45	cytokine	cytokine	JJ
cord-281487-x0a9qgjs	242	46	storm	storm	NN
cord-281487-x0a9qgjs	242	47	syndrome	syndrome	NN
cord-281487-x0a9qgjs	242	48	Preventing	prevent	VBG
cord-281487-x0a9qgjs	242	49	cytokine	cytokine	NN
cord-281487-x0a9qgjs	242	50	storm	storm	NN
cord-281487-x0a9qgjs	242	51	syndrome	syndrome	NN
cord-281487-x0a9qgjs	242	52	in	in	IN
cord-281487-x0a9qgjs	242	53	COVID-19	COVID-19	NNP
cord-281487-x0a9qgjs	242	54	using	use	VBG
cord-281487-x0a9qgjs	242	55	α-1	α-1	JJ
cord-281487-x0a9qgjs	242	56	adrenergic	adrenergic	JJ
cord-281487-x0a9qgjs	242	57	receptor	receptor	NN
cord-281487-x0a9qgjs	242	58	antagonists	antagonist	NNS
cord-281487-x0a9qgjs	242	59	Publisher	Publisher	NNP
cord-281487-x0a9qgjs	242	60	's	's	POS
cord-281487-x0a9qgjs	242	61	Note	Note	NNP
cord-281487-x0a9qgjs	242	62	Springer	Springer	NNP
cord-281487-x0a9qgjs	242	63	Nature	Nature	NNP
cord-281487-x0a9qgjs	242	64	remains	remain	VBZ
cord-281487-x0a9qgjs	242	65	neutral	neutral	JJ
cord-281487-x0a9qgjs	242	66	with	with	IN
cord-281487-x0a9qgjs	242	67	regard	regard	NN
cord-281487-x0a9qgjs	242	68	to	to	IN
cord-281487-x0a9qgjs	242	69	jurisdictional	jurisdictional	JJ
cord-281487-x0a9qgjs	242	70	claims	claim	NNS
cord-281487-x0a9qgjs	242	71	in	in	IN
cord-281487-x0a9qgjs	242	72	published	publish	VBN
cord-281487-x0a9qgjs	242	73	maps	map	NNS
cord-281487-x0a9qgjs	242	74	and	and	CC
cord-281487-x0a9qgjs	242	75	institutional	institutional	JJ
cord-281487-x0a9qgjs	242	76	affiliations	affiliation	NNS
cord-281487-x0a9qgjs	242	77	Conflict	conflict	NN
cord-281487-x0a9qgjs	242	78	of	of	IN
cord-281487-x0a9qgjs	242	79	Interest	interest	NN
cord-281487-x0a9qgjs	243	1	The	the	DT
cord-281487-x0a9qgjs	243	2	authors	author	NNS
cord-281487-x0a9qgjs	243	3	declare	declare	VBP
cord-281487-x0a9qgjs	243	4	that	that	IN
cord-281487-x0a9qgjs	243	5	they	-PRON-	PRP
cord-281487-x0a9qgjs	243	6	have	have	VBP
cord-281487-x0a9qgjs	243	7	no	no	DT
cord-281487-x0a9qgjs	243	8	conflict	conflict	NN
cord-281487-x0a9qgjs	243	9	of	of	IN
cord-281487-x0a9qgjs	243	10	interest	interest	NN
cord-281487-x0a9qgjs	243	11	.	.	.